C0445117;Neoplasm present
C0445115;reception
C0002716;Disease
C0002712;Amylases
C3893296;TRAIL receptor activity
C1518466;Xenograft procedure
C0446455;Macrophage Activation Syndrome
C0965941;indopan
C4280020;Synthetic Lethality
C0002707;Disease
C0230415;Respiratory Diaphragm
C0423791;Patients
C0196878;Pain management
C1327728;Hysterectomy
C0184898;Stenosis of rectum
C0184893;Immunocompromised Host
C0184894;Patients
C0184899;Retroperitoneal Space
C2353893;golimumab
C1999167;matrix Gla protein
C4519250;FLT1 protein human
C0446432;Progressive Neoplastic Disease
C3158055;Cell Line Tumor
C0446430;Spinal Cord
C0446434;X-Ray Computed Tomography
C0458417;Thickened
C0953947;FRAP1 protein human
C1327709;METTL3 gene
C4522891;AKAP12 gene
C1518478;Nutraceuticals
C1292570;Community
C0279702;Multiple tumors
C0854178;Adrenal Gland Neoplasms
C2700604;Hypertensive disease
C2700603;Apoptosis
C0243769;Enzymes
C1446298;Macrophage Activation Syndrome
C0182209;Perforator
C0267716;Hernia
C2063389;Neoplasms
C1302401;Perianal Paget's disease
C0242422;Consultation
C0242428;Adult
C4231054;Hypoglossal nerve structure
C2930967;Patients
C4054987;Patients
C0230425;Infantile Neuroaxonal Dystrophy
C1999123;Endoscopy (procedure)
C0854193;RAB8A protein human
C0183518;Implantation procedure
C0183516;Indomethacin
C1517194;Family history
C0879468;regorafenib
C0423772;Cutaneous Fistula
C0496779;Adult
C0518609;Child
C0950008;garcinone E
C0242402;Pain Postoperative
C1568724;Inflammatory Bowel Diseases
C1292533;PEBP1 gene
C0520917;Increased metabolic requirement
C0158570;Hereditary hemorrhagic telangiectasia
C1844666;TIGIT gene
C0302617;Uncertainty
C4042939;rectal function
C0063717;Interleukin 6 Receptor
C4042946;Persons
C4283936;Radiotherapy Conformal
C0184821;Retrospective audit
C4042940;Colorectal Carcinoma
C4510867;CD69 protein human
C2077983;intestinal type Gastric Adenocarcinoma
C0700903;RAC-Alpha Serine/Threonine Kinase
C0761993;Gene Expression
C1422291;12-dilinolenoyl-3-(4-aminobutyryl)propane-123-triol
C1159705;lipid storage
C0147866;claudin 4
C1832661;Relative (related person)
C0206711;Assessment information
C0303928;Apoptosis
C1159731;nucleoside transport
C0457151;Structure of iliac artery
C0206701;Patients
C0879427;AKR1A1 wt Allele
C0206702;Obstruction of colon
C4054953;Cytoreductive Surgery
C0146550;trefoil factor
C0854142;capecitabine
C1844696;Neoplasms
C0544910;Immunohistochemistry
C0302600;treatment failure
C0206704;Carcinoma Large Cell
C0387539;Malignant tumor of colon
C0842176;Metachronous Malignant Neoplasm
C0206708;Woman
C0856757;dilated veins
C0206732;Immunohistochemistry
C0205400;abdomen scan
C0036098;Adenoid Cystic Carcinoma
C0387583;Endoplasmic Reticulum Stress
C0505385;Macrophage Activation Syndrome
C0529351;darifenacin
C0206733;Strawberry nevus of skin
C0940617;Woman
C0399565;fdg pet
C1518424;Ethnic group
C0074414;sevoflurane
C0457138;Lesion
C1519751;Post-Translational Protein Processing
C3809991;Genes
C0446498;Abdominal mass
C0446497;Discharge body substance
C0036087;MSH6 gene
C0206725;bevacizumab
C0206724;Sex Cord-Stromal Tumor
C0446495;Macrophage Activation Syndrome
C1519748;Ubiquitin-Proteasomal Pathway
C0206727;Neurilemmoma
C0206728;Rectum
C0903677;GEN1 gene
C0529334;Keratin-19
C0036078;Adverse reactions
C0206754;Peritonitis
C0854119;Ultrasonography
C0206755;Mass Spectrometry
C0086418;GPR35 protein human
C0529338;Neoplastic Cell Transformation
C0446461;lymph nodes
C0206750;Patients
C4280018;Sessile Serrated Adenoma/Polyp
C4509816;Neoplasms
C1423592;Catabolism
C1423599;Patients
C2699119;Complication
C2111525;Patients
C1423594;Colorectal Cancer
C1518440;Endothelial Cells
C0206743;Child
C0940607;Ileocolic intussusception
C0206745;Mice Knockout
C0061126;Malignant Neoplasms
C0520990;Host defense
C0086409;Ethnic group
C1422277;Body tissue
C0024091;Neoplasms
C4255069;Neoplastic Cell Transformation
C0458452;Carcinoma Signet Ring Cell
C0771377;Transplantation Autologous
C0458450;Prostatic Urethra
C0085101;Immunotherapy
C0388911;Vascular Endothelial Growth Factor C
C0085104;research center
C0338656;Trinitrobenzenesulfonic Acid
C1412886;HCT116 Cells
C0074455;Agent
C0301363;Assay
C0000097;Parkinson Disease
C3544385;TNF-related apoptosis-inducing ligand
C3544383;cell cycle phase transition
C0796679;Irinotecan-Eluting Beads
C0036043;Process
C1423546;Adenocarcinoma
C0012091;Intercellular adhesion molecule 1
C1412893;Cultured Cell Line
C2711393;Patients
C0024075;Laboratory Procedures
C1159668;iron transport
C0074445;shellac
C0074447;Lectin
C1653876;Sergio
C1422212;Adenocarcinoma
C1424876;EXOSC1 gene
C1423541;Malignant Neoplasms
C0012066;Protoplasm
C2699153;LINC00460 gene
C0036037;Plexus
C0037369;Cancer Survivors
C0504075;Present
C0013395;Pancreatic duct
C1423559;Colorectal Carcinoma
C0037366;H19 gene
C0504074;Anus
C0013390;Woman
C1158366;Helper-Inducer T-Lymphocyte
C0024045;Low-Income Population
C1424887;NEGR1 gene
C1424881;Neoplasms
C0085110;Severe Combined Immunodeficiency
C0807878;premalignant lesion
C0085112;SCID Mice
C0085113;CD69 protein human
C0085114;High Density Lipoprotein Cholesterol
C0314657;Genetic Predisposition to Disease
C0085115;CD4/CD8 ratio procedure
C0086447;Neuroendocrine carcinoma metastatic
C1422239;EZH2 protein human
C0036025;Mutation
C1171322;tissue homeostasis
C0542339;Clone Cells
C0074460;Zingiber officinale
C0265034;Patients
C0348000;Stenosis of rectum
C0049330;HCT116 Cells
C0073138;Growth
C0796693;Pelvis
C1422236;Tumor cells malignant
C0024050;Child
C0348002;Urinary Diversion
C2735310;Patients
C0280661;Clinical Trials
C0279671;Patients
C0085148;Gastrointestinal Hemorrhage
C0085149;Ulcer
C0279672;Brachytherapy
C1882857;Rat Small Intestine
C1412849;Neoplastic Cell Transformation
C0025353;World
C0026682;Glycoconjugates
C0026683;Mucocele
C0026684;Patients
C0001383;Transcription Genetic
C3820394;Malignant Neoplasms
C0278348;Antibodies
C0348015;Neoplasms
C1423506;Paraneoplastic Encephalomyelitis
C0040982;Tissue Adhesions
C0038661;general population
C1882848;Rat Sarcoma
C0279682;Patients
C0085136;Angiomatous Meningioma
C0036002;Liver Cirrhosis
C0399619;Adenoma
C1424835;Adenocarcinoma
C0327949;Salmo salar
C0279680;Voltage-Dependent Anion Channels
C1844596;Stiffness
C0040987;Patients
C0074480;sialosyl-Tn antigen
C1160609;extracellular matrix organization
C0001374;Acyl Coenzyme A
C0024031;Patients
C1412856;BVES gene
C0026691;Mucocutaneous Lymph Node Syndrome
C1268905;Patients
C0348024;Hypothyroidism
C1424849;Body tissue
C0085167;Ultrasound guided biopsy
C0039987;Secondary Neoplasm
C0556991;Fuel
C0039985;Coughing
C1325174;HCT116 Cells
C0314621;Hypermethylation
C0049308;5-Methylcytosine
C0337383;Local excision
C0027996;Niacin
C0110611;Stiffness
C0110613;Carcinogenesis
C1519810;Ovarian Carcinoma
C0026661;RNA Recognition Motif
C0314627;Stem cells
C0086492;J-Pouch
C0085162;Jaundice Obstructive
C0014695;Stage III Colon Cancer
C0085155;oxaliplatin
C1423524;Patients
C0278372;Functional assessment
C0542378;Patients
C0073177;AKT Signaling Pathway
C1424852;Carcinogenesis
C0037317;Symptoms
C0037316;Sleep Deprivation
C0001390;Colorectal Carcinoma
C0123931;Cholangiocarcinoma
C0013369;Anti-Bacterial Agents
C0013331;Dutch Population
C0085187;telomere
C0085188;Secondary Neoplasm
C0012002;Ovarian Carcinoma
C0040952;Pharmaceutical Preparations
C0278302;Patients
C0339901;Acute respiratory infections
C0037303;Osteoporosis circumscripta
C0014661;Patients
C0037301;Extravasation
C0026649;Actins
C0040958;huperzine B
C0242350;Implants
C0001347;Acute-Phase Proteins
C0242354;Malignant tumor of colon
C0242358;Cells
C1412804;Cohort
C0279639;Nodule
C0278307;Anorectal Diseases
C0038636;AKR1A1 wt Allele
C1709246;SATB2 gene
C0085183;Persons
C0279637;Malignant neoplasm of anus
C0085185;Isolation procedure
C0748877;Support System
C0280630;Turcot syndrome (disorder)
C0085177;Eukaryotic Cells
C0013343;Chromoendoscopy
C0496675;Evaluation
C0001339;formononetin
C0723595;Male population group
C0241028;Male population group
C0073194;Acids
C0040942;Colorectal Neoplasms
C0003999;Malignant neoplasm of stomach
C0003997;Severe (severity modifier)
C0026652;Cancer-related fatigue
C0025320;Woman
C0003995;Antileukemic Agent
C0026654;Vascular Diseases
C0003993;Tumor cells malignant
C1412812;Carcinogenesis
C0242349;Proliferating Cell Nuclear Antigen
C0085174;Misoprostol
C0039959;Thiouridine
C1281905;Obesity
C0281974;Neoplasms
C0279652;Inflammation
C0664702;Membrane
C0963236;Tumor cells malignant
C3892027;Cultured Cell Line
C0748864;Appendix
C0279654;Male population group
C1710263;Swedish
C0279651;Anabolism
C1337111;Hemorrhage
C0748861;Complete atrioventricular block
C0027950;TAE226
C0001363;Carcinoma Transitional Cell
C0002690;cancer recurrence
C0242339;Mice Obese
C1412821;Drug resistance
C0039947;FOXM1 gene
C3894683;ALOX12 wt Allele
C0038615;Pharmaceutical Preparations
C0278329;Infantile Neuroaxonal Dystrophy
C0014644;Patients
C0940598;Pedunculated colonic polyp
C0085198;Reconstructive Surgical Procedures
C0279663;Nicotinamide N-Methyltransferase
C0015982;Fibrin
C1337105;HPR gene
C0014653;Cohort
C0026639;Carcinoma
C0267613;Disorder of appendix
C0267614;Chronic appendicitis
C0026636;Inflammatory disease of mucous membrane
C0002688;Chemoradiotherapy
C1293946;aminosalicylic acid
C0244989;Protein-Serine-Threonine Kinases
C0002680;HT29 Cells
C3641653;Health care facility
C1424810;Malignant Neoplasms
C0217396;Patients
C1337108;MAP3K8 gene
C0015950;Colorectal Carcinoma
C0242390;Gastroenteritis
C0242391;LGALS9 protein human
C4545644;Secondary Neoplasm
C0026605;Patients
C0242392;Gallic acid
C0003968;colon growth
C4545645;Neoplasm Metastasis
C0001304;Perianal
C0003964;Cell-Free DNA
C0003962;Long Term Survivorship
C0039925;Thiopental
C1700874;Metastatic Renal Cell Cancer
C0014628;soluble
C0194261;Pharmacotherapy
C1171347;Carcinoma of anal margin
C0013301;Multiple ulcers
C1171346;Candidate Disease Gene
C1327760;Cell Count
C0242382;Patients
C0963281;Apoptosis
C0027944;Chronic disease
C0242387;Polyp of large intestine
C0040900;Dysplasia
C0242388;Multiple symptoms
C0734203;Bacteria
C3472245;angiogram
C0376900;Colorectal Carcinoma
C0279606;Middle Aged
C1254351;ulvan
C0015965;Sacrococcygeal teratoma
C0013303;Single lesion
C0015967;Human cells
C1709218;tumor growth
C0253023;Toxic effect
C0230388;Medical Devices
C0577059;Patients
C0280604;Patients
C0241039;Woman
C0577053;X-Ray Computed Tomography
C0003988;Asian Americans
C0242379;Community
C1554184;Dual
C0267663;Patients
C0014609;Spectrum Analysis
C0015936;Seizures
C0170270;amphiphysin
C0015934;Colitis
C0255672;Homo sapiens
C1255664;Diagnostic radiologic examination
C0280617;Neurologic Symptoms
C1171362;mitochondria-nucleus signaling pathway
C1302461;Patients
C0242363;Von Hippel-Lindau Syndrome
C0001314;Interventional procedure
C4519167;Overall Response
C0279628;Barrett Esophagus
C0279626;Esophageal Neoplasms
C0015944;Cohort
C0193011;Anorectal manometry
C1519680;Lactobacillus rhamnosus GG
C0687568;Stenosis
C0374190;Operation on rectum
C0193014;Patients
C0228207;Metastatic malignant neoplasm to brain
C0879393;Sebaceous Adenocarcinoma
C0193017;Incision of rectum
C0699540;melanoma
C1519678;Tumor Expansion
C0015914;Fertilization
C1518345;tomography
C1518340;No Evidence of Disease
C1519670;CD276 gene
C0003918;research center
C0027908;CNS - Brain (MMHCC)
C0205558;False Negative
C1280660;Nodular lesions
C0473935;Accumulation
C0027902;Neuropsychological Tests
C1519665;Tumor-Associated Process
C1519666;Solid Neoplasm
C0255813;soluble
C1521980;ERICD gene
C0448967;ileum
C0280803;Reactive Oxygen Species
C1326500;Leukocyte Trafficking
C0399468;Oral sinus
C1001184;sphingosine 1-phosphate
C1819716;Genome Mitochondrial
C1519697;Mice Nude
C1517033;Secondary malignant neoplasm of bone
C1519692;TNF-related apoptosis-inducing ligand
C0939537;imatinib
C4305988;IGF2BP3 wt Allele
C0229526;Neuroendocrine Tumors
C0915585;Epidermal Growth Factor Receptor
C3282903;treatment options
C0879389;general population
C0879391;Lower Extremity
C0879390;Mismatch Repair
C1519687;Tumor Oxygenation
C0940520;Rectum
C4330937;Colonic polypectomy
C0447612;Thickened
C4507372;metastatic colorectal cancer
C0168014;mitogen-activated protein kinase p38
C0267841;Woman
C0184980;Colorectal Low Grade Intraepithelial Neoplasia
C0051816;Alkaloids
C1293950;Colorectal Carcinoma
C1517052;Secondary Neoplasm
C0267831;Neoplasm Metastasis
C0267830;Liver Abscess
C0051821;Diarrhea
C2939419;Mice Nude
C0184979;Intestinal Obstruction
C0422322;colonoscopy
C3486709;Neoplastic Cell Transformation
C0051844;Chronic colitis
C0472699;Patients
C0062505;Chondroitin Sulfates
C0062503;Heparitin Sulfate
C0158644;Congenital anomaly of lung
C1843463;Patients
C0099808;7-ethyl-10-hydroxycamptothecin
C1506307;Pharmaceutical Preparations
C0184918;Colorectal Cancer pT1 TNM Finding v6 and v7
C3665675;Acclimatization
C0445054;Patients
C0062529;Neoplastic Cell Transformation
C1519614;Cancer Research Group
C0184921;Inguinal lymph node group
C0184922;Cyst
C0184924;Dermatologist
C0061202;KCNK9 gene
C0184908;Slow transit constipation
C0062534;cytokine
C0061200;colon growth
C0337196;Organ
C1519606;Transgenic Model
C0184913;Extraction
C1446338;Patients
C0184904;Adenoma
C1519630;Symptoms
C1423699;Tumor tissue sample
C0796520;ETV6 gene
C0422389;Patients
C3266069;Patients
C0037299;Pyoderma Gangrenosum
C0061223;Asthma
C4283853;C4A wt Allele
C3254086;CYP19A1 protein human
C0037293;Skin tag
C1519628;Molecular Transport
C0075857;Mus
C0940500;Cell Count
C0457021;Urinary Incontinence
C0459683;Abdominal stoma
C0074529;Immune response
C0037285;Skin Manifestations
C1148916;nucleotide binding
C0037286;Patients
C4283882;Mutation
C0085203;Metastatic malignant neoplasm to brain
C0217529;Cell Proliferation
C0817096;Sebaceous Adenocarcinoma
C0037284;ruxolitinib
C1422382;TP53 gene
C0217525;Non-alcoholic Fatty Liver Disease
C2037144;Patients
C1999091;Cardiac Status
C0037274;Pyoderma Gangrenosum
C1148926;adenosinetriphosphatase activity
C0037278;Communicable Diseases
C0447687;Infiltration
C1148923;CD274 protein human
C3810883;Neoplastic Cell Transformation
C0086528;Ethnic group
C1422390;Mutation
C0870935;Ulcerative Colitis
C0217511;Lysis
C1422393;Negative Regulation of G2 Phase
C1446340;removal technique
C1446348;Postoperative stricture
C0013298;Lamina Propria
C0062585;Rattus norvegicus
C0085221;Right inguinal region
C0085222;Inguinal part of abdomen
C0554478;Patients
C0013294;Neoplasm of ampulla of Vater
C0013295;Duodenal Ulcer
C2975148;Animal Model
C0085228;Tumor tissue sample
C0013291;Stomach
C0013292;Duodenal Obstruction
C0013293;Pancreatic Neoplasm
C0073240;DICER1 protein human
C1880359;Opioids
C0025274;Menarche
C3641722;VIPR2 gene
C2987127;Malignant Neoplasms
C2963158;Patients
C2987128;Neoplasms
C0796563;geriatric patients
C0049241;5-hydroxymethylcytosine
C3544265;Patients
C0025270;SIAH2 gene
C2987120;Oncogenes
C3544266;occult malignancy
C0038585;Substance P
C0577100;Patients
C0086543;Cataract
C1422336;neoplasm regression
C1424999;Rectosigmoid Carcinoma
C1122259;Gene Silencing
C0085216;Mus
C1098186;ferroptosis
C0819757;Oncogenes
C0025286;Angiomatous Meningioma
C0301258;UBXN2A gene
C0542476;Patients
C0302583;Protoplasm
C0074565;Singlet Oxygen
C0025289;Patients
C1879358;Primary malignant neoplasm of endometrium
C1171217;Cohort
C0061275;colon growth
C0085243;Mice Inbred NOD
C0086574;TNFRSF25 gene
C0529494;Proto-Oncogene Proteins c-akt
C0038577;Organoids
C0085249;Chronic Obstructive Airway Disease
C0025252;Extracellular
C0025251;Tumor cells malignant
C0025255;Neuropilin-2
C3544285;Toxic effect
C0339897;Liver and Intrahepatic Biliary Tract Carcinoma
C0577123;Abdominal skin scar
C0038563;CD69 protein human
C0013289;Woman
C0037231;Imbalance
C0086565;Patients
C0963182;Tankyrase
C0025268;Hirschsprung Disease
C0025267;Gastrinoma
C0025266;ECE1 gene
C0025260;Mus
C1446301;Liver neoplasms
C0280785;Diffuse Astrocytoma
C0037221;Congenital Abnormality
C0086597;Mediate
C0014582;Cell Death
C2711227;gene therapy
C1424945;Squamous cell carcinoma of esophagus
C3146221;Juvenile
C0027895;vasoactive intestinal peptide
C0073287;LAMP3 Gene
C0001261;Opportunistic Infections
C0025234;fluvastatin
C0027893;Pancreatic Polypeptide
C0001263;Patients
C1879327;shogaol
C0014597;Peptidoglycan
C0040861;Genetic Counseling
C0085255;Left colon
C0014599;Epithelial hyperplasia
C1700929;Carcinoid tumor of rectum
C1700928;Carcinoid tumor of rectum
C0037215;Wnt Signaling Pathway
C0278474;IMPACT gene
C1880301;Malignant Neoplasms
C0014591;Symptoms
C0025248;Membrane Glycoproteins
C0745041;Patients
C3496194;PRSS8 protein human
C0001250;Chronic infectious disease
C2987172;Prolow-Density Lipoprotein Receptor-Related Protein 1
C0278479;removal technique
C3484182;Photochemotherapy
C0086582;contextual factors
C0015895;Fertility
C0014563;Muscle Cells
C1424969;ABT 263
C0278488;Small bowel obstruction
C0013230;Transformation function
C0278485;Patients
C0278484;Mus
C1412984;apatinib
C0278480;DNA
C0303848;Allium sativum
C0026549;Microbiome
C0025219;wogonin
C0001288;Paroxysmal nocturnal dyspnea
C0025213;Cytoplasm
C1879344;Biliary papillomatosis
C0039869;Patients
C0278498;Supportive care
C0278499;Chemoradiotherapy
C0085279;Patients
C1424977;Signal Transduction
C1424976;Neoplasms
C0278493;Patients
C4087082;Mus
C1325288;cell cycle regulator
C0026559;Morphogenesis
C0040845;apoptosis signaling
C1159527;glucose uptake
C0073299;Ubiquitin
C1882982;Gastroenterologist
C1412999;Carcinogens
C0001271;Fusiform cell
C0027882;Calcitonin Gene-Related Peptide
C0025222;Non-Small Cell Lung Carcinoma
C0027883;Peripheral
C1424972;CYSLTR1 gene
C0038527;Hernia
C1423644;Malignant neoplasm of lung
C0107103;Growth Factor
C0085272;Alzheimer's Disease
C0039840;Leukoencephalopathies
C0400966;End Stage Liver Disease
C0242473;Anus Prolapse
C0027858;Patients
C1530072;Antidepressive Agents
C0027853;Paresis
C1412925;Epithelial Cells
C0039848;Colon structure (body structure)
C0013218;advanced disease
C0013216;Paralysed
C0015879;Body tissue
C1517092;aggressive cancer
C1412930;Germ Line
C0266427;Neoplastic Cell Transformation
C0040822;Tremor
C0025209;Detection
C0003873;Immune System Diseases
C0267750;Patients
C0025202;Large Cell Lung Neuroendocrine Carcinoma
C0025201;Histones
C3472164;Patients
C0085292;Pruritus
C0325285;Damaliscus lunatus
C0085295;TYROBP gene
C0013227;STIL wt Allele
C0014559;Colorectal Carcinoma
C0193083;Renal mass
C0014520;Perianal Paget's disease
C1424925;Iodides
C0229473;Mixed carcinoma
C0015852;Glycolysis
C2183253;Diagnostic radiologic examination
C1708063;Did not receive therapy or drug for
C1412940;Antibodies Anti-Idiotypic
C0001246;Intestines
C1424929;Genes
C0027836;Site
C0027830;Benign Neoplasm
C0027831;Gastrinoma
C0027832;Neurilemmoma
C0040808;pemetrexed
C0002570;CEL gene
C3895894;epithelial cell apoptotic process
C3845593;Major change
C0040809;Patients
C0193072;Anorectal adenocarcinoma
C0747646;Patients
C0193064;Partial proctectomy
C0014533;Adipose tissue sample
C0194396;Patients
C1424933;LRIG1 gene
C0746319;Patient observation
C0001239;Dynamics
C0027849;Rattus norvegicus
C0267732;Hiatal hernia with obstruction but no gangrene
C0242444;Population at Risk
C0001231;Cushing Syndrome
C1412958;polyp benign
C0002563;Combined Modality Therapy
C0181089;Catheter guide wire device
C1424930;Genes
C0013203;Persons
C0193062;polyp benign
C0193063;Woman
C0253166;Mammals
C0027819;Brain Neoplasms
C0637261;Uptake
C0003847;Structure of arteriole
C0003842;Injury of liver
C3641766;Patients
C3257924;Extraction
C0193050;Patients
C0578477;Patients
C0014511;Neoplasms
C0400936;Patients
C4087029;Nitroglycerin/Sodium Citrate/Ethanol Solution
C0267792;Hepatitis B
C0014518;Laparoscopic Colectomy
C0015846;Fentanyl
C0001206;Growth Hormone
C1710348;colorectal Diseases
C0265126;Pathologic Neovascularization
C0003862;Arthralgia
C0302592;Applicator - device
C0278403;Mice Nude
C0027809;Benign Neoplasm
C0228194;Brain Neoplasms
C0002527;Amino Acids Sulfur
C0002525;Methionine
C0027803;Extracellular
C0002520;Sugars
C0325223;Elaphodus cephalophus
C0242488;PTK2 gene
C0002521;Malignant tumor of colon
C0003850;Community
C0267771;abdomen scan
C0424909;Family
C0301271;Apoptosis
C0267925;Stenosis of bile duct
C0915452;Chinese herbs
C0677881;Patients
C0267926;Postoperative biliary stricture
C0003805;Malignant tumor of colon
C3640077;Anastomosis of rectum
C0677886;geriatric patients
C0267922;Patients
C1721094;DNA Cleavage
C0242632;T-helper cell type 1
C0242633;TIGIT gene
C0242638;Validation
C0254610;Immune Cell
C0419073;Colonic Neoplasms
C0230653;Protein Component
C1282966;Male population group
C1521895;Patients
C1266002;Lung
C0677874;Clinical Complete Response
C0229664;CA-19-9 Antigen
C1266005;Basaloid squamous cell carcinoma
C0879290;Sebaceous Adenocarcinoma
C1328819;PFKFB3 gene
C1519544;Toll-Like Receptor Pathway
C1817201;tissue maintenance
C0242629;DDX58 protein human
C1135918;Colon structure (body structure)
C0879259;Splenomegaly
C0193114;Assay
C0230625;cell process structure
C0677861;Bilateral Malignant Neoplasm
C0677862;Partial Resection
C1293659;Very high
C0242610;Reading Frames (Nucleotide Sequence)
C1518248;Malignant neoplasm of pancreas
C1518245;Primary Carcinoma
C1520537;13q
C0278601;Mastectomy
C0419095;Secondary malignant neoplasm of bone
C0205695;Cohort
C0205698;Intussusception
C0205697;Rectum
C0205699;disorder control (procedure)
C0003818;Malignant neoplasm of gastrointestinal tract
C0229649;Mammary gland
C0677850;Early-Stage Breast Carcinoma
C4508356;TANC1 gene
C0003811;Cardiac Arrhythmia
C1229075;Intestinal Microbiome
C1568520;anlotinib
C1868801;Appendiceal mucinous neoplasm
C0242606;Mice Nude
C0242608;FILIP1L gene
C1518271;Malignant neoplasm of gastrointestinal tract
C0194422;Removal of bladder catheter
C0156149;Emergency procedure
C0265308;Rattus norvegicus
C4318939;Nasal Swab (procedure)
C3256797;tumor growth
C1422084;CYP1B1 protein human
C0132172;diacetyldichlorofluorescein
C0156147;Cohort
C1519595;Nucleotides
C2111394;Patients
C0203057;Obstruction
C0194412;Prostatectomy
C2111393;Patients
C0240016;Patients
C1266043;Carcinoma
C3280437;Neoplasms
C1422091;CUL7 gene
C1721048;Non-infective diarrhea
C0229671;Aspartate
C0230664;bile acid metabolism
C0194401;Mean score
C0870883;Organic Cation Transporter
C0675239;Thyroid carcinoma
C0241311;chlorodihydroxypyridine/potassium oxonate/tegafur
C0267941;Malignant Neoplasms
C0242656;Persons
C3640014;Patients
C0253307;Enzymes
C0051959;Agent
C0664589;Pharmaceutical Preparations
C3266123;Melanosis coli
C1266024;Flat adenoma
C1266025;Persons
C0677898;Persons
C0242643;P-Glycoprotein
C0242647;Lymphoma
C0156156;Patients
C1518275;Low Grade Malignant Neoplasm
C1266090;Sigmoid colon
C1436698;BAMBI protein human
C1880510;Hereditary Leiomyomatosis and Renal Cell Cancer
C0544702;Papilla
C0301521;Tumor cells uncertain whether benign or malignant
C1134659;Angiogenesis Inhibitors
C1422040;Reperfusion Injury
C0182400;Participant
C1879526;Colonic epithelium
C0456086;Patients
C1135993;Wasting Disease Chronic
C0062638;EIF4EBP1 protein human
C3280470;Colonic epithelium
C2699348;Clinical Study Reports and Related Information
C0302837;Chronic disease
C1266074;Intraductal papillary-mucinous carcinoma invasive
C2457024;CT of abdomen
C4511939;Crohn Disease
C0073302;WTAP gene
C0050668;activin A
C1855575;Intussusception
C1422064;DNA Repair
C3749582;Vestigium
C4255259;Total mesorectal excision
C4053869;Viral Breakthrough
C0063984;CXCR4 gene
C0059003;necroptotic process
C1422073;Severe Acute Respiratory Syndrome
C1422070;Immune
C0456070;Growth delay
C1855585;Patients
C0205643;lymph nodes
C0205642;Neoplasms
C0205645;Surgical margins
C2698046;Azadirachta indica flower extract
C0543419;Pelvic Neoplasms
C0543414;Colorectal Carcinoma
C1519516;MRC1 wt Allele
C1422002;Has difficulty doing (qualifier value)
C0073328;colon growth
C1424662;Cancer-Associated Fibroblasts
C0059020;Cell Proliferation
C0857836;Colorectal Carcinoma
C0037179;Tumor cells malignant
C0230613;Zonula Adherens
C1842211;Diverticulitis
C1412697;Mutation
C4511908;Carcinogenesis
C0302821;Colon structure (body structure)
C3665346;Disease
C0398480;Enthesitis-Related Arthritis
C0037167;Clone Cells
C0038495;Students Medical
C0203005;Liver diseases
C0061355;Hormones
C0013194;Cohort
C1881824;Polymerase Chain Reaction
C0544726;Patients
C0038492;student
C1881821;Patients
C0399785;Adenoma Villous
C0073343;Colorectal Carcinoma
C1134631;Participant
C0243902;tumor growth
C0205653;Polyp of large intestine
C1881814;First line treatment
C0085313;Pharmacotherapy
C0796419;Laboratory Procedures
C3666697;polyphenols
C1134640;Male population group
C0085319;Cryptosporidium parvum
C0544711;Detection
C0025186;Mitosis
C0870811;Life Style
C1435338;Mutation
C0870810;Crohn Disease
C1519524;TFF1 protein human
C1519522;Tissue Microarray
C1422035;Non-Small Cell Lung Carcinoma
C1519523;Tissue Model
C1519521;Detection
C0870816;Ethnic group
C0038476;Malignant Neoplasms
C1425959;Cell Proliferation
C0038478;Struma Ovarii
C0399805;Carcinoma Transitional Cell
C0134835;P-Selectin
C0337561;Granddaughter
C0001187;Abnormality of mitochondrial metabolism
C0025153;Cytopathic effect
C1412647;Hypersensitivity
C0001186;Acridines
C0001185;Acridine Orange
C0554118;Patients
C0086661;Ubiquitination
C0312255;Proteobacteria
C0337576;Aunt
C0037135;Phosphotransferases
C0963088;Intestines
C0013182;Pharmacotherapy
C1412653;ATP5B gene
C0567439;Disease
C0001175;Sexually Transmitted Diseases
C0544771;Ulcer solitary
C0072027;Colorectal Carcinoma
C0026492;Gastrointestinal Diseases
C0038454;general population
C0014485;procyanidin
C0037125;complex (molecular entity)
C0544769;Patients
C0027796;Pharmaceutical Preparations
C0423909;Memory Long-Term
C0027793;Synaptic Transmission
C0530129;Adaptive Immunity
C0060060;Pharmaceutical Preparations
C0084035;ferrostatin-1
C0086692;Liver Failure Acute
C0856619;Sexual function
C0038441;Stress Disorders Traumatic
C0085355;Human Platelet Antigens
C1326292;Pyroptosis
C0013162;Antimalarials
C0544757;Myxoglobulosis
C1708109;Intestines Small
C0073374;rifaximin
C0520798;Hepatic schistosomiasis
C0026473;PFKFB3 gene
C1425984;Catenins
C1425980;EXOSC6 gene
C1424651;Apolipoproteins B
C0038432;diabetic
C0014467;eosinophil
C0085387;Diclofenac
C0278582;Brachytherapy
C0038435;Patients
C0278584;Biopsy
C0278583;Cell of Claudius
C0025118;Medicine
C0398518;Neoplasm Metastasis
C0026447;Monkeys
C1413938;DCX gene
C1413939;Calcibiotic Root Canal Sealer
C0002475;Carcinoma of anal canal
C0013138;Drosophila <fruit fly genus>
C0278589;Chemoradiotherapy
C1567292;Myeloid-Derived Suppressor Cells
C1425928;Chronic Obstructive Airway Disease
C0038425;Escherichia coli
C0314875;Probiotics
C1842176;Inflammatory Bowel Diseases
C0072061;Epicatechin
C0026455;Glioblastoma
C0543488;radiologist
C1412616;mRNA Expression
C1158535;translesion synthesis
C1412617;Cefaclor
C0002460;American Indians
C1183517;Rectum
C0014479;geriatric patients
C0060095;Metabolism
C0014442;sialyl Lewis x
C0040732;Cholangiocarcinoma
C0014441;Epidermal Growth Factor
C0015772;Calcium Channel Blockers
C0014440;Antioxidants
C1159892;epidermal cell differentiation
C1184808;Bone structure of sacrum
C0040739;Evaluation
C0040736;Spleen Tissue
C0026428;Monitoring Immunologic
C0581714;Buccal smear procedure
C0027752;Schwann Cells
C0072097;Colorectal Carcinoma
C0543478;Cohort
C0001168;tomography
C1412628;Biological Processes
C1412626;Intraductal papillary mucinous neoplasm
C0567400;Malignant Neoplasms
C0531492;Intestinal Cancer
C4255212;Pain Postoperative
C1424600;SART3 gene
C0734011;mass lesion
C0807679;Radiology studies
C0750979;Adult
C0038402;Bacteria
C1424616;NR1H4 gene
C0554101;Villous atrophy
C0399839;Stomach Carcinoma
C1413963;ANOPHTHALMIA AND PULMONARY HYPOPLASIA
C1413961;MCM5 gene
C1413962;Catenins
C1157223;ATP biosynthesis
C1413960;DDX20 gene
C0567416;Inflammation
C0026432;Patients
C0543467;ovarian neoplasm
C0291573;irinotecan liposomal
C0027765;Depressive disorder
C0001157;Neoplasms
C0567415;Persons
C0544794;Perforated diverticulitis
C1413966;ANOPHTHALMIA AND PULMONARY HYPOPLASIA
C0002482;Acids
C0796494;Ground Glass Opacity
C0039738;Metals
C0039736;associated conditions
C0085390;Woman
C0108555;Multiple tumors
C0085393;Emergency operation
C0278544;Total mesorectal excision
C0026408;Reverse Transcriptase Polymerase Chain Reaction
C0002438;Colon structure (body structure)
C0459914;Antidiarrheals
C0242594;Patients
C0003765;Attention
C0242596;Locally Advanced Malignant Neoplasm
C0027732;Carcinoma Transitional Cell
C0003762;Autophagy
C0040709;Pharmaceutical Preparations
C0254579;5-(6)-carboxyfluorescein diacetate succinimidyl ester
C0278553;Patients
C0014432;Pharmaceutical Preparations
C0013103;wound complication
C0278554;Patients
C0750952;Digestive System Neoplasms
C0040706;Transillumination
C1998103;Complication
C0027746;Nerve Degeneration
C0002423;Psoriasis
C0002424;Cancer Research
C0027741;opioid use
C1413906;DAPK1 gene
C0734004;anatomical layer
C0027740;Adrenergic Fibers
C0734007;Thickened
C0459920;Community
C0014436;Enzyme Precursors
C0734001;Thickened
C0278556;Persons
C0734000;Edema
C0015732;Chemotherapy Regimen
C3894443;reactive oxygen species biosynthetic process
C0278561;Patients
C0241238;Abdomen
C0001128;Gallic acid
C1328887;human study
C0001122;Gastrointestinal perforation
C0003781;Gases
C0039704;Tetrazolium Salts
C0014406;Hepatocyte
C4231241;Anal abnormalities
C0015734;Fecal Impaction
C0409679;Woman
C0015733;TNFSF13B gene
C0278575;Squamous Epithelial Cells
C0014412;Primary sclerosing cholangitis
C0965644;AQP4 gene
C0337514;Sister
C1327543;Immune Cell
C0001117;Acid-Base Equilibrium
C0002445;Cecum
C0027726;Phytotherapy
C1413927;Cell Count
C0241240;Male population group
C1413923;Epithelioma
C0278579;Re-Irradiation
C2930789;mutant
C0193176;complete Blepharoptosis
C1304890;Neuroglia
C0578122;Embolization of portal vein
C0963057;Toll-like receptor 9
C1326205;Persons
C1326207;gemcitabine
C0278506;Patients
C1654934;Chronic Obstructive Airway Disease
C0193171;Left colectomy
C3157065;dendritic cell differentiation
C1708130;advanced cancer
C0027708;Kidney
C1328856;Immunoprecipitation
C0181186;Cicatrix
C1256770;Ketogenic Diet
C0193158;Screening procedure
C3895731;monounsaturated fatty acid biosynthetic process
C1328840;Persons
C0241279;Structure of left axillary region
C4545429;Surgery Image-Guided
C0181173;Massive hemorrhage
C3714800;CLDN1 gene
C0193144;Rectal irrigation
C1708154;Neoplasms
C0292818;EPHB2 protein human
C0349539;Middle Aged
C0003738;Materials
C1328839;autoimmune inflammatory bowel disease
C3844190;Patients
C0349534;general population
C0324255;Landrace pig
C0349536;Autofluorescence Imaging
C1721101;Genes
C0278535;Persons
C0349530;Stomach Neoplasms
C1721104;DNA Breaks
C0229779;Dissecting hemorrhage
C0914005;Malignant Neoplasms
C1327616;Epithelial Cells
C3280504;Crypt hyperplasia
C0278704;Survivors
C1818645;ribonucleoprotein complex biogenesis
C1254144;Human Microbiome
C0278701;general population
C0227121;Redness
C0229783;Structure of pancreatic lymph node
C2353542;Infiltration
C0229789;Edema
C1266129;Omentum
C1519427;Malignant Neoplasms
C0677984;African race
C1266119;Patients
C0242732;Organ
C4521453;Pyotraumatic dermatitis
C0242735;Biological Processes
C1521743;Cardiovascular Diseases
C1484476;Microorganism
C0242738;mRNA Expression
C1135809;Weight decreased
C2340229;Macrophage Activation Syndrome
C1521745;Abdomen incision
C0242739;Secondary Neoplasm
C2613138;Gene Expression
C1521747;leptin receptor
C1521751;Neoplasms
C1533734;Administration procedure
C1328910;Neoplasms
C0242724;DNA Sequence
C0242726;Neoplasms
C0215136;Pharmacotherapy
C0496867;Benign neoplasm of rectum
C1280474;Transfer factor - respiratory measure
C0242792;Progression-Free Survival
C0228487;Inulin
C1377916;Benign Vascular Neoplasm
C0156263;Ureteric fistula
C0132298;neurotrophic factor
C1377919;Stage IV Nasopharyngeal Carcinoma
C4510788;Operative Surgical Procedures
C1519477;House mice
C1519474;Mouse Spleen
C1377913;Pleural Mesothelioma
C4076626;Early gastric cancer
C1506158;Vesicle SNARE Proteins
C3640144;Lymphocytes Tumor-Infiltrating
C3242274;Therapeutic radiology procedure
C0229793;Secondary Neoplasm
C0229792;Jejunum
C0229791;Neoplasm Metastasis
C4050026;Peste-des-petits-ruminants virus
C3653446;Today
C1266156;Multicystic mesothelioma benign
C3811902;methylate
C3242284;Patients
C1819995;Proteins
C4305789;Magnetic Resonance Imaging
C1458155;tipifarnib
C1266144;Malignant Neoplasms
C3485619;Angiogenesis Inhibitors
C0156272;Diverticulosis
C1266147;Neuroendocrine carcinoma grade 1
C0181209;Hook
C0170531;Caco-2 Cells
C0399644;Benign condition
C1135868;Primary malignant neoplasm of lung
C0399642;Reconstructive Surgical Procedures
C0399643;Proximal subtotal gastrectomy
C3918715;Oar
C1830377;cancer recurrence
C0349380;Potato chips
C1423498;Relative (related person)
C0205725;DNA
C1422163;CTCF gene
C1879646;Affected Area
C1422165;Purines
C1423497;Growth
C0146894;Peripheral blood mononuclear cell (cell)
C0037098;tailor
C4053960;Neoplasms
C1135873;Choriocarcinoma
C0086707;Alkaloids
C3665429;Recurrent hemorrhage
C1159825;polyphenols
C0074725;Tissue Donors
C0074727;sodium borate
C3266262;Male population group
C0144237;Silvan
C0037088;Acute Chest Syndrome
C0686055;Neoplasms
C0085405;recurrent prostate cancer
C0399626;Rigid sigmoidoscopy
C2243080;Intestinal necrosis
C0037080;HCT116 Cells
C0085407;Malignant tumor of colon
C1880658;Feline urological syndrome
C0037083;Embryonic Development
C1880656;Patients
C0399622;Screening procedure
C0399623;Evaluation procedure
C1134558;martynoside
C0399620;Macrophage Activation Syndrome
C0457276;Patients
C4303178;Cohort
C0049065;Histone Deacetylase
C0061444;Glucuronic Acid
C0062773;Colorectal Carcinoma
C1817393;Mus
C1134564;irinotecan liposomal
C0037075;Patients
C0037073;Obstruction of colon
C0107264;Cessation of life
C1158512;Tumor Burden
C1422195;MIR455 gene
C0348083;Patients
C1879655;Closure by staple
C0772313;Tumor cells uncertain whether benign or malignant
C0445275;Anesthetics
C0205766;Myxofibroma
C0085423;Isolate - microorganism
C1422129;Enzyme-Linked Immunosorbent Assay
C0398359;Woman
C1842325;Adenocarcinoma
C0038394;Bacteria
C0013090;skin toxicity
C0229730;Hypertrophy
C1521726;Magnetic Resonance Imaging (MRI) of Liver
C3808302;Watery diarrhea chronic
C0472888;Incisional hernia
C0085413;Intraductal papillary mucinous neoplasm
C0061465;colon growth
C0229747;Secondary Neoplasm
C0398368;Jejunum
C1424790;Genes
C0025086;Colorectal Carcinoma
C0073432;Transformation function
C0073434;Neoplastic Cell Transformation
C1520401;Dynamics
C0025080;Colonic lesion
C0242706;Disease
C0072108;Transcription Genetic
C0242708;Antirheumatic Drugs Disease-Modifying
C1424792;Chronic Obstructive Airway Disease
C0061472;Mental disorders
C0203126;Operative Surgical Procedures
C0013075;Nodule
C0037047;Sibling
C0230704;Protoplasm
C3665472;Secondary malignant neoplasm of liver
C3665478;oxaliplatin
C1519414;Solitary Nodule
C4039634;Male population group
C0026381;Molecular Probes
C0040691;Missense Mutation
C0040690;Adenocarcinoma
C0013089;Birth
C0387696;Standardization
C0039694;disease stage
C0040682;ras Proteins
C0037039;Immune Cell
C1842350;Patients
C4255186;Autophagy
C0086767;Elements
C0013081;Chronic Obstructive Airway Disease
C1881930;Tretinoin
C1508753;Reconstructive Surgical Procedures
C0038362;Tumor marker measurement
C0025066;Electrocardiography
C2746052;Dermatitis
C0074785;Plasma membrane
C1855663;Kaufman oculocerebrofacial syndrome
C1521713;Serotonin
C0025063;Mediastinal Neoplasms
C0025062;Mediastinal Emphysema
C0038354;Outpatients
C0040674;removal technique
C1424749;Infiltration
C0039685;Patients
C3821327;cell-cell adhesion
C0038353;Gastric Dilatation
C0038352;Gastric Content
C0038358;Subtotal gastrectomy
C0037025;receptor
C0038356;Gastrointestinal Diseases
C1412762;Open Reading Frames
C0038351;Multiple lesions
C0040679;ferroptosis
C0027697;Patients
C0026367;Hemorrhage
C0002395;Cohort
C0025037;Congenital Abnormality
C1183428;Solocyte
C0027695;Analgesia Epidural
C3160718;Malignant Neoplasms
C0084133;Polyubiquitin
C0037017;Shrimp
C0554244;Capsule Endoscopy
C0039677;Congenital dyserythropoietic anemia
C0040661;STAT1 gene
C0040669;Real-Time Polymerase Chain Reaction
C1337091;CCL4 gene
C0001056;Inflammatory Bowel Diseases
C0001057;Malignant Neoplasms
C1412777;Finding of body mass index
C0026376;Molecular Biology
C0072149;Biological Factors
C0580545;Blood glucose normal
C0085484;Enterobacter cloacae
C0038333;Stilbenes
C0015696;Intestinal dysbiosis
C0041984;Toxic effect
C0040654;Patients
C0013030;Dopamine
C0015695;Cancer Cell Growth
C0581870;Male population group
C0041980;Triglycerides
C0037004;Sebaceous Adenocarcinoma
C0015691;multiple pathologies
C0025018;Carcinogenesis
C1158483;DNA Alkylation
C1412785;Microtubule-Associated Proteins 1A/1B Light Chain 3-II
C0025017;Food
C0027679;Patients
C0747497;Cicatrix
C0544886;Patients
C0027672;Persons
C1184738;Metastatic Lesion
C3146409;Chromatin
C0120341;growth factor-activatable Na-H exchanger NHE-1
C0085478;Porphyromonas gingivalis
C0014372;SLC9A3 gene
C0085479;Bacteria
C0118022;Homeostasis
C0039654;Intercellular adhesion molecule 1
C0040649;Biologic Development
C0014370;Patients
C0040648;liver development
C1158475;Cohort
C0027686;Milk spots of pericardium
C0025023;Transcription Genetic
C0301470;Stool Softener
C0300140;EEF1A1 protein human
C1184743;IL27 gene
C1424706;HCT116 Cells
C0041963;Ureterostomy procedure
C1567160;Intestines
C0015674;BCL2 gene
C0041964;Malignant neoplasm of lung
C1256801;FPR1 protein human
C0314761;Oral cavity
C0014346;Pulmonary Fibrosis
C0039644;HT29 Cells
C0015672;Hypoglycemia
C0041967;Necrotic debris
C0001028;Acetate-CoA Ligase
C0027653;Structure of sphincter ani muscle
C0003682;Accumulation
C0027651;Tissue Donors
C0027652;Neoplasms by Histologic Type
C2964281;perfluorooctanoate
C0038317;Spontaneous hemorrhage
C0593802;Retinoid X Receptors
C0013018;Tissue Dissection
C0014355;FATE1 gene
C0015686;Iodides
C0015688;Nonesterified Fatty Acids
C0014356;Intestinal Microbiome
C0041951;iatrogenic injury
C0015687;Fatty Acids
C0085498;Infantile Neuroaxonal Dystrophy
C1424712;Malignant tumor of colon
C0015684;Colonic Neoplasms
C0015683;Ligase
C1412731;MCL1 gene
C0746131;lung lesion cavitary
C0747460;capsanthin-capsorubin synthase
C0040624;SNAI1 gene
C0747465;Patients
C3147783;Immunity
C3147785;Body tissue
C0072186;Propionic acid
C0002345;Phenotype
C0027667;Neoplasms Unknown Primary
C0027662;Patients
C0027663;Right colon
C0015689;CD69 protein human
C0796357;Premenstrual syndrome
C0581833;En Bloc Resection
C0041942;Blood
C0014323;Entamoeba histolytica
C1159772;Immunohistochemistry
C0040616;Buspirone
C0040613;Malignant neoplasm of splenic flexure of colon
C0041945;Ligands
C0040615;Clozapine
C0001047;JNK Pathway
C0001040;Body tissue
C0457193;Soft tissue mass
C1424721;Body tissue
C0014327;Enteral Nutrition
C0015663;TNFSF14 gene
C0041931;Hypersensitivity
C0014335;Perforation of small intestine
C0084183;Vitamin D3 24-Hydroxylase
C1337027;Transcription Genetic
C3160734;phagocytic cup
C1424734;Tumor Progression
C1424736;Mutation
C1412751;BCAT1 gene
C0027646;Cohort
C0028978;Proton Pump Inhibitors
C0028977;Primary Liposarcoma
C0399713;Jejunal interposition
C0027642;MicroRNAs
C1158438;sphingolipid metabolic process
C0027643;Neoplasm Recurrence Local
C0003695;polarization
C0027645;Neoplasm Seeding
C2364172;Cancer Patient
C1424731;Malignant Neoplasms
C1337019;Well Differentiated Malignant Neoplasm
C2711421;Carcinoma of ampulla of Vater
C0016964;B4GALT1 gene
C3858690;Pharmacotherapy
C0016960;Cytosine deaminase
C0039601;Carcinogenesis
C1302392;Adenomatous Polyposis Coli
C1337013;Teleradiotherapy with iodine-125
C1337011;Von Hippel-Lindau Syndrome
C2330838;Dissecting hemorrhage
C0264010;Hepatic osteodystrophy
C0735446;Present
C0241374;Woman
C0240043;Hematoma Subdural
C0735449;Secondary Neoplasm
C0239059;Obesity
C0015641;NT5C2 gene
C0664613;Apoptosis
C1337005;Epithelial Cells
C1567130;Ovarian Carcinoma
C0265338;South East Asian
C0028959;Mus
C1710596;Adenocarcinoma of ampulla of Vater
C3896974;Monoclonal Antibodies
C0041917;Tegafur
C0041912;Patients
C0027625;Genes Regulator
C0027626;Perineural spread
C0027627;Mice Nude
C0028953;Oligonucleotides
C0041909;Metastatic Renal Cell Cancer
C0796392;Community
C1708287;Anus
C0796396;Iodine-125
C0278678;Vascular Endothelial Growth Factor Receptor
C0016978;gallbladder neoplasm
C0016979;Cell Surface Proteins
C1518174;Rat Colon
C0016976;Large Mass
C0016977;Adult
C0278687;work up
C1326341;Aspartate
C0041904;Vitamin D3 24-Hydroxylase
C0028928;Patients
C0242692;Secondary malignant neoplasm of soft tissues
C1629836;Tumor Immunity
C0028925;Plants Medicinal
C0265325;Endometrioid carcinoma ovary
C1293808;Peritoneum reconstruction
C0242696;Neoplasms
C0242697;Surface
C0001002;Growth
C0004991;Patients
C0292991;stage colon cancer
C0677908;durvalumab
C0228390;AIF1 gene
C0278689;removal technique
C0278688;Appendicitis
C0423866;Lanugo
C0723457;Stop brand of fluoride
C0338724;Woman
C0028938;Meningioma
C3653518;Apoptosis Regulatory Proteins
C0266642;Laparoscopic Colectomy
C0242687;Compliance
C1293821;Perineum reconstruction
C0016956;Galectin 4
C1412719;UBE2Q1 gene
C0016955;Alkaloids
C0028908;Flavonoids
C3653501;Adult Liver Carcinoma
C1280511;Radical hysterectomy
C0004936;SPINK5 gene
C0004933;Scientific Study
C0265385;Peutz-Jeghers Syndrome
C4521398;United States Military enlisted E4
C3472375;Vagina
C0265384;Hereditary Nonpolyposis Colorectal Cancer
C0494164;Lung
C0494165;Plant seeds
C1709582;Evaluation
C0004927;Healthy Lifestyle
C1301034;Persons
C0677950;Biological Markers
C1569757;STAT3 gene
C0280953;Neoplasms
C0028910;Negative Regulation of S Phase
C1268865;Gastroparesis
C1157190;polysaccharide biosynthetic process
C3896943;Phosphorylation
C0879179;Ileus
C0003625;polyphenols
C0280962;Patients
C0240066;Adult
C0677946;Magnetic Resonance Imaging (MRI) of Liver
C0324145;Oils
C0677948;geriatric patients
C0677949;Persons
C0016904;gamma-Aminobutyric Acid
C2711413;Hospitals
C0337438;SMALL BOWEL BACTERIAL OVERGROWTH
C0279980;Esophagus
C2712743;Carcinoma Small Cell
C0003617;Cystadenocarcinoma Mucinous
C0003618;Patients
C0003615;Virulence Factors
C0677930;Endometrial Endometrioid Adenocarcinoma
C0003614;Colorectal Neoplasms
C1327622;Practitioner
C0004943;Behcet Syndrome
C0003611;Appendicitis
C0677932;Level of the first lumbar vertebra
C4521361;MYBPC3 wt Allele
C0349410;Coherent
C0677936;Lung
C0966897;MRC1 gene
C1709599;Surveillance Epidemiology and End Results (SEER) Program
C1556474;Patients
C0016911;Mus
C4517098;Cohort
C0376495;Acupuncture procedure
C0025831;Gene Silencing
C0677646;Adenocarcinoma
C0677647;Neoplastic Cell Transformation
C1566558;Asians
C0410000;Patients
C0013856;Electrophoresis Agar Gel
C4327687;macrophage migration
C0013862;SDS-PAGE
C4543399;Somatostatin analog
C0024518;CD8A wt Allele
C1528289;B-Lymphocytes
C4050171;Patients
C0855052;Anal part of perineum
C0221941;Dehiscence
C0410013;Soft tissue lesion
C0855060;Omentum
C0037812;Scientific Study
C0037813;Spectrum Analysis
C0037816;Speculum
C0843083;Anorectal fistula
C0011206;Patients
C0664336;SPHK2 gene
C0037815;Diagnosis
C3714605;Pain Perception
C0424670;Weight for height
C0678951;immunologist
C0678953;hereditary factors
C0677626;SP1 gene
C0001883;Process
C0013839;Electromyography
C0221910;stage I cervical cancer
C1290386;Patients
C0037805;melanoma
C1098658;HIPK2 gene
C0678941;FAT1 gene
C0855073;Patients
C0000545;American College of Cardiology/American Heart Association Lesion Complexity Score A
C0678945;Colorectal Carcinoma
C0677616;Abdominoperineal resection
C0412694;Stable Disease
C0221921;Assay
C1964029;Screening procedure
C0221925;Rattus norvegicus
C1097317;Malignant Neoplasms
C3896766;CD69 protein human
C0221971;Lymphoid hyperplasia
C0412624;Computed Tomography (CT) of Pancreas
C0207661;Chronic ulcerative colitis
C0870668;hospitalized patients
C0412620;Varicosity
C0870666;Patients
C1567848;Cells
C2698204;Colon structure (body structure)
C0425946;Consolidation Chemotherapy
C0939239;Inflammatory Bowel Diseases
C0231303;Disease
C0879005;Catheter drainage
C0001815;Primary Myelofibrosis
C4505065;Alcohol consumption
C0001811;Persons
C0220650;Therapeutic procedure
C0220655;Malignant pericardial effusion
C0220654;Cytological Techniques
C0160420;Injury of kidney
C2064225;Patients
C2064226;Italians
C0927222;Neoplasms
C3535907;Colorectal Carcinoma
C0401998;Clinic nurse
C4505053;research
C0677667;Intraperitoneal chemotherapy
C0000511;Squamous cell carcinoma of esophagus
C0207683;Cytopathic effect
C0870646;High Risk Populations
C0220620;Breast
C2316467;Reactive Oxygen Species
C2699517;Therapeutic procedure
C1373218;Malignant neoplasm of colon stage IV
C0449900;Malignant tumor of colon
C0424621;Patients
C1036338;Aphrocallistes vastus
C4505047;Nitrosative Stress
C1300201;Pale red color
C1541263;Patients
C1300200;Microcirculation
C0220633;Eye
C0220630;Patients
C0013806;Liver neoplasms
C1096021;Patients
C1822803;Carcinogenesis
C1822802;SNHG7 gene
C0013801;Malignant neoplasm of sigmoid colon
C0013804;Endoscopic dilatation
C3714634;Cohort
C0858970;Taurine
C4505038;Local excision
C1156201;Histone Deacetylation
C1518869;Hantavirus Infections
C1156205;Body tissue
C0053917;Severe (severity modifier)
C3271738;Antibodies Bispecific
C0806060;Functional disorder of intestine
C0545811;Groove
C0545813;Anastomotic Leak
C0687028;Stroma
C0001807;Patients
C0870604;Child
C0870602;matrix Gla protein
C1158886;CAPG wt Allele
C0053932;FATE1 gene
C0545827;Anastomosis
C1516225;Ambulatory Care Facilities
C0557806;School
C0917801;Cohort
C1156212;chromatin silencing
C2829230;Promoter Regions Genetic
C3256127;Immunoglobulins
C0053942;Borax
C1516213;Ectopic pancreas
C4038478;HLA class I & II
C0545839;Malignant neoplasm of duodenum
C0376405;Elderly (population group)
C4038479;HLA class I
C1516211;Cancer Model
C0388437;Serum
C3271788;vascular endothelial growth factor signaling pathway
C0521874;Victim of neglect (finding)
C0376452;RICTOR gene
C2829275;DLX6-AS1 gene
C0518214;Persons
C1421392;AKT Signaling Pathway
C3811844;Assay
C0461643;Continuous mass closure
C0434014;Injury of diaphragm
C0053959;Growth
C1421394;KEAP1 gene
C1421399;Colorectal Carcinoma
C1421397;Bacterial Infections
C0280274;Hepatitis C Chronic
C1531897;Woman
C1432048;MAP Kinase Cascade
C0376466;gastrointestinal function
C1158811;rRNA transcription
C0051300;Apolipoprotein E
C1420072;Catenins
C1158816;CDK6 gene
C2339173;Macrophage Activation Syndrome
C1420071;Mus
C1516231;nontreatment
C1517564;Lymphocyte
C1420073;Chronic Obstructive Airway Disease
C0221909;Chronic colitis
C4111629;Fabiola
C0858952;Lipopolysaccharides
C3810531;Interventional procedure
C0521857;Increased drug resistance
C1420083;Lymph node excision
C1158849;Patients
C0076611;Quinones
C3810537;Stereotactic Body Radiation Therapy
C0111429;DFNA5 gene
C0699040;Heparitin Sulfate
C1420089;SLC11A2 gene
C1075974;7-methoxyheptaphylline
C0461628;Non-absorbable suture
C2352110;Anti-Anxiety Agents
C0064635;Paclitaxel
C3822506;acetyltransferase complex
C3641177;PEG-3350/Sodium Sulfate/Sodium Chloride/Potassium Chloride/Sodium Ascorbate/Ascorbic Acid-based Laxative
C0376443;Pathologic Response
C0520510;Fruit
C0077932;Peptides
C1420092;Neoplasms
C1420091;SLC12A2 gene
C0077938;Cells
C1420098;SLC14A1 gene
C1516250;Patients
C0280220;stage ovarian epithelial cancer
C3846509;Neck
C0243281;Toxic effect
C1882413;Malignant tumor of cervix
C1144173;soluble
C1506928;TRANSCRIPTION FACTOR
C1421354;hepatoma cell
C0520571;Fibrosis of bile duct
C0545892;Stenosis
C0064658;lard
C1699633;Multiple lesions
C4507608;Carnitine
C3244092;expression level
C1421361;Neoplasms
C3846514;Nerve
C3810570;Mesothelioma
C0280242;stage rectal cancer
C1156182;membrane disassembly
C0100804;Tumor cells malignant
C0520562;Dilatation of intestine
C3810578;macromolecule
C0520561;metastatic hypernephroma
C1419057;Fluorouracil
C3810571;anatomical layer
C0940195;Friable gastric mucosa
C2246997;transferrin transport
C1420046;Vitamin K 3
C0035173;Persons
C0280252;Persons
C0064677;latrunculin A
C0035179;huperzine B
C0035172;Analysis
C1518918;Pattern Recognition
C1421388;DNA Helicases
C1421387;Ubiquitination
C1833454;Spasm
C1421313;Adipose tissue
C1422646;Patients
C0035168;Transection (procedure)
C3872830;Colon structure (body structure)
C3810599;FLNA wt Allele
C0545841;Intussusception
C4281724;Protein S100-A9
C4281719;Protein S100-A8
C0074018;Tumor Necrosis Factors
C0035151;Clinical Treatment
C2267003;Mouse Model
C0390803;Stat3 Signaling Pathway
C1158770;granzyme B
C4281710;N-Cadherins
C0035150;Long-Term Synaptic Depression
C4281712;Catenins
C0023185;Clinician
C1517604;Residual Tumor
C0772289;Persons
C0630906;Malignant Central Nervous System Neoplasm
C0281534;oxaliplatin
C0338237;Disease
C0036471;Dermatitis
C1422666;Glycolysis
C0011175;Hospital Readmissions
C1156140;EIF2AK4 gene
C0280209;Patients
C0050063;TERF2IP gene
C0377800;Growth
C0051395;Butyric Acids
C0024487;Spectrum Analysis
C0024485;PSA Failure
C1518962;Malignant neoplasm of prostate
C1420002;Neoplasms
C4256789;Cell surface
C1419029;Pancreatic carcinoma
C1421348;JDP2 gene
C1420016;SGTA gene
C0338248;Volumetric-Modulated Arc Therapy
C0281548;Cytoreductive Surgery
C0338240;Malignant Female Reproductive System Neoplasm
C0280218;stage bladder cancer
C1699656;Radionuclide Imaging
C0545876;Macrophage Activation Syndrome
C0339573;CDKN2B-AS1 gene
C0050078;Glutathione
C1419030;Adult Liver Carcinoma
C1420010;UBXN2A gene
C0035139;Reflux
C1422672;Specimen Type - Stool = Fecal
C0749736;Sudden death
C0580247;Enteropathogenic Escherichia coli
C0036450;fluvastatin
C0231217;Fever
C3163956;Colon structure (body structure)
C0231218;Gastrointestinal Diseases
C0023138;Laurence-Moon Syndrome
C0024467;lectin B Phytolacca americana
C0206250;Pelvis
C0206253;Vaccines Combined
C1882495;MRC1 wt Allele
C0035126;Plasminogen Activator Inhibitor 1
C3845259;Severe activity
C1012452;endosymbiotic eubacteria
C0231224;Octreotide
C0035110;Staple Surgical
C0206248;protrusion
C0206249;Liver carcinoma
C1423944;Microsatellite Instability
C0024477;Mus
C0011168;Patients
C0232552;Gastric acid secretion
C0231221;Intussusception
C0013794;Gastrointestinal Motility
C0062088;Negative Regulation of G2 Phase
C1422622;histone deacetylase 3
C0037763;Satoyoshi syndrome
C0023115;Rattus norvegicus
C0206275;Patients
C0221874;Protection
C0036435;Author
C0037766;Irritable Bowel Syndrome
C0011135;Vomiting
C0195130;Abdominoperineal resection
C0724419;capecitabine
C1421304;Biological Processes
C1421309;Transcription Genetic
C0011145;Positron-Emission Tomography
C0036420;Woman
C0012472;Growth acceleration
C0281508;Malignant Neoplasms
C0036421;Scleroderma
C1096061;Genetic Variation Analysis
C0025787;Colorectal Carcinoma
C1265415;cytotoxicity
C1701790;Abnormality of mitochondrial metabolism
C1423960;Pancreatic carcinoma
C3163918;Main portal venous trunk
C0036425;Disease
C3546524;Transcription Genetic
C0024426;Intestinal Microbiome
C0024429;macrophage
C0678933;Colorectal Carcinoma
C1882454;Old age
C0231255;Postoperative infection
C1336237;Cytoreductive Surgery
C0927195;CCL7 gene
C0011121;Antibiotics
C0641638;NCME
C0001779;Adult Fanconi syndrome
C1156199;Organoids
C0269858;Woman
C4050094;X-Ray Computed Tomography
C0001774;Agaricales
C0001771;Collagen
C0303596;Yttrium-90
C0024432;TREM2 protein human
C0232567;Colorectal Carcinoma
C1336227;Patients
C1276114;Granulomatous inflammation
C1423911;COLEC12 gene
C3533232;Hypoglycemia
C0183115;Scanning Systems
C0024400;Macaca mulatta
C3533236;Complete cystectomy
C3845278;Persons
C2963492;Tumor necrosis
C0555278;Patients
C1423923;Heinz-Ehrlich Body Measurement
C0025746;blank
C0024419;Patients
C0001792;Persons
C1264124;Pelvic lymphadenopathy
C2613185;Ribonuclease III
C1881134;Biliary stricture
C3845286;Enthesitis-Related Arthritis
C0678908;brain function
C0011109;Adult
C0013765;Laboratory Procedures
C0231243;Hyperthermic Intraperitoneal Chemotherapy
C0011106;Gravidity
C1516170;ING3 gene
C0206414;Genes Reporter
C1711178;Homo sapiens
C1567768;Liver carcinoma
C3896683;Evaluation
C2316368;Gastric Neuroendocrine Neoplasm
C3714745;Bile acid sequestrants
C1517495;Microsatellite instability-high solid malignant tumor
C3714738;Early Intervention (Education)
C0425856;Woman
C0700613;Paroxysmal nocturnal dyspnea
C1555767;bevacizumab
C0025723;SUV39H1 gene
C0232717;Patients
C0376387;Transplant Recipients
C1565115;Apoptosis Inducing Proteins
C3464953;Proteins
C3896693;Heparitin Sulfate
C1555762;Hematology+Medical oncology
C0013746;Biopsy
C1517488;Embryonic Development
C1553101;Nutritionist
C0205101;Breast Cancer Cell
C1516193;Hemophilia NOS
C3714726;Patients
C0205108;Tumor cells uncertain whether benign or malignant
C0205107;Germ Line
C1567781;MST1 protein human
C1565120;Apoptosis
C1325653;Parafibromin
C0207761;lenvatinib
C0206431;Antigen Presentation
C0205100;Afferent neuron
C0172537;Urokinase Plasminogen Activator Receptor
C0206430;Antigen Processing
C0376358;Italians
C4086228;Pharmaceutical Preparations
C4293696;Male population group
C1516188;Marital Status
C0389661;TEV protease
C0486805;Fragments
C1134719;Breast Carcinoma
C0700635;Patients
C2331996;Primary Carcinoma
C0001758;Supportive care
C1846919;SMG1 gene
C2829187;Lactobacillus rhamnosus GG
C0109289;Alkaloids
C0184511;Malignant neoplasm of anus
C0013725;Eicosanoids
C0161899;Laparoscopic total gastrectomy
C0184517;Genomic Profile
C4505192;antileukoprotease
C0232741;Patients
C0400527;Pancreaticoduodenectomy
C0205127;Muscle Fibers
C4050247;Leucine-Rich Repeats and Immunoglobulin-Like Domains Protein Family
C4050242;Persons
C1326961;Malignant Neoplasms
C1325635;U 73122
C3641247;Lesion
C0915142;Anti-Inflammatory Agents Non-Steroidal
C2699414;Committee
C3714787;Motility
C1121403;indole-3-lactic acid
C0148873;SMARCE1 gene
C0205117;Epithelial Cells
C3714774;Cap device
C2613367;DSTN gene
C2612036;protein kinase A signaling
C1516197;Mus
C2676768;Cell Proliferation
C2613365;VWC2 gene
C0205146;Lymphocyte
C0205145;Neuroglia
C0232722;Control Groups
C0205148;HCT116 Cells
C0001727;Postoperative Complications
C0390690;Tumor tissue sample
C3714763;Tumor cells uncertain whether benign or malignant
C4049272;Cholangiocarcinoma
C3883362;Neoplasms
C0375071;Radiotherapy planning
C3896679;Rectal Carcinoma
C0677776;Family
C0205132;Adenocarcinoma Cell
C0870535;Cancer Survivors
C3714756;Persons
C0161856;Patients
C4505151;Molecular Response
C0161819;Patients
C1158744;Adenocarcinoma
C1518744;Neoplasms
C4050215;Mixed Neoplasm
C0341676;Pyelectasia
C0687150;Parathyroid Gland Adenocarcinoma
C1158730;METTL3 gene
C4075512;Patients
C1506770;Cell Survival
C0391908;Multiple lesions
C0051405;Polyunsaturated Fatty Acids
C0424576;Fit and well
C1530433;hematoporphyrin monomethyl ether
C0279391;Risk Assessment
C0917710;Lesion
C0376335;Patients
C1420182;TCF4 gene
C1517454;TP53 gene
C1420188;Neoplasms
C0391976;Patients
C0917707;Cannulation
C0391978;Marrow
C1516119;everolimus
C0521989;Dextran Sulfate Sodium
C4505109;Diploid Cell
C3811719;Ectopic Gene Expression
C1516116;BALB/c Nude Mouse
C1531773;Child
C1420196;Paneth Cells
C1555720;Standardization
C1420194;GPI gene
C3653294;Piroxicam
C0292369;Colorectal Undifferentiated Carcinoma
C0424595;colonoscopy
C4025268;Male population group
C0424596;Abdomen
C0424594;adverse effect due to surgery
C0521974;Liver damage
C0917735;Rectal Carcinoma
C1158728;RNA Processing
C0424589;Fluorouracil
C0278097;Cohort
C2830138;Hypersensitivity
C0278092;Sexual Satisfaction
C2830135;BRAF gene
C0076727;LRP6 gene
C0123538;Patients
C0807283;Neoplasms
C1421479;IMPACT gene
C0341703;Elevated CA19-9
C0063435;CXCR4 gene
C1882536;Sarcoma
C1419152;Deferoxamine
C3811765;Stromal Cells
C3811761;oxaliplatin
C0268696;Mus
C0267366;Patients
C0075429;Neoplasms
C0267360;Patients
C3546446;regulated cell death
C3809437;Enlarged pancreas
C0581602;Chemoradiotherapy
C0035078;Deep Vein Thrombosis
C0064775;Folic Acid
C1157366;glycosphingolipid biosynthetic process
C0052796;Macrolide Antibiotics
C1420151;Up-Regulation (Physiology)
C0497481;Patients
C0473491;Patients
C0036397;Science
C1156067;Mitochondrial Fusion
C0447192;Present
C2733078;Synchronous primary carcinomas
C0075444;succinyl-coenzyme A
C0266012;Ectopic breast tissue
C0023078;Neoplasm Metastasis
C1420164;fatty acid metabolism
C3546463;fatty acid oxidation
C0229089;Exophthalmos
C2974289;Tumor cells uncertain whether benign or malignant
C0036387;VHL gene
C0266006;Secondary malignant neoplasm of lymph node
C1420170;Adenocarcinoma of large intestine
C0076765;Mucous Membrane
C1419195;Ectopic Gene Expression
C0230070;Venous site
C0050156;Conjugated Linoleic Acid
C1420173;Glycolysis
C1420176;SNAI1 gene
C0341745;Complication
C1420105;Adenosine Phosphosulfate
C0036375;College
C1419118;Pancreatic carcinoma
C0011079;Necrotizing fasciitis
C0036378;School
C0341742;Adrenergic alpha-Antagonists
C0011071;tumor removal
C1419112;Pancreatic carcinoma
C2735670;Acute colitis
C1419115;Estimated blood loss
C1419114;Secondary Neoplasm
C1266852;Biological Relative
C1955924;knocked out
C0529085;RAB26 gene
C1955928;Hepatic
C1420102;Malignant Neoplasms
C0796126;AICARDI-GOUTIERES SYNDROME 1
C1421446;VEGFB gene
C1419129;Adult Fanconi syndrome
C0340427;Patients
C0338106;Paraneoplastic Syndromes
C1955933;p21-Activated Kinase 1
C1422779;RNA metabolic process
C0447187;Adenocarcinoma
C0280317;Malignant Head and Neck Neoplasm
C0024399;Drug Kinetics
C0024398;Macaca
C0267395;mesenteric occlusion
C3149729;Homo sapiens
C1422775;Cancer Cell Growth
C2244223;cellular homeostasis
C1422771;GPD1L gene
C1420128;Chronic Obstructive Airway Disease
C1168005;Diverticular Diseases
C0037683;Son (person)
C0011053;Homo sapiens
C0195299;Hemorrhage
C0280321;Patients
C1422787;Patients
C2184149;living situation
C0024369;Catabolism
C0023038;Absorbable suture
C0447155;Urinary Retention
C0280324;Squamous cell carcinoma
C1518846;intraepithelial
C0544683;Normal saline
C0063490;Inflammation
C0750862;Malignant Neoplasms
C0267380;colonoscopy
C0555307;Inflammatory Bowel Diseases
C0278007;Patients
C1420123;SLC1A5 gene
C1955907;Esophageal Neoplasms
C0063493;Interleukin-12 Subunit p35
C1955908;Pathologic Processes
C0063491;indole-3-carbinol
C0086132;CD69 protein human
C1421452;Antibodies Anti-Idiotypic
C0278008;Macrophage Activation Syndrome
C0278016;Hard stool
C0011061;Deamination
C1421467;mitogen-activated protein kinase p38
C0011065;World
C1419142;Patients
C2733022;Non-Neoplastic Disorder
C0267374;Inflammation
C0023047;Attention
C0267375;Mus
C1156019;microtubule cytoskeleton organization
C0267372;Malignant Neoplasms
C0267373;Symptoms
C0024375;Protein-Lysine 6-Oxidase
C1422796;CDC2 Protein Kinase
C1420132;Transcriptional Regulation
C0037661;Duodenal ampulla
C1422727;Malignant Neoplasms
C0230005;Alopecia
C0231337;Adult
C0037663;Body tissue
C1422724;Colorectal Carcinoma
C0024348;Perforation of small intestine
C0183294;Sigmoidoscopes
C0025677;Skin carcinoma
C1335073;Lymphocyte
C0205042;Stenosis
C1711212;Glandular Differentiation
C0074175;Tumor cells malignant
C0000379;Abnormality of mitochondrial metabolism
C0024341;Malignant Neoplasms
C3821167;Neoplasms
C0038999;tomography
C0037668;Somatotropin-Releasing Hormone
C0086152;Behavior
C0086153;bile acid metabolism
C0037650;Symptoms
C1422736;Cohort
C1421403;USP28 gene
C0206369;Splenosis
C0281603;Receptors Tumor Necrosis Factor Member 10b
C0036323;Cohort
C1421408;Problem
C1421406;PDCD1 gene
C0497406;Adult
C1421405;Cortactin
C1711206;research
C1335060;Non-Small Cell Adenocarcinoma
C0206364;K-ras Oncogene
C0001699;Liver Abscess
C1553183;Metals Heavy
C0302189;Cell Count
C1979927;Tumor cells malignant
C0037659;Hepatocyte
C0037657;Carcinogenesis
C0302180;Anogenital
C0086143;X-Ray Computed Tomography
C0232645;Intestinal mucosal permeability
C0233973;Patients
C0012344;Colitis
C0529099;Colonic Neoplasms
C1335056;T-Cell Activation
C0037643;huperzine B
C1335057;Amino Acids
C0011011;Daughter
C0205065;Clear Cell Malignant Neoplasm
C0302158;Mus
C0244635;soluble
C1266873;Bladder epithelial cell
C3846440;capecitabine
C0000392;Obesity
C0025653;Stress
C0220668;Patients
C2937289;Adapt (substance)
C0036315;Schistosoma
C0086168;Dissociation
C0578057;Woman
C0037633;Malignant tumor of colon
C1422756;STOML2 gene
C0024337;Attention
C1419100;T-Cell Activation
C0205052;Epithelial Cells
C0205054;Multiple lesions
C1553165;Colorimetry
C0013687;effusion
C0012359;Jaundice Obstructive
C0038969;Injury wounds
C1336364;carboplatin/paclitaxel
C0024305;Screening colonoscopy
C0205082;Stomach Carcinoma
C0183251;Malignant tumor of cervix
C0024302;multicatalytic endopeptidase complex
C0002994;Hypersensitivity
C0205090;Stem cells
C0205091;Myeloid-Derived Suppressor Cells
C0013658;Patients
C0038941;Postoperative Complications
C1881237;Lung Neoplasms
C0025646;SUPPLY NOT OTHERWISE SPECIFIED
C4229017;Persons
C0302149;Serous effusion
C0024312;Cessation of life
C0025641;Calcibiotic Root Canal Sealer
C1311076;SMO protein human
C0665744;Neoplasms
C0013631;Health center
C0026946;Infection by Basidiobolus
C0026948;Adenocarcinoma of large intestine
C0578022;Primary biliary cirrhosis
C0184567;Anus
C0967993;KEAP1 protein human
C0302113;Hepatectomy
C0013633;Health Care
C0232698;Frequency of bowel action
C0401805;Malignant Neoplasms
C3161429;Patients
C0205094;Plasmacytoid Dendritic Cells
C0554063;Lesion
C3872768;Endoscopic Submucosal Dissection
C0001675;LARS gene
C0025627;Methaqualone
C0205099;B-Lymphocytes
C0001674;Pharmaceutical Preparations
C1312385;avitriptan
C0012315;Dihydropyridines
C0038925;Omentum
C1711297;Adenoma of large intestine
C2674432;Homo sapiens
C0001629;Thyroid carcinoma
C0206538;Matrix
C0001625;mass cystic
C0001624;tomography
C0206530;Autosomal dominant hereditary disorder
C0001622;Lung Neoplasms
C0184666;Intestinal Obstruction
C1325318;Epithelium
C0183336;Sleeve
C0013618;Plasma Proteins
C0184661;Recurrent squamous cell carcinoma
C0871799;Neoplasms
C0038913;Kidney Transplantation
C1314650;Colitis Ischemic
C0220847;Male population group
C0666743;House mice
C0001618;Adrenal Gland Neoplasms
C0447541;Multiple lesions
C0001617;Immunosuppressive Agents
C4086370;Malignant Neoplasms
C1531698;Malignant neoplasm of anus
C0002949;Aneurysm Dissecting
C3896578;Syndrome
C0002940;Malignant neoplasm of pancreas
C0678723;cetuximab
C2916831;Apoptosis
C1302689;Epithelium
C1301359;Biopsy
C0218504;Colorectal Carcinoma
C0038902;Endometriosis of appendix
C0013621;Zoonoses
C1516031;FADS1 gene
C0002979;angiogram
C0001646;Tumor Progression
C0232804;Chemotherapy Regimen
C0002978;Macrophage Activation Syndrome
C0232805;Patients
C0678711;Fatty Acids Volatile
C0002976;Thymidine Phosphorylase
C1567665;DLD gene
C0206552;Receptors Cytokine
C0001645;Bisoprolol
C0026900;Malignant Neoplasms
C0205221;Tumor cells malignant
C1302652;Male population group
C0678714;Capsaicin
C0001641;Acute retention of urine
C1302656;Second Primary Cancers
C0220825;Coherent
C1964257;Capillary plexus
C0386040;EPHB4 gene
C3872566;Obstructive lesion
C0026914;Lung diseases
C0108082;Colorectal Neoplasms
C0001632;removal technique
C0002963;Patients
C0014939;cytokine production
C3642227;TNNT2 gene
C0871786;internalization
C1072272;Plant seeds
C0013604;penis
C1157706;butyrate biosynthetic process
C1278444;Hormone replacement therapy
C0230203;Carcinomatosis
C0002915;Pain Postoperative
C0231537;Cathodal closure clonus
C0002911;Colon and Rectal Surgery (procedure)
C0185953;Patients
C1749862;cohesins
C0871754;fluoropyrimidine
C0664123;TP73 gene
C0205234;Tumor cells uncertain whether benign or malignant
C3463949;Almeida
C0903042;TFF3 gene
C0002903;Muscle
C1302645;Polyp of small intestine
C1292754;Lymphoma
C1096244;Rectal Neuroendocrine Neoplasm
C0220898;Predisposition -- attribute
C0398086;Anticoagulation Therapy
C0014912;Estrogens
C1819426;chemokine production
C1516076;Asymptomatic Mass
C0232841;Injuries Surgical
C0002938;Neoplasms
C0002934;Patients
C0857460;Thrombocythemia Essential
C0002932;Secondary procedure
C1047211;Arthrospira platensis
C0325079;Cryptoprocta ferox
C0871735;executives
C1723257;MMP3 protein human
C0205255;Anus
C0206588;Receptors Nuclear
C0002928;Hematuria
C0231528;Patients
C0915024;Glycolysis
C0002921;Patients
C0678745;drug absorption
C1292778;Patients
C0582591;Patients
C1819461;interleukin-8 production
C0185908;Patients
C4508788;Lysine
C0173924;Neoplasms
C0376659;Autoimmune Response
C1518624;Fluorides
C1819459;Lipopolysaccharides
C4267692;Veins
C0376669;polyphenols
C1519941;Health care facility
C1819464;tumor necrosis factor production
C3268357;p38 MAPK signaling
C1167117;RAD51D gene
C1882717;BARRIER
C0161919;Malignant neoplasm of sigmoid colon
C0678792;drug potency
C0809786;Present
C2987189;Pancreatic Intraductal Tubulopapillary Neoplasm
C0846764;Mus
C0064833;Leukocyte Elastane
C0161930;Drainage procedure
C0109329;saliva
C1819443;interleukin-16 production
C0063517;exatecan
C1517339;Negative Regulation of G1 to S Transition
C1517336;G-Quadruplexes
C0220806;Central Nervous System Stimulants
C0064858;Fumarate Hydratase
C0521622;Bilateral hydronephrosis
C1397014;Community
C0220819;device aspects
C0076829;Alkaline Phosphatase
C1168401;Malignant Head and Neck Neoplasm
C3811629;Chimeric Antigen Receptor T-cells
C0521613;Patients
C0521619;Obstruction of pelviureteric junction
C1421170;Body tissue
C3642279;Sirolimus
C1518681;Survivors
C0052889;Patients
C4050317;Adenocarcinoma of small intestine
C0458219;Vitamin D Deficiency
C0447562;CD69 protein human
C0136960;sulforafan
C3811619;Malignant Neoplasms
C1517348;hainanolide
C1517342;Cultured Cell Line
C0123658;Stage III Colon Cancer
C1517341;NUP153 gene
C1421118;TRG-GCC2-6 gene
C1421117;Patients
C0278148;Symptoms
C0242191;Pacific Islander Americans
C0991566;Bead Dosage Form
C1869689;Inflammation
C1155075;monocyte activation
C0278140;Abdomen
C1434437;Antitumor Response
C0518015;Fecal Immunochemical Test
C0518014;Patients
C0266153;Rectum
C0123707;Body tissue
C0518010;Patients
C1180033;Wall of blood vessel
C1421113;TRE-TTC3-1 gene
C0556303;Healthy Volunteers
C0750558;Patients
C1155064;NK Cell Activation
C0242184;Mus
C1155065;PTPN2 gene
C1179028;Endothelium of sinusoid
C1423784;Aggravated Colitis
C0376707;Patients
C0267470;Strangulation of intestine
C0736268;Plasma
C4038617;Gastrointestinal tract reconstruction
C0230189;Macrophage Activation Syndrome
C0279495;Males
C0242170;Malignant neoplasm of anus
C3811665;DNA Damage
C0279492;Primary malignant neoplasm of prostate
C2756034;p53 signaling pathway
C0521654;Water
C0267468;X-Ray Computed Tomography
C1881349;primary tumor
C0268799;Cyst
C0267466;Endoscopic dilatation
C0267467;Transabdominal Ultrasound
C0291147;tuberous sclerosis complex 2 protein
C0267464;Metastatic Carcinoma to the Uterine Cervix
C0267465;Stenosis of intestine
C3713076;Cell Cycle Arrest
C1182671;Epithelial Cells
C1155080;Neoplasms
C0965245;IL17RE gene
C0086209;Symptoms
C0037592;metastatic colorectal cancer
C0024296;Helper-Inducer T-Lymphocyte
C1676759;TNFSF9 protein human
C0518003;autonomic function
C0267454;Dihydropyrimidine Dehydrogenase Deficiency
C1833692;Patients
C0024299;Protein-Losing Enteropathies
C0230193;Mass of body structure
C0230194;Secondary Neoplasm
C0340775;Ruptured varicose veins
C1882616;Nail-Patella Syndrome
C1336082;Thymic Squamous Cell Carcinoma
C1843013;Cancer Gene Mutation
C0024264;Curcumin
C0351437;Score 3
C0025598;diabetic
C1267822;Colon structure (body structure)
C0340771;Venous hemorrhage
C0086231;Enzyme Immunoassay
C0558921;Patients
C2246761;cholesterol efflux
C1423744;TET1 gene
C0086225;biomedical tube device
C1423747;Patients
C1157681;pyrimidine salvage
C0048220;Colorectal Carcinoma
C0037579;Soft Tissue Neoplasms
C3544174;Reconstructive Surgical Procedures
C0281779;anal condyloma
C0038898;Patients
C0037567;Patients
C0038896;Study
C0700287;Transanal Endoscopic Surgery
C1337392;Ulcer
C0025570;Rare Diseases
C0048212;Malignant Neoplasms
C0074279;IMPACT gene
C0036238;Satellite Viruses
C0194086;Renal mass
C0086252;inflammatory response
C0036220;leukemia
C0280455;advanced cancer
C0533668;ANGPT1 protein human
C1882628;claudin 4
C0037556;Sodium Tetradecyl Sulfate
C0700276;IMPACT gene
C1336052;Spindle Cell Neoplasm
C1155041;regulatory T cell differentiation
C0700271;Virus
C0280457;Secondary Neoplasm
C1155046;T-Cell Proliferation
C0267494;Operative Surgical Procedures
C0036228;Kynurenine
C0278138;Mild pain
C0012242;Consultant
C0400843;Intussusception
C0012243;Italians
C3896609;Unresectable Malignant Neoplasm
C0086279;Family Caregivers
C0230127;Lesion
C0036211;Sarcoma 180
C0012240;Reconstructive Surgical Procedures
C0205160;secondary group
C0205161;Chronic Obstructive Airway Disease
C0206492;Antibodies
C0024225;Ovarian Carcinoma
C0001589;Adolescents Male
C0595989;Patients
C0268732;Mus
C0242114;DNA
C0026882;CDH1 gene
C0025552;Thallium
C0024221;Lymphatic vessel
C0400841;Patients
C1423704;PRPF19 gene
C0400855;Retrograde intussusception
C1423706;soluble
C0036202;Cholangitis
C1423702;Body tissue
C0038862;Peristomal fistula
C3897941;Lymphocyte
C0025568;Carcinoma Endometrioid
C1711326;Small intestine carcinoma
C0024236;Crohn's disease of vulva
C0595998;Household composition
C0001575;Abscess
C0074289;Amino Acids
C0025564;Cell Death
C0024232;Patients
C0772088;Tumor tissue sample
C1709016;Microarray
C0194053;Conventional (Clear Cell) Renal Cell Carcinoma
C0581359;Stent device
C0400865;Motility disorder of intestine
C1336028;Solid Growth Pattern
C1300072;cancer recurrence
C0024204;Physical findings
C0049506;Fluoxetine
C0024203;Lymphangiography
C0220781;Hybrids
C0244756;fibrillin-1
C0183396;Mass Spectrometers (device)
C0400862;Carcinoma
C1180098;Neoplasms
C0086287;Posterior exenteration of pelvis
C0400877;Functional disorder
C0941218;Small Lesion
C0024215;Endoscopy of intestine
C0024214;Lymphangiectasis
C0024219;Lymph node excision
C0026879;Mutagens
C0544357;Hypersensitivity
C0025543;glutamate carboxypeptidase II human
C0531041;human cell line
C0086282;Family member
C0014898;Superoxide Dismutase
C0012238;Digestive System Disorders
C0230168;Severe Sepsis
C0556338;Drinker
C1336005;Somatostatin analog
C0012200;Liver carcinoma
C0026848;Myopathy
C1565020;Globo H Antibody
C0025519;Mus
C0002876;Tetrahydrouridine
C0025517;Intestinal Microbiome
C0026845;Pelvic floor exercises
C0002874;Aplastic Anemia
C0267446;Child
C0026846;Animal Disease Models
C0025516;Enzymes
C1855073;Disease
C0002871;Mass of intestine
C0595944;Sebaceous adenoma
C1167093;SWI/SNF complex
C1881363;Laser Fluorescence
C0014869;Peptic Esophagitis
C0038836;Cytoplasmic matrix
C0014868;MicroRNAs
C0038838;caspase-3
C0230166;Cystic Neoplasm
C0014866;Esophageal Stenosis
C0014871;Duodenal Metastases
C1881358;Intestines
C0340708;Woman
C0545698;Nodule
C0267436;Dysbiosis
C4086297;Malignant neoplasm of colon stage IV
C0014876;Less often
C4086299;glucose high
C0230148;Thymoma
C0195331;Radical hysterectomy
C0400827;Ligation
C0700200;Presyncope
C0400829;Chinese herbal medicine
C0001566;SR 57746A
C0002895;Mouse Model
C0182021;Obturators
C0026820;Muscle Contraction
C0002893;Refractory anemias
C0001563;imatinib
C0013516;Pericardial effusion
C0014848;Multiple Sclerosis
C2673202;Liver carcinoma
C0038817;Ultraviolet B radiation
C1277200;Patients
C4086268;Exacerbation
C0196652;Neurectomy
C0014852;Colonization
C3897929;Evaluation procedure
C0195325;Cystadenocarcinoma Serous
C0400839;Ulcer of rectum
C0026837;Surgeon
C0026832;Pyruvate Kinase
C0001551;advanced disease
C0025500;Breast
C1711309;Poorly differentiated carcinoma
C0014859;Middle Aged
C0230150;Macrophage Activation Syndrome
C0231484;Muscle function
C1710082;Hypoglycemia
C0206655;Cohort
C0026809;Endotoxins
C0678856;Surgeon
C0857362;Patients
C0182129;Indocyanine Green
C0206643;ANO1 gene
C1505266;TP53BP1 protein human
C0579086;Problem
C0871685;Cancer Patient
C1506592;MIR1-2 gene
C0870358;Counselee
C0133195;Transcription Genetic
C1518578;Oncology Group
C0013504;Operative Surgical Procedures
C0014836;Patients
C0014834;Streptomycin
C4086499;Patients
C0013502;Patients
C0014833;Escherichia
C0206675;Adenomatoid Tumor
C0206674;Bladder mucosa
C0206677;Benign Neoplasm
C0001527;Carotene
C1325410;Malignant tumor of colon
C0206671;Eccrine acrospiroma
C0677501;Male population group
C1302773;Cells
C0376597;Intestinal cell
C0014806;Anti-Bacterial Agents
C3642356;Dendritic Cells
C0388570;HMMR protein human
C0206663;Child
C4302239;Functional fecal incontinence
C0001515;Adhesiveness
C0002845;Fluorouracil
C0001511;TERF2IP gene
C3665041;Organic Cation Transporter 2 Inhibitors [MoA]
C0170127;Adenosine Phosphosulfate
C0001510;Operation on abdominal region
C0002844;Hormone refractory prostate cancer
C1568884;colon growth
C0410158;Patients
C1300127;Organ
C1096106;Extraction
C1518595;Probes
C0423402;Arteries
C0169101;SRT1720
C0206696;Child
C4531082;Low grade appendiceal mucinous neoplasm
C0230321;Swelling
C0206699;Mesosigmoid
C4531084;Immune response
C0206698;Fibrosis Liver
C1313407;Neoplasms
C0146462;E2F transcription factors
C0870300;Patients
C0206691;Secondary malignant neoplasm of skin
C0857322;Patients
C0206693;STK11 gene
C0206692;Intestines
C0206695;Neoplastic disease
C0204032;Present
C0846669;Nutritional status
C0871633;Woman
C4518268;Adenocarcinoma of small intestine
C3714542;Cells
C3463824;Assay
C0206686;Adrenal Gland Neoplasms
C0206685;Pancreas
C0206687;Uterus
C0230338;SUBCUTANEOUS TUMOR
C1711368;nardilysin
C0206682;Follicular thyroid carcinoma
C0206681;Tumor tissue sample
C0206684;MSH6 gene
C1710038;First line treatment
C0678889;Ablation
C0242303;Homeo Box Sequence
C0387288;Photosensitizing Agents
C1711390;Pharmacotherapy
C0678870;colon function
C1122962;multicatalytic endopeptidase complex
C0678871;Transanal Endoscopic Microsurgery
C0171406;NADH dehydrogenase (ubiquinone)
C1711397;Biopsy
C0678879;Patients
C0592018;Pancreatic carcinoma
C1096155;Ileocolic intussusception
C3897752;Neoplasms
C0581394;Swelling of lower limb
C0326287;Ant-thrush (organism)
C3714524;Sarcoma
C3714516;RALA gene
C0052929;Targeted Therapy
C0230318;Structure of psoas muscle
C0002804;Malignant neoplasm of hepatic flexure of colon
C0678862;venous drainage
C1265292;Methicillin-Resistant Staphylococcus aureus
C1529274;Symptoms
C0678869;procyanidin
C3714514;Immunocompromised Host
C0232970;Proton Pump Inhibitors
C0376538;Porcine Reproductive and Respiratory Syndrome
C3714584;Child
C0603200;A549 Cells
C0858603;wave slowing
C1868500;Persons
C2004491;Macrophage Activation Syndrome
C0338265;Clinical Complete Response
C0376545;Lung
C0376544;Tumor Suppressor Genes
C1626404;Male population group
C3280118;Mild disorder
C4518217;Micropapillary adenocarcinoma
C0859969;Colectomy
C1168327;Patients
C0376515;Chronic Fatigue Syndrome
C0376518;Mus
C0376520;Heme
C1155003;Genes
C1155008;b-cell proliferation
C0810640;Social Networks
C3714552;Paresis
C1519840;Urothelial Neoplasm
C3714556;protrusion
C0376571;BRCA1 gene
C0747079;Osteoporosis
C1098710;Immune System Diseases
C0220925;Teratology
C2316164;Control Groups
C1434580;caspase-7
C1517205;Flare
C2004459;Transsexual (finding)
C0123759;Cycloserine
C1421283;Digestive System Neoplasms
C0748390;Carboplatin
C0220905;regulatory
C1518563;Older Population
C0220908;Gastroenterologist
C0206620;Lymphangioma Cystic
C0064993;Spleen Tissue
C0206622;Adenomyoma
C0206624;removal technique
C0206623;Lung
C0036189;Pulsatilla chinensis
C0376560;Colorectal Cancer
C0459424;Patients
C0459423;Patients
C0459422;Male population group
C0110468;Hyperplasia
C1520868;Neoplasms
C1446539;Chemoradiotherapy
C0302339;Pharmaceutical Preparations
C0051696;Calcium Channel Blockers
C0076992;cell growth
C0544420;Polymers
C0024188;Bone Marrow-Derived Cell
C1690939;20/25
C1421249;Immunologic Surveillance
C0037494;Control Groups
C0341950;Abscess
C0086305;Indocyanine Green
C1880101;Adjuvant Radiation Therapy
C1156273;iron ion homeostasis
C0280599;altretamine/etoposide/methotrexate protocol
C0267596;Patients
C0267597;Male population group
C0520459;Mutation
C1421246;TXK gene
C1421244;Colorectal Carcinoma
C0024192;Stenosis
C2247930;Secondary malignant neoplasm of liver
C0063695;Serum
C0063693;Protein Corona
C0242290;Organogenesis
C1880137;Patients
C1880136;Radical excision
C0242295;Iron Overload
C0242297;Defecation
C1001866;Colorectal Carcinoma
C0266257;Patients
C0302313;Osteolytic lesion
C2987342;LEE011
C0075689;Synaptosomal-Associated Protein 25
C0267581;colonoscopy
C0025498;Cystadenocarcinoma Mucinous
C0267582;Patients
C0751993;DDX53 gene
C0965129;Hydroxymethylglutaryl-CoA Reductase Inhibitors
C0751985;phenylpyruvate decarboxylase
C0254260;nobiletin
C0340643;Adverse effects
C0012197;phthalates
C0036140;Sodium Chloride
C4281805;Chimeric Antigen Receptor T-cells
C4281804;Substance-P Receptor Human
C4281806;Right colon
C0074349;Mus
C0751984;Malignant Neoplasms
C1421268;Patients
C1421267;Neoplasms
C0751980;research study
C0557702;Window (physical object)
C1506606;Solid carcinoma
C0038792;Anti-Inflammatory Agents
C1423854;In complete remission
C0617814;Polysaccharides
C0038790;sulfurtransferase
C1156245;tomography
C1156244;Anti-Antibodies
C0280544;Patients
C0025474;Phlebosclerosis
C3148643;phosphatidylinositol 3-kinase signaling
C0024141;inhibitors
C0735009;Rupture
C1422520;KLF4 gene
C0751973;Cancer-Associated Fibroblasts
C0376618;Endotoxemia
C1280903;Pancreatic Neoplasm
C0751969;RNA
C0012176;Fatty acid biosynthetic process
C1280902;Patients
C0012177;Colitis
C0086344;Immune response gene
C0012173;Peritonitis
C0037455;Analysis
C0700374;Edema
C0012171;Balanced diet
C3812881;Congenital diaphragmatic hernia
C0376620;Fecal Microbiota Transplantation
C0376622;HCT116 Cells
C1519904;Vaccinia Vaccine
C0025483;Diastasis
C0001497;Phosphoric Acid Esters
C0376623;Neoplasms
C3544050;LYPD8 gene
C0376628;Chromosome Breakage
C0544452;Disease remission
C1423861;Patients
C0458074;HIV Coinfection
C0036111;Typhoid Fever
C0086376;Proto-Oncogene Proteins p21(ras)
C0012144;Secondary Neoplasm
C0013470;Mus
C0520481;Pulsatilla chinensis
C0038774;Homo sapiens
C0024128;pemetrexed
C0520484;Mice Nude
C1157592;Nucleotide Biosynthesis
C0024121;MicroRNAs
C0074398;transcription factor activity
C3824899;HER-2 protein
C0036117;Malignant tumor of colon
C0038762;Taurine
C0012155;Diverticular disease of colon
C0038760;Colorectal Carcinoma
C0337037;Cell physiology
C0278252;Prognosis good
C1423887;Neoplastic Cell Transformation
C1422556;Anatomic structures
C0086369;Actinomycosis
C0278250;FDX1 gene
C0353980;Osmotic laxative
C0376601;Integrase Inhibitors
C0025465;Pedicle
C0036108;Oncorhynchus mykiss
C0038769;Colorectal Carcinoma
C1423884;Catenins
C0278259;Multimodal Imaging
C0459385;Brain tissue
C0194194;Carcinoma Transitional Cell
C0038750;Sulfites
C1423817;Tumor cells malignant
C0014780;Hybrids
C0073080;resazurin
C0073081;Patients
C0026766;Lung
C0205284;Lymphocyte
C0024109;African race
C0026769;Esophageal Achalasia
C0001468;SPEN gene
C0026764;Propranolol
C1880192;Vitality
C1096176;Guanidines
C0002792;Patients
C0013456;Patients
C0012125;Bentyl
C0279516;Dysentery
C0013459;major surgery
C0230255;Patients
C0086388;Education Medical Graduate
C0230259;Nodule
C0024117;BRD9 gene
C0024115;Malignant Neoplasms
C0001455;Cyclic AMP
C0205276;Mesenchymal Stem Cells
C0268843;Total mesorectal excision
C0916139;Carcinogenesis
C0268842;Diverticular Diseases
C2734537;Physicians
C0281839;Rupture of esophagus
C0230250;Carcinoid Tumor
C1423836;Tumor tissue sample
C0014762;leukemia
C0751912;SPINK5 gene
C0195495;Pathogenic
C1422502;Hepatocyte
C0279530;Malignant Bone Neoplasm
C0700361;Patients
C0242210;Cytoplasm
C0001480;Protoplasm
C0001483;Adenoviruses
C0544482;Inflammation
C3884528;Patients
C0279538;Plastic surgeon
C1422516;Adenocarcinoma
C0014772;nivolumab
C0013443;Canis familiaris
C0038720;Malignant tumor of colon
C0555198;Patients
C0195488;Patients
C0025424;Mercury
C0073096;epithelial sodium channel
C0026753;Multiple Birth Offspring
C1709157;Relative (related person)
C0242209;Amino Acids
C3884535;Neoplasms
C1423842;IL17A protein human
C0038727;Infantile convulsions and paroxysmal choreoathetosis familial (disorder)
C1336128;Laparoscopic radical hysterectomy
C0014742;HLA-B Antigens
C1568891;Obesity Visceral
C0556453;Exercise
C0002759;Apocrine adenocarcinoma
C0026727;lobe
C0242271;Retirement
C3871222;removal technique
C0002757;Stem Cell Factor
C0242275;Enzyme-Linked Immunosorbent Assay
C0266239;Patients
C0026724;Matrix Metalloproteinase 3
C0267567;Rectal Carcinoma
C0678812;Metastatic malignant neoplasm to brain
C0267566;Magnetic Resonance Imaging
C0916194;Neoplastic Cell Transformation
C0267561;Operative Surgical Procedures
C0230284;Fascia
C4302335;Duodenum
C0001418;Ileocolic intussusception
C0242262;Evaluation procedure
C0001413;Protein Kinases
C0267557;Kidney Failure Acute
C0002743;Alkaloids
C4316927;Endothelin-1 human
C0182158;Pads
C4304995;Perianal skin
C0013428;Male population group
C4531138;Short telomere length
C0230295;Surgical sutures
C0085098;Police
C0700325;Clinical Response
C0171484;Presenilin-1
C0267548;ileum
C0001443;2'-fluoro-2'-deoxyadenosine
C0002771;Perianal pain
C0002772;Community
C0230260;Carcinomatosis
C0700329;Physical shape
C0230278;Lipoma
C0002769;Study
C0002766;Neurolysis
C0267537;Antibiotics
C0001430;Benign Neoplasm
C0267532;Patients
C0267533;colonoscopy
C0002763;Caffeine
C0002760;Neoplasms by Site
C2064167;Neoplasm Metastasis
C1312140;Patients
C0630889;human cell line
C0230273;Symptoms
C0013404;Ischemic stroke
C0151977;Patients
C0871554;Tutors
C0151971;Primary ulcer of intestine
C0870221;Boys
C0594374;irinotecan
C0315096;Perforation of colon
C0162633;Viral Shedding
C1451683;Cytoplasm
C1425395;Motility
C2001938;protein phosphatase 6
C1260954;Enzyme-Linked Immunosorbent Assay
C0667830;caspase-3
C1764827;Gram-Negative Bacterial Infections
C0162638;Mice Nude
C0199900;Macrophage Activation Syndrome
C0150637;assessment.initial
C1412092;oxaliplatin
C0149640;Patients
C0872896;Angiogenic Process
C0860888;Magnetic Resonance Imaging
C0162643;Basis
C0679817;Relative (related person)
C0376029;Woman
C2266918;Colorectal Cancer
C1882082;Supportive care
C0162648;cancer care
C0162646;Surgeon
C0149678;latent infection
C0123047;Phosphodiesterase Inhibitors
C1690006;Lattice corneal dystrophy Type I
C3252172;Peptides
C1955541;Esophageal Neoplasms
C0679804;family intervention
C0679803;guided intervention
C0679809;Patients
C4086580;Midline Shift
C0402883;Silicon Dioxide
C0400222;Pelvic Floor Disorders
C1523807;proteasome-mediated ubiquitin-dependent protein catabolic process
C0149663;Intestines
C3541329;Anti-Inflammatory Agents Non-Steroidal
C0315063;Intestinal Microbiome
C0871549;trametinib
C1954276;Patients
C0315057;Chromobacterium violaceum
C0679860;Cancer Survivors
C0678530;Natural Science Disciplines
C0679862;Patients
C1511876;Cholangiocarcinoma
C0175906;Patients
C1136197;Solid Neoplasm
C0150600;Biopsy
C0281190;Persons
C1424020;Proteins
C4048280;Immune response
C3494442;Toxic effect
C0149614;adnexal mass
C1424025;liter/second
C0149615;Allogeneic bone marrow transplantation
C4086564;Mass Effect
C0151924;Inflammation
C3483776;Fluorouracil
C0905462;Present
C0040186;Structure of tibial nerve
C1523873;capsanthin-capsorubin synthase
C1522544;CSF2RA protein human
C0039194;Helper-Inducer T-Lymphocyte
C1412058;dioscin
C1413387;Appendiceal mucinous neoplasm
C0039198;Lithocholic Acid
C1412056;Gene Circuits
C0039195;Transcriptional Regulation
C3494454;Immune Cell
C0221502;Hospitals
C3494456;Wound Healing
C0221500;Evaluation
C0871525;therapist
C0040184;Secondary Neoplasm
C2240301;Neoplastic Cell Transformation
C0392998;Postoperative Complications
C1523842;Lumbosacral spine
C3470496;Micropapillary carcinoma
C0860871;Patients
C3829547;Patients
C0860864;Patients
C0860865;Patients
C0556085;Arteriosclerosis
C0596981;Epinephrine
C0209851;Adenocarcinoma of large intestine
C0151942;Patients
C2347168;Non-Small Cell Lung Carcinoma
C4086555;CST3 gene
C0679838;Cholangitis
C0596988;nintedanib
C1882062;Antineoplastic Agents
C2584620;Portal vein thrombosis
C1260969;Patients
C0341305;Adenocarcinoma of small intestine
C0343965;Globalization
C0041485;Amino Acids
C1413336;Ornithine Decarboxylase
C1282334;Dissecting hemorrhage
C3686472;Body Parts - Canal
C1414662;Protein Overexpression
C4086522;Childhood Solid Neoplasm
C1751580;short-chain fatty acid activation
C1414669;TRANSCRIPTION FACTOR
C1295653;Adult Liver Carcinoma
C1414671;Chromatin
C0041479;Tissue Adhesions
C1414670;CD69 protein human
C0341318;Patients
C1425328;Cervical Adenocarcinoma
C0040145;Patients
C1413347;CES1 gene
C0281163;educational intervention
C0679897;postoperative rehabilitation
C1414674;Patients
C0860803;Fast Growing
C1413342;Gene Mutation
C1414672;Secondary malignant neoplasm of bone
C0436226;High-Risk Cancer
C0282491;Gland
C1413349;Chronic Obstructive Airway Disease
C0282493;Rectal polyp
C0027183;Multiple Sclerosis
C1425324;Malignant tumor of colon
C0808232;Secondary malignant neoplasm of vertebral column
C3494414;Histone H3 Lysine 27
C1426651;Multiple tumors
C0041466;Malignant tumor of colon
C1449308;GLI1 protein human
C0040137;Fine needle aspiration biopsy
C4049599;Solid Neoplasm
C0040132;Mass of body structure
C1414688;Proliferation (morphologic abnormality)
C0281176;Patients
C1413357;Malignant tumor of colon
C2752631;functional differentiation
C1414685;Transcription Genetic
C1413355;CFL1 gene
C1414684;Colorectal Carcinoma
C1426669;Mouse Cell Line
C0042789;Community
C1414692;Homeostasis
C1067936;Phasis
C1414691;Mus
C0041455;Neoplasms
C0341339;Mus
C0341334;Patients
C0341335;risk factors
C0341336;Ulcer
C0281185;Community
C0281186;Prostate specific antigen measurement
C1412036;Italians
C0281187;Laboratory Procedures
C0678544;wave - physical agent
C3543908;SLC7A11 gene
C0436241;Malignant tumor of cervix
C0341332;Patients
C0475801;Leukemia Prolymphocytic B-Cell
C0042776;Microorganism
C0015153;Assay
C0039128;Communicable Diseases
C0016485;Food Preservatives
C0042779;protrusion
C1642385;Animal group
C0751690;Pancreas
C0030797;Lymph Node Involvement
C0030793;Right hemicolectomy and end to end anastomosis of ileum to colon
C0003161;Flavonoids
C0003162;Growth
C0751691;Perineurioma
C1366509;Migration Cell
C0392943;Patients
C0042765;Oxygen
C0341356;Complicated diverticular disease of large intestine
C0040100;Histological Techniques
C0015161;Signal Transduction Pathways
C1414635;Transcriptional Repression
C4505465;Benign condition
C1413301;Secondary malignant neoplasm of liver
C1101534;Huangqin-Tang
C1283694;Thickened
C0042769;Communicable Diseases
C0030788;Transsexual (finding)
C0003158;Rafoxanide
C0030785;X-Ray Computed Tomography
C0004482;Severe colitis
C1570187;HCT116 Cells
C2681866;IMPACT gene
C0039103;Male population group
C0017797;Extracellular
C0039101;Pelvis
C0066801;Flavonoids
C0017796;Crypt
C3900018;NF-E2-Related Factor 2
C1427957;Patients
C0678594;Cancer Stem Cells
C1427958;Signal Transduction Pathways
C0015133;Systemic Chemotherapy
C1366512;Cholangiocarcinoma
C1366514;Complication
C1366513;Cell Cycle
C4505456;Human immunodeficiency virus (HIV) status
C1366515;LEPR gene
C0749356;Male population group
C1414648;FMOD gene
C0341365;Diagnostic radiologic examination
C1427952;YBX1 gene
C0392921;Drug Delivery Systems
C0042742;Antigens
C0392920;advanced disease
C0341377;pathologic fistula
C3697172;Bone structure of cranium
C1427969;GA-Binding Protein Transcription Factor
C1413323;Promoter Regions Genetic
C1366524;wound complication
C0016470;Infiltration
C1366526;BTG2 gene
C0042749;Viremia
C1511806;House mice
C3470400;Patients
C3853222;Prognosis bad
C0027121;Dermatomyositis
C0341374;Adenocarcinoma of rectum
C0017776;Microorganism
C0017770;Neoplasms
C0762434;15-Hydroxyprostaglandin dehydrogenase (NAD+)
C3890228;Chemicals
C0282402;Laboratory Procedures
C0005789;Malignant Neoplasms
C0028429;Entire ear
C0028426;Patients
C0003123;MTHFR gene
C0004454;Accumulation
C1415912;IFNB1 gene
C0751651;Mitochondrial Diseases
C0738677;primary tumor
C0017789;Protoplasm
C1427906;Serious Adverse Event
C0042721;Antiviral Agents
C4482236;Homo sapiens
C1328252;Patients
C0016452;Colorectal Neoplasms
C0004448;Community
C0005779;Patients
C0521421;Nose
C0005778;Patients
C4038855;Portal embolisation
C0030744;Homo sapiens
C0005775;Inspiration function
C0054856;Patients
C0053524;Cultured Cell Line
C0078803;Inflammatory Bowel Diseases
C0005773;Stomach
C0005771;SERPINE2 gene
C3891560;Immune response
C0436188;Volumetry
C0053529;Neoplasms
C1293095;Robotic Surgical Procedures
C1293091;Patients
C0740981;Symptoms
C0740980;high-risk group
C0053530;Extraction
C0077503;NFKB1 gene
C1414603;ELF4 gene
C2350701;Oxidative Stress
C3179006;Neoplasms
C0054869;Extracellular Matrix
C0054868;Neoplastic Cell Transformation
C0017757;Phosphorylation
C3158983;mitochondrial permeability transition
C0017767;Tumor tissue sample
C0017764;GLUCOSIDASE
C1823654;DNA hypermethylation
C0017765;Peony
C1427926;Microsatellite instability-high colorectal cancer
C1823656;Malignant neoplasm of gastrointestinal tract
C0015101;Ethylmaleimide
C0751623;World
C3179010;Anus Neoplasms
C1136102;host cell surface
C1823651;Tumor tissue sample
C1414618;Chronic Obstructive Airway Disease
C0941053;Patients
C0003130;Intraepithelial Neoplasia
C3179017;Positive Surgical Margins
C1427923;SPINK5 gene
C1427920;Mutation
C1834304;Esthesia
C0016400;Focus Groups
C0700023;Dicyclomine
C3891518;Esophageal Neoplasms
C0065538;Oxidative Phosphorylation
C0005740;Bleomycin
C0268134;DNA Repair Gene
C0533453;AHR protein human
C0017735;Glucose
C0497156;Macrophage Activation Syndrome
C0017742;Glucose Transporter
C0016412;Folic Acid Deficiency
C0016410;Invasive Carcinoma
C0521463;Neoplasms
C0724000;Twenties
C0521464;Edematous skin
C0064219;Transformation function
C3661263;tumor growth
C0030700;Patient Readmission
C0016419;toll-like receptor 4 signaling pathway
C0030705;DPYSL3 gene
C0030701;Neoplasms
C2981722;Malignant Neoplasms
C0341406;Radionuclide Imaging
C0017710;Gastroparesis
C0450442;Vomiting
C0341402;Necrotizing fasciitis
C0740940;Complication
C0185373;Condoms Male
C0341407;Enteric intussusception
C0005767;Voluntary Workers
C0004434;atezolizumab
C2919733;high-risk group
C0053574;Cessation of life
C1366475;Microsatellite Instability
C0233494;SUPPLY NOT OTHERWISE SPECIFIED
C0232164;Cardiac function
C0233495;Health Personnel
C0017718;Oxidative Stress
C1750270;Mammalian Cell
C1656978;Vimentin
C0233497;Community
C0522772;colorectal resection
C0521440;Blood Vessel
C0521448;Accumulation
C1366486;Reverse Transcriptase Polymerase Chain Reaction
C1366487;FAP gene
C1317556;Natural killer cell function
C3889229;Body tissue
C0017725;PRKAA1 wt Allele
C3179062;Fiducial Markers
C2239360;DPY30 gene
C1522577;Klinefelter Syndrome
C0005707;Blastocystis
C3554594;Solid Neoplasm
C0315124;Clostridium leptum
C0315125;Bacteria
C0315126;Bacteria
C1175743;Genes Overlapping
C2239353;Patients
C0221423;Pharmaceutical Preparations
C1149472;STAT3 gene
C0388088;Protein Phosphatase 2A
C1112160;Microsatellite Instability
C1136170;Appendicitis
C1173118;Gastrointestinal dysfunction
C1883364;polyp benign
C0507191;Hypertrophy
C0065591;Colonic epithelium
C0315106;Bacteremia
C3242770;Analysis
C1136180;Animals
C0147080;Symptoms
C1883350;Patients
C0174680;Cancer Cell Growth
C1846366;Patients
C4325505;Right atrial mass
C2347112;Neoplasm Metastasis
C0076275;tumor growth
C0076278;Colorectal Carcinoma
C0064280;macromolecule
C0232100;Exsanguination
C0175996;Mucins
C3179034;RNA Messenger
C0149684;Partial Resection
C1150423;Matrix Metalloproteinase 2
C0221460;Farmers
C3890285;Real-Time Polymerase Chain Reaction
C0473169;Pilot
C3890287;Human tissue
C1136135;Defecation
C0556110;Colorectal Carcinoma
C0199939;Carcinoma of ampulla of Vater
C0162657;actin cytoskeleton organization
C1956962;Stage IV Rectal Carcinoma
C1136140;Reproduction
C0174641;fisetin
C3277418;Adenomatous Polyposis Coli
C0556120;Colorectal Carcinoma
C3661202;Oncogene Proteins
C0159028;General symptom
C1870006;PTPRC protein human
C0149778;Soft Tissue Infections
C0919938;Jejunal interposition
C0341268;Multiple ulcers
C3494363;Microorganism
C1700035;Mus
C1018829;polyphenols
C1954124;High-Grade Squamous Intraepithelial Lesions
C3470388;Patients
C0860760;ph normal
C0341274;Concurrent Chemoradiotherapy
C1318902;Colorectal Carcinoma
C0162768;EPHB4 gene
C0150788;caffeic acid
C0426732;Large prostate
C1511737;histone deacetylase 6
C3495676;Patients
C1448177;TRPV4 gene
C0162735;Anti-Anxiety Agents
C0162734;Diffusion weighted imaging
C3818725;corticotropin human
C0149784;cancer recurrence
C0040087;Thymidine Phosphorylase
C0149782;Male population group
C0149783;Granulomatosis
C0150773;Anal pain
C0150775;Transformers
C0871424;Drug Packaging
C0040083;Angiogenesis Factor
C0040085;Colorectal Neoplasms
C0162745;COLLAGENASE
C0040077;Thymidine Phosphorylase
C0556179;Survivors
C0039082;Single lesion
C1412166;Actins
C3494323;early detection of colorectal cancer
C1149384;Patients
C3470354;Glioma
C1510420;Gland
C1425478;Neutrophil Extracellular Traps
C4086681;Overall Survival
C0162713;Toxic effect
C0148405;Diterpenes
C1136085;Refractory Neoplasm
C1136080;Ability
C0039070;Tachycardia Ventricular
C0377278;Proteins
C0678646;Malignant Neoplasms
C1510411;Body tissue
C0040061;Malignant Neoplasms
C0162728;Pharmaceutical Preparations
C0149726;Male population group
C0149725;Tuberculosis
C1412182;Extracellular Matrix
C1412181;Proteolysis
C0041385;Interleukin-8
C0149750;Malignant neoplasm of transverse colon
C2347055;Fluorouracil
C0916006;Plants
C0150740;Evacuation procedure
C1436157;Colorectal Carcinoma
C0860752;Increased lactate
C0040053;Veins
C4528280;Secondary malignant neoplasm of liver
C1424167;Cell Proliferation
C0040048;Solid Neoplasm
C0040046;Left internal jugular vein
C0234913;Woman
C3843708;First line treatment
C1510438;Luciferases
C1511767;Immunity
C0317563;sphingosine 1-phosphate
C0919989;Woman
C1955474;Patients
C0027088;Endometriosis
C1510432;Radiotherapy planning
C0929301;Heterophil
C1522406;Autophagy
C0041370;Protein Phosphatase 2A Regulatory Subunit PR53
C0640041;Neoplasms
C1823840;Multiple tumors
C0449437;Patient status
C0040038;Malignant Neoplasms
C0041368;Superoxide Dismutase
C0041365;Locally Advanced Malignant Neoplasm
C0040034;Pharmacotherapy
C0041364;Carcinoma Small Cell
C0678695;Toxic effect
C0331860;Laboratory Procedures
C0449430;Visceral Pain
C1293116;Primary Health Care
C1412128;fatty acid oxidation
C0041361;Immune response
C0027051;Anti-Inflammatory Agents Non-Steroidal
C1425435;Malignant Neoplasms
C0042693;Social Networks
C0003082;Apigenin
C1293115;Patients
C3470316;Tumor Progression
C1413460;mRNA Expression
C0040028;American College of Cardiology/American Heart Association Lesion Complexity Score C
C0041356;Spices
C2981795;advanced cancer
C1412137;Tumor Cell Invasion
C1413469;CLDN2 gene
C1413467;Adenocarcinoma of small intestine
C3830456;Discrepancy
C0003075;Anions
C2919828;Adult
C0003070;Animals Wild
C1426772;RNA Interference
C1293122;Ability
C0027061;Rattus norvegicus
C0042679;multicatalytic endopeptidase complex
C0041348;Tubulin
C1004293;Coprococcus
C0041343;Female Genital Diseases
C3816154;LINC00901 gene
C0042672;Vinca Alkaloids
C0150706;Minimally Invasive Surgical Procedures
C1413477;Phytic Acid
C0281297;Stage IVB Uterine Corpus Cancer
C0016382;Rare Diseases
C1413475;GKLF protein
C4086621;Clinical Trials
C0030699;Evaluation
C0030695;Patients
C0497093;Age
C0028360;Pharmaceutical Preparations
C1293130;Binding (Molecular Function)
C1293132;trametinib
C0341217;Amputation Stumps
C0042666;Musculoskeletal torsion function
C0040005;Patients
C0330562;Plant seeds
C1413484;Blood Vessel
C2752522;Capsid Proteins
C0030685;Indomethacin
C0149707;Hematuria
C1426797;Mucous Membrane
C1424135;Crypt
C2681724;Neoplasms
C0039003;Exercise
C0042655;videocassette
C0016368;cytotoxicity
C0425424;Patients
C0017696;Metabolite
C4048328;Alaska Natives
C0016365;Mirtazapine
C0425422;Patients
C0039005;Family suidae
C0282560;matriptase
C0015031;Malignant Neoplasms
C3829491;Isolated Tumor Cells
C0748164;Multiple Pulmonary Nodules
C0016360;activity level
C0282563;Colorectal Carcinoma
C0041327;Patients
C1823882;U2AF2 gene
C0027015;Myeloma Proteins
C0003047;Animal Diseases
C0810473;Patients
C0750484;Cohort
C1835863;Nose
C0342569;Patients
C3816168;Second Primary Cancers
C2169814;Male population group
C0041312;Abdomen
C0750479;Tube feeding of patient
C0031990;Oxicams antiinflammatory and antirheumatic drugs
C0041317;Tuberculosis Male Genital
C0763617;Ribosomes
C0027028;Jejunum
C0004366;Kidney
C0030664;Pathology
C0027022;Myeloproliferative disease
C0004364;Primary biliary cirrhosis
C0005695;general population
C0030660;Elderly (population group)
C1425404;ATP6V1C2 gene
C0005690;removal technique
C0027021;Interleukin-6
C0030669;Surgical Pathology specialty
C0016343;phosphoramidate
C0016344;NUCB1 gene
C0342579;Patients
C0341248;Chronic duodenitis
C1412104;PAXIP1-AS1 gene
C0282583;Pathological Dilatation
C0749474;lobe
C0425440;Colorectal Carcinoma
C2680419;Biological Processes
C1412102;Patients
C0652089;Neoplasms
C1412103;cetuximab
C0282588;Drug Resistance Neoplasm
C1823860;Growth
C0054943;Body tissue
C0004398;Intussusception
C0412123;removal technique
C0003064;nifuroxazide
C0003062;monoamine
C0004391;interstitial cell
C1835841;Tumor cells malignant
C0017689;Erythema
C0017687;Hepatocyte
C0016356;Ulcer
C0016352;Fluorometry
C1412113;Malignant neoplasm of anus
C1366645;House mice
C1412111;Reactive Oxygen Species
C0281267;bilateral breast cancer
C0282598;Screening colonoscopy
C0282599;Retrospective Cohort Study
C0293237;Membrane Transport Proteins
C0751785;Patients
C0295893;Malignant neoplasm of brain
C1425426;Body tissue
C0751781;Dentatorubral-Pallidoluysian Atrophy
C0342582;Male population group
C0018988;Tumor cells malignant
C0016325;Fluoride Poisoning
C0042610;Veterans
C0017654;Symptoms score
C2363916;Male population group
C0016321;Fluorescent Probes
C0220283;Liver neoplasms
C1822478;Trauma rates
C1366537;Bacterial Infections
C0003009;Alzheimer's Disease
C0282521;DNA
C4543702;pembrolizumab
C0282523;Adenocarcinoma of duodenum
C0424093;Cohort
C0762318;Neoplasms
C1101322;Anti-Inflammatory Agents
C0078933;Blood Vessel
C0054967;CD6 antigen
C0017658;Glomerulonephritis
C0016327;Mammals
C3889123;SMG1 wt Allele
C0281206;Leukotriene Receptor Antagonist [EPC]
C0534858;Reperfusion Injury
C0282539;Palestinian race
C0546861;Doxorubicin
C1281196;Entire right ovary
C0031955;Anti-Bacterial Agents
C1367872;Metastatic Ureteral Neoplasm
C0763658;BIRC3 protein human
C0750430;Large Mass
C4048302;soluble
C0018966;Dietary Iron
C0282547;Assay
C0018965;Symptoms
C4325600;meiotic nuclear division
C0233577;Non-Small Cell Lung Carcinoma
C0018964;Hematoxylin
C1632842;Appendiceal Neoplasms
C3179121;Saponins
C0750426;Pouchitis
C2680450;subapical complex location
C1366555;Persons
C0282540;arab ethnic group
C0245561;Pain Postoperative
C3686650;Obstruction
C0004358;Cytoplasm
C1366550;Acute Chest Syndrome
C0005684;Spina Bifida
C0005682;Macrophage Activation Syndrome
C0005680;Black race
C0450363;Epithelial Cells
C0017638;Brain Neoplasms
C0017639;Intestinal Pseudo-Obstruction
C0017636;Malignant neoplasm of brain
C0282557;Immune Response Mucosal
C0016315;Fluorescence
C4050636;Ethanol
C0556202;Pancreatic Ductal Adenocarcinoma
C0282552;beta-Chemokines
C0282553;Immunity
C0282554;Colonic Neoplasms
C0449381;oxaliplatin
C0245557;therapeutic autologous dendritic cells
C0003015;Perindopril
C0030600;Stomach Carcinoma
C1366563;TFF2 gene
C0031939;Melatonin
C0016318;intracellular protein transport
C0018944;Postoperative Hemorrhage
C0018943;Hematology (discipline)
C2680477;Tumor tissue sample
C0018941;Thrombocytopenia
C0700148;Colon structure (body structure)
C0425382;Colorectal Carcinoma
C0546816;CD69 protein human
C0076316;Body tissue
C0400084;Ischemia
C2917212;Stomach
C0031928;Health care facility
C2680470;Clone
C0018946;intracranial metastatic tumor
C0031921;Escherichia coli
C4266455;removal technique
C0018951;ribosome biogenesis
C4266454;Appendix
C0521585;Fluorouracil
C0520251;Patients
C0052350;arginyl-glycyl-aspartic acid
C3650625;Abnormal uterine bleeding
C0078960;Anterior Cruciate Ligament
C0005615;World
C0271844;Parathyroid hyperplasia
C0076305;tetramethylpyrazine
C1366587;SPHK2 gene
C0256264;Marginal Zone
C0018956;flavan-3-ol
C0018922;Intracranial
C0018920;Hemangioma Cavernous
C0282507;Heat Stress Disorders
C3266814;Action
C4231719;Wnt receptor complex
C0354604;Advanced Malignant Solid Neoplasm
C0006948;Carbamates
C4266460;Lesion
C0018926;Patients
C0018923;Biopsy
C0018932;follow-up
C0282515;Rectal polyp
C0065684;mannose receptor
C0282512;Faculty
C0005632;Laxatives
C0232292;Patients
C0078988;risk factors
C4038952;Patients
C1100024;Lymphoid Cells
C0052377;Clonal Expansion
C0018939;Hematological Disease
C0018935;Cell Count
C0063034;IL17 Signaling Pathway
C0087009;Hospital specialist
C0700101;Carcinoma Transitional Cell
C1136031;Gene Silencing
C0870186;Patients
C1511790;Postoperative Hemorrhage
C1869153;Mus
C1305671;Cytology procedure
C3890199;GA-Binding Protein Transcription Factor
C1511789;Cervical Adenocarcinoma
C0006931;bile acid metabolism
C0185468;Patients
C0077678;Catabolism
C4300350;Severe colitis
C0172161;Stage III Colon Cancer
C0018916;Hemangioma
C0018915;Hepatic
C0088359;14710-tetraazacyclododecane- 14710-tetraacetic acid
C3266856;Transgendered Persons
C0700124;Dilated
C2363973;Patients
C0006901;Hyperplasia
C0221512;Woman
C1510483;histological diagnosis
C0006904;calcitonin receptor-like receptor
C3541167;Adenocarcinoma
C1318969;Patients
C2348331;Patients
C0184114;Extraction
C1149372;Cohort
C1510475;Intestinovesical fistula
C0184113;Decompression of intestine
C1522449;Mice Nude
C1318968;Ultrasonography
C1510470;Rattus norvegicus
C1318963;Readiness
C1317608;Patients
C1522495;Biopsy
C0258855;aggressive cancer
C0556213;Gastric Adenocarcinoma
C3266877;Seminoma
C1317600;patient symptoms
C1968835;Mycobacterium avium Complex
C0087044;TCF4 gene
C0556227;Colorectal Carcinoma
C3889161;Colorectal Neoplasms
C0871489;teams
C0063083;Toxic effect
C0087068;99mTc-Human Serum Albumin
C0556234;Middle Aged
C1140999;Patients
C0075086;Homo sapiens
C3686612;Present
C0162772;Abnormality of mitochondrial metabolism
C0087065;Taurine Lithocholate
C0233532;Microbiome
C1522486;Solid Neoplasm
C1522485;Tracer
C2363923;Falls
C0870134;ancestors
C0870132;Colorectal Carcinoma
C0871463;surgical patients
C0162788;Analysis
C0162782;Malignant Neoplasms
C0162781;Thiobarbituric Acid Reactive Substances
C0087051;Secondary Neoplasm
C2000799;EPHB2 protein human
C0317608;Lactobacillus plantarum
C0162789;Analysis
C0400447;Surgical Management
C0920809;Thickened
C0871311;Patients
C1979775;Oncology drugs
C0596790;Carcinoma Signet Ring Cell
C0162871;Aortic Aneurysm Abdominal
C0087086;Colon Carcinoma
C0449719;Cancer-Associated Fibroblasts
C0424403;Elderly (population group)
C1413188;Patients
C1426490;Small cell carcinoma of lung
C0149889;Vagina
C0400469;Pancreatic Intraductal Papillary-Mucinous Neoplasm
C1512944;T-Cell Receptor
C1512948;macrophage
C0391861;Patients
C0391860;Chronic disease
C1451465;PTK2 protein human
C0857021;Patients
C1512942;Paget Cell
C0860675;Ruptured Appendicitis
C1511605;Neoplasms
C1511606;Abdomen
C1425182;Diastasis
C0041296;Lower respiratory tract infection
C0041290;Laboratory Procedures
C1835909;T-Lymphocyte
C1414460;Tumor Angiogenesis
C1415790;Craniosynostosis
C0582103;Asymptomatic
C2348280;Chronic disease
C0679624;Malignant neoplasm of gastrointestinal tract
C0162832;Basis
C0162830;Radiation Damage
C1823924;Colorectal Carcinoma
C1440756;Neoplastic Cell
C0041282;Patients
C0162836;Gluteal
C0041281;Injection of therapeutic agent
C0162834;Woman
C1413149;Neoplastic Cell Transformation
C0860603;Duration
C1172033;Inflammation
C0041271;Diverticular Diseases
C4325235;Constipation
C0750197;Cancer Patient
C1413153;Malignant Neoplasms
C0206116;TYROBP gene
C0149871;Kidney Failure
C0557165;Survivors
C1413159;Adenocarcinoma
C2348264;Functional disorder of intestine
C2362561;Persons
C1413157;Adenocarcinoma
C0206111;Motility
C1512980;Neoplasms
C0221715;Male population group
C0041260;Tissue specimen
C0123257;Patients
C0582119;Mitochondrial Membrane Outer
C0123256;Patients
C1413161;Dendritic Cells
C0400439;Secondary Neoplasm
C0376284;Multimodal Imaging
C1512977;Cellular signal transduction
C0412412;Accumulation
C0042582;Laparotomy
C1425148;Chronic Obstructive Airway Disease
C0042580;Patients
C0028296;Nonagenarians
C0041249;Mental disorders
C2737259;Cell Count
C0042578;Pharmaceutical Preparations
C1427739;MAP Kinase Cascade
C0041242;Alpha 1
C1427738;lysophosphatidic acid
C0016284;Patients
C1414424;Specimen Type - Serum
C1415755;Polyp of large intestine
C1414421;EPAS1 gene
C1415752;MET protein human
C3830326;Electrochemiluminescence
C1414429;Secondary Neoplasm
C0111208;Poor outcome
C3843645;1-10
C3843646;Adenoma
C3843647;Survivors
C0042567;Vertebrates
C0041236;TRYPSIN
C4505263;Cytoplasm
C0679651;Symptoms
C4505265;Cohort
C1822624;Phosphorylation
C0030580;Secondary Neoplasm
C0016293;Pharmaceutical Preparations
C1415764;Fumarate Hydratase
C1414432;Neurons
C3483978;Participant
C1414431;Fusion protein
C1415761;Cytoplasmic matrix
C3468355;female genital cancer (diagnosis)
C1413108;Human tissue
C0810300;Ursodiol
C0162801;intestinal adenocarcinoma
C0149801;Hospitalization
C0280089;Carcinoid tumor of lung
C0449774;Cancer Stem Cells
C0342895;Mus
C1822614;gemcitabine
C0016263;Necrosis
C3203359;Parenchyma of spleen
C0679646;Calcium Dietary
C0028246;Colon structure (body structure)
C3470691;Chronic Obstructive Airway Disease
C4288171;Submucosal Lesion
C0041213;Trypan Blue
C0042542;diphyllin
C0243092;intestinal adenocarcinoma
C0016278;Persons
C3542813;Long Term Survivorship
C1414459;Hybrids
C0243095;Patients
C0030560;Air
C4505245;Receptor Notch4
C1413121;CAPZA1 gene
C0679637;Pain Postoperative
C0028259;Mass of body structure
C0030567;Neurodegenerative Disorders
C3203360;Chemoradiotherapy
C0030563;Real-Time Polymerase Chain Reaction
C4289495;Adenocarcinoma
C1425106;Colorectal cancer specimen
C1425101;Secondary Neoplasm
C0149826;Family history
C3470687;Cultured Cells
C0041200;Salmo trutta
C0677043;Histopathology
C0282682;Inflammation
C0281351;Patients
C0282683;Angiogenic Process
C0391841;Oxygen content
C0041206;Patients
C4036467;Gray-zone
C0004259;Patients
C3854325;Dermatitis Atopic
C4086720;Patients
C1749467;KL protein human
C0030552;Neurologic Examination
C0030551;parent
C1415714;Urinary Diversion
C0751455;Adenocarcinoma
C2677107;SCOLIOSIS ISOLATED SUSCEPTIBILITY TO 5
C0031886;Aichi virus
C2677108;SCOLIOSIS IDIOPATHIC SUSCEPTIBILITY TO 4 (finding)
C3842346;Elderly (population group)
C0042520;Plasminogen Activator Inhibitor 1
C4288189;Tubular adenoma
C0474700;Stomatitis
C0281361;Mus
C4086729;lymph nodes
C3203348;Biological Factors
C4520854;Patients
C0005575;Biotin
C0341593;Rectum excision (procedure)
C1427702;Adenocarcinoma of large intestine
C0582175;infection as a complication
C0053725;bis(cyclopentenecarboxylato)-12-diaminocyclohexane-platinum(II)
C0030548;Patients
C0030547;Encephalopathies
C0018889;Helminthiasis
C0017558;Gill structure
C1512909;Organoids
C0042514;Syncope
C3541532;Body tissue
C0042510;Syncope
C0018882;Helix (Snails)
C0679688;Persons
C4520844;School Health
C1822654;Cessation of life
C0043847;caspase-3
C3469659;Cell Survival
C1414408;EZH2 gene
C0666361;Bone lesion
C1414407;Malignant Neoplasms
C1414406;Patients
C1414405;LINC00174 gene
C0004271;Persons
C0836921;RUNX3 gene
C0836924;Colorectal Carcinoma
C0449738;T-Lymphocyte Subsets
C0031866;Phytochemicals
C0043832;Cell Death
C0751429;Stage IV Colon Carcinoma
C3495919;Cystic Fibrosis
C0016234;Neoadjuvant Therapy
C0018894;Bile Acids
C0279068;Cancer Patient
C0017563;Inflammation
C0004268;Larva
C0030520;Lesion
C0028210;Severe inflammation
C1835951;Cancer of Digestive System
C0031855;Patient Discharge
C0052418;Neoplasm Metastasis
C0017535;Giardia lamblia
C0016204;Anus
C0018866;Erinaceidae
C0282646;Cell Count
C0281318;partial response
C0282649;Urokinase Plasminogen Activator Receptor
C0751416;Survivors
C0701159;Patient in hospital
C0243041;ANTXR1 wt Allele
C0243043;Membrane
C0243044;ATP8A2 protein human
C0243045;Receptors Tumor Necrosis Factor Member 10b
C0006886;Protein Phosphatase 2A
C0342917;Liver damage
C0031845;Adult
C0295967;Cohort
C0005544;Hospitals General
C2700007;Patients
C4013784;regorafenib
C2919552;zotarolimus
C3842383;Tubular villous adenoma
C3842384;colonoscopy
C2931201;systemic therapy
C1113679;Colon and Rectal Surgery (procedure)
C2931202;Urachal cancer
C1872855;adjuvant therapy
C0031843;Community
C0317944;Parvimonas micra
C0317943;Blautia producta
C3180220;RNA Messenger
C0279000;Electroporation Therapy
C0929176;Hepatic
C3179233;MEK-ERK Pathway
C0018873;HeLa Cells
C3179230;Anti-Angiogenesis Effect
C0993756;Disease
C0243032;Tuberculosis
C0523843;Cell Count
C1845248;Outbursts
C0065749;Plasmids
C0243035;MIR1-2 gene
C0243037;Pharmaceutical Preparations
C0243038;Mus
C0031837;Physics
C0005532;biology (field)
C0052430;Antibiotics
C0206093;Neuroectodermal Tumors
C3662314;Patients
C3853043;Insurance Beneficiary
C0052432;Platinum
C3179234;Indoleacetic acid
C0016219;Flowers
C0031831;Icterus
C0341602;Surgical incisions
C1150635;Mast/Stem Cell Growth Factor Receptor Signaling Pathway
C0065751;Alkaloids
C0065752;Old age
C1113652;High-Grade Squamous Intraepithelial Lesions
C0341600;Patients
C0243021;Pharmaceutical Preparations
C0341605;Stomal bleeding
C0006863;Candidate Disease Gene
C1821244;Normal development
C0004238;Electrocardiography
C0341608;Stomal varices
C3890009;Proteinuria
C0053776;bisantrene
C0052441;SP1 gene
C0005560;Metastatic Renal Cell Cancer
C1835886;Angiogenic Process
C0018847;Heat Shock Protein 27
C0929193;Disease
C0279025;Primary malignant neoplasm of prostate
C1823897;VEGFA gene
C0279027;Patients
C3890011;PIN1 wt Allele
C0018850;Molecular Chaperones
C0342942;Surgical Procedures Laparoscopic
C0341610;Patients
C0031809;Bendamustine/Bortezomib/Dexamethasone Regimen
C1415700;Patients
C0460043;Neoplasm Metastasis
C0304627;Inflammation
C3890018;HSP90B2P wt Allele
C0282675;Tertiary Care Centers
C0005558;Metastatic Carcinoma to the Uterine Cervix
C1823893;Multiple tumors
C3640966;Pericardial effusion
C1858576;Patients
C0460048;removal technique
C0232370;Florid red complexion (finding)
C1294197;Mucous Membrane
C0558507;Patients
C0018823;Cardiomyopathy Familial Idiopathic
C1306673;Stage
C0243082;Thalidomide
C0282608;Body tissue
C0243083;Patients
C0243087;Heart
C0005507;Assay
C0522567;Mild inflammation
C0522568;Moderate inflammation
C0522569;Bladder mucosa
C0053799;Adrenergic beta-Antagonists
C0270629;Epidural Abscess
C0740721;Disease
C0051134;Neoplasms
C0018827;Muscle Cells
C2700041;Colorectal Carcinoma
C0018834;Capsaicin
C0282614;Operative Surgical Procedures
C0243072;Tumor Progression
C0243077;metastatic hypernephroma
C1846535;Stem cells
C1123023;antileukoprotease
C0018801;Anti-Inflammatory Agents
C0282624;ovarian neoplasm
C1123019;Domestic Sheep
C0282625;SRMS gene
C0342978;Abdominoperineal resection
C0521210;Sessile polyp
C2314848;Euchloe ausonia
C0005527;Patients
C0521213;Laboratory Procedures
C0005525;Oncogene Proteins
C0076456;Transverse colon
C0006826;South Asian
C0268353;BARRIER
C0018809;Patients
C1317301;Cirrhosis
C0018802;Clinical Observation
C0282636;Cell Respiration
C3156592;Inflammatory Bowel Diseases
C1123009;vasculogenesis
C0282638;Surgical Wound Infection
C0474643;Vaccines
C3156591;Colorectal Neoplasms
C0534519;mRNA Expression
C0282639;Fenofibrate
C0243052;Crohn Disease
C1367578;TP53 gene
C0005516;Stage IV Colorectal Cancer
C0005515;Skin carcinoma
C0460002;MLH1 gene
C0460004;Adenoid Cystic Carcinoma
C1571338;Growth
C3539197;Malignant Neoplasms
C0210995;FAMILIAL ADENOMATOUS POLYPOSIS ATTENUATED (disorder)
C1883589;Adverse Event Outcome
C2350562;Chemicals
C0870071;Health center
C0206008;Congenital Abnormality
C1955856;CD69 protein human
C0919766;Decreased vitamin D
C1306645;Macrophage Activation Syndrome
C0919765;Malignant tumor of colon
C1511667;Cell Death
C0184252;Medical Valves
C0077791;Colorectal Carcinoma
C0006812;irinotecan
C1511661;DNA Damage
C0596843;brexpiprazole
C0303390;Cobalt-55
C0064494;Surgical circumferential margin finding
C0087111;Biologic Development
C0582205;Analysis
C1955822;NOAC protocol
C1523645;production of miRNAs involved in gene silencing by miRNA
C2362527;Cachexia
C1306613;Pancreaticoduodenectomy
C0206031;Hospitals High-Volume
C0206034;DNA Nucleotidylexotransferase human
C1450093;FBXO10 gene
C1523647;miRNA binding
C4303971;Gastrointestinal Diseases
C0087134;Uninsured
C1320928;Resident (physician)
C0087136;African American
C0270612;Beriberi
C0270614;Patients
C0920779;Colitis Ischemic
C0087130;Perceived quality of life
C0089793;dieckol
C0206058;Gastrinoma
C3266992;Adenocarcinoma of lung (disorder)
C0233677;Patients
C0871356;Sexual function
C2362501;Homo sapiens
C0243001;Gastrointestinal perforation
C0546535;postoperative analgesia
C0245662;Apoptosis
C1979852;Neoplasms
C1425074;UCN3 gene
C0075189;Phosphoproteins
C2350522;Surgeon
C0087162;Peripheral Neuropathy
C1077578;Bikinia le-testui
C0497327;Cohort
C1979844;Trypsin Inhibitors
C0596803;iron metabolism
C1702824;necrostatin-1
C3179280;Radiation-Sensitizing Effect
C0206076;Woman
C1883562;Working Group
C3192263;Marinesco-Sjogren syndrome
C1450054;Artificial nanoparticles
C2919576;Patients
C1536999;cancer angiogenesis
C0206082;Woman
C2239176;Long-Term Potentiation
C0232338;Jejunum
C1883559;Negative
C0206062;Lung Diseases Interstitial
C2919572;Digestive System Disorders
C0206061;Neoplasms
C0206066;Myocutaneous flap
C0206065;primary tumor
C4314646;Patients
C1210564;Administration Oral
C0378796;SLC6A2 protein human
C1512804;Insulin Signaling Pathway
C0907709;Centromere
C1425274;Transcription Genetic
C0041199;Troponin
C0197607;Implantation procedure
C0400330;Abdominoperineal resection
C1425289;Circulating Tumor DNA
C0424316;Exuberance
C3820816;quiescence
C0596890;Aurora Kinase A
C1210581;Prebiotics
C1425291;Methylation
C1425292;Epithelial Cells
C1749524;Tumor Necrosis Factor Ligand Superfamily Member 6
C0861876;Recurrent Hepatocellular Carcinoma
C1512814;gastrointestinal toxicity
C1512812;DCBLD1 gene
C1512811;Integrin Inhibition
C3539125;Neutrophil Extracellular Traps
C0303190;Copper-64
C0041165;Communicable Diseases
C0232504;Hemorrhagic diarrhea
C1822712;Signal Transduction Pathways
C1511518;Diploid Cell
C2216322;Malignant tumor of colon
C1260873;Clinical Observation
C3470592;ENO3 gene
C0149978;Middle Aged
C0041158;Trocar
C1413260;Cytoplasm
C0861819;Pharmacotherapy
C3844813;Patients
C0042487;Venous Thrombosis
C1511504;Gastric Adenocarcinoma
C0596883;Colon structure (body structure)
C0919721;Digestive System Neoplasms
C0861814;Papilla
C2363781;Multiple Cerebrovascular accidents
C0679739;peer
C3470585;oxaliplatin
C0605411;Neoplasms
C0162969;Birth
C0219510;mutant
C1413274;Single Nucleotide Polymorphism
C0376152;Bone Tissue
C0376154;Skin callus
C1452875;Colorectal Carcinoma
C3554772;Persons
C0679729;research
C0030499;Parasitic Diseases
C0030498;Parasites
C0304497;RNA
C1425259;Metabolism
C2350467;alpha-galactosylceramide
C0221839;Colorectal Neoplasms
C0920746;Patients
C2350466;Lymphoma
C0848860;endocrine carcinoma
C0233820;Cohort
C1272820;Secondary malignant neoplasm of liver
C0016194;Escherichia coli
C1413289;pyridine
C1413287;Tumor Suppressor Genes
C0596869;Neoplasm of lymph node
C1426592;Tumor cells malignant
C1512853;epithelial to mesenchymal transition
C2242626;Hypertension Portal
C0861830;Pancreaticoduodenectomy
C2242628;Pouchitis
C0666411;Tumor cells uncertain whether benign or malignant
C0401641;Hospitals
C0016169;Human Papillomavirus
C0016167;Anal Fissure
C0042454;Velopharyngeal Insufficiency
C0341422;Patients
C1858709;HEPATIC FIBROSIS SEVERE SUSCEPTIBILITY TO DUE TO SCHISTOSOMA MANSONI INFECTION
C0016163;Fishes
C0030472;Hematologic Neoplasms
C1415877;Colorectal Cancer
C1846723;Adipogenesis
C1415876;Mutation
C0149939;Malignant Neoplasms
C0029473;Peristomal fistula
C0341439;Ascites
C0042446;sphingosine 1-phosphate
C0043775;Endoplasmic Reticulum Stress
C1272883;Diastasis
C1101610;Cancer Cell Growth
C0174906;Constipation
C1415888;Cutaneous Melanoma
C1413227;Adenocarcinoma of rectum
C1822742;SLC25A32 gene
C3661066;TDM-621
C0042449;liver infection
C0053800;Extracellular Signal Regulated Kinases
C3470541;Colorectal Carcinoma
C0028156;Biological Factors
C0028155;Dysentery
C0436343;Patients
C0028158;Body tissue
C0005496;Signal Transduction
C0436345;topiramate
C0005495;Origin of Life
C0042440;Colorectal Carcinoma
C0005492;Malignant Neoplasms
C0149925;Liver
C0017472;MSH6 gene
C0017473;Persons
C1822730;Western Blotting
C1414563;Malignant tumor of colon
C0966063;phenolic acid
C0028128;Protoplasm
C0029453;Osteoporosis circumscripta
C0029456;Persons
C1426548;Growth
C0149955;Malignant Neoplasms
C0031789;Growth
C0042425;Adenosquamous carcinoma
C1414571;Prognosis good
C3843504;aflibercept
C0016158;Food
C0016157;Colon Carcinoma
C0679750;concomitant disease
C1413248;Disease Progression
C0255194;intestinal adenocarcinoma
C1413244;Genes
C0030446;tat Genes
C0267179;Gastrocolic fistula
C3470560;Colorectal Carcinoma
C1425225;Magnesium
C0162905;Cell Proliferation
C0029463;Persons
C1834700;Pneumonia
C1425224;Tumor tissue sample
C0122005;Genes
C1821461;Patients
C0042413;Vasopressins
C0018787;Adverse reaction to drug
C4505353;colonoscopy
C0809246;Non-Small Cell Lung Carcinoma
C0004135;Wound Healing
C0004134;Leukoencephalopathies
C3805278;Hepatitis C
C0751571;reproductive system disorder
C1822781;Gene Expression
C0018799;Diabetes Mellitus Non-Insulin-Dependent
C1427829;Malignant neoplasm of gastrointestinal tract
C1328050;Patients
C0751569;Metastatic Renal Cell Cancer
C0017463;cancer diagnosis
C0018790;Intestines Small
C4505345;Rapamycin-Insensitive Companion of mTOR Protein
C1415842;In complete remission
C0436307;Suppuration
C0029446;Neoplasms
C0028115;bacteriocin
C0005456;Malignant neoplasm of brain
C1414518;ACSL1 Gene
C0030421;Colon structure (body structure)
C1415846;Colorectal Carcinoma
C0281481;Adult
C0004120;Homo sapiens
C0031753;lymph node positive
C0018767;Participant
C0449616;Submandibular triangle structure
C0150904;Interventional procedure
C0006780;Nail-Patella Syndrome
C0150905;Therapeutic procedure
C0017431;Endometriosis
C1415856;ID3 gene
C0065839;Complementary and alternative medicine
C1822777;IL5 protein human
C1414521;Antitumor Response
C1414520;CDC2 Protein Kinase
C0109013;Neoplasms
C0005486;Colorectal Carcinoma
C1820119;Motility
C1415857;Oncogenes
C0436331;Symptom aggravating factors
C0031740;Ability
C3156642;Patients
C0751551;Radical excision
C0738591;Large Mass
C0006790;Squamous intraepithelial lesion
C0017440;Gentian Violet
C0005477;Biochemistry
C1367731;MAPK8 gene
C0004144;Atelectasis
C4086837;Carcinoma Transitional Cell
C0400395;Patients
C3156633;hepatoma cell
C0280100;LGALS9 protein human
C0017411;Endometriosis
C3829290;Lewis Rat Strain
C0005427;Biliary Tract Surgical Procedures
C0005423;Icterus
C1858663;CABIN1 gene
C0031727;MAP kinase kinase kinase activity
C2047258;methylsulfonylmethane
C0231170;Disability
C0268450;Mutation
C0231173;Patients
C0231178;risk factors
C0017416;bevacizumab
C1832037;AZD-7762
C0018747;Ethnic group
C1856007;Patients
C0559938;Perforation of ileum
C0017421;Adenocarcinoma
C0017420;Granulomatous inflammation
C0063208;alginate
C1112211;Veins
C0005417;Patients
C0029408;Degenerative polyarthritis
C0031715;Mus
C0031716;Choline
C0267111;Barrett Esophagus
C0029401;Diagnosis
C0017429;Cytomegalovirus
C0231187;Decompensation
C0017428;Pancreatitis Chronic
C0018724;Persons
C3181682;Malignant neoplasm of kidney
C1822692;Hexokinase 2
C0232488;Abdominal colic
C2062866;Acute occlusion of artery
C0279134;Prostate
C1819041;protein kinase activation
C0064548;Fluorouracil
C0522622;Rectum
C0243144;Bone structure of rib
C1883644;EIF4A3 gene
C1868019;Operative Surgical Procedures
C0522621;Ascending colon
C1282273;Pancreaticoduodenectomy
C3891218;CELF6 gene
C1112209;Intraabdominal Infections
C0006746;Colorectal Carcinoma
C1282272;Reconstructive Surgical Procedures
C1318793;8-oxo-7-hydrodeoxyguanosine
C0005446;FRAP1 protein human
C0004114;Astrocytoma
C0545309;Pharmaceutical Preparations
C0031707;Aggressive Clinical Course
C0232483;Surgical Replantation
C0232487;Pancreatic duct
C3253708;Tumor Progression
C0031701;DNA Damage
C0018735;Health Policy
C0751507;Carcinogenesis
C1427808;DEPTOR gene
C0751506;REM Sleep Deprivation
C0063220;Cancer Patient
C0473237;Male population group
C1367656;Malignant tumor of colon
C4544822;Cohort
C1822686;Mutation
C1522281;Vitamins
C0005437;Alkaline Phosphatase
C1558210;Intraoperative Injury
C0005435;Interventional procedure
C1535597;Mus
C0052573;astragalin
C1415826;Colorectal Carcinoma
C1415825;Postoperative fistula
C0232493;Patients
C0232491;Catechol O-Methyltransferase
C0232492;Billroth I Procedure
C1833334;Patients
C0018738;Intervention regimes
C0232495;Elderly man
C0100748;SMAD2 gene
C1368999;Telangiectasis
C0424295;DNA Replication
C0006726;Participant
C0267167;Ursodiol
C0740844;Radiography Abdominal
C1832073;Patients
C2047215;Herpesvirus 5 infection
C3179302;NF-E2-Related Factor 2
C0018704;Indocyanine green angiography
C0063245;Amino Acids
C0243192;ONC201
C4543510;Patients
C1367671;Cachexia
C0006736;Intrahepatic bile duct
C1317452;Turcot syndrome (disorder)
C1318786;Assay
C1846661;Pelvic lymphadenectomy
C0449575;Nonalcoholic Steatohepatitis
C0449574;Malignant neoplasm of anus
C1112240;Secondary malignant neoplasm of lymph node
C0763464;N-ras Genes
C0005404;Uptake
C0075246;stevioside
C0005401;Aneurysm
C3662487;inhibitors
C0005400;Sulfoglycosphingolipids
C0270769;Spinal Cord
C0063252;desflurane
C0064582;Viable cells
C0255156;Myeloid Leukemia Chronic
C0341539;Elective Surgical Procedures
C0521390;Cations
C0919654;Patients
C0206131;Engineer
C1306754;Patients
C2348124;Colorectal Carcinoma
C1512886;Internal Ribosome Entry Sites
C0919661;Mus
C0596952;Permeability
C0920638;Robotic Surgical Procedures
C0221780;Extravasation
C1150587;TLR4 protein human
C0557351;Patients
C1150582;Phosphotransferases
C1511540;CpG Island Methylator Phenotype
C0244404;Pharmaceutical Preparations
C2350439;Feces
C2895206;Autoimmune disease (systemic) NOS
C2037866;Patients
C2363736;Cancer Patient
C0376196;Opium
C0160390;Selenium
C0206152;Secondary Neoplasm
C0556030;S100A4 gene
C0487852;hydatids
C4300109;Clinical Trials
C0521377;Large Mass
C1511573;Cell Count
C0596935;Metabolism
C0270724;Interstitial Radiation Therapy
C4279909;Shelf Life Food
C0532025;Proto-Oncogene Proteins c-akt
C0315222;Edwardsiella tarda
C0521362;Goblet Cells
C0184351;Prophylactic treatment
C0871261;Immunity
C0521367;Adenoid Cystic Carcinoma
C1511562;Malignant neoplasm of sigmoid colon
C0219458;silicon phthalocyanine
C1512896;Clinical Trials
C0919671;subileus
C0183029;Blades (device)
C0545322;Neoplasm Metastasis
C0858252;Homo sapiens
C0303226;Gallium-68
C0596913;Coordination Complexes
C1882332;Macrophage Activation Syndrome
C0184348;Air
C0871236;Association Therapy
C0920688;Geriatric Assessment
C0945984;Homo sapiens
C0232462;Inflammatory Bowel Diseases
C0920687;Primary Health Care
C0233794;PISD gene
C0232478;Persons
C1547547;Schedule II Substance
C1522260;naringin
C1150540;Study
C1136240;Negative
C0919691;DNA Nucleotidylexotransferase human
C0473296;Open Resection
C1449159;Jejunal mucous membrane
C0303231;pregnane X receptor
C0219472;SPINK5 gene
C0256421;Intestines Small
C0219474;Bax protein
C1318700;sildenafil
C3891256;Body tissue
C2338738;Colon Carcinoma
C0206194;Erotic feeling
C0221791;Kidney Failure
C0206193;Excision
C1136254;Patients
C0243102;enzyme activity
C0860594;inhibitors
C0883208;Lymphoma cells
C1259909;Colorectal Neoplasms
C3891267;Carcinogens
C0232459;Antiemetics
C0099260;Angiogenic Process
C0206187;AXIN2 gene
C1522240;Airway Obstruction
C0596902;Nuclear accumulation
C0596901;Hybrids
C0206190;Macrophages Peritoneal
C2919684;Romanian
C1882340;Non-alcoholic Fatty Liver Disease
C1956415;Activities of Daily Living (activity)
C0065058;Colorectal Carcinoma
C0077046;sucralose
C0113222;invasive growth
C0810150;Mucous Membrane
C0282082;Merkel cell carcinoma
C0810152;Malignant Female Reproductive System Neoplasm
C1519315;RNA Small Interfering
C0065054;Colorectal Carcinoma
C1519312;Signal Transduction Inhibition
C1956422;IL27 gene
C1257789;Secondary malignant neoplasm of lung
C0596563;Mus
C0596562;Proteins
C0282090;Bisacodyl
C3471351;Malignant tumor of colon
C1519302;Adenocarcinoma of small intestine
C2350399;Metabolome
C0151517;Carcinoma Small Cell
C1257759;mRNA Degradation
C0342257;Patients
C0077063;SLC2A5 gene
C1506024;Transitional cell carcinoma of bladder
C0137209;Cell cluster
C0534283;Octreotide
C1518003;Chemo-radiotherapy
C0065078;lissamine rhodamine B
C0004903;Cessation of life
C0078388;TJP1 gene
C3255672;Neoplasms
C0597879;Intestinal metaplasia
C0596545;Asians
C0065088;Catenins
C2350360;Pharmaceutical Preparations
C0920605;Neoplasms
C1532338;Acute myocardial infarction
C0282046;Surgery Day
C0392548;Disease
C1704729;Diagnostic radiologic examination
C0295352;Serotonin 5-HT-3 Receptor
C0077072;Defecation
C0560564;Stromal Neoplasm
C0751283;DDB-1 and CUL4-Associated Factor 7
C0560560;Intestinal Diseases
C1704726;Participant
C1704723;Tumor cells malignant
C1518010;Neoplasm Metastasis
C3280670;PREGNANCY LOSS RECURRENT SUSCEPTIBILITY TO 1
C2931822;Colorectal Neoplasms
C0211705;Mitogen-Activated Protein Kinase Kinases
C0920627;Orphan Diseases
C2362324;Colorectal Carcinoma
C0861727;Pharmacotherapy
C0907649;Signal Transduction Pathways
C2350345;Protein Kinases
C1518048;Malignant tumor of colon
C1257793;Homo sapiens
C1257792;SOX17 gene
C0920619;gene therapy
C0920616;Mus
C0920618;neoplasm remission
C0920617;Patients
C1267116;Carcinoma
C0597834;Patients
C1704746;Macrophage Activation Syndrome
C2350332;AKT Signaling Pathway
C3472669;Diagnostic radiologic examination
C0751265;Woman
C1704743;Treatment Protocols
C0920610;Manipulation procedure
C0596508;Embryonic Stem Cells
C4047398;Patients
C1425792;EZH2 protein human
C1424461;Tumor cells malignant
C0332835;Hepatitis B Surface Antigens
C1424460;NLRP3 gene
C0439742;Lymphocyte
C0440744;cytokine production
C1424462;Nucleoplasm
C0440747;PDCD1 gene
C1412493;Diarrhea
C1412498;AQP8 gene
C1690432;Patients
C1412497;Wnt Signaling Pathway
C1412494;Mus
C0993595;Hypersensitivity
C3472608;Colon structure (body structure)
C0440752;Janus kinase
C3472607;Pancreatobiliary-type carcinoma
C1293484;TNFSF14 gene
C0401149;Rectal Prolapse
C1510924;Secondary malignant neoplasm of liver
C0679408;Lesion of stomach
C0679407;FABP2 protein human
C0332857;Anastomosis side to side
C0332856;Anastomosis end to side
C0332855;Anastomosis side to end
C0401151;Cardiovascular Diseases
C0332853;Malignant neoplasm of transverse colon
C3471303;Migration Cell
C0221082;Frailty
C0740577;Male population group
C0038280;Endometriosis
C0440738;Liposomes
C0738267;Neoplasm Metastasis
C2677316;Cell Count
C0040597;Clip
C4048686;Body tissue
C0678133;Taxol
C0038270;Patients
C1413772;secretory protein
C1413773;Neoplasms
C4086963;intestinal adenocarcinoma
C0524903;Oils Volatile
C0498085;Carcinoma
C0667477;SDHA gene
C0741899;Endoscopic Ultrasound-Guided Fine Needle Aspiration
C0524909;Intestinal Microbiome
C0427716;Enzyme-Linked Immunosorbent Assay
C0039597;Yolk Sac Tumor
C2713498;Metazoa
C4046039;Liver diseases
C0741884;ovarian
C1825933;Fumarate Hydratase
C0678121;Colorectal Carcinoma
C0741885;Cohort
C1824605;CCDC80 gene
C0741886;Malignant neoplasm of sigmoid colon
C0039590;Metastatic Malignant Testicular Germ Cell Tumor
C1412457;Colonic mucous membrane
C2713490;pros protein Drosophila
C4528578;Suspected malignancy
C0040577;Immune System Processes
C1425779;Patients
C0038257;Covered Stent
C0330230;Prophylactic treatment
C0596570;NOX4 gene
C0038250;GABA-A Receptor
C0678118;Ultracentrifugation
C0026267;Patients
C4527238;Lung
C4527233;Endometriosis
C0596577;Immune System Processes
C0027597;Oxides
C1423114;Colorectal Carcinoma
C1425775;Antitumor Response
C1423112;neuronal
C1825912;Body tissue
C0331570;Phenolics
C0330240;Alkaloids
C0678107;Glutamyl transferase
C0596581;Frail
C2712185;Persons
C1425781;Malignant tumor of colon
C1100660;PCSK9 protein human
C0026277;Rectum
C1825916;lymph nodes
C3843422;Females
C0679381;Pediatric Disorder
C0259628;Malignant tumor of colon
C0235656;Vertebral column
C0014268;Mus
C0038238;Stenosis
C0678054;Liver and Intrahepatic Biliary Tract Carcinoma
C0014264;Plasma
C2954564;FZD3 gene
C1366897;MAPK12 gene
C1137883;Biologic Development
C0039561;Plant Preparations
C4086919;Serum
C0221013;Woman
C1823200;Colon Carcinoma
C1412407;TRPV1 gene
C1412403;ANK2 gene
C4277664;Behavior
C1366894;Lipopolysaccharides
C0702249;Adenocarcinoma
C0014279;Engineering
C0476644;Diagnostic Services
C0014272;mitochondria-nucleus signaling pathway
C0040549;Okadaic Acid
C1412418;Adenocarcinoma of small intestine
C1413749;Chronic Obstructive Airway Disease
C0026259;Topoisomerase II
C0003595;LDL-Receptor Related Protein 1
C3854133;Lesion
C0026255;Italians
C0003593;DGAT2 gene
C0475311;Harbor
C4277658;Solute Carrier Proteins
C0015576;Germ-Line Mutation
C0014245;Additional procedure
C2713587;Polymers
C1449705;Laboratory Procedures
C0475309;Education Medical
C1825843;Tumor cells malignant
C1824513;Neoplasms
C0014241;Bacillus intermedius ribonuclease
C0679362;Anus
C1149888;Adult
C0014243;Obstruction
C0678034;Spironolactone
C1413754;Symptoms
C1412424;Body tissue
C1413755;CSNK1D gene
C1412429;Malignant neoplasm of thyroid
C1412428;Wnt Signaling Pathway
C1413756;CSNK1E gene
C0223657;Structure of ischial spine
C1112566;Patients
C1112565;Patients
C4277685;Microbiome
C3160815;Polycystic Kidney Autosomal Dominant
C1149880;Cross Reactions
C2953246;Progressive Neoplastic Disease
C2062516;Colorectal Carcinoma
C0014257;Blood supply aspects
C0753802;Laboratory Procedures
C0728867;Drug effect disorder
C1327386;protein stabilization
C1326057;epithelial cell differentiation
C0222331;Merkel cell carcinoma
C1413766;colon growth
C1412430;Neoplasms
C0221002;Hyperparathyroidism Primary
C0524910;Hepatectomy
C1413762;Tumor cells malignant
C0524914;Tissue specific
C0027567;Lung
C0026237;JNK Pathway
C1413769;Dissecting hemorrhage
C1148564;Cells
C0450011;Patients
C1425745;Immune response
C0039538;Fine needle aspiration biopsy
C0236970;Alcohol-Induced Disorders
C1149827;acetylcholinesterase activity
C0040511;Gastrinoma
C0426359;Woman
C0524984;SLC6A2 protein human
C0004897;Ursidae Family
C0027530;Mass of body structure
C2700280;cancer therapy
C0439663;Persons
C0439662;Clinical Response
C0055738;Plants
C1328695;Malignant Neoplasms
C0221060;Patients
C0015560;Patients
C4049944;Liver and Intrahepatic Biliary Tract Carcinoma
C2290247;Agaricomycetes
C0041834;Perianal
C0026219;Study
C0027543;Avascular necrosis of bone
C0027544;Urethra
C0439659;Beginning
C0524979;Intestines
C4011395;Mature adipocytes
C0150270;Evaluation
C0027540;Duration
C0014239;interleukin-6 receptor activity
C1823226;UAMC-2526
C0016860;Furosemide
C0680395;Malignant Neoplasms
C0441971;Patients
C1824550;Patients
C0524963;Cohort
C1136539;Peptides
C0401074;Adenocarcinoma
C0055753;Present
C0055754;Symptoms
C0003584;Paget Disease Extramammary
C0079722;LAG3 wt Allele
C2315931;Secondary malignant neoplasm of lung
C3160858;Patients
C0680398;Mean score
C0015535;Communicable Diseases
C0015537;Faculty Medical
C0451306;Patients
C1823210;C1orf64 gene
C1413725;CRY2 gene
C0332942;Congenital deviation
C0967223;Patients
C0054434;Proto-Oncogene Proteins c-akt
C0054433;Defecation
C0016879;Acute colitis
C0933845;Pancreas
C0546333;Patients
C0028829;Octogenarians
C0919532;Congenital dyserythropoietic anemia
C2348001;Age Cohort
C0919538;Microsatellite instability-high colorectal cancer
C0028821;Neoplastic Cell Transformation
C0079744;Lymphoid neoplasm
C4278916;Colorectal Carcinoma
C1257826;Chromosome Stability
C1257825;Genomic Stability
C0015522;Embryonic Development
C1704807;RNA
C0919524;Patients
C0919528;Carcinogenesis
C0489903;Chemotherapy Regimen
C0028833;Radionuclide Imaging
C0079731;B-Cell Lymphomas
C0223603;dendritic shaft
C0015528;factor XIII
C0067762;N-Acetylneuraminic Acid
C0596609;Gene-Environment Interaction
C0200949;Blood culture
C3158583;resveratrol
C1824590;Extracellular Vesicles
C0151594;Umbilical pain
C1824592;Patients
C4049918;Polyunsaturated Fatty Acids
C1173590;Reactive Oxygen Species
C0002210;Neoplasms
C4277602;Catenins
C0053139;Apoptosis
C0187514;removal technique
C2350307;Cytoplasm
C4277609;Stomach Neoplasms
C0016832;Microorganism
C0558347;Recurrent disease
C0897751;hordenine
C0003537;Male population group
C1257806;Intestinal metaplasia
C1330959;Hormone Therapy
C1533698;Neoplasms
C0475372;Tumor stage T1
C0920533;ZBTB33 gene
C0450094;Colectomy
C1704820;Solid Neoplasm
C0079784;Tumor-Associated Macrophage
C1556381;Patients
C1556380;Patients
C0016807;Anemia Sickle Cell
C0016801;Fumarates
C0151526;Infant Newborn
C0319923;Fungi
C0475358;rapid diagnosis
C0079772;T-Cell Lymphoma
C0079773;Lymphoma T-Cell Cutaneous
C0151521;Patients
C0861772;Xeloda-Oxaliplatin Regimen
C0053169;Malignant Neoplasms
C0450076;Gradient method
C0847483;Low Anterior Resection
C0560617;Mouse Muscle
C1257838;Protoplasm
C0003507;Patients
C0489950;Hodgkin Disease
C0521059;Glucans
C0920584;Lymphoma Non-Hodgkin
C4309078;Chronic inflammation
C2930586;RNA
C4024608;Malignant neoplasm of colon stage IV
C0151544;Colorectal Carcinoma
C0151546;Cells
C3494038;pregnane glycoside
C1269815;Cohort
C3640764;Patients
C1304649;Infrared spectroscopy
C0125272;PIKFYVE gene
C4277637;Stenosis
C1257899;Genotoxic Stress
C0632858;V33
C0065175;CA-19-9 Antigen
C0125323;Genes
C1257890;Population Group
C0151603;Edema
C1293528;recurrent prostate cancer
C0151636;Cancer Patient
C1257879;Diet
C0597984;Cholangitis
C0152964;Patients
C1519215;Organ
C0101334;Dextran Sulfate Sodium
C0077172;Chronic disease
C1571809;Visceral manipulation
C1702242;SUB1 protein human
C0534397;Malignant Neoplasms
C2931926;multicatalytic endopeptidase complex
C1281569;Undifferentiated illness
C0558355;Patients
C2349254;Rectal Carcinoma
C0596638;SMAD4 gene
C0750081;Woman
C1969646;Neoplastic Cell Transformation
C0559681;Perioperative complication
C0282163;Immigrant (person)
C1160185;transduction
C1969641;Genetic Polymorphism
C0557037;Patients
C0643538;6-cyano-5-methoxy-12-methylindolo(23-a)carbazole
C2349249;Chemoradiotherapy
C2349244;Malignant neoplasm of descending colon
C2349245;Malignant neoplasm of sigmoid colon
C0681814;Comet Assay
C2350239;Persons
C1519221;Secretory cell
C0920508;Enzyme-Linked Immunospot Assay
C0545067;Tumor thrombus vascular
C0919511;Colorectal Carcinoma
C1883047;Cold polypectomy
C0596611;Receptor Protein-Tyrosine Kinases
C0596610;gene interaction
C2930619;Undifferentiated illness
C0920502;Hereditary Malignant Neoplasm
C1519255;Instrumental activities of daily living
C1519252;geriatric patients
C0751394;Malignant Neoplasms
C0919509;Hereditary Nonpolyposis Colorectal Cancer
C0596620;Cholecalciferol
C0392400;Peritoneum
C1704860;Transcription Genetic
C0282193;Carcinogenesis
C0749075;Child
C1268567;Vascular Endothelial Growth Factor Receptor
C1519247;Indocyanine Green
C0907533;NOS1 protein human
C0282122;Respondents
C1292266;Coagulation protein
C1449886;Focal Adhesions
C1424587;Neoplastic Cell Transformation
C0441960;Patients
C1956385;Anterior
C1424590;RNA
C0678209;TNF receptor-associated factor 6
C1377708;colon rectal
C0681850;Malignant neoplasm of gastrointestinal tract
C0751366;Radiation-Induced Cancer
C4479222;Increased apoptosis
C1424597;Organoids
C0038179;Starch
C1510809;Secondary carcinoma
C0221191;Judge
C1510800;Infiltration
C0221198;Relative (related person)
C0038172;Thyme oil
C0114612;DNA glycosylase
C0283470;Tumor cells malignant
C3472518;International student
C2678521;Chronic Obstructive Airway Disease
C0740693;Abscess
C0269115;Gynecologic Surgical Procedures
C0139903;Plasma membrane
C0139905;Cell Proliferation
C0040480;Vimentin
C0439631;Malignant neoplasm of brain
C2700050;Neuroendocrine Tumors
C0259795;Enteritis due to radiation
C0026196;PLOD2 gene
C4288280;Neoplasms
C0257137;Caco-2 Cells
C0039485;Seizures
C1824735;Neoplasms
C1413896;CYR61 gene
C0014180;Carcinoma Endometrioid
C0002199;Cancer invasiveness
C0027497;Pharmacotherapy
C1293558;Ethanol
C0027498;Patients
C1823407;Tumor Progression
C0002191;Neoplastic Cell Transformation
C0026162;Severe (severity modifier)
C2678545;Lung
C0040461;Mucous Membrane
C1412575;PLAGL2 gene
C1510810;Academia (organization)
C4527364;Adult Fanconi syndrome
C3820663;TORC1 signaling
C0040457;Tooth Supernumerary
C1424569;DGCR14 gene
C0679560;Non-Neoplastic Disorder
C0038136;Nation
C1412588;Tumor cells malignant
C0678236;Congenital malrotation of intestine
C0439603;Frequencies (time pattern)
C0667570;Combined Modality Therapy
C4528684;Patients
C0329155;Leiostomus xanthurus
C1824700;Adrenocortical carcinoma
C0014175;Cicatrix
C1824701;Growth
C1824702;Esophageal carcinoma
C3843309;Adenocarcinoma
C0678222;WNT9B gene
C2713393;Tissue Specificity
C0014173;Endometrial Hyperplasia
C0282111;Materials
C0740651;Evaluation procedure
C0282114;Process
C0679557;Hospitals
C1510835;Homo sapiens
C2752965;prostate gland growth
C0681873;gene therapy
C1824709;hepatoma cell
C0014145;Testis
C1424504;Infiltration
C2979983;risk factors
C1824658;Neoplasms
C0039446;Late effect of medical intervention
C0039445;Coordinated Care
C1412521;Immune Cell
C2979982;Woman
C0027459;National Health Programs
C0728993;Woman
C4277544;Biologic Development
C1412528;HUNK gene
C0027452;Endoscopic Submucosal Dissection
C4277543;NLRP3 gene
C0028785;Skin Ulcer
C0003483;Abdomen
C1425830;Quantitative Reverse Transcriptase PCR
C3843353;Liver carcinoma
C4277548;PIEZO2 gene
C0041755;anamorelin
C4023452;Colorectal Carcinoma
C1412533;Malignant Neoplasms
C0246421;Hormone Therapy
C1825971;Glycolysis
C0002144;Transplantation
C1112459;First line treatment
C1413868;FRAP1 protein human
C1135117;oxaliplatin
C0235782;Primary sclerosing cholangitis
C0028792;Colorectal Carcinoma
C0438280;Duodenum
C0039421;Technology
C0016786;HCT116 Cells
C0041740;School
C0015450;Cranial nerve deficits
C0039423;early detection of colorectal cancer
C0234428;Male population group
C1861617;CCI gene
C1112442;Disease
C4527316;T-Cell-Specific Surface Glycoprotein CD28 human
C0246415;Metastatic Epidermoid Carcinomas
C1112446;Wound closure
C2315852;Neoplasm of small intestine
C0002171;Alopecia Areata
C1424521;Cancer of Digestive System
C0002170;Co-morbid conditions
C0210492;Matrix Metalloproteinases
C0039411;Patients
C0016799;leupeptin
C0014137;Endocrinology
C0014136;Endocrine system
C1425869;Neoplasms
C0014132;Endocrine Gland Neoplasms
C0016790;Chronic Obstructive Airway Disease
C0040408;Metachronous Malignant Neoplasm
C1135135;gastrointestinal toxicity
C1135130;bevacizumab
C0040405;Physical findings
C0028775;Hospitals
C0028778;Appendicitis
C1556274;hypertension complications
C4529962;Fatty Liver Disease
C0027442;Probes
C0185047;Stripping
C0681797;Health care facility
C0003492;Patients
C0014139;Endocytosis
C0969726;Glucosides
C0039400;Proliferation (morphologic abnormality)
C0066503;soluble
C0221170;Malignant Neoplasms
C0016762;Pharmaceutical Preparations
C4277581;Patients
C4277580;Neoplastic Cell Transformation
C0185033;Bladder Neoplasm
C0004779;Basal cell carcinoma
C0269108;Woman
C0521119;Membrane Proteins
C0269106;Patients
C2700166;Screening procedure
C0269102;Colon structure (body structure)
C1413811;Early gastric cancer
C0054521;calmodulin-dependent protein kinase III
C0741933;Cancer Patient
C0016767;Berries
C1824688;Cell Survival
C0066511;microcin
C1257909;Elderly man
C0028754;Voluntary Workers
C4277577;EPB41L2 gene
C0185027;DNA Methylation
C0027423;Nodular lesions
C0004763;Hiatal Hernia
C0028756;Poor outcome
C1413824;Secondary malignant neoplasm of liver
C0968453;ITLN1 protein human
C4277573;Sexual and Gender Minorities
C0185023;Rectum excision (procedure)
C0004760;Patients
C0185026;CDC37 gene
C1413822;Secondary Neoplasm
C0439531;per period (qualifier value)
C1425800;LIPI gene
C0174383;Matrix Metalloproteinase 11
C1837991;Pathogenic
C0741926;cardiac patient
C0016778;Uracil
C0259768;Complication
C0016741;Malignant Neoplasms
C0258439;GA-Binding Protein Transcription Factor
C0066522;COL5A2 gene
C0221152;Patients
C0221151;Malignant tumor of cervix
C0185010;Perforation of colon
C0004799;Heparitin Sulfate
C0003469;Mus
C0003467;general population
C0028723;Multiple malignancy
C0004793;ENPEP gene
C0003463;Induction Chemotherapy
C0054541;Liver Cirrhosis
C0185012;Corner Minus
C0003461;Recurrent squamous cell carcinoma
C0054543;Endoplasmic Reticulum
C0078518;WR 1065
C0054549;Periodontitis Juvenile
C0016745;Replication Origin
C1302181;Patients
C0175697;Colonic mucous membrane
C0728940;Metastatic malignant neoplasm to brain
C0247771;Antigens Neoplasm
C0028736;Antineoplastic Agents
C0053225;Functional disorder of intestine
C1412515;ARG1 gene
C0003451;Viral hepatitis
C1413844;Patients
C3843385;Patients
C0392459;Patients
C1326120;Transcription Genetic
C0162350;Rectal Neuroendocrine Neoplasm
C0919418;Wnt Signaling Pathway
C0003402;Liver damage
C0521158;Mus
C0077204;Colitis
C0162358;Tumor Initiation
C0559761;Biopsy of stomach
C1533585;Colorectal Carcinoma
C1532253;Colorectal Carcinoma
C0559769;Lesion
C1519274;Neoplasms
C0067889;Oxidation-Reduction
C0016733;Conventional (Clear Cell) Renal Cell Carcinoma
C1327441;Human body
C1704926;Pharmaceutical Preparations
C0151686;Mus
C0053246;Apoptosis
C0016734;Secondary Neoplasm
C0319838;Fungi
C0475269;Hyalinosis Systemic
C1257910;Tumor Progression
C0605290;ELF3 gene
C1823381;TMEM121 gene
C1823382;Cessation of life
C0079883;Pain
C0897640;Liver neoplasms
C0919437;Transcriptional Activation
C3842085;7 mm
C0920425;Advanced Malignant Solid Neoplasm
C0920424;Solid carcinoma
C3842088;Cohort
C3842089;Patients
C0920421;cancer regression
C0920420;biological adaptation to stress
C0920423;cancer seeding
C0016701;Freezing
C3542023;tubulobulbar complex
C0920418;Neoplasms
C0919425;AHR protein human
C0079870;CYP1A1 protein human
C0054593;Adenocarcinoma
C0004749;Contrast enema
C0054594;Immune Cell
C1257928;Malignant Neoplasms
C0919427;Nausea
C3842090;1 mm
C0919432;SMAD3 gene
C0883003;Pharmaceutical Preparations
C0763282;Patients
C0151659;Intestinal gangrene
C0234402;Nail-Patella Syndrome
C1257975;Local
C0319810;Fomes fomentarius
C1257974;Regenerative Medicine
C1327414;cytokine secretion
C1327413;Estrogens
C1148454;Male population group
C0162316;Retinal Hemorrhage
C3891006;Intestines
C0521184;Diagnosis
C0175631;Animals
C2930680;Omentum
C0221102;GOLPH3 protein human
C0150312;Edema
C0079891;Indigenous Population (Natives)
C0175637;Health evaluation
C0174307;Syndecan-2
C0162326;Neoantigen
C1270937;Radiation dose
C0862981;Surgical Procedures Laparoscopic
C1269955;Mus
C0919453;ovarian
C0078569;Antidepressive Agents
C0065264;CD69 protein human
C1149793;arginase activity
C2001625;neutrophil
C0162327;Endometrioid carcinoma ovary
C1173436;cetuximab
C0521173;Steroid therapy
C1257954;Anti-Inflammatory Agents
C1257952;ubiquitin-protein ligase
C2352801;Catenins
C0235710;Symptoms
C0920467;American College of Cardiology/American Heart Association Lesion Complexity Score A
C1148475;mecarzole
C0176940;Analyzers Physiologic Middle Ear Acoustic Reflectometry
C1159123;Nitric Oxide
C0860348;Patients
C0112088;Pharmaceutical Preparations
C1545588;Dysbiosis
C0004704;Evaluation
C0919466;monooxyethylene trimethylolpropane tristearate
C0151664;Abdominal Abscess
C0872319;Populations Underserved
C0872318;Ultracentrifugation
C0558429;HYAL1 gene
C0151739;Secondary malignant neoplasm of lung
C0849867;Peritoneum
C1510747;Diagnostic radiologic examination
C3494245;RNA Double-Stranded
C0597645;Viral Carcinogenesis
C0559365;Stenosis
C0125440;Sitosterols
C0175713;Cohort
C0151723;cetuximab
C0151728;Chronic inflammation
C3494251;Bone plates
C1883178;Subclone
C3494253;Colonic lesion
C0596326;Colon Carcinoma
C0162404;Mus
C0522067;Patients
C0317492;Eggerthella lenta
C3494226;Laparoscopic Colectomy
C0559385;Bone structure of ilium
C3494220;Small Intestinal Carcinoid Tumor
C0598958;Neuroprotection
C3495559;Male population group
C0751075;Digestive System Neoplasms
C3494234;primary tumor
C0597637;vascular endothelium permeability
C1701032;Colonic Neoplasms
C0136123;Angiotensin-Converting Enzyme Inhibitors
C0597635;vapor
C0341172;Patients
C1282538;Ascending colon
C1520113;Mus
C2362103;Diagnostic radiologic examination
C1412289;radiotracer
C0392773;Anastomosis end to end
C1171194;Survivors
C1449563;Heart Transplantation
C1449562;Primary Cell Culture
C0282282;Males
C0597601;Transcytosis
C0598934;Mice Nude
C1522779;epidermis development
C0598935;Apoptosis
C3494205;Anti-Inflammatory Agents
C1425596;NOX1 gene
C1425595;Cessation of life
C1520120;Replication Origin
C1521452;Chromosome 5 Short Arm
C1412290;Infiltration
C1412291;Contraceptives Oral
C0598941;Biological Neural Networks
C0597610;indole
C1510779;colon growth
C1412299;Lateral habenular nucleus
C3181079;Mus
C1424272;Malignant neoplasm of liver
C0597611;Biological Processes
C1519105;research
C1424276;Transcription Genetic
C3494218;Logistic Regression
C0402606;Carcinogenesis
C0138741;Hematologic Tests
C0631225;Sesquiterpenes
C0558010;Perineal Trauma
C0392751;Patients
C1424288;Adenocarcinoma of large intestine
C0522094;Medium chain fatty acid
C0522095;Long chain fatty acid
C2349104;V4+
C0558024;Evaluation procedure
C0740375;Colon Carcinoma
C1704982;Mitochondrial electron transport chain
C1704981;Hyperparathyroidism-Jaw Tumor Syndrome
C1449575;Colorectal Neoplasms
C0907411;Homeostasis
C0040399;Probes
C0038078;Squid
C0040395;Ileocolic intussusception
C0040398;Implantation procedure
C0413365;Patients
C0343729;Human Papillomavirus
C1282573;Flatus tube
C0968383;JNK Pathway
C0400043;Malignant neoplasm of sigmoid colon
C1618912;Pharmaceutical Preparations
C1424222;Mitochondrial Degradation
C0449327;Patients
C3820502;caspase-independent cell death
C0440992;Gluteal
C0451641;Patients
C0424000;valbenazine
C1413587;Signal Transduction Pathways
C1413588;Chromatin
C1824805;Colorectal Carcinoma
C1425569;FRAP1 protein human
C0400056;Pelvic Neoplasms
C0440995;Complication
C1425565;Negative
C0026093;Migrants
C2919945;Cavernous Hemangioma of Brain
C0451615;Operative Surgical Procedures
C1739685;Neoplasms
C1100850;Adult Fanconi syndrome
C1412268;Aspartate Transaminase
C0014084;Child
C0027396;Mucous Membrane
C0752319;Genes
C1282548;High resolution
C1955394;chemokine receptor
C0452956;Gastric Adenocarcinoma
C0596383;docetaxel
C0969690;Perioperative complication
C1424250;Inflammasomes
C0400076;Cerebral Infarction
C0752312;lung growth
C0669846;Colorectal Carcinoma
C0341106;Helicobacter pylori
C0426636;Clinical Response
C1823521;SLC13A5 gene
C0282207;Color finding
C0282208;Bladder dysfunction
C1425516;INDO wt Allele
C0038039;Nutritional status
C1823526;RPL4 gene
C1451803;Vomiting
C0015392;Uveal melanoma
C1414865;Rectal Carcinoma
C0558078;Male population group
C0679225;Fatty Acids Volatile
C1414863;Secondary carcinoma
C1414862;MUC2 gene
C0994638;Colon structure (body structure)
C4227635;Neoplasms
C1414860;Patients
C4085873;First Degree Relative
C1425512;Neoplasms
C0002073;Skin carcinoma
C1425514;IL17RE gene
C1426843;Control Groups
C0026042;Social Networks
C0427965;treatment failure
C0400018;Large Mass
C1425527;Inflammation
C0041674;Community
C1425526;Pancreatic carcinoma
C1426858;FEZF1-AS1 gene
C1414874;Intestines
C0039350;Sulfonic Acids
C0670896;Immune System Processes
C0271568;Cohort
C4085887;Hernia
C0003392;pemetrexed
C0002062;Uncaria rhynchophylla
C0342442;ACTH-dependent Cushing's syndrome
C1522706;Neoplasms
C0042997;Malignant Neoplasms
C0041667;Postoperative Complications
C0038013;Spinal Fractures
C0042995;Vulvar Neoplasms
C0039343;Endoscopy (procedure)
C0014048;Encephalitis Virus St. Louis
C0042993;Malignant Female Reproductive System Neoplasm
C0015376;Rift Valley Fever
C0679201;Social Networks
C1413555;Homo sapiens
C1413552;human cell line
C1412220;Carcinoembryonic Antigen
C0995982;Salmonella
C0440924;Perioperative complication
C0026022;Microscopy Fluorescence
C0597668;Complication
C1366752;Cell Count
C1412228;ADCYAP1 gene
C0439962;Colorectal Carcinoma
C0026024;Image analysis
C1293212;Malignant neoplasm of anorectum
C1824837;ruxolitinib
C0026020;Transmission Electron Microscopy
C0038002;oxaliplatin
C0015385;Edema
C0426642;telotristat ethyl
C1412236;Growth
C1510714;Colorectal Neoplasms
C1413561;Pharmaceutical Preparations
C0041657;Community
C0026032;Laceration
C0002085;BET1L gene
C1413569;Transitional cell carcinoma of bladder
C1366763;SAS
C1412239;Patients
C0027361;Larva
C0026030;Homo sapiens
C0027362;Human Age Group
C1424212;Patients
C0427979;metastatic colorectal cancer
C1424211;Neoplasms
C0015357;Disease
C1823449;TMIGD1 gene
C1426802;Malignant Neoplasms
C0741611;bowel ischemic
C1426803;Malignant Neoplasms
C0015350;Implantation procedure
C0003364;angiotensin II
C0028661;Patients
C0919386;Reconstructive Surgical Procedures
C0002031;Algae Brown (eukaryote)
C0003360;Symptoms
C0741614;Co-morbid conditions
C0079904;Vitamin D3 24-Hydroxylase
C0235895;Complication of implant
C0920367;Spectrum Analysis
C1426819;hepatoma cell
C0040300;Image Cytometry
C0014038;Encephalitis
C0042963;Pharmacotherapy
C0042960;Obesity
C1823437;colon growth
C0042961;Intestinal Volvulus
C0016693;Enzymes
C1414833;Tumor cells malignant
C0026018;Pathologic Neovascularization
C0185181;Hemorrhoids
C0026019;Transmission Electron Microscopy
C0041638;Metastatic Lesion
C0027341;Biologic Development
C1413503;Transcription Repressor/Corepressor
C1148780;Epithelium
C0920357;Topoisomerase Inhibitors
C1328480;Patients
C0016662;Fractures Open
C0198488;Conventional Surgery
C0259849;Malignant Neoplasms
C1413512;Patients
C0002059;topiramate
C2917359;Diabetes
C0029974;SAG gene
C0079925;Nucleic Acids
C0003385;Malignant Neoplasms
C0030971;Persons
C0002055;Tongue
C1413514;Cancer of Digestive System
C2750737;DIARRHEA 5 WITH TUFTING ENTEROPATHY CONGENITAL
C3843213;Pharmacotherapy
C0014009;Immunocompromised Host
C0198482;opioid use
C3845876;Patients
C2955668;Colorectal Carcinoma
C1823412;Immune Cell
C0041618;Large Mass
C0055966;soluble
C0742919;Mass of body structure
C0003376;fludarabine
C1364020;Intraductal papillary mucinous neoplasm
C0003374;Atovaquone
C0029984;Thymidine Phosphorylase
C0450254;Colonic Diseases
C0259831;Punch biopsy (procedure)
C0259832;precancerous lesions
C0872283;Intervention regimes
C0679182;Patients
C0017973;Glycosaminoglycans
C0042939;Patients
C0041609;Liquid Chromatography Mass Spectrometry
C1328466;oxaliplatin
C0004659;Patients
C0028625;Secondary Neoplasm
C0028621;Nucleosides
C0003324;Immune Cell
C2917337;Malabsorption
C0004651;Proteins
C0003320;Mus
C0079941;MicroRNAs
C4034203;Leucine aminopeptidase measurement
C0030958;Epithelial Cells
C0030957;Vertebral column
C0030956;Pancreatic Polypeptide
C0017977;echinacoside
C0742906;Elevated C-reactive protein
C1835466;Woman
C0017987;Flavonoids
C0017982;Malignant Neoplasms
C0729936;Neoplasm Metastasis
C0148199;Metastatic Renal Cell Cancer
C0896246;Floxuridine
C0003316;Immune response
C0523404;Laboratory Procedures
C0005978;Bone Wires
C0003315;Lymphocyte
C0030940;Patients
C0027303;NADP
C0004641;Nisin
C0005971;Bioprinting
C0028630;Transcript
C0030946;Extracellular
C0016658;Vertebral column
C0017953;Glycopeptides
C1148759;Serum Response Factor
C0017952;Metabolism
C0450204;Intussusception
C0029939;Discrepancy
C0162493;granzyme B
C0221273;Child
C1823460;Malignant Neoplasms
C0524724;removal technique
C1823461;Cells
C1824794;Pharmaceutical Preparations
C0524722;patient is female
C0028606;Antisense Oligonucleotides
C0872262;Cholangiocarcinoma
C0029936;Ovariectomy
C0003343;Leptocyte
C1414805;Chordoma
C0053339;Polyubiquitination
C1836775;Patients
C0015300;Right eye
C0342500;CD69 protein human
C0260860;Screening colonoscopy
C0221284;HIV
C0221283;Mouse Model
C0872278;Perianal sinus
C1823450;Colorectal Carcinoma
C0003339;Tumor cells uncertain whether benign or malignant
C0030920;Zollinger-Ellison syndrome
C0003335;Immune response
C0029944;Drug Overdose
C0004663;Bacteria
C1159409;Genes
C0004661;Bile salt hydrolase
C3843265;Line 2
C0017968;Ligands
C0015306;Hereditary Multiple Exostoses
C1847498;Child
C0065337;Signal Pathways
C0235812;Patients
C0317558;Akkermansia muciniphila
C2700406;Patients
C0004613;Communicable Diseases
C1520150;Wild Type Mouse
C0004612;Bacteria Aerobic
C0004611;Escherichia coli
C0185115;wound complication
C0004610;Endometrial adenocarcinoma
C0005940;Child
C0185117;MicroRNA Gene
C0185112;patient is female
C0185111;Neurosurgical Procedures
C0534100;Cancer Cell Growth
C0065331;HT29 Cells
C1520166;Growth
C1184482;pancreas and duodenum
C0175795;Laxatives
C0005939;Bone Development
C1508499;X-Ray Computed Tomography
C0004604;bevacizumab
C1508496;Colorectal Carcinoma
C0029925;ovarian neoplasm
C0004600;Secondary malignant neoplasm of skin
C0029921;early detection of colorectal cancer
C0016617;research
C1364082;Carcinogenesis
C0209548;Lung
C0175763;Carcinoma Neuroendocrine
C0003308;Itraconazole
C0005967;Child
C1303103;Gastrointestinal Stromal Tumors
C0922960;Biliary tract structure
C0004630;inflammatory response
C0005961;Patients
C1520145;Autoimmune Response
C3641892;Radiotherapy Conformal
C1823491;WNK1 protein human
C1823492;AGO2 gene
C1823493;Ubiquitination
C0004627;Malignant Neoplasms
C0005957;Infiltration
C0005955;ACSL5 gene
C0004623;Peptic Ulcer
C0005954;Neuroendocrine carcinoma metastatic
C0052059;Extracellular
C0005953;Bromsulphalein
C1519167;Hep G2 Cells
C1183135;Tumor thrombus
C0151779;GBP4 gene
C0235855;sepsis secondary
C1283903;Fibrosis
C0885516;Disease
C0522165;Dermatologist
C0221210;Rare Diseases
C1183107;Set of tubal glands
C2315751;Malignant neoplasm of prostate
C0221219;Cancer Patient
C1160466;Proteins
C0317504;Dorea formicigenerans
C0175754;Uveal melanoma
C0259817;Woman
C0860204;Stenosis
C2217386;Prostate Cancer staging
C0151763;Diet High-Fat
C0209554;Intermembranous space of mitochondrion
C1545484;intercellular bridge
C0304207;Inflammation
C0221224;Invagination
C1099354;NLRP6 gene
C0017906;Mucins
C0920317;Urinary Diversion
C0175723;Bands
C0175722;Colorectal Neoplasms
C0235833;Author
C1872431;Colitis
C1185747;Stenosis
C3494264;Nucleotides
C1098057;Pharmaceutical Preparations
C1185740;reproductive system disorder
C0065390;Spironolactone
C0065391;Spironolactone
C0175735;Scissors (device)
C0175730;Patients
C0234518;oxaliplatin
C0005919;Human tissue
C0885503;Colitis
C0151786;Patients
C0005911;Colorectal Carcinoma
C0005910;Body Weight
C0162425;Participant
C0221209;Patients
C1185751;Surgical incisions
C1570403;ASAH2 protein human
C0162429;Pharmacotherapy
C3541089;Growth
C0149531;Hemorrhage
C0392618;Decreased body mass index
C0657912;Metastatic Urothelial Carcinoma
C1535926;Persons
C0150523;Patients
C0559483;rosmarinic acid
C0162519;Anabolism
C0124235;Acute colitis
C0149523;Patients
C0149521;Genome
C0597774;polyps
C1752727;Proteasome Pathway
C1535939;Caucasoid Race
C1883298;Rectal Carcinoma
C1883299;Patients
C0328038;Cyprinus carpio
C0559494;IMPACT gene
C1510610;Infection by Basidiobolus
C0812445;mRNA Expression
C0162529;Cancer invasiveness
C1257634;seven-transmembrane G-protein-coupled receptor
C0175808;Colorectal Carcinoma
C0076096;Patients
C0150543;Vincristine
C0150544;Hypertensive disease
C0439805;Patients
C0163826;GPC1 gene
C2350029;CD8A wt Allele
C1535919;Fetal Chromosomal Aberrations
C0151867;Ligation
C2603343;Wound infiltration
C0076080;Dacarbazine
C3543626;Leukopenia
C0149543;Chordoma
C0618333;CSF1R gene
C3203086;Adenocarcinoma
C1447076;beta-Thromboglobulin human
C0812425;Organoids
C0162508;Up-Regulation (Physiology)
C0304066;Pharmaceutical Preparations
C3712772;leptin
C1523936;Apoptosis
C0162505;Growth
C0151811;Neoplasm Metastasis
C0341069;Ileoileostomy
C0151815;Ischemic enteritis
C0293060;dieckol
C0560435;Does skip
C1423053;Protein Overexpression
C0163807;Surgeon
C1447020;Graft-vs-Host Disease
C0597721;Inflammatory cell
C0389003;cyclooxygenase 1
C1522662;Isolation procedure
C4011708;Dilated small intestine
C0124209;Doxorubicin
C0378368;Migration Cell
C1883259;Patients
C1423062;Inflammasomes
C1423063;Patients
C1883256;advanced disease
C0596402;Child
C1883252;Colon structure (body structure)
C1449677;Cyclotides
C1423065;Tumor Suppressor Genes
C3529352;LDL Cholesterol Lipoproteins
C0559459;Fetus
C1423066;Exhaustion
C1883289;Airway Obstruction
C0304013;cell growth
C3470132;Chronic Obstructive Airway Disease
C1522639;Spleen
C1519010;Cancer-Associated Fibroblasts
C0040289;Implantation procedure
C1522642;T-Cell Receptor
C1871293;Mus
C0209738;Inflammation
C0040288;Cryptic Splice Sites
C1014208;MIA gene
C0039290;Exons
C0558141;Abdominoperineal resection
C0039294;Plants
C0597716;Malignant tumor of colon
C1535950;Therapeutic radiology procedure
C3252089;DNA Damage
C4527188;Neoplasms
C0559474;Medical History
C1449699;Vipoma
C0040284;Tissue culture
C0597718;Colorectal Carcinoma
C1412361;Chromosomes Human Pair 21
C4482622;Solid carcinoma
C1413690;Chronic Obstructive Airway Disease
C0039286;Endometrial Carcinoma
C1412365;Neoplasms
C0368909;Plasma membrane
C0753791;Cessation of life
C2748260;Liver Ultrasonographic Elastography
C1423016;Adenomatous Polyposis Coli
C1423011;Immunity
C0039277;Polysaccharides
C0740476;Complication
C0702196;Magnetic Resonance Imaging
C1667752;Trans-Activation Genetic
C1423021;ZEB2 gene
C1425683;TP53 gene
C1424354;Leukemia Myelocytic Acute
C0426576;Edema
C0015295;Tandem Repeat Sequences
C0282386;Pneumonia
C0596495;rapid diagnosis
C4527158;Neoplasms
C0041582;Peptic Ulcer
C1423039;interleukin-22
C1423032;Adenocarcinoma
C1423033;Body tissue
C4084684;Malignant Neoplasms
C0027270;Protoplasm
C0039259;Veins
C0740455;Malignant tumor of cervix
C1412398;Malignant Neoplasms
C0740457;Procedure findings:Finding:Point in time:^Patient:Narrative
C0027280;NAD(P)H Dehydrogenase (Quinone)
C0679342;upper GI neoplasm
C1412324;Malignant tumor of colon
C0596476;east indian
C1412322;Carcinogenesis
C0679347;Woman
C1412323;Pharmaceutical Preparations
C1412320;FBXW7 gene
C0596473;High risk factors
C0740441;Acute diarrhea
C0028589;Cells
C0003289;vilazodone
C1414989;Liver carcinoma
C1414988;Neoplastic Cell Transformation
C0042890;Amino Acids
C1823649;contextual factors
C0682997;Oils Volatile
C1424304;Cultured Cell Line
C0003280;Clinical Trials
C0343641;Anal canal
C1426964;Cutaneous Melanoma
C0003281;Insertion of arterial stent
C1267092;DPYSL3 gene
C1823635;Gene Silencing
C1412335;Growth
C0015282;Adenoid Cystic Carcinoma
C1412333;Central Serous Chorioretinopathy
C1413662;CPA1 gene
C1414994;Trans-Activation Genetic
C0282333;Depressive Symptoms
C1413661;Veins
C0380603;Body tissue
C1412338;Acetaldehyde
C0680323;Western society
C0027260;Biochemical Pathway
C0003272;Antibody-Dependent Cellular Cytotoxicity
C1836945;Infiltration
C0812407;glucuronide
C0042874;Animal Model
C0015259;Behavior
C0015258;soft tissue
C0042872;Vitamin D-Binding Protein
C0015252;Icterus
C0042870;Complex Regional Pain Syndromes
C1366875;MAPK11 gene
C1412347;Calcibiotic Root Canal Sealer
C0740422;Pelvic swelling
C1412344;Long Intergenic Non-Protein Coding RNA
C2337090;Hypertrophy
C0015250;Carcinoid tumor of rectum
C1739768;apixaban
C0282347;African race
C3472710;Neoplasms
C0680319;modern society
C0030896;Patients
C0030892;Mannose
C0427861;Fever
C0304097;Cell Survival
C1400398;Patients
C0682972;Hemostatic function
C1425650;Neoplastic Cell Transformation
C0030899;Stomatitis
C0282359;Intestines
C4482613;Feces
C1449619;Detection
C1823611;Proto-Oncogene Proteins p21(ras)
C0039215;thymidylate kinase
C0753723;Mutation
C1823615;Transforming Growth Factors
C3687252;Concurrent Chemoradiotherapy
C1412356;ALOX12 wt Allele
C0679316;Dysmotility
C0041538;multicatalytic endopeptidase complex
C0679317;hypomotility
C4542604;Hereditary hemorrhagic telangiectasia
C2808468;Cima
C1366882;MAPK1 gene
C0003297;Abnormal digestive tract function
C4085989;Krukenberg Tumor
C1836923;Symptoms
C1823619;Neuropeptide Y Receptor Type 2
C0003292;Conservative Treatment
C4289767;Complement C5a
C0015230;Symptoms
C1426926;Small cell carcinoma of lung
C1364113;Colonic Neoplasms
C0694897;Schwann Cells
C0694890;RET gene
C0027215;Musculoskeletal torsion function
C0003244;Malignant neoplasm of lung
C1630409;colonoscopy
C0919267;Minimally Invasive Surgical Procedures
C0003242;Oncolytic Viruses
C0207072;neuronal
C0003243;Small cell carcinoma of lung
C1413613;ITK protein human
C0054720;Carbomer-940
C0003240;Azithromycin
C0003241;Antibodies Bispecific
C0694891;Malignant neoplasm of pancreas
C3806166;EGFR Antibody
C1174937;Proprotein Convertases
C0016576;Functional disorder of intestine
C0679250;Easy
C1425604;MYOZ3 gene
C1122016;SPINK5 gene
C0679254;Both lungs
C0042849;Physiological Processes
C0694884;Patients
C0042845;High-Grade Squamous Intraepithelial Lesions
C0694888;Metastatic malignant neoplasm to brain
C0005898;Sexually Transmitted Diseases
C0030863;Pentamidine
C4034374;Primary sclerosing cholangitis
C0004565;Mus
C0003234;Anthracycline Antibiotics
C0694883;PRKAA1 wt Allele
C0003232;Typhlitis
C0005893;Stage III Colon Cancer
C0004561;PRMT5 gene
C1414956;Colorectal Neoplasms
C0005891;Patients
C0259972;Vascular Endothelial Growth Factors
C0475433;Macrophage Activation Syndrome
C0234698;Caucasoid Race
C0015249;Syndrome
C4289789;Human Papillomavirus
C0015214;Patients
C0016542;Abdomen
C1426948;Hypersensitivity
C0679246;Hepatectomy
C0679247;treatment options
C0042839;Tretinoin
C1112682;Secondary Neoplasm
C0694879;EXT2 gene
C0872187;Pharmaceutical Preparations
C0694878;Patients
C0221353;Malignant neoplasm of sigmoid colon
C2700343;Genes
C0030851;Edema
C0694872;Mutation
C0919289;Growth
C1414968;Neoplasms
C1859539;Progressive liver disease
C0271650;Diabetes Mellitus
C4264481;Participant
C0003261;Immunoblotting
C1426941;protein expression
C0235996;Patients
C0920269;cancer recurrence
C1148673;Antibiotics
C0450139;Jejunum
C0728747;Overall Response
C0221366;Embryonic cyst of Gartner's duct
C0030842;Vancomycin
C1859543;Current Therapy
C0003250;Mus
C0475411;Local excision
C0030847;Biopsy
C0016522;Foramen Ovale Patent
C1174905;ERK Signal Tranduction Pathway
C0487470;aggressive cancer
C0245382;Glycoproteins
C1149946;Calcineurin activity
C0872169;Giant cell hyaline angiopathy
C0003209;Colonic lesion
C0042815;Visual Analog Pain Scale
C0872165;Enteroaggregative Escherichia coli
C0524865;Perineal Trauma
C0003205;Septicemia
C0005863;CFLAR protein human
C0524869;O(6)-Methylguanine-DNA Methyltransferase
C0077404;Extracellular
C0920283;USP11 gene
C1414900;PAWR gene
C3843156;Esophagus
C0440786;Augmented bladder
C0233397;Patients
C0872173;functional disability
C0450119;Rectus Abdominis
C1150946;Human tissue
C0440790;Accumulation
C0016533;Forceps
C0017861;Glycerin
C0728725;Low pH
C0450113;Gluteal
C4289797;Antibodies Anti-Idiotypic
C0524851;Homologous Gene
C0524850;Surgical Manipulation
C0004525;Apoptosis
C0920274;Signal Transduction Pathways
C1556095;Korean race
C1414917;Adenocarcinoma
C0401181;Metastatic Renal Cell Cancer
C0439775;Aspartate Transaminase
C1750186;Bcl-2 Activity
C0256022;Cholangiocarcinoma
C0030827;Clostridium perfringens
C0016536;Male population group
C1655760;Cohort
C1426905;Stomach Carcinoma
C1150957;Growth
C0221391;Anthraquinone glycoside
C0221390;Non-Bacterial Thrombotic Endocarditis
C1148636;Lipid Binding
C0246694;pro-apoptosis
C0005889;Intestinal Secretions
C1556085;german race
C0005885;tomography
C4035673;Secondary malignant neoplasm of lymph node
C3641907;Immobilization
C0017837;Tumor cells malignant
C0256015;protein kinase C gamma
C0016504;Hypesthesia
C4047662;Colon structure (body structure)
C1568042;Paclitaxel
C0064113;Antifungal Agents
C4045009;Colorectal Carcinoma
C1823570;Body tissue
C0425152;Community
C1823571;Ubiquitination
C0523503;Chronic Obstructive Airway Disease
C0524832;Lung excision
C0003211;Myocardial Infarction
C0005874;Blushing
C0920298;Patients
C0259990;Advanced Malignant Solid Neoplasm
C0077415;Pharmaceutical Preparations
C1413603;Childhood Solid Neoplasm
C0066772;ENPP2 gene
C0439792;Natural Killer Cells
C0440779;Macrophage Activation Syndrome
C0259901;Empowered
C0259902;Gastrulation
C0053471;Colorectal Carcinoma
C0898753;SAFB protein human
C0861461;Surgical Procedures Laparoscopic
C0005821;Blood Platelets
C0304119;Staphylococcus aureus
C0162597;aerobic glycolysis
C0162596;Patients
C0162595;Antibodies Anticardiolipin
C3880144;Disease
C4277707;Oxygen Radical Absorbance Capacity
C4277709;Malignant tumor of cervix
C0017817;NAA50 gene
C0017822;human cell line
C0597815;Chronic disease
C4035627;Malignant tumor of colon
C2169178;irradiation modality
C4035626;high-risk group
C0210657;Treatment Protocols
C1016955;Plant seeds
C0004519;Mus
C0524889;erbB-2 Receptor
C0005847;Physical findings
C1172384;BZW2 gene
C0392676;Patients
C0522224;Pharmacotherapy
C0392674;SIRT6 gene
C0222603;Malignant Neoplasms
C0162578;Tumor thrombus
C0005842;Anemia
C0005841;CD69 protein human
C0222605;Mass of body structure
C0162574;Neoplastic Cell Transformation
C0222600;Lymphoma Non-Hodgkin
C0222601;Single lesion
C1122087;adalimumab
C0199850;Malignant Neoplasms
C0559546;Immune System Processes
C2169187;Immobilization
C0222607;Kidney
C1519052;trastuzumab
C2931758;nivolumab
C1519050;Phosphatidylinositide 3-Kinase Inhibitor
C0175898;Colorectal Carcinoma
C0005839;Endothelial Cells
C3494192;Arteries
C3494197;Tumor cells malignant
C0474166;Symptoms
C3542289;Body tissue
C3494163;Hospitals
C0208355;Muscle
C1328504;Proton Therapy
C0162557;Benign Neoplasm
C0235974;World
C0450184;Intussusception
C0850760;cardiovascular problem
C0149566;Anatomic Site
C4024983;Renal pelvic carcinoma
C0318711;Child
C4264438;Compound heterozygous
C0247952;Administration Topical
C1158013;Nonsense Mediated mRNA Decay
C3494179;Tumor Microenvironment
C4277731;Autophagy-Related Proteins
C4277735;Operative Surgical Procedures
C0235982;Biliary Tract Cancer
C4264446;Transverse colon
C0475468;Adenocarcinoma metastatic
C1159372;Growth
C4289741;Continent Urinary Diversion
C0076172;cytotoxicity
C4264447;Poorly cohesive carcinoma
C0162535;electrical resistance
C0222647;Round cell tumor
C0163868;Decreased Immunologic Activity [PE]
C0475463;Colorectal Carcinoma
C0475466;Veins
C2169144;Insertion of pack into vagina
C4264454;Low-Frequency Microsatellite Instability
C0561837;Patients
C0235969;Patients
C0389071;Enzyme-Linked Immunosorbent Assay
C1872549;karavilagenin B
C1658773;centrosome duplication
C0548471;Reconstructive Surgical Procedures
C1417778;Patients
C0272285;Intestines
C1442738;Malignant Neoplasms
C1416447;phosphatidylinositol 3-kinase signaling
C3273087;Patients
C1417771;fibrogenesis
C1415113;Cell Survival
C0585418;decompression tubes
C0079225;colon growth
C0814997;Crypt
C0887909;RNA
C0103405;Colon Carcinoma
C0103404;Adenoma
C1416450;Anoxia
C0031272;Homo sapiens
C0332441;Normal tissue morphology
C1416457;Digestive System Neuroendocrine Neoplasm
C0056593;E2F3 gene
C0079218;Mass of body structure
C0332448;Prognosis good
C0597415;Colorectal Carcinoma
C0332447;Morphologically abnormal structure (morphologic abnormality)
C0080202;Direction
C0043251;Splenectomy
C0043250;Chronic diarrhea
C0068570;Signal Transduction
C2322705;Neoplasms
C0849640;skin damage
C0043246;Jejunum
C0574785;Symptoms
C0032594;Refractory Neoplasm
C1442759;Secondary malignant neoplasm of lung
C0018284;Neuregulins
C1416467;SMARCE1 gene
C0018282;Mus
C0260271;Inflammatory Bowel Diseases
C0082896;Wild Type
C1861172;apixaban
C0343101;Patients
C0043242;Superficial abrasion
C0127400;Mediator brand of benfluorex hydrochloride
C0043241;Pelvic abscess
C0043240;Epithelial proliferation
C0031268;Pet Animal
C0031269;Autosomal dominant hereditary disorder
C0850639;Melanosis coli
C1428445;Mitosis
C1416473;macrophage
C0032580;Metachronous Malignant Neoplasm
C0812309;LTB gene
C1416471;cancer therapy
C0598720;RNA Transport
C0032584;Melanosis coli
C0018296;MTOR gene
C0740178;Laboratory
C0332461;Cecum
C0079238;Digestive System Fistula
C1441416;Prostate volume
C0031256;Petechiae
C3549289;Myeloid-Derived Suppressor Cells
C0812306;Tamoxifen
C1416405;Renal Cell Carcinoma
C0019593;Postmenopausal state
C0285558;Ubiquitination
C1416402;Liver carcinoma
C0332472;Hepatocarcinogenesis
C1416401;Inflammatory disorder
C1620114;Malignant Neoplasms
C0020580;Symptoms
C0332479;Invariant Natural Killer T-Cells
C0031246;Surgical repair
C2826609;Crypt
C0006290;Sarcoidosis
C0548441;General Anesthesia
C1417746;Neoplasms
C1332270;Skin appendage adenoma
C0020598;Hypocalcemia
C3850136;African race
C0018270;Mice Nude
C0332482;Abnormal shape
C3850137;Colorimetry
C1620101;Neoplasms
C1620102;MHC class I peptide loading complex
C1153522;Tumor cells malignant
C1416419;Patients
C0043210;RRH gene
C0476288;Digestive symptom
C1850473;Male population group
C0032568;Carcinogenesis
C1417752;Negative
C0043207;Chronic Obstructive Airway Disease
C0079280;Tumor Angiogenesis
C0079281;Discontinued
C0007590;DNA Replication
C0007591;Patients
C0007595;Colorectal Neoplasms
C1874451;Biliary stricture
C1332262;Patients
C1416427;Liver carcinoma
C1514925;Diploid Cell
C0021896;Morphine
C0006267;Colorectal Carcinoma
C0020564;Patients
C4288812;Renal Cell Carcinoma
C1416423;IMMT gene
C4288814;Metabolism
C1706912;Pneumonia
C0021890;Patients
C1428406;TFRC gene
C2743752;Histone deacetylase inhibitor
C0080274;geriatric patients
C0909826;fluorescein sodium
C0909825;Body tissue
C0476273;Patients
C1333585;Suppressor
C1416431;Neoplasms
C0006270;Adenoma
C1417767;RNA Small Interfering
C1333581;Cell Survival
C1417768;ABCB1 gene
C0019588;Symptoms
C1417769;Cultured Cell Line
C0019587;TJP1 gene
C0079278;Abdominal symptom
C1415106;Tumor tissue sample
C0586713;RPL5 gene
C0586714;Endoscopic biopsy
C1514918;Endoscopy (procedure)
C1416433;Malignant neoplasm of anus
C0586716;Quantitative PCR analysis
C1320286;Patients
C0080264;Axilla
C0369760;Organic acid (substance)
C1332257;Patients
C1332259;Anal canal adenocarcinoma
C1332243;general population
C1333574;Equilibrium
C1333573;RPL5 gene
C0019559;Male population group
C1332244;Patients
C0007570;Small intestine carcinoma
C0033860;Pathologic Processes
C0020541;Varicosity
C3539878;Patients
C1562590;Cancer Patient
C0007577;Immune response
C0596155;Peritoneum
C0007578;Protoplasm
C1176289;Mammary Neoplasms
C0728475;ultra
C1321585;Patients
C0236580;Laboratory Procedures
C3537219;Zinc Finger FYVE Domain-Containing Protein 9 human
C0080298;Proto-Oncogenes
C1332249;Ampulla of Vater Signet Ring Cell Carcinoma
C3887461;HPV-High Risk
C0019569;Rectum and sigmoid colon
C1334894;HCT116 Cells
C0007581;apoptosis signaling
C3179871;Programmed Cell Death Type II
C0007582;Embryonic Development
C0007584;RAB8A protein human
C0019564;Hippocampus (Brain)
C0007585;Organoids
C0007586;Biochemical Pathway
C0006255;Bronchi
C0019562;Islet Cell Tumor
C0007587;colon growth
C0019560;Hip Joint Implantable Prostheses (device)
C0007589;Ganglioneuroma
C3887460;High risk of
C0020557;Malignant tumor of small intestine
C4082178;ARHGEF1 gene
C0032529;leptin
C0020550;Malignant Neoplasms
C3898115;OVCAR-3
C2959722;Bcl-2-Like Protein 11 human
C0032520;Microsatellite Instability Analysis
C0032521;Colonic Diseases
C1417708;Tumor Necrosis Factor Receptor
C0018207;Homo sapiens
C1332223;Phosphorus Metabolism Disorders
C1417712;RAD51D gene
C0018203;Primary immune deficiency disorder
C4539740;Patients
C0249880;Cardiac Arrest
C0598798;Diffuse Large B-Cell Lymphoma
C0021851;Thickened
C0021852;aquaporin 3
C0006222;resveratrol
C0006223;Bromine
C0021853;Altered microbiota
C0596130;Persons
C0598790;Malignant neoplasm of lung
C0402000;Empowered
C3850141;Acute-On-Chronic Liver Failure
C0596138;autocrine
C0250870;Adenocarcinoma of large intestine
C0033844;Pseudotumor
C1334889;Notch Signaling Pathway
C0020538;Essential Hypertension
C0187067;Operative procedure on hand
C0006233;Cell Count
C3538559;2-Mercaptoethanesulfonic Acid
C0008897;Human Class I Antigens
C1956000;EPHB2 protein human
C0007569;Chronic obstruction
C3549205;Endothelial Cells
C1333530;Tumor tissue sample
C0020505;Obesity
C0021838;Mus
C0020507;Angiogenic Process
C0754727;Malignant Neoplasms
C0021839;Aspartate
C2957112;Folic Acid Transporters
C0007531;Laceration
C0596112;Asparagine
C1273428;Colorectal Cancer pT1 TNM Finding v6 and v7
C0260252;Emission spectroscopy
C0021833;Intestinal Fistula
C0021831;Long-Term Survivors
C0006205;Rectum
C0007537;Serum
C0333727;Area
C0671970;Hyalinosis Systemic
C0596119;Malignant Neoplasms
C0682638;Signal Transduction
C0682639;CISD2 gene
C1956061;TOLLIP protein human
C0333721;Magnification
C0813622;Serum
C0033822;ileum
C1333533;AKAP8 gene
C1319226;Symptoms
C0683962;Males
C1333535;FGF10 gene
C0021849;Body Fluids
C0021846;Animal Disease Models
C0020517;Animal Disease Models
C0598783;FABP4 gene
C0021847;Gliosis
C0260249;Tissue fiber
C2983415;Perianal
C1273412;Chronic radiation proctitis
C0021841;Intussusception
C0020510;Nodular hyperplasia
C1956064;Orotracheal intubation
C0597452;Cytometry
C0671983;Dysplasia
C0021845;Peritonitis
C0968181;Depressive disorder
C0021843;Malignant Female Reproductive System Neoplasm
C0006217;Caspase-Dependent Apoptosis
C1333527;Lipid Metabolism
C0683954;Patients
C0682625;Biliary Tract Cancer
C1333524;Liver
C0598754;Stromal Cells
C0597423;Colorectal Carcinoma
C0585479;Patients
C0008845;Citalopram
C1319200;Postoperative Complications
C2934490;PHA-793887
C3549253;high-risk group
C0033808;Pseudomonas
C0597427;CST3 gene
C0033809;Pseudomonas aeruginosa
C2610587;Mitogen-Activated Protein Kinases
C0682610;ileum
C0885297;Intestine - Large Intestine - Colon (MMHCC)
C0021826;cetuximab
C0008855;leupeptin
C0008858;Mitochondria
C0007528;Intussusception of colon
C0262880;Transmission Electron Microscopes
C0585462;Malignant neoplasm of sigmoid colon
C0585464;Adenocarcinoma of cecum
C0683939;Medical Devices
C0598766;Xenograft Model
C0683935;cancer therapy
C0872084;capsanthin-capsorubin synthase
C4321104;Body tissue
C1284117;Sigmoid colon
C0224522;Synoviocytes
C1537663;MARCH8 gene
C1537665;MARCKSL1 gene
C1562632;Sebaceous Gland Neoplasms
C1536338;Local excision
C0427245;Pain
C1319308;Eosinum eosin Homeopathic preparation
C1319309;Transection (procedure)
C1334941;Neoplastic Polyp
C1826700;B-Lymphocytes
C4072741;Intravenous contrast
C0729737;Patients
C1826706;Neoplasms
C0442893;Gingival Diseases
C0225861;Metric
C0872097;Non-Small Cell Lung Carcinoma
C0225860;Large Mass
C2923839;Risk level
C1319310;Liver damage
C1261473;Mus
C0008838;Metastatic Epidermoid Carcinomas
C1319312;Hemoglobin G
C1511022;BRCA1 Gene Mutation
C1333600;Transformation function
C1319315;Mice Nude
C0729707;Rectal artery
C2826588;Chronic Active Colitis
C3539812;Multiprotein Complexes
C1321605;Patients
C0717726;Mus
C2825250;Adoptive Immunotherapy
C0671870;Neuropeptides
C1956080;Vacuum-Assisted Closure
C1285478;Lesion
C1537647;Aggravated Colitis
C0008809;Antibiotics
C0682537;SPINK4 gene
C0442867;World
C0682533;Hybrids
C0872070;nucleocytoplasmic transport
C0766823;Carcinogenesis
C0872079;protein protein interaction
C0008810;Patients
C0872076;Mus
C3539807;Myosin Phosphatase Rho-Interacting Protein human
C1537657;ITK protein human
C0225844;Neoplasms
C0442876;Prostate
C0682524;ISOLATE COMPOUND
C0442874;Patients
C0163159;phthalates
C0682523;Interleukin-1 Receptor Accessory Protein
C3540820;Protein phosphorylation
C1826751;R3HCC1 gene
C0441519;Liver and Intrahepatic Biliary Tract Carcinoma
C3899478;Patients
C0153792;Stage III Hodgkin Lymphoma
C3815805;Foregut
C0126174;Pain
C3492700;1-(13-carboxypropyl)-47-carboxymethyl-147-triazacyclononane
C0441517;Patients
C0250850;Patients
C0441516;Radical prostatectomy
C1309950;Excretory function
C1826743;Malignant tumor of colon
C0537809;Serum
C0606070;Genetic Carriers
C3540815;CD4 Positive T Lymphocytes
C0872054;Epstein-Barr Virus Infections
C0069906;mRNA Expression
C1563937;Atherogenesis
C0236556;Alkaline Phosphatase
C0237881;Statistical Significance
C0596170;Neoplasms
C3540840;Observation - diagnostic procedure
C0596177;Biocompatibility
C0430879;Health care facility
C0392190;Intestines
C0694552;Patients
C0920184;Stomach Neoplasms
C0694551;Male population group
C1825409;Patients
C2611831;HCT116 Cells
C1550661;NDRG4 gene
C0682578;Stomach
C2103070;Disarticulation
C2333337;Serum
C1440080;Epithelium
C1753319;Ribosome Subunits Small Eukaryotic
C2103078;Colorectal Cancer pT1 TNM Finding v6 and v7
C0225883;Neoplasm Metastasis
C0441508;Extraction
C0441509;Control Groups
C0237865;Propensity to adverse reactions to drug
C0441503;Anorectal Treatment
C0441506;Absorbable suture
C1825468;Chronic Obstructive Airway Disease
C2611812;Tumor cells malignant
C1826797;REV1 gene
C0165747;lobaplatin
C1825459;Polyubiquitination
C0068613;Neoplasm Metastasis
C0524533;Patients
C1608426;Compensated Hepatic Cirrhosis
C1826785;Neoplasms
C1427067;Cessation of life
C0523207;Evaluation procedure
C1824114;Neoplasms
C1415098;GCLM gene
C1826778;protein expression
C1427079;Apoptosis
C0524528;22q13.3 Deletion Syndrome
C1166829;Patients
C1514964;epithelial to mesenchymal transition
C3813209;Patients
C0381424;Colorectal Carcinoma
C0574825;Sephardic Jew follower of religion
C1610733;Prostate-Specific Antigen
C0069966;palmitoleic acid
C1608408;Malignant cell transformation
C0056650;Glycosides
C1538907;Glutathione
C1608407;Patients
C0524516;Canis
C0861352;Communicable Diseases
C1514955;Cullin 1
C0887963;Toxic effect
C0201811;sigmoid polyp
C0887965;Experimental Animal Models
C0141783;Flavonoids
C0102137;CATALASE
C0070943;Choline phosphatase
C0608663;Colorectal Carcinoma
C4288754;Male population group
C1550600;Colorectal Carcinoma
C1537628;Child
C0056661;Mus
C0079304;Gastric Varix
C0070971;phthalocyanine
C1824182;Apoptosis
C1428348;Patients
C1441322;Escherichia coli
C1849402;Increased echogenicity
C0380162;antibody conjugate
C1824164;Ectopic Gene Expression
C1825497;Autophagy
C3273031;Woman
C1415047;Cancer-Associated Fibroblasts
C1825498;Autophagy
C1415053;Elevation procedure
C1416383;IL12RB1 gene
C0066005;Clostridium perfringens
C1416380;WNK1 protein human
C0887914;Eukaryotic Cells
C0079323;Cirrhosis
C1428361;Catenins
C0452221;Osteomyelitis of vertebra
C1512346;Comorbidity
C0043162;Whole-Abdominal Irradiation
C1416395;Tumor Microenvironment
C1415063;intrinsic apoptosis
C0524550;Nucleotide Excision Repair
C0441583;Liver neoplasms
C0043157;Caucasians
C0056696;Disease
C1537619;promoter
C1415068;Sulfoglycosphingolipids
C1511002;b cell differentiation
C1512335;D3 lymph node dissection
C0055367;Photochemotherapy
C0441587;Stent device
C0850666;Patients
C1416562;mRNA Expression
C0346957;Prostate
C0031164;Mitochondrial Membranes
C1442858;Kidney
C0018188;Granuloma
C0333641;Paresis
C1416567;ECM2 gene
C1417892;G1 to S Transition Process
C0332316;Patients
C0054048;Proto-Oncogene Proteins c-akt
C0080331;Social Networks
C0043144;Carcinoid Heart Disease
C0081660;mitogen-activated protein kinase p38
C0031150;Cellular Immunity
C0032483;Bowel preparation
C0031153;Carcinomatosis primary
C0031154;Mass of intestine
C0598864;Demethylation
C0344304;Abdomen distended
C0586854;Medical biochemist
C1427221;Squamous cell carcinoma of esophagus
C0332326;Gleason Grading System
C0597535;Success
C0032487;Intestinal cell
C1427224;Heart failure
C0346979;Treatment Protocols
C0031142;Hyperthermic Intraperitoneal Chemotherapy
C0346977;Malignant neoplasm of spleen
C0346976;Malignant neoplasm of pancreas
C0079366;Flow Cytometry
C0019494;Mannose
C1416589;mRNA Expression
C3813046;Malignant tumor of cervix
C0968086;RBM15 protein human
C1428560;Mammals
C1836296;Patients
C0346975;Male population group
C0836205;Necrosis
C1428567;Malignant Neoplasms
C0031148;Normal saline
C3840622;5 - 9
C0031149;secondary group
C3827687;Ellagic Acid
C3827688;Complication
C0032460;Non-alcoholic Fatty Liver Disease
C0043113;Endoscopic Submucosal Dissection
C3537183;cancer prevention
C0560268;Volume fraction
C0309989;Chemicals
C1836286;Patients
C0031133;Peristalsis
C1440204;Colorectal Carcinoma
C1704426;Platelet Glycoprotein 4 human
C0033799;MicroRNAs
C0982374;RICE BRAN
C0006160;Brenner Tumor
C0079380;Mismatch Repair Protein
C0019475;promoter
C1416526;JAG2 gene
C0078058;Patients
C0078056;Endothelial Cells
C1416521;ITSN2 gene
C0812252;Family
C1154744;GA-Binding Protein Transcription Factor
C0812253;epithelial to mesenchymal transition
C0043100;Weight
C0032456;Non-Small Cell Lung Carcinoma
C0346993;Invasive Carcinoma
C0032458;CYP1A1 gene
C0346991;Secondary malignant neoplasm of omentum
C1332397;Tumor cells malignant
C1417862;Fascia
C3813051;Long Term Survivorship
C0018154;Lactobacillales
C1415205;Squamous epithelium
C0333695;Alteration of chromosome structure
C0740277;Radicals (chemistry)
C0018150;Peptic Ulcer
C1417861;soluble
C0812241;AT 13387
C0031119;Neurilemmoma
C0812244;Receptors Tumor Necrosis Factor Member 10b
C0020473;Hyperlipidemia
C0812242;Colonic epithelium
C0033774;Pruritus Ani
C0033775;Dermatologic disorders
C0031117;Stage III Colon Cancer
C0752253;Growth Factor
C1415210;GPR15 gene
C1417874;Fluorodeoxyuridylate
C1416540;KARS gene
C0560219;Malignant neoplasm of mouth
C0007471;Probes
C0006141;Bilateral Mass
C1332381;Syndrome
C0006142;World
C0128818;RUNX2 gene
C2983588;Diet
C0006145;Breast Diseases
C0021775;Male population group
C0020443;Cholestatic liver disease
C0006147;Ability
C1622638;Ubiquitination
C0812230;Gene Expression
C0021770;Intermediate Filaments
C0812233;12-dipalmitoylphosphatidylglycerol
C0812231;WNT2 gene
C0752248;Colorectal Neoplasms
C0032433;Putrescine
C0812236;PTEN gene
C3346612;Dorcatragus megalotis
C0812235;Liposomes
C0344355;Head and Neck Carcinoma
C1428523;Chronic Obstructive Airway Disease
C0031106;Okadaic Acid
C1416552;Body tissue
C0272394;Chemotherapy Adjuvant
C1442823;oxaliplatin
C1442824;Liver carcinoma
C0006153;Lactulose
C1415229;Negative
C0018133;DPP4 protein human
C0020452;Hyperemia
C0079399;Gender
C0018131;Cohort
C0006159;Breeding
C0331053;Plant seeds
C0020456;Immune response
C0079394;Cyclin D1
C0020459;Insulin Resistance
C1415223;Severe (severity modifier)
C0812222;RPL4 gene
C0297674;Ellagic Acid
C0598801;Small Lesion
C1332379;BAK1 gene
C0812229;IL27 gene
C0812228;Hypoxia-Inducible Factor 1
C1427202;Membrane Transport Proteins
C0021758;Biologic Development
C0020429;Inflammation
C0007450;Felis catus
C1333690;SLC4A2 gene
C0006121;Colorectal Carcinoma
C0007452;Cattle
C0021753;MicroRNAs
C0007457;Pneumocystis jiroveci pneumonia
C0021756;Cellular Immunity
C0007458;Neoplasm Metastasis
C0021755;cytokine
C1298805;Anastomotic Leak
C0429821;Urethral closure mechanism
C1298802;Anastomotic Leak
C0272325;Patients
C0442804;External Beam Radiation Therapy
C0235378;Hepatotoxicity
C4082285;Insulin Receptor-Related Receptor human
C1333686;GNAZ gene
C0489461;Colorectal Carcinoma
C1417821;Patients
C1417825;bile acid metabolism
C0020431;Colon and Rectal Surgery (procedure)
C0318078;Ruminococcus gnavus
C0021764;Immunologic Factors
C0596286;Multiple malignancy
C0318074;PCSK7 gene
C0020437;Patients
C0442816;Normal limits
C2347948;Patients
C0021760;Secretory Immunoglobulin A
C0442811;Very low
C0334901;Clinical pathologist
C4082295;Tumor cells uncertain whether benign or malignant
C0032405;Glycolysis
C1704489;Colorectal Carcinoma
C0932050;Growth Factor
C1417835;Carcinogenesis
C0007430;Patients
C3898008;Palliative Radiation Therapy
C1416502;Injection
C0489479;Radiometry
C0006104;Low grade glioma
C0260314;Cystoscopy
C0006105;Dyspnea
C0033727;High-Risk Cancer
C0007439;Extraction
C0199171;Medical procedure
C3875321;Inflammatory dermatosis
C1417837;Colorectal Carcinoma
C0199176;Warming blanket
C1417839;Patients
C0199175;Persons
C1537486;mRNA Expression
C0596260;Esters
C1333664;Signal Transduction Pathways
C0021747;Immune Cell
C0019425;Disease
C0262967;Interventional procedure
C0006110;Donor person
C0006111;Brain Diseases
C0489488;Liver carcinoma
C0021740;IL17RE gene
C1416512;Colorectal Carcinoma
C0596263;Immune System Diseases
C0007447;neuronal
C0021743;MB21D1 gene
C0006118;monooxyethylene trimethylolpropane tristearate
C1318045;Persons
C0403229;Patients
C0033713;Negative
C1333652;G6PD gene
C0596235;Cancer Stem Cells
C0596233;KLK1 gene
C0740201;Neoplasms
C0007412;Catecholamines
C1563761;Chronic Obstructive Airway Disease
C3850088;Complement C5a
C1970246;Angiogenic Process
C0729890;Residual Tumor
C0596237;cancer complication
C0007422;Cathartics
C0597573;Lymphoma
C0021721;Intercellular Junctions
C0596240;Cancer Pain
C0007427;Hepatitis B
C1621396;Mitochondria
C2347900;Best Overall Response
C3850096;Cellular Reprogramming
C1334977;Non functioning pancreatic endocrine tumor
C0222084;Secondary malignant neoplasm of skin
C3850063;Biliary Elimination
C0405832;patient is female
C4084880;Disease
C0334957;Research Personnel
C1334966;Hereditary Nonpolyposis Colorectal Cancer
C0021708;Hospitals
C0596223;brca gene
C0008732;iatrogenic injury
C0008731;physiological aspects
C0021701;Biological Factors
C3850077;Drug Liberation
C0007407;Chronic abdominal pain
C1620047;FKBP12-rapamycin associated protein
C3850079;Appendiceal mucinous neoplasm
C0596227;british
C1262869;removal technique
C1260204;Pharmaceutical Preparations
C1825500;Body tissue
C1825502;ATG16L1 gene
C1825503;Autophagy
C1826836;Wnt Signaling Pathway
C0442760;3/9
C0935989;Administration Oral
C3275700;Hepatic inflammation
C0225972;Body Fluids
C0393386;Patients
C1285572;Immunocytochemistry
C1285573;Microspheres
C1512249;Laparoscopic hysterectomy
C0199230;Anus
C1332402;Mouse Model
C4321237;Proteinuria
C0681331;Core needle biopsy
C1095906;Malignant Neoplasms
C0379099;diphyllin
C1512233;Candidate Disease Gene
C0429770;Organs at Risk
C0960938;red fluorescent protein
C0429774;Residual urine volume
C0237962;Curative Surgery
C0199220;Anoscopy
C1514892;ATP-Binding Cassette Transporters
C1333723;GTF2H1 gene
C1536220;Myocardial Infarction
C1537528;Neoplasms
C0679006;Cohort
C0430797;Cohort
C1057625;Oils Volatile
C0683983;European American
C0442748;6/4
C0442749;Incontinence
C1273551;High risk factors
C1273550;Crotoxin
C0683971;Cessation of life
C0442751;Male population group
C0163275;Cancer-Associated Fibroblasts
C1320408;Patients
C2825146;Aversion
C2347883;Radiation
C2825142;Social Networks
C0428462;Malignant neoplasm of prostate
C3657270;stage IV non-small cell lung cancer
C1538866;Ubiquitination
C1031004;IMPACT gene
C4321251;CYCS wt Allele
C0442757;Anastomotic Leak
C4321252;WWOX wt Allele
C1826879;Body tissue
C2608320;Patients
C1307407;Gene Expression Regulation
C0262950;Secondary malignant neoplasm of bone
C1512286;Gynecologic Oncologist
C0249989;Combined Modality Therapy
C0887899;Inflammasomes
C0429742;Radionuclide Imaging
C0442726;Endoscopic Ultrasound
C0212694;Proteins
C1742799;Splenda
C0887892;Membrane Proteins
C1825534;Ranitidine
C2347861;Patients
C0262941;myofasciitis
C1824201;Patients
C3539704;MTR wt Allele
C1837514;Malignant Neoplasms
C0596290;Chemotaxis
C0068704;RNA Small Interfering
C0933344;Excision biopsy
C0222001;Atrophic
C0694675;Veins
C0068707;Extracellular
C0596295;cellular pathology
C0887872;Cell Communication
C1260298;Immune response
C3899376;Validation
C1537569;LGR4 gene
C3539739;Carcinogenesis
C0222007;Atrophic
C4084801;Biopsy
C0887870;Adaptor Proteins Signal Transducing
C0235329;Dermoid cyst of ovary
C1825511;HMCN2 gene
C0262926;Outpatients
C0235328;Sigmoid Neoplasms
C0235326;Patients
C0680022;member
C2359826;Pilomatrixoma
C1308727;SNAP receptor
C0056730;Tumor cells malignant
C1537570;beta catenin
C0235325;Patients
C1825588;IKZF1 gene
C0850572;Colonic Diseases
C1415199;Malignant neoplasm of oropharynx
C0586905;Pediatric surgeon
C1415195;GPC3 gene
C1415193;Glypican
C1490417;Microorganism
C0332397;tomography
C0680091;Adenomatous Polyposis Coli
C0586901;Colorectal surgeon
C4264624;Persons
C0332393;treatment failure
C0201925;Electroporation
C0056744;macromolecule
C1514821;Primary Health Care
C0812297;Growth
C0201927;Hematologic Tests
C1825577;mRNA methylation
C1825578;IGF2BP3 wt Allele
C1825579;Adenocarcinoma
C0537969;TRIM25 gene
C1441471;Regulators (device)
C0680085;early adulthood
C0935912;Synchronous Lesion
C1514815;Adult
C1825575;Neoplasms
C1825576;IGF2BP1 gene
C0812284;Cohort
C0812287;TRANSCRIPTION FACTOR
C0043094;Spleen
C0343055;Radiation
C0679083;Operative Surgical Procedures
C4288612;Indocyanine Green
C0068742;Dysentery
C0812281;Non-Small Cell Lung Carcinoma
C0524645;Marines
C0812271;Neoplasms
C0812278;Plants
C1514845;Toxic effect
C0887832;Mass Spectrometry
C0031093;Bacteria
C0680063;Offspring
C0031099;Tannerella forsythia
C0886515;Extracellular
C2919010;Chest
C0812270;Long Term Survivorship
C3669246;Homo sapiens
C0081714;Colon Carcinoma
C0887840;Neoplasms
C0812265;ATP8A2 protein human
C0536615;Epithelial Cells
C4321267;Neoplasms
C0441476;removal technique
C1415158;RNA Long Untranslated
C1415157;Adenocarcinoma
C0079427;Polyubiquitination
C1538830;TRIB2 gene
C1368354;geriatric patients
C0079429;Genes vif
C0200635;Rectal Carcinoma
C1537502;Guanine Nucleotide Exchange Factors
C1427130;Tumor Cell Invasion
C0535350;Transcription Genetic
C2827774;Severe colitis
C1416491;Surgical Procedures Laparoscopic
C1513528;DDX53 gene
C0887829;fatty acid metabolism
C1427145;Carcinogenesis
C1514850;Mutation
C0079419;Metabolic Profile
C1837594;UHRF1 gene
C2827787;Anti-Bacterial Agents
C3840736;Colectomy
C0043053;Disease
C1427148;Metastatic Lesion
C0607430;Lectin
C1442760;inflammatory response
C0043047;Neurologic Deficits
C0043046;Wasting Syndrome
C0068788;Membrane Potential Mitochondrial
C0031066;Dehiscence
C0427184;No incoordination
C0935929;Hydroxymethylglutaryl-CoA Reductase Inhibitors
C0439165;Percent (qualifier value)
C0128897;Pancreas
C1415188;Primary sclerosing cholangitis
C0044369;1-dodecylpyridoxal
C4289970;Patients
C0850541;foley catheter removal
C1415181;GOT1 gene
C3814448;Endoscopic dilatation
C1825598;Gases
C2754343;SMAD4 gene
C0394664;skin toxicity
C1427164;Transcription Genetic
C1538823;Carcinogenesis
C0536651;Flavonoids
C0201975;Cell Count
C3826426;cohesins
C0442797;First Degree Relative
C0043031;Hemorrhage
C1428499;SDAD1 gene
C3827754;Tumor Infiltrating Macrophages
C0019398;Pyrroles
C3814236;cell growth
C0079460;Diffuse Large B-Cell Lymphoma
C1417530;Jejunal mucous membrane
C0116973;Eudragit L
C4225412;Splenomegaly
C1008916;sphingosine 1-phosphate
C1622572;T cell costimulation
C0332677;Major injury
C0103647;Cytoplasm
C1417547;PCDH7 gene
C0033692;Extracellular Matrix
C0006098;Frail
C1332075;Ovarian Carcinoma
C1332070;refractory cancer
C0332685;Thermal injury
C1151154;Tumor cells malignant
C2715081;bis(135-benzenetricarboxylate)tricopper(II)
C1622567;lymphocyte costimulation
C0079459;Immune Cell
C0043012;Patients
C1705859;RNA metabolic process
C0031039;Fruquintinib
C0033680;Radionuclide Imaging
C1442514;MAPKAPK2 gene
C0033684;ZBTB33 gene
C0031021;Body tissue
C0079488;Peptic Ulcer
C1418880;RPL4 gene
C0019372;Patients
C0021699;Gastric mucosa
C1428200;Transitional cell carcinoma of bladder
C1704532;Localized Malignant Neoplasm
C0020361;Acids
C0033687;RAB27A wt Allele
C1704537;Study
C1704536;Self Expandable Metallic Stents
C1417566;Cohort
C0742597;Patients
C0006079;Carcinoma
C3853822;1-(4-((4-(dimethylamino)piperidin-1-yl)carbonyl)phenyl)-3-(4-(46-dimorpholin-4-yl-135-triazin-2-yl)phenyl)urea
C3839524;Impaired cognition
C0079471;Mutation
C0586519;Neoplasms
C0141947;Wnt Signaling Pathway
C0754570;HCT116 Cells
C1368066;Patients
C0032343;Male population group
C0033677;Pancreaticoduodenectomy
C0031019;tomography
C0790233;Distilled water
C0536217;Receptors Tumor Necrosis Factor Member 10b
C0034991;Stable Disease
C1418824;Stomach
C0018026;Immunostimulating conjugate (antigen)
C0034993;Hospitals
C1319072;Screening procedure
C1608239;Specimen Type - Bile fluid
C0020349;Birth
C0021670;Hypoglycemia
C0033666;Ubiquitination
C0368663;Pharmaceutical Preparations
C0562508;Hospitals
C0982262;Rattus norvegicus
C0019369;Herpesviridae
C1417504;Patients
C1417505;Primary malignant neoplasm
C1333362;Adenocarcinoma Cell
C0032320;monooxyethylene trimethylolpropane tristearate
C1151115;Quercetin
C0019360;Patients
C0283149;PKN1 protein human
C2984584;Carcinoma in Situ
C1859049;Cancer Patient
C2984586;Liver neoplasms
C1417507;MVD gene
C1333368;Program
C0034987;Tandem Repeat Sequences
C0032326;Patients
C1334699;Lipoma
C1418844;DNA
C1333355;Cultured Cell Line
C0006020;CD69 protein human
C0033640;DFNA5 gene
C0319634;Genus Tuber (fungus)
C0022984;Mus
C0022983;Patients
C0021655;Hyperinsulinism
C1418840;PPP2R2C gene
C0343387;treatment guideline
C0343386;Inflammatory disorder
C0127615;skin toxicity
C0018019;Capra hircus
C1418854;PPT1 gene
C2703093;bortezomib
C0019348;Herpes Simplex Infections
C0006030;Cultured Cell Line
C0020332;Malignant Neoplasms
C0021665;TCEAL2 gene
C0007367;alginate
C0020336;SIAH2 gene
C0021666;Cancer-Associated Fibroblasts
C0729596;Edema
C0729595;IMPACT gene
C1622501;Membrane Potential Mitochondrial
C0742558;Animal Disease Models
C0033631;Protein Hydrolysates
C0742559;Rectum excision (procedure)
C0034963;Natural regeneration
C0033634;STAT3 gene
C1332018;protein expression
C0345904;LIAS gene
C0345905;Primary Malignant Liver Neoplasm
C0019317;geriatric patients
C0222181;analgesic effect
C0008662;MIR770 gene
C0007332;GA-Binding Protein Transcription Factor
C0008664;ALOX5 gene
C3537453;GBA wt Allele
C0008668;Mucins
C0345907;Patients
C0021634;Transanal Minimally Invasive Surgery
C3826297;Pathogenic fungi
C1537388;HSPB6 gene
C3178775;Eosinophilic inflammation
C1537383;Body tissue
C1333336;CXCL1 gene
C1333321;Duodenal Gastrin-Producing Neuroendocrine Tumor
C0345916;Duodenal Neoplasms
C0019328;Male population group
C0754515;epithelial to mesenchymal transition
C0741204;Arteries
C0021641;Hepatocyte
C0008679;Persons
C0597252;Plant Development
C0033618;Protein Binding
C1512072;Nitric Oxide
C0427514;bevacizumab
C0046917;Accumulation
C3178793;Messenger RNA Isoforms
C0960880;angiotensin converting enzyme 2
C3178790;Endoscopic Submucosal Dissection
C0222169;Secondary Neoplasm
C0022942;Intestines
C0033607;Saquinavir
C2347813;Cmax
C0010961;Erythema
C1335962;Western Blotting
C0022959;Leptocyte
C0022957;Esophageal Neoplasms
C0019305;protrusion
C1742862;Transsexual (finding)
C0008651;SMC1A gene
C1299802;Patients
C0333951;Aging
C0008652;Tumor Suppressor Genes
C0729555;Patients
C0021622;Biometry
C0010979;Daphnia
C0333957;Cell Count
C0034927;Suspected malignancy
C0332624;Neoplastic Cell
C0586596;XAF1 gene
C0235480;Kidney Transplantation
C1333308;Carcinoma
C1335965;Signet Ring Cell Gastric Adenocarcinoma
C1335951;Woman
C1335952;Ascending colon
C1742831;dotatate gallium ga-68
C0022924;Hyperlactatemia
C0562577;Mocking
C1321301;Genes Regulator
C0008625;Colorectal Carcinoma
C0008628;Neoplasms
C0010947;Malignant neoplasm of lung
C2960520;patient is female
C0586544;Epididymis
C0258174;Myeloid-Derived Suppressor Cells
C1825708;Chronic Obstructive Airway Disease
C1261209;Midline incision
C0022938;Colonic mucous membrane
C0599871;American College of Cardiology/American Heart Association Lesion Complexity Score C
C0345958;Male population group
C0599874;Patients
C0008630;Chronic Obstructive Airway Disease
C0008633;Genome
C0007301;Cartilage
C1176475;Breast
C2960517;Stage III Colon Cancer
C0009968;Abnormality of mitochondrial metabolism
C0010957;Tissue damage
C0333977;Cystic Adenomatoid Malformation of Lung Congenital
C0599878;partial response
C3178744;Mus
C0368608;Diarrhea
C0022907;Homo sapiens
C0333983;TFF1 protein human
C0009933;Placebos
C0009932;exhaust
C1175175;BRD4 gene
C0010927;temozolomide
C3178754;Malignant neoplasm of prostate
C1536078;Carcinoma of lung
C3890853;Transcription Genetic
C0022917;Cells
C0009940;Convalescence
C0333992;Acanthoma Clear Cell
C0010934;Dactinomycin
C0333997;Mucous Membrane
C1335929;Patients
C0199242;Anticoagulant prophylaxis
C3178761;High-Risk Cancer
C1826955;RUFY3 gene
C1826954;Histone H3 Lysine 9
C1825625;Transformation function
C2585282;Blood glucose concentration
C1563722;Malignant Neoplasms
C1512127;Patients
C1334703;American College of Cardiology/American Heart Association Lesion Complexity Score C
C1334702;Male population group
C1826944;Colorectal Neoplasms
C4019079;Patient Transition
C0633372;Signal Transduction Pathways
C0150077;Broken skin
C4019071;Prophylactic treatment
C0009924;Contrast Media
C4082333;SNHG14 gene
C1563732;Birth
C1536105;Pericardial effusion
C1512117;Patients
C0452453;melanoma
C1275863;Disease
C1825602;Chronic Obstructive Airway Disease
C0452423;Colorectal Carcinoma
C0209143;Lysine
C2106772;Proctopexy
C1563740;Macrophage Activation Syndrome
C2346449;sorafenib
C1563744;Lipogenesis
C4297010;Malignant tumor of colon
C1537403;Mus
C0683626;human group
C0947828;Patients
C0440447;ALCAM protein human
C1524102;Lipid droplet
C0174045;Motility
C0908273;Diastasis
C1285240;Diabetes Mellitus Non-Insulin-Dependent
C0656017;Blood
C4019053;Satoyoshi syndrome
C0009905;Digestive System Disorders
C0150093;Hospitals
C0150094;CONSECUTIVE SAMPLE
C4528750;Carboplatin
C0235401;Hepatitis C
C0947833;Billroth I Procedure
C1441165;Polymers
C3946033;Bacteria
C0222146;Paget Disease Extramammary
C4084937;Bacterial Infections
C3538741;Stomach Carcinoma
C1261287;Cholestatic liver disease
C1512167;XAF1 gene
C0669372;Epithelial Cells
C0190979;Assay
C0246118;Peptides
C0836189;Observation - diagnostic procedure
C0234122;Inhibitory potential
C1442495;Neoplasm Metastasis
C0682356;Witnesses
C0259419;HCT116 Cells
C0597298;CEP131 gene
C0452415;Persons
C0597297;CEP131 gene
C0597295;MicroRNAs
C1428195;Cells
C0452410;Dietary Fats
C3658228;S100B gene
C4072935;ileum
C1537472;Myeloid Leukemia Chronic
C0682346;program participant
C0440438;SMAD4 gene
C0175325;Gallbladder
C0427460;Colorectal Carcinoma
C1537447;Cell Proliferation
C4045363;Carcinogenesis
C1826968;Glycoproteins
C3658208;Non-infective diarrhea
C3538756;Symptoms
C1454489;PTPRF gene
C0669365;Body tissue
C3816904;Immune Cell
C0682323;Partner in relationship
C3658200;Cultured Cell Line
C0234112;CXCL1 gene
C1416167;IGKJ2 gene
C1417499;Colorectal Cancer
C0392339;Malignant neoplasm of lung
C1442457;2 Weeks
C0330090;Flavones
C1417493;Carcinogenesis
C1417494;Primary malignant neoplasm of lung
C0067518;N-(4-aminophenethyl)spiroperidol
C1417496;Neoplasms Fibrous Tissue
C1417497;Small intestine carcinoma
C1428141;mRNA Expression
C0054201;Patient Discharge
C1441129;radioactive iodine
C1443775;epidermal growth factor receptor signaling pathway
C1825692;HT29 Cells
C0526950;Syndrome
C1824365;Body tissue
C0476481;Patients
C4274302;Moxibustion
C1836348;Muscular Atrophy
C1611835;Specialist
C0538927;Anti-Inflammatory Agents
C1609502;Veins
C1825689;KIAA1429 gene
C0067533;Inflammatory Bowel Diseases
C1514727;ras Proteins
C1514725;Rare Lesion
C0549622;Malignant Female Reproductive System Neoplasm
C0056889;House mice
C1428162;neuronal
C4274338;Patients
C0163305;pyrrolidine dithiocarbamate
C4288963;Sexually Transmitted Diseases
C1824348;Cancer Patient
C3273256;Observation - diagnostic procedure
C1514714;Rag1 Mouse
C3273253;BRAF gene
C0055568;Cholic Acid
C0055565;Epithelial Cells
C2911645;Mus
C1372955;Ulcerative Colitis
C0163314;Serum
C1837655;Multifactorial
C1299895;Rare Diseases
C4287665;Butyrate-Producing Bacteria
C1418788;MNX1-AS1 gene
C0525678;silence
C3815648;Malignant tumor of colon
C1538716;Secondary malignant neoplasm of lymph node
C3815646;Adenocarcinoma Cell
C0079543;Invasive Carcinoma
C1418783;Infiltration
C1417453;Pharmaceutical Preparations
C0032290;Patients
C4310256;Placebos
C1538712;Body tissue
C1538714;Colorectal Carcinoma
C1823078;Catenins
C1525410;Mucous Membrane
C0032285;Multiple Organ Failure
C0068899;irinotecan liposomal
C0054252;Hysterectomy
C0055580;Bacteroides
C3853921;Author
C0524338;Elderly woman
C0524337;Lower abdominal pain
C0934502;Wall of large intestine
C1538720;MYL9 gene
C4274343;Patients
C1513400;Study
C1513403;Mesothelioma
C0947814;primary closure
C1428114;Microorganism
C0151317;Suppuration
C0066248;Gallic acid
C0524324;Patients
C0151313;Patients
C0019294;Hernia
C0392355;Neoplasms
C0078238;Cyclic AMP Response Element
C0020282;Illness (finding)
C0020281;Tumor cells malignant
C0812198;N-Cadherins
C1514760;Receptor Cell
C1861303;Plant seeds
C0836131;Cell Count
C0020291;Deubiquitinating Enzymes
C0020295;Macrophage Activation Syndrome
C0081876;Proton Pump Inhibitors
C0200765;Cytometry
C0032268;Pneumocephalus
C0141981;Laxatives
C1153706;Bacteremia
C0007292;Colorectal Carcinoma
C0007294;tocophersolan
C2681088;Colon Carcinoma
C1151028;oxidoreductase activity
C0019270;Adenocarcinoma
C0752063;Enzymes
C3178814;Exome
C2728259;EZH2 gene
C0078257;Pharmaceutical Preparations
C0559004;Patients
C1705969;Colorectal Cancer
C3178812;Tetraspanins
C3178810;Chronic Obstructive Airway Disease
C1704632;atezolizumab
C0033572;Core needle biopsy
C0033573;Locally Advanced Malignant Neoplasm
C0019284;protrusion
C1417660;YBX1 gene
C1417663;multicatalytic endopeptidase complex
C2239875;Colorectal Carcinoma
C3178824;CDC2 Protein Kinase
C0033575;Patients
C0033578;Prostatic Neoplasms
C0345873;Neoplasm of rectosigmoid junction
C0033579;Patients
C0994163;Biliary stricture
C0007271;Intestines Small
C1417679;Neoplasms
C0033563;Dynamics
C0021576;Cyclophosphamide
C0332575;Insulin-Like Growth Factor I
C0332573;Child
C0034896;Surgical procedure finding
C0034895;Woman
C0345883;Neoplasm of anal canal
C0034897;high-risk group
C0752046;CYP1A1 gene
C4239921;Present
C0007284;Carp fish
C0852920;SMOX gene
C0007286;Carpal Tunnel Syndrome
C0033551;PTGS2 protein human
C0034882;radiologist
C0079595;Neoplasm of small intestine
C0007289;Edema
C0021585;Larva
C2239899;Helper-Inducer T-Lymphocyte
C0559031;Anti-Antibodies
C0034885;Malignant tumor of colon
C0033554;Iodides
C0034884;Rectal Fistula
C0034887;Surgical Endoscopy
C1550291;Macrophage Activation Syndrome
C0032225;malignant disease
C1550297;Kidney Failure Acute
C0034888;Persons
C0032227;Krukenberg Tumor
C0345893;Child
C0345891;Intestinal polyposis syndrome
C0033559;Prostaglandins E
C1332166;PET/CT scan
C4022853;Relative (related person)
C0019236;Herbicides
C0022885;Luciferases
C0008586;Secondary carcinoma
C0022886;Institutes
C3853758;TP53 gene
C0007258;Body tissue
C3166861;Neoplasms
C0599909;stress related disorder
C1705924;TAC1 wt Allele
C1705920;Species
C1418951;MTOR gene
C0007262;Carnitine O-Palmitoyltransferase
C1956108;Retinal Vein Occlusion
C0019247;Localized Malignant Neoplasm
C0034861;Esophageal Neoplasms
C1956109;Colorectal Neoplasms
C0045510;C57BL/6 Mouse
C0007269;Adipose tissue
C0019240;Herb
C1956100;Polyunsaturated Fatty Acids
C0379214;miriplatin
C0599918;Patients
C0634829;Esters
C0021562;inpatient
C0995456;Alloprevotella
C0032200;Carcinogenesis
C0034865;Recombination Genetic
C3841787;7 - 9
C0032207;oxaliplatin
C1418963;Inflammasomes
C0296594;Colorectal Carcinoma
C1443924;Patients
C1176309;multicatalytic endopeptidase complex
C0019212;Complication
C0008562;Isolation procedure
C0008565;Carbon
C1176306;Substance P Receptor
C1455900;Woman
C0020205;SNAP receptor
C1321489;Sebaceous Gland Neoplasms
C0033529;Malignant tumor of colon
C0200931;Neoplasms
C2911690;Disease Controlled
C1705947;Diffuse Large B-Cell Lymphoma
C0033522;Gastrectomy
C1418975;Cohort
C0008574;Control Groups
C1334791;Moderately Differentiated Malignant Neoplasm
C0021547;Growth
C0022877;Antenatal screening procedures
C0139706;Colorectal Carcinoma
C0562641;Pathogenic organism
C0021540;Patients
C0034840;Reading Frames (Nucleotide Sequence)
C0034845;Tumor cells malignant
C0033513;Tumor cells malignant
C0597360;receptor expression
C0021516;nerve supply
C3178892;Therapeutic procedure
C0743997;Appendix
C0740005;Obstruction
C0596036;Toxic effect
C0008546;Methionine
C1322797;Transverse colon
C0010868;Mitochondria
C0969119;Deacetylation
C1538595;other medicated shampoos in ATC
C1332126;Wnt Signaling Pathway
C0034833;Receptors Progesterone
C1332125;CSNK1A1 gene
C1201698;Polysaccharides
C0034835;PARP14 gene
C1332110;Woman
C0007220;Cardiovascular Agents
C1418914;Patients
C0008551;Ubiquitin
C0007222;Chronic diarrhea
C3826170;Seizures
C0596043;Cytoplasm
C0008559;Mass Spectrometry
C1970431;Persons
C0297858;Neoplasms
C0441729;Type 1
C0402112;Tumor Progression
C0019209;Hepatomegaly
C0022827;SLC6A2 protein human
C2742502;Proteinuria
C1550229;Aneurysm
C1550227;Congenital dilatation
C0008520;House mice
C0597345;TP53 Gene Mutation
C1956110;Evaluation
C1538577;Physiological Processes
C2095755;Primary malignant neoplasm of uterine cervix
C0034817;Receptors Immunologic
C0235592;Cervical lymphadenopathy
C0010843;Malignant Neoplasms
C0597357;Gene Expression Regulation
C0597356;Tumor tissue sample
C0597354;APLNR gene
C0034805;Rattus norvegicus
C0947795;Hepatectomy
C0034804;intracellular signal transduction
C0034807;Stem cells
C1538589;Prostaglandin Receptor
C1702088;Attention
C1970415;FTO gene
C0332501;Cancer Stem Cells
C0597358;receptor binding
C0010852;Cytoskeletal Proteins
C1334756;Disease
C0034800;physiological aspects
C0332509;Liver
C0034802;Extracellular Signal Regulated Kinases
C0010853;TRANSCRIPTION FACTOR
C0960756;Tumor Progression
C3537372;DNA
C1837808;RNA Messenger Splicing
C0333848;Russell body
C0010825;NR4A2 protein human
C1261322;Multimodal Imaging
C0598658;ERBB3 Receptor Protein-Tyrosine Kinase
C0010823;Colectomy
C0547070;Stage IV Colon Carcinoma
C0345836;Ileal Cancer
C0345832;Intussusception
C0022818;Sarcosine
C3538699;Histocompatibility Antigens Class I
C0729650;Health care facility
C0886296;Patients
C0008519;Duodenum
C0332523;geriatric patients
C1261317;Patients
C0742615;Diet Mediterranean
C1825819;Cell Invasion
C0010834;BATF2 gene
C1333402;Colorectal Carcinoma
C3889729;Rectal Carcinoma
C1550269;Jugular Internal
C1550266;Body Fluid Discharge
C3178870;Chronic liver disease
C0586688;Intrahepatic Cholangiocarcinoma
C0009812;Patients
C0009813;Constriction procedure
C0009818;Large Mass
C0010803;Neoplasms Fibrous Tissue
C0009817;Long-Term Synaptic Depression
C1704693;Stem cells
C0333865;Cytologic atypia
C0597304;zymogen activation
C0010806;Neoplasms
C0586686;Malignant Neoplasms
C1334721;Intestines Small
C1550262;Veins
C0742608;Mucous Membrane
C0246283;Heat-Shock Proteins 70
C0599973;Uterus
C0333873;Anal canal
C1564881;Family
C3890735;Stomatitis
C0010815;Cytokinins
C0010813;caspase-3
C0010818;HIV
C1262620;Participant
C0333875;Vitamin B 12
C0598647;iboga alkaloid
C1334715;Metastatic carcinoid tumor
C0223552;Magnetic Resonance Imaging (MRI) of Pelvis
C1538632;Nucleic Acids
C3539919;Diagnostic radiologic examination
C1538631;Up-Regulation (Physiology)
C0671771;Tryptophan
C4045494;ribociclib
C0056912;colon rectal
C0009807;Constitutions
C0009806;Symptoms
C1334818;Benign Neoplasm
C3250643;Cancer stage i
C1334811;Epithelioma
C3250649;Patients
C1334810;Mucinous Lesion
C0632197;Signal Transduction Pathways
C0935727;Medical Devices
C1539941;Insulin-Like Growth Factor I
C0427385;CD69 protein human
C1538613;Cooper
C1538615;Tumor cells malignant
C3720715;Polysaccharides
C2348970;Destructive procedure (surgical)
C1513344;Mitogen-Activated Protein Kinase Inhibitor
C3899187;Patients
C1079230;MIR155 gene
C1823122;histone chaperone
C1550321;Dehiscence
C0596070;Americas Ethnicity
C1823120;FRAP1 protein human
C1825785;Chronic Obstructive Airway Disease
C0056942;survivin
C3539957;Long Term Survivorship
C1512048;Double Stranded DNA Virus
C4249264;House mice
C0442969;Robotic Surgical Procedures
C0234246;Patients
C0441635;Goblet Cells
C0234245;Combined Modality Therapy
C3658354;Phosphotransferases
C0442967;Malignant neoplasm of anus
C1550315;Synovial
C0596087;Non-Resectable Hepatocellular Carcinoma
C0209278;oxaliplatin
C1538686;Hydrolysis
C1512034;Patients
C0428642;Anus
C1454580;AXIN2 protein human
C1564907;Immune System Processes
C1564904;RUNX2 gene
C0442973;Ultrasonic guidance procedure
C2334322;Bone structure of ilium
C1536021;Dysbacteriosis
C1514693;Locally Advanced Malignant Neoplasm
C2610891;Mus
C1550300;Secondary Neoplasm
C3467876;Withholding Treatment
C3274677;Melanosis coli
C2347610;Chemosensitivity
C1824430;Acute colitis
C2681105;MTOR gene
C1261381;Endoscopic dilatation
C1539986;Fluorouracil
C0055637;Chromogranins
C0055635;Colon Carcinoma
C0055633;Carcinoid Heart Disease
C1538659;Mutation
C0682458;Patients
C0947746;Gastrointestinal Therapies
C1524026;Natural Killer Cells
C0876994;Cardiac Arrest
C1539997;Neoplasms
C0054314;Neoplasms
C1259063;Flavonoids
C1513380;Immunohistochemistry
C1836407;Patients
C0442951;removal technique
C0234233;Patients
C2825314;Expression procedure
C1455888;Patients
C0394871;Study
C0081937;Multiple tumors
C1428264;Patients
C0862312;Epithelioid mesothelioma malignant
C0876973;Patients
C0393559;Solid Neoplasm
C0055661;Apigenin
C0392220;Medical Devices
C1428277;promoter
C0079611;Evaluation
C0055666;epithelial to mesenchymal transition
C0056997;Galactosylceramides
C1428272;DNA Methylation
C0079613;Fenamole
C0164786;INPP5D gene
C0851683;Pancreatic Ductal Adenocarcinoma
C3501358;Patients
C0055670;Non-Small Cell Lung Carcinoma
C1141648;Body tissue
C1860127;Impaired T cell function
C2827950;Patients
C0382876;Curcumin
C1837789;Colorectal Carcinoma
C0475021;Colonic hematoma
C1611701;Detection
C1142985;Ulcerative Colitis
C1704708;Hypersensitivity
C0392209;Community
C1428295;Tumor tissue sample
C0079633;Atrophic
C3816827;PPFIA4 gene
C1370419;Patients
C1273390;Ablation
C4287543;Fatty Liver Alcoholic
C0032173;Platelet Activation
C1514628;CFLAR protein human
C0524466;hemangiopericytoma
C0019196;Abnormal glucose tolerance
C0248813;Danggui Buxue Tang
C1515955;Endoscopy finding
C0876926;Patients
C1823196;Gain of Function Mutation
C0033497;Multiple Myeloma
C0223522;Magnetic Resonance Imaging (MRI) of Pelvis
C4310385;Cabotegravir
C0020196;spacer device
C0032167;Materials
C0067684;Patients
C3815540;Neoplasms
C1823185;Tumor tissue sample
C0766577;PRKAA1 wt Allele
C1417595;Growth
C0150103;Fiducial Markers
C0151436;capecitabine
C0077025;Functional disorder of intestine
C0200898;DNA analysis
C0021493;Mus
C1515974;Perivascular Epithelioid Cell Neoplasms
C1539901;Chromatin
C0033488;soluble
C0067692;N-acetylcytidine
C1823178;Body tissue
C0032140;Urokinase Plasminogen Activator Receptor
C2825347;Immunoglobulin A Human
C0032143;alteplase
C0033474;Acids
C0020179;Chorea
C0392247;Radiation proctitis
C3669048;Kidney
C1513300;Cell Count
C3272080;Myeloid-Derived Suppressor Cells
C0065042;Colorectal Carcinoma
C0439394;MCM8 gene
C1429589;CA-19-9 Antigen
C1428258;mitogen-activated protein kinase p38
C3815322;Carcinogenesis
C1825064;mRNA Expression
C1151389;PIK3CA gene
C0359916;Curcumin
C1427570;Integrin Signaling Pathway
C1426245;Metabolic Diseases
C0814514;Behavior
C1137094;Patients
C1453853;HCT116 Cells
C0058778;CD4 Positive T Lymphocytes
C0754353;Bacteroides fragilis
C0041066;Impaired cognition
C0042397;Patients
C0057455;Immune System Processes
C1825045;5' Region
C2239789;Neoplastic Cell Transformation
C3827320;Patients
C0333307;Colonic mucous membrane
C1826382;Hypersensitivity
C1825050;Chronic Obstructive Airway Disease
C0334634;Transverse colon
C0042395;CD8A wt Allele
C0347943;Fundus
C0753015;Mitochondrial Membrane Outer
C0310628;Up-Regulation (Physiology)
C0346627;Persons
C0549357;abdominal adhesions
C0056132;Malignant Neoplasms
C1707811;Pharmacotherapy
C0042384;Mucosal Infection
C0042381;Vascular Diseases
C0742343;GNAS gene
C1140694;Bio-Informatics
C1426208;Berberine
C0333324;Spontaneous Perforation
C1414228;RNA
C1414223;promoter
C1414224;MIR363 gene
C0057472;Biological Processes
C0765067;Solid Neoplasm
C0057470;deoxyuridine triphosphate
C0756983;CENPK gene
C2752214;Cell Cycle Progression
C0042373;Hypertension Portal
C0004096;NR1H4 gene
C0029396;Primary malignant neoplasm of rectum
C0004093;Patients
C1428862;Leukocyte L1 Antigen Complex
C1428863;ZNF334 gene
C2239791;DNA Methylation
C0334663;Sarcoma
C0042366;Protection
C0346647;Secondary malignant neoplasm of pancreas
C1273810;Retrospective Studies
C1426212;Colonic Neoplasms
C1149036;Guanosine Triphosphate Phosphohydrolases
C0016069;Ficain
C0347988;Inductively-Coupled Plasma Mass Spectrometry
C1414249;KCNE4 gene
C0056167;Adrenocortical carcinoma
C0016065;Polyostotic fibrous dysplasia
C1864650;Transcription Factor AP-1 human
C0017393;Mutation
C0333343;Body cavities
C1273802;research
C1414244;Male population group
C0262493;Patients
C1402294;Long Term Survivorship
C0262491;Intestines
C1428889;recombinational repair
C0028040;Alkaloids
C0813207;Operative Surgical Procedures
C0334683;Skin Basal Cell Carcinoma with Sebaceous Differentiation
C0042345;Jejunum
C0041014;Biologic Development
C0287766;Migration Cell
C0333355;Mouth Diseases
C1414256;Hypersensitivity
C1415587;Stomach
C1850015;Normal gastric mucosa
C3889630;Pro-Opiomelanocortin human
C0041004;Uric Acid
C0599662;cytotoxicity
C0743630;Woman
C0744961;Rectal Prolapse
C0042333;Toxic effect
C0017375;Diarrhea
C1273864;Personal administration
C0030350;Cytopathic effect
C1273869;Multimodal Imaging
C2715222;Secondary carcinoma
C0017372;Genes Suppressor
C2335608;Macrophage Activation Syndrome
C0004057;Aberrant Crypt Foci
C0585012;Patients
C0005388;Body Parts - Canal
C0030354;Gastrointestinal polyps
C0030353;Iron deficiency anemia
C0031686;Protein phosphatase
C0005380;Bacteria
C0031689;Cytoplasmic matrix
C0069494;Liver carcinoma
C0226791;Hemorrhage
C0016059;Immune response
C0016057;Fibrosarcoma
C0016055;Neoplasms
C1720838;Tissue Donors
C0016053;Irritable Bowel Syndrome
C0017382;Triage
C0730328;Middle Aged
C0016052;Standard of Care
C0597010;special populations
C2717891;Biofuels
C1706546;Natural Products
C0004048;Patients
C2585575;Male population group
C2728549;acute Phlebothromboses
C0743626;lobe
C0031672;Colorectal Carcinoma
C0250400;mRNA Expression
C0005372;Neoplasms
C0031676;Colonic Neoplasms
C0718690;Patients
C0083792;Neuroendocrine Cells
C0031678;Real-Time Polymerase Chain Reaction
C0238775;Mass of urinary bladder
C0017359;SARS coronavirus
C0042313;Penicillins
C0016026;Cytoskeleton
C3889650;Yttrium-90 microspheres
C0018687;Persons
C0598312;Metabolite
C1655202;protein expression
C0237419;Gynecologist
C1415537;K-ras Oncogene
C1414205;Malignant tumor of colon
C1404837;Drug-induced Nephropathy
C0018681;Male population group
C1416865;LIPA gene
C1415533;Stomach
C1414201;Catenins
C1414202;Cultured Cell Line
C3853650;melanoma
C0598317;Etoposide
C3156720;interferon-gamma secretion
C2348908;Patients
C3889664;CBR1 wt Allele
C1415540;Tumor tissue sample
C0192890;Biopsy
C1332690;Multiple malignancy
C1332692;Stroma
C0018696;Retrospective Cohort Study
C0017365;Genes Spliced
C0016034;Patients
C0018695;Survivors
C0017362;RNA methylation
C0586358;Patients
C0730307;Carcinoma of ampulla of Vater
C0016030;Lactobacillus rhamnosus GG
C1719867;lactate dehydrogenase A
C0028017;Colorectal Carcinoma
C1258215;Adenocarcinoma
C0031654;TFEB gene
C0005390;Helper-Inducer T-Lymphocyte
C1332697;CCNE1 gene
C0017337;Biosynthetic Pathways
C0016006;PTK2 gene
C0019999;Validation
C1272575;therapeutic vaccine
C0019994;histological diagnosis
C0006681;Anemia
C1332681;Secondary malignant neoplasm of lung
C0019993;Adult
C1332680;Dendritic Cells
C1272578;Adult
C0633227;Oxidation-Reduction
C0006684;Amlodipine
C0633225;PRDX4 protein human
C0020985;Circumferential Supracrestal Fiberotomy
C1150095;peptidase activity
C0030312;Patients
C0178576;Cross link
C1656559;digestive tract development
C0017339;Intestinal Microbiome
C1332688;Oxygen
C0016017;Hemostatic function
C1332673;ACKR2 gene
C0016016;Urokinase Plasminogen Activator Receptor
C0017347;HOXD10 gene
C0017344;Genes Epistatic
C0192871;Varicosity
C0549379;Cytoreductive Surgery
C0018670;Pancreatic Neoplasm
C0006699;Anemia
C0030303;Complication
C0031638;ibudilast
C0004002;AES gene
C0562342;Gastroenterologist
C0599635;Body tissue
C3470867;Polyubiquitination
C0032961;Pregnancy
C0335912;PDLIM5 gene
C0599638;Colitis
C0237485;Attendants -- group
C0598309;Polycyclic Hydrocarbons Aromatic
C0030305;Pathological Dilatation
C1333992;Hereditary Ovarian Carcinoma
C0020966;Interleukin-2
C1428808;MCF-7 Cells
C0020969;Immunity Innate
C0017313;Clinical Decision-Making
C1720823;Secondary malignant neoplasm of vertebral column
C0549383;Patients
C0192861;Adenocarcinoma of cecum
C1720825;mesalamine
C0720930;Phosphorylation
C1333990;Autosomal dominant hereditary disorder
C0549387;Accelerated Neoplasm Growth
C0192865;Anastomosis of rectum
C0178555;chemical cofactor
C0192866;Colon Carcinoma
C0192863;Postoperative Complications
C0020960;Virus
C0020963;Monoclonal Antibodies
C0020962;Defecation
C0192867;Neoplasms
C0020964;Mus
C0006669;Serum
C3853695;primary tumor
C0005367;Bicarbonates
C4082587;Myeloid Cells
C3469890;CERS4 gene
C0032950;Cronkhite-Canada Syndrome
C0017319;cancer recurrence
C0032952;Patients
C0406803;Syringocystadenoma Papilliferum
C0236124;Adenocarcinoma of small intestine
C2717879;Patients
C0019988;Retrospective Cohort Study
C1273874;Test request
C2717875;Epithelial proliferation
C1720816;Endometrial Diseases
C0262401;Duodenal Cancer
C1415502;HCRTR2 gene
C0006674;decanoic acid
C0006675;Protoplasm
C3241921;Patients
C0020971;Mus
C1416831;Carcinoma
C0020975;Aftercare
C0031617;Lecithin
C0238792;TNFSF11 protein human
C1415508;Vitamin D3 24-Hydroxylase
C3156756;lymphocyte migration
C0031610;Liver carcinoma
C0334608;Meningioma
C0634473;PKM gene
C0020944;Rectal Balloon
C0430414;Laboratory Procedures
C0192964;Male population group
C0152025;Polyneuropathy
C0192963;Transversus Abdominis Plane Block
C0393022;systemic administration
C0007974;Chelating Agents
C0006644;Central Nervous System Stimulants
C2922974;Elderly (population group)
C0850292;Liver and Intrahepatic Biliary Tract Carcinoma
C0935624;Present
C0005304;Colorectal Carcinoma
C0152020;Postoperative fistula
C1705285;Patients
C0178653;gastrointestinal transplantation
C4082569;Fibroblasts
C1318457;Stereotactic Body Radiation Therapy
C0032930;Diarrhea
C1332763;Cytoplasm
C0152013;Lung Neoplasms
C0153349;Patients
C2945603;Incontinence
C0006657;Stage III Colon Cancer
C0152018;CENPL gene
C0597097;Patients
C0430404;Urinary tract infection
C0032923;Albumins
C0032927;Barrett Esophagus
C1332759;MicroRNAs
C3493605;phospholipid-hydroperoxide glutathione peroxidase
C0019932;Amino Acids
C1306459;Metachronous Malignant Neoplasm
C1959582;Multiple polyps
C0393005;post operative (finding)
C2717940;SP1 gene
C3203639;Sigmoid colon
C1141926;Evaluation
C0005329;Biliary Tract Cancer
C0178638;Jejunum
C0006625;Cohort
C0127082;Interstitial Collagenase
C4307257;Neoplasms
C1331418;Surgeon
C0006629;Woman
C2348869;Glycome
C0214733;Kidney
C0018606;Myeloid Leukemia Chronic
C1332743;CDX2 gene
C2717959;Exosomes
C2717955;tomography
C3179495;Clinician
C1306460;removal technique
C0152035;Chinese People
C0430425;C-reactive protein
C0006631;erbB-2 Receptor
C0006632;Iron deficiency anemia
C1523491;Transcriptional Regulation
C1306468;Cytoreductive Surgery
C0430420;Locally Recurrent Malignant Neoplasm
C0152032;Engaged to be married
C0140057;Cohort
C1332735;Toll-Like Receptor 1 human
C0180950;Stomatitis
C1332733;caspase-3
C0104398;cetuximab
C0683440;exfoliative cytology
C0020903;Colorectal Carcinoma
C0180936;Polyp of large intestine
C1367307;VEGFA gene
C0671457;Malignant neoplasm of prostate
C0007935;Flavonoids
C1705241;Delta (difference)
C0633190;NF-E2-Related Factor 2
C0683444;Hypersensitivity
C1318418;Epithelial Cells
C0947647;neoplasm immunotherapy
C1332722;Plication
C0178629;Control Groups
C2945640;Liver
C3889687;Aortic valve disorder
C4071854;Disease
C0225425;Surgical Endoscopy
C0006611;Patients
C0393078;Patients
C0006613;Pre-op diagnosis
C4082532;IL34 gene
C2347509;Patients
C0214743;Interleukin-13
C0019929;Tumor cells malignant
C0237403;Patients
C0586370;Neoplasms
C0599682;Woman
C1320716;Elective Surgical Procedures
C1332701;Immune Cell
C1332703;CCR9 gene
C0598363;Patients
C3179452;ELAV-Like Protein 2
C1718572;Superior mesenteric vessels
C0910379;PKM gene
C0597032;PDCD1 gene
C0947630;CARBONATE DEHYDRATASE
C3899025;monomethyl auristatin E
C2129214;Loose stool
C2348813;Ascites
C0406778;Dermatopathia pigmentosa reticularis
C0238711;australian
C0019906;Cancer Cell Growth
C0406775;Malignant Neoplasms
C0019904;Homozygote
C1826315;Cell Invasion
C1826316;DNA Mitochondrial
C1621887;Transcriptome
C0333361;Colon structure (body structure)
C0332030;research
C1865926;Sulfoglycosphingolipids
C2610960;Digestive System Neoplasms
C0441161;Flexible endoscope
C2033117;papillary Renal adenocarcinoma
C1522102;Mouse Melanoma
C4045546;RNA Small Interfering
C0669192;metastatic colorectal cancer
C1368683;DBNL gene
C0007906;Cytopathic effect
C0682132;Intestines
C1140671;Ascorbic Acid
C0682134;citizen
C0683465;Fasting
C0333386;Male population group
C0864875;Re-Irradiation
C0683468;Necrotizing fasciitis
C2610958;Necrosis
C0683454;Extraction
C0333390;Patients
C1512772;high-risk group
C4071824;malignant disease
C0127014;MAP4
C0682125;Primary Health Care
C1414186;Serum Response Factor
C1825027;Oxidative Phosphorylation
C1414184;DUSP2 gene
C0682194;Malaise
C1826354;Chronic Obstructive Airway Disease
C1826357;Glutathione
C1426160;Patients
C4058811;partial response
C0369355;Hexokinase 1
C0537408;B-Lymphocytes
C2934928;ALDH2 gene
C1140621;Edema
C1426180;Biosynthetic Pathways
C2360551;Pancreatic Ductal Adenocarcinoma
C2347585;Carcinoma
C1426173;Multiple tumors
C1511460;Autophagy
C1825008;Colorectal cancer specimen
C0069515;High-Frequency Microsatellite Instability
C2752275;Patients
C1426185;SIN3A gene
C0428152;Assay
C0404187;Patients
C0538721;Magnesium
C0443758;Carbohydrate antigen
C2933603;palbociclib
C1608841;Persons
C2348895;Great Relative
C1826320;Polycomb Repressive Complex 2
C1378050;Malignant Neoplasms
C1621812;Apoptosis
C1511484;Epithelial ovarian cancer
C3541678;Cell Proliferation
C1414386;Intestines
C0262593;Complication
C1707903;Cell Count
C0082514;Cells
C0057555;desmoplakin
C0599702;reuptake
C0599705;Patients
C0536128;Antioxidants
C1188555;Cyanobacteria
C0262584;Complete atrioventricular block
C1425042;CCL28 gene
C1426374;Carcinogens
C0117719;Receptor Protein-Tyrosine Kinases
C0042285;Amino Acids
C2742797;anti-tumor necrosis factor therapy
C0030293;Pancreatitis
C1825167;hepatoma cell
C0030290;Pancreatitis
C0262576;Nerve palsy
C2239669;Study
C0030299;Male population group
C0030298;Peptides
C0030297;Postoperative chemotherapy
C0334513;Cytoreductive Surgery
C0815704;Abscess
C0334515;Mesothelioma biphasic malignant
C1850165;Elevated IL6
C0029297;Accumulation
C1413086;Protein Overexpression
C0549473;calcitonin receptor-like receptor
C1875453;Pharmaceutical Preparations
C0030283;Polycystic Kidney Autosomal Dominant
C1826486;Mitoxantrone
C4489445;Fusiform cell
C0082529;hepatoma cell
C2753459;Protein Component
C1707934;Epithelial Differentiation
C0030288;Abdominal discomfort
C1707937;Stomach
C0030286;Pancreatic Diseases
C0537423;Paclitaxel
C1415672;colon growth
C1875400;human cell line
C0334533;Arteriovenous hemangioma
C0030274;Tissue Donors
C0017296;Steatohepatitis
C0333200;Sigmoid colon
C1537904;Cell Proliferation
C1415675;Antisense RNA
C0030279;Hepatectomy
C0070574;Plant Preparations
C0333205;Mural thrombus
C1427656;Neoplasms Fibrous Tissue
C0814435;Post-transplant lymphoproliferative disorder
C1428985;Liver carcinoma
C2980094;Erythema Multiforme
C1414351;Ribavirin
C0441087;methylate
C0549410;Pharmaceutical Preparations
C4021753;Abnormality of the immune system
C1152568;cyclin-dependent protein kinase inhibitor activity
C1273935;Interventional procedure
C1273937;Not significant
C1415684;Signal Transduction Pathways
C4287809;Cancer Cell Growth
C1427665;Non-Neoplastic Disorder
C1428997;Autophagy
C1426335;therapeutic autologous dendritic cells
C1426334;Ribosomal RNA
C0029282;CEL gene
C2825616;Fatigue
C1414360;5'-3' Exoribonuclease 2
C0042237;Radiotherapy planning
C0042232;Swelling
C0044894;N-Cadherins
C2010501;diffuse GASTRIC CANCER
C1513959;Colon structure (body structure)
C0069590;Lipids
C1425010;tumor growth
C0286540;Gastrointestinal Diseases
C1426348;Infiltration
C2980074;Mitogen-Activated Protein Kinase Kinase Inhibitor
C0029250;Cytometry
C1414371;TRIM16 gene
C1413041;Neoplastic Cell Transformation
C4021734;Acriflavine
C1414377;FGF19 gene
C1414378;Adenocarcinoma Cell
C0030247;Neck
C1425022;Carcinogens
C0971285;MCF-7 Cells
C0274576;Colorectal Carcinoma
C3661727;Weight Loss Adverse Event
C0814409;Patients
C0299856;p21-Activated Kinases
C0599784;Myeloid-Derived Suppressor Cells
C1428949;Adenocarcinoma
C0017256;CD274 protein human
C0031560;Tumor cells malignant
C0042210;methylsulfonylmethane
C1272654;Surgical Wound Infection
C0935584;Patients
C0017255;Gene Activation
C1414304;EFNA5 gene
C3890506;PACERR gene
C1415634;Adenocarcinoma of large intestine
C3890508;Body tissue
C1415633;Cytoplasm
C1415631;TRANSCRIPTION FACTOR
C1269001;Entire gallbladder
C1416960;ZKSCAN3 gene
C0042219;Protoplasm
C0030234;Invasive Carcinoma
C0585134;Analgesics
C0029235;Zoonoses
C0030231;advanced disease
C1415637;Adenocarcinoma of large intestine
C1402315;Vascular lesions
C0032897;Adult
C0598463;Functional Status
C0935598;Pelvic Diaphragm
C0042200;general population
C0017263;FRAP1 protein human
C0018595;Haptoglobins
C0262501;curative treatment
C1415645;Transcription Genetic
C2717775;Scientific Study
C0017262;Gene Expression Regulation
C0597134;Colorectal Carcinoma
C0585129;Reconstructive Surgical Procedures
C0018592;Patients
C1416974;MAGEA2 gene
C0017260;Gene Deletion
C3853568;Single Nucleotide Polymorphism
C3853565;High Affinity Nerve Growth Factor Receptor human
C1415649;Adenocarcinoma of large intestine
C1415648;Adenocarcinoma of large intestine
C1428956;Abdomen
C0082584;Tacrolimus Binding Proteins
C1720951;AAVS1 gene
C0020889;Structure of pelvic blood vessel
C0019898;Homosexuals
C0017237;Gelatin
C0018563;Muscle
C0599766;Colon and Rectal Surgery (procedure)
C1416989;Growth
C1559280;Patients
C0020883;Patients
C0020885;Ileocolic intussusception
C0043528;Pharmaceutical Preparations
C0020888;Covered Stent
C0020887;Rectal artery
C0029216;Transection (procedure)
C0597108;Nucleotide Metabolism
C0020880;Swelling
C0031542;Left colon
C0599770;Germ Line
C0043515;Peptic Ulcer
C1416991;MALT1 gene
C0935577;work teams
C0599773;Pharmacotherapy
C0935576;Metastatic Small Intestinal Adenocarcinoma
C1547282;Show
C0226896;Edema
C1416998;Pharmaceutical Preparations
C1414333;Cultured Cell Line
C3852217;guselkumab
C1414334;Patients
C0226893;Gas Chromatography-Mass Spectrometry
C0029227;Operation on colon
C0030201;Extraction
C0030200;Ketamine
C0029224;Organic Chemicals
C0598447;fluorophore
C0599779;Vitamin E
C1426317;Tissue specific
C0250501;Ginger extract
C3178206;Cell Cycle Progression
C3493429;rosoxacin
C1428909;Signaling Protein
C1720920;release of sequestered calcium ion into cytoplasm
C0019878;Organism
C1657761;Radiation proctitis
C1305188;Typhlitis
C0599740;TXNL1 gene
C0006560;Postoperative Complications
C0020861;Antibodies
C0152060;Anastomotic Constriction
C0032857;ESD gene
C0178693;genome sequencing
C1416928;Cohort
C1416926;High Level
C0599745;lipid mediator
C0032850;Fowls Domestic
C1428900;Malignant tumor of colon
C0599748;High resolution
C0032856;Povidone
C1960448;Hyperammonemic encephalopathy
C0018557;Transcription Factor AP-1 human
C1332795;AXIN1 gene
C1332794;PTK2 gene
C0599752;Fungi
C0018553;Malignant neoplasm of transverse colon
C0599755;RALA gene
C0018552;Gland
C0946292;Thalidomide
C0029209;Clinical Complete Response
C0020877;Ileitis
C0020876;Ileal Neoplasms
C0153381;Oral Microbiome
C2931091;Patients
C0153382;GPD1 gene
C2584321;Patients
C3827296;biological adaptation to stress
C0152055;Family counseling
C1416936;Patients
C0140079;Insulin-Like Growth Factor Receptor
C0599757;Microfold cell
C1285945;Prostate carcinoma
C1428910;Rectal Carcinoma
C0031511;secondary group
C1332796;ITK protein human
C1428927;Cell Count
C0262537;Left inguinal hernia
C1720947;TNFRSF10A protein human
C3840262;Study
C2717746;Screening procedure
C2717745;Microorganism
C0178679;Histogenic Process
C0007874;Macrophage Activation Syndrome
C1368816;Sebaceous Gland Neoplasms
C0007876;Cesarean section
C3470773;Cohort
C0031505;Phenylthiourea
C0152081;Pustular psoriasis
C1706636;Malignant neoplasm of colon stage IV
C1415619;sildenafil
C0031507;Phenytoin
C3853572;Ephrin Type-B Receptor 1 human
C1415617;HMGCS2 gene
C4489472;Hemorrhage
C3839280;Long-Term Survivors
C0599725;Cell Death
C0019868;Mus
C0044800;12-Hydroxy-581014-eicosatetraenoic Acid
C2717755;Prophylactic treatment
C0262527;Woman
C0599732;cell injury
C3540316;ZIC5 gene
C0192975;Abdominoperineal resection
C0192973;removal technique
C1416953;Malignant Neoplasms
C0006556;DNA Complementary
C0020852;Patients
C0006558;Insulin
C0032824;Adenoma of large intestine
C3470763;Cancer invasiveness
C1415629;Colorectal Neoplasms
C1415627;FOXA2 gene
C1415626;FOXA1 gene
C1318484;Chimera disorder
C1270004;Coffin-Siris syndrome
C1705316;TERT wt Allele
C0032821;Potassium
C0020823;pathologic fistula
C3470827;Transcriptional Activation
C3469836;Cell Proliferation
C3469837;PKM gene
C0006521;hepatobiliary disease
C3241937;Persons
C0006523;alpha-ketoglutaric acid
C0153470;Dissecting hemorrhage
C0683525;Terminal illness
C0020838;Body tissue
C3890596;Injection
C0238815;Gastroenterologist
C0153467;Medical pathologist
C0201519;Closure by staple
C0007868;Woman
C0178784;Perivascular Epithelioid Cell Neoplasms
C0443625;Patients
C0683517;Antibiotics
C1511382;C57BL/6N Mouse
C0382265;purinoceptor P2X3
C0018517;Half-Life
C0456909;Male population group
C2717822;Family
C0201544;prostate cancer screening
C0456900;Prostate
C3469857;Ubiquitination
C2945759;Persons
C2348747;Rectal Carcinoma
C0683509;Evaluation
C1332866;Right colectomy
C1559311;Rare Diseases
C1332850;Cardiac Lymphoma
C0597192;Hepatocyte
C0007841;Ceruloplasmin
C0597198;Behavior
C1306587;Patients
C4055086;Severe (severity modifier)
C0007847;AMIGO2 gene
C1416918;kallistatin
C1416914;Mutation
C0019829;Child
C0598496;Berberine
C0153439;Intussusception
C3241973;Adult
C1029130;Epithelial Cells
C0153433;Lymph node excision
C0153434;Intussusception
C0178735;cyclodextrin polymer
C2681324;Ubiquitination
C0153435;Surgical Procedures Laparoscopic
C0153436;Incarcerated Inguinal Hernia
C0585174;Varicosity
C0585175;Choriocarcinoma metastatic
C0585179;Colorectal Carcinoma
C1318539;Organizing thrombus
C3252639;SP1 gene
C0019800;Liver carcinoma
C0597170;paracrine
C0226876;melanoma
C0226875;intestinal adenocarcinoma
C0153426;Mus
C0597177;Adaptive Immunity
C0153427;Small bowel obstruction
C0153425;Duodenum
C1332838;Glycolysis Pathway
C3888239;treatment options
C0406636;Lupus erythematosus tumidus
C3241999;Malignant neoplasm of anus
C1367449;Cancer Research Group
C0671550;Cancer-Associated Fibroblasts
C1561643;Toxin
C0153452;Cancer of Digestive System
C1332826;Dexamethasone
C0140145;APEX1 protein human
C1332823;Tumor cells malignant
C0961814;DLD gene
C1332821;IL17RE gene
C3277934;Anomalous
C0418624;Pharmaceutical Preparations
C0153443;Malignant tumor of rectosigmoid junction
C0153446;HPV-High Risk
C1332819;CXCL5 gene
C0007806;Patients
C0153440;Segmentectomy
C1332816;Malignant tumor of colon
C1367456;ACPP gene
C1332817;Oxygen
C1815726;Colorectal Carcinoma
C0850149;Symptoms
C0441031;Jejunum
C1826439;RNA Small Interfering
C1512646;Colorectal Carcinoma
C1826432;Inflammatory Bowel Diseases
C0404093;Abdominal hysterectomy
C1367460;High-Grade Squamous Intraepithelial Lesions
C0404089;Endometrial adenocarcinoma
C0814472;osthol
C0813145;Colonic Neoplasms
C1332801;SLC22A16 gene
C1332803;CTNNB1 gene
C0178708;Crypt
C2681352;multiple pathologies
C0333252;Male population group
C1367472;FN1 gene
C0814466;Overdiagnosis
C0526839;TP53 gene
C1511300;docetaxel
C1367477;soluble
C0334595;Ganglioneuromatosis
C1537925;Adult Fanconi syndrome
C1537924;RIPK3 gene
C2887821;Left sided colitis
C2681389;CWC22 gene
C1826412;Mutation
C0333262;Vesicle (morphologic abnormality)
C0105770;Persons
C0456980;Surgical sutures
C1864739;Signal Transduction
C0456984;Test Result
C1138240;Selenium
C0333279;Intestines
C1512658;Immunodeficient Mouse
C0430389;Cell Count
C0333276;Arteries
C2919491;Patients
C0384826;Cellular Senescence
C0430385;Lamina Propria
C0333282;Occult hemorrhage
C1523348;Dephosphorylation
C1523347;TRANSCRIPTION FACTOR
C3274016;Rectal Neoplasms
C0333288;Licensed Practical Nurse
C3274012;Adult
C0370220;Homo sapiens
C1826481;NT5DC3 gene
C0852713;Patients
C0333291;Capsule Endoscopy
C0526873;Structure of venule
C0333297;Patients
C1523351;T-Lymphocyte
C0813175;inhibitors
C1537996;HT29 Cells
C0058978;Ulcerative Colitis
C3697716;Acute flaccid paralysis
C0070628;Plasma
C0069639;Colorectal Neoplasms
C3815306;Biochemical Pathway
C2945710;Autophagy
C0082608;Scorpion Venoms
C0995188;Did not receive therapy or drug for
C0058989;Neoplastic Cell Transformation
C0455610;Pelvis
C0404066;Hereditary Nonpolyposis Colorectal Cancer
C0042196;Mucosal Infection
C1826446;Therapeutic radiology procedure
C1826449;Mus
C0358591;Postmenopausal state
C1522002;SLMAP gene
C0443640;Tissue Donors
C0742390;Patients
C1826442;Inflammatory Bowel Diseases
C2945703;Patients
C2945704;refractory cancer
C0404079;Patients
C0404077;Laparoscopic radical hysterectomy
C0369247;G Ab
C4071900;Granulomatosis
C1522009;Fatty Acids
C0202823;Emergency operation
C0070627;Colitis
C1415351;Infiltration
C1416682;Antitumor Response
C1439328;Body tissue
C0057672;nerolidol
C0030193;Compartment syndromes
C0030190;Reperfusion Injury
C1414024;Apolipoproteins B
C0057678;Anti-Inflammatory Agents
C2983683;Volumetric-Modulated Arc Therapy
C0042172;Protoplasm
C0742132;cervical cancer metastasis
C1416693;KIF11 gene
C0334861;Biologist (general)
C0030186;Perianal Paget's disease
C0055023;Vitronectin
C0960491;Growth
C1416699;Ubiquitin
C1825299;PFDN1 gene
C0333538;Lower Extremity
C0334866;Malignant tumor of peritoneum
C0042160;Malignant melanoma metastatic
C0476089;Malignant Female Reproductive System Neoplasm
C1415375;Malignant Neoplasms
C0029180;Carcinoid Tumor
C0069679;co-treatment
C0017195;Large Mass
C0017196;Malignant neoplasm of stomach
C0017193;Deep Sedation
C0260037;Well Differentiated Pancreatic Endocrine Tumor
C0841913;Chemotherapy Adjuvant
C3815103;Neoplasms
C1656373;Stem cells
C0501123;Thrombophlebitis
C0476073;Papillary neoplasm
C1706711;Appendectomy
C0971134;interleukin-22 receptor
C1706712;Patients
C0332219;Disease Outcome
C1825293;FFAR2 gene
C0069676;Immune response
C0043481;Liposomes
C3828416;Dermatitis Phototoxic
C0042149;Mixed carcinoma
C0334885;General surgeon
C0031495;Cell Death
C1414057;Wnt Signaling Pathway
C0235081;Male population group
C1426033;Neoplasms
C1427361;Cessation of life
C0042140;Uterine Prolapse
C1441657;Xenograft procedure
C0068355;Melatonin
C1706721;Clear Cell Malignant Neoplasm
C1416640;KIF5C gene
C0042139;Patients
C1442934;Growth Factor
C0017178;Cytomegaloviral colitis
C0334897;Obstetrician
C0042134;Hemorrhage
C0017173;Patient Discharge
C1513817;Multicenter Study
C2982391;Protoplasm
C3828434;Patients
C0079027;Control Groups
C1441604;Malignant neoplasm of anus
C0344211;Primary Health Care
C1415320;Gene Expression
C0043457;Zebrafish
C0043454;Colitis
C0017189;Administration Oral
C1416657;KLF1 gene
C0333575;Fatty infiltration
C0017184;Electroacupuncture
C0017185;Persons
C0333574;Fatty-acid synthase
C1416655;KIT gene
C1415323;GSN gene
C0333571;Lung
C0017181;Metastatic Renal Cell Cancer
C1427306;Homo sapiens
C0029166;Patients
C0029162;Cancer Patient
C1416661;Colorectal Carcinoma
C1416660;RAB26 gene
C1512505;Extrinsic
C0017154;Helicobacter pylori
C1416669;release of sequestered calcium ion into cytoplasm
C0017151;Serum
C0017152;gastroesophageal
C1414006;therapeutic autologous dendritic cells
C0017150;Multiple Endocrine Neoplasia Type 1
C1513838;TRPC3 gene
C0816951;Psoas Abscess
C0080038;Problem
C0537111;Immune response
C0082699;Ginseng Preparation
C0287990;Pharmaceutical Preparations
C0080032;Pleural Effusion Malignant
C0031465;Acids
C0031469;Microcirculation
C0042105;Nonulcer dyspepsia
C0017168;Coffee
C0525129;WY 14643
C0018494;Neoplasms
C0017160;RNA Viruses
C1622989;PEPTOSTREPTOCOCCUS ANAEROBIUS
C2753772;sphingolipid signaling pathway
C0030125;Alcian blue stain method
C0030123;4-Aminohippuric Acid
C0067067;Challenge
C4273559;Patients
C0080024;Piebaldism
C0031453;Lysine
C1427329;Extracellular Matrix
C0032787;Underweight
C0032788;Complication
C1428656;Ectopic Gene Expression
C3816499;Persons
C0910167;caspase-3
C0043425;Retroperitoneal Neoplasms
C0017135;Lesion
C0017136;Epithelial Cells
C0019796;Carcinoma of ampulla of Vater
C1417935;Digestive System Neuroendocrine Neoplasm
C0587437;Clinical Trials
C0079068;c-myc Genes
C1416602;mRNA Expression
C1416601;Genistein
C0017130;Gastric Adenocarcinoma
C3891714;Metastatic teratoma
C3539633;Malignant Neoplasms
C0948775;high weight
C0029119;Colon structure (body structure)
C0029118;Intestines
C0067071;Endoplasmic Reticulum Stress
C3827142;Patients
C0029112;Opiates
C0080058;GTP-Binding Proteins
C0237677;Patients
C0080054;Receptors Tumor Necrosis Factor Member 10b
C0080055;TP53 gene
C0744727;Colorectal Carcinoma
C0525183;Small Molecule
C0262627;Patients
C0017145;Esophagogastroduodenoscopy
C0006497;Merkel cell carcinoma
C1416613;Colorectal Carcinoma
C0043419;Dairy Products
C3539622;Natural Killer Cells
C1705455;mRNA transcription
C0005135;Fruit
C1416617;KCNQ5 gene
C1417947;Neoplastic Cell Transformation
C0031430;Dexamethasone
C0275965;Reactivation tuberculosis
C0031437;polygene
C0235025;Chemotherapy-induced peripheral neuropathy
C0043405;Yersinia <bacteria>
C0017118;Hand-Assisted Laparoscopy
C0079083;Retroperitoneal lymphadenopathy
C3889414;Probes
C0006462;Organic Cation Transporter
C1333791;geriatric patients
C0017110;Argon
C0262613;Destructive procedure (surgical)
C3539652;Lymphocytes Tumor-Infiltrating
C0031428;Phenols
C0587450;Hospitals
C1333798;Patients
C1333799;Illness (finding)
C1333783;Tissue section
C1333782;Patients
C0017129;Thickened
C1417965;OPRM1 gene
C3839127;Protein coding gene
C2753730;Patients
C0587444;Hospitals
C3180636;Clausena harmandiana
C3156956;Patients
C0080065;Proto-Oncogene Proteins c-myc
C1428614;Body tissue
C0032743;Single lesion
C1332455;Cell Cycle Arrest
C3539672;Extracellular Vesicles
C1658974;Energy Metabolism
C0020746;Ice
C0019751;HLA-C Antigens
C0020740;Tumor Suppression
C0971116;Cultured Cell Line
C0007776;calcitonin receptor-like receptor
C1862288;Chronic disease
C3839184;Pharmacotherapy
C0275911;Small bowel obstruction
C1706732;First line treatment
C0080095;Receptors Colony-Stimulating Factor
C1333763;Gastric Cardia Carcinoma
C1332431;Persons
C0017102;Organic sulfur compound
C3840171;Seromucinous cystadenoma
C0007785;Proctocolectomy
C0152171;Patients
C0080089;Cognition
C1333768;imatinib
C1332420;BLNK gene
C0960441;Colorectal Carcinoma
C1417912;RNA Messenger Splicing
C0262655;Woman
C3537035;Non-Small Cell Lung Carcinoma
C0319232;Human herpes simplex virus
C1319441;Patients
C0235031;carboplatin/etoposide
C0032718;Stent device
C0005122;Encephalopathies
C0333501;Acute necrosis
C1258005;Fucose
C1333754;Mucins
C1332425;BMP3 gene
C0019737;Erythema Multiforme
C1417921;Migration Cell
C0719712;inflammatory response
C0020732;Iatrogenic Disease
C0007765;Subependymal Glioma
C0006434;Wounds and Injuries
C3539688;Colonic Neoplasms
C0007766;CDKN2B-AS1 gene
C0005117;Gene Silencing
C0333516;Enterovirus 71
C1969111;Transcriptional Activation
C1332415;BIRC3 gene
C1260325;Neoplasms
C1318127;CENPK gene
C1332412;Immunotherapy
C0251991;Proto-Oncogene Proteins c-akt
C2934718;Inflammation
C0140283;Epidermal growth factor receptor inhibitor (product)
C0598174;Cohort
C0007735;Participant
C1511276;Stem cells
C0153594;Cohort
C1333859;Patients
C0427008;Connexins
C1258068;Malnutrition
C0237607;Outpatients
C0152254;Mus
C0006413;Patients
C0007745;Neoplasms
C1512598;IL6 Signaling Pathway
C0178874;Adrenergic Fibers
C2681660;N(6)-methyladenosine
C2349952;Patients
C0429680;Dynamic compliance
C2350948;Malignant Neoplasms
C0685808;Supernumerary gallbladder
C1333834;Grade 1 Malignant Neoplasm
C1511291;Breast Cancer Model
C1490590;Faecalibacterium prausnitzii
C4321361;Patients
C0152276;Sarcoma
C1490589;Bacteria
C1042496;Meta
C1537899;Adenocarcinoma
C1089142;Fungi
C1537893;HCT116 Cells
C0851346;Immune response
C0201683;Present
C0587477;Hospitals
C0683206;Tumor Progression
C0429629;Patients
C0599474;cholesterol biosynthesis
C2958713;Rectal Carcinoma
C1826507;DNA Replication
C0200345;Mass Spectrometry
C0910119;Histone Deacetylase
C1368404;Reconstructive Surgical Procedures
C0007704;Isolation procedure
C0587464;Hospitals
C0201679;High-Grade Squamous Intraepithelial Lesions
C0007709;cohesins
C0250604;Eotaxin
C0852695;Biopsy of Mucosa
C0599444;Neuroglia
C3540600;Microtubule-Associated Proteins 1A/1B Light Chain 3
C1523298;Embryonic Development
C4321335;Patients
C0418981;Small cell carcinoma of lung
C0852681;Closure by clamp
C0200363;Diabetes
C0153567;Hematopoietic Neoplasms
C0393293;Destructive procedure (surgical)
C0164209;aprepitant
C4526535;Malignant tumor of colon
C4526534;Physical Examination
C0587487;Hospitals
C0201699;Mass Spectrometry
C0587482;Hospitals
C0587481;Hospitals
C1826556;Adrenocortical carcinoma
C0683243;Social Networks
C3275427;Male population group
C4526526;In complete remission
C4526525;Feline urological syndrome
C4526521;Patients
C1512523;Cisplatin
C4526520;Patients
C1826546;inflammatory response
C0178829;Cancer of Urinary Tract
C4055109;Advanced Malignant Solid Neoplasm
C4055105;Clonal Evolution
C0154830;Undifferentiated illness
C4526519;Folinic Acid-Fluorouracil-Irinotecan Regimen
C0153500;Patients
C1537839;MIR200B gene
C0178825;Positive Surgical Margins
C4526517;bevacizumab
C0154833;Retinal vascular disorder
C1621636;TOR signaling
C0672596;C1QC gene
C0165519;Notch Signaling Pathway
C1562800;Colonic Neoplasms
C0057721;Immune
C1512511;Primary Prevention
C0478664;Localized enlarged lymph nodes
C0069717;Laryngopharyngeal Dysesthesia
C2825899;Mucous Membrane
C0684550;Stereotactic Body Radiotherapy
C2347379;Chemoradiotherapy
C4056441;tipiracil / Trifluridine
C0057732;diatomite
C0814337;Patients
C1826526;HCT116 Cells
C2993063;Atlanta
C2347362;Colorectal Carcinoma
C1537811;Subgroup A Nepoviruses
C0971087;Colorectal Carcinoma
C1415276;Malignant tumor of colon
C1415273;TECR gene
C1826596;PLEKHG5 gene
C1415278;Neoplastic Cell Transformation
C1415277;Secondary carcinoma
C1427252;FBXW8 gene
C0226901;Macrophage Activation Syndrome
C1537860;Carcinogenesis
C1415284;di-tert-butylperoxy-335-trimethylcyclohexane peroxide
C2348678;Casein Kinase II
C1826586;Patients
C1513882;Analysis
C1537876;Malignant Neoplasms
C1513887;research study
C1512554;insulin-like growth factor 2
C1537879;RNA circular
C0142812;CD69 protein human
C1441554;Cell-Free DNA
C0598197;Colorectal Carcinoma
C1149209;Endoplasmic Reticulum
C1537848;Cell Survival
C1537847;melanoma
C2347335;Mesocarp
C1622911;Cell Death
C0598196;microbial disease
C1864814;Inflammatory Bowel Diseases
C1837222;EIF5A gene
C1512589;huperzine B
C1537846;Growth
C0082731;PEBP1 gene
C0201622;Toxic effect
C0042076;Renal Cell Carcinoma
C0069751;Patients
C0042070;Macrophage Activation Syndrome
C0042071;Plasma
C1427290;Cells
C1826560;Tumor cells malignant
C1826566;Carcinogenesis
C1826565;Body tissue
C0729078;Growth
C3661443;Analysis
C1511246;Equilibrium
C0042065;Carcinoma Transitional Cell
C0142831;Plasma
C2825836;Radiodermatitis
C1414143;Patients
C0042056;Urochordata
C0260178;Intestinal Cancer
C0260176;advanced cancer
C0017097;HBEGF protein human
C1414146;Protein Overexpression
C0549207;Neoplasm Metastasis
C0079104;Anus
C1149187;Dendritic Cells
C1428785;Chromatin
C1415484;HBE1 gene
C2825840;Intractable diarrhea
C2752385;SPTY2D1 gene
C0549217;Turkish population
C0971025;Polymers
C1706823;Dendritic Cells
C0005098;cytotoxicity
C0043375;Accumulation
C0029089;Patients
C0334748;Gastrointestinal Diseases
C0068451;Berberine
C0068450;Biochemical Pathway
C1414165;ESD gene
C0031381;Aspartate
C0042036;Air
C1415491;Homo sapiens
C0042034;Long-Term Survivors
C0030054;Virulence
C0017075;Benign Neoplasm
C2239425;Stat3 Signaling Pathway
C1656251;subcellular fractionation
C1414168;Postoperative Complications
C0017070;Ganglia Spinal
C1706832;Appendiceal Neoplasms
C0115305;Endothelial Cells
C0142923;Selenium
C0235195;Sedated state
C0029053;Decreased translucency
C1705504;Surgical incisions
C1426148;Colorectal cancer early onset
C3540595;vasoactive intestinal peptide
C0042029;Microbial susceptibility tests
C0042027;Adenocarcinoma Clear Cell
C1414174;research study
C2825821;Angiogenic Process
C0042025;Patients
C0042024;nerve sparing
C0526532;ENKUR gene
C4045969;Physical Barriers
C1414178;Non-Small Cell Lung Carcinoma
C2239419;AMER3 gene
C3491084;xylooligosaccharide
C2752369;H2O2 scavenging
C0564863;tomography
C4057931;Intra-Arterial Infusions
C0080103;phosphatidylinositol 3-kinase signaling
C0042021;Anoxia
C0029064;angiogram
C0043352;Mouth Diseases
C0042020;Meta Analysis (statistical procedure)
C0070788;T-Cell Surface Glycoprotein CD4 human
C1138490;Body tissue
C0017054;Neoplastic Cell Transformation
C1137168;BIBR 1532
C1150132;Adenocarcinoma Cell
C1150130;HCT116 Cells
C0005068;Benzofurans
C0032699;Porifera
C1416771;Doxorubicin
C0043335;Intestines
C1959616;Lipids
C0031350;Participant
C0017067;Pelvis
C0042001;Enzymes
C0042002;Uridine Monophosphate
C0030020;Oximes
C1864985;Progressive disorder
C0333450;Patients
C1175421;antibody conjugate
C0729262;Total colectomy
C0080124;HOXC11 gene
C0031354;Persons
C1416783;SNAP23 gene
C1414121;DNA hypermethylation
C0333467;lopinavir
C0019693;Sexually Transmitted Diseases
C1416788;cytokine
C1513713;Goblet Cells
C2347296;Peritonitis
C0720890;Pharmaceutical Preparations
C0441290;Icterus
C1416785;Tumor Cell Invasion
C1513717;Mucinous Differentiation
C0441291;decompression tubes
C1427430;Ubiquitination
C0540883;Epithelial Cells
C0576808;Crohn Disease
C0030016;Pentose Phosphate Pathway
C0030015;Tumor cells malignant
C3827002;lobe
C0030013;Birth
C0029016;FSCN1 gene
C0260194;Rectal Diseases
C0030012;Histone deacetylase inhibitor
C0030011;Oxidation
C1416799;Anal pain
C1415467;DNA hypermethylation
C0020699;Postmenopausal state
C0017040;Gamma-glutamyl transferase
C1416797;Intestinal Cancer
C0333471;Collagenolysis
C0332140;Tissue metabolism
C1428770;Apoptosis
C0332149;Relative (related person)
C0005078;Benzopyrans
C0029020;Antibodies Anti-Idiotypic
C0081476;GPI gene
C0033993;Glycolysis
C1426113;Tissue Adhesions
C0043301;High resolution
C0079189;Mice Nude
C0018340;INDUCIBLE cAMP EARLY REPRESSOR
C3829684;RTP4 gene
C3829683;Long Intergenic Non-Protein Coding RNA
C1416728;Neoplasms
C0080179;Vertebral column
C0080178;Malignant neoplasm of urinary bladder
C0237798;Nonhuman primate
C0031321;Stomach Diseases
C1428701;cinobufotalin
C0031323;Pharmacist
C0948657;Increased cancer antigen 125
C1705569;Stomach
C0031327;schisantherin A
C0286738;Protease Inhibitors
C0718566;Patients
C0729218;Immunosuppressive Agents
C0020672;Surgical Procedures Laparoscopic
C0019682;Immunologic Deficiency Syndromes
C0020676;atezolizumab
C0947333;Physical activity.status
C3827014;stage colon cancer
C0033979;Psyllium
C1705576;Patients
C1704244;Recurrent squamous cell carcinoma
C1704241;Silver
C0029005;E6 protein Human papillomavirus type 16
C1416738;Adenocarcinoma of large intestine
C0033972;Peripheral Neuropathy
C3842674;Day 5
C0863194;Patients
C3842675;Patients
C0032646;Patients
C1704247;Pathologic Response
C3842676;Patients
C0019655;Biopsy
C1306294;Diffusion weighted imaging
C0019652;melanocyte
C0018320;mitochondrial toxicity
C1705590;Malignant neoplasm of anus
C1416746;KRT8 gene
C1273723;Secondary Neoplasm
C1416745;cytokeratin 20
C1959620;Adverse reactions
C1416740;KRT3 gene
C0006349;Pharmaceutical Preparations
C0031307;Signal Transduction
C0033968;Distress
C0031308;Tumor cells malignant
C1705586;SIR-Spheres
C4489276;Kidney Failure
C2216702;Persons
C0599529;Medical Devices
C1704259;Oxytocin Receptor
C1704258;Bladder mucosa
C0080194;Muscle strain
C0044602;Proto-Oncogene Proteins c-akt
C0007680;Central Nervous System Agents
C0599532;Anti-Inflammatory Agents
C3540512;Immunoblotting
C3540513;Ligation
C0019664;History
C1427407;Tumor cells uncertain whether benign or malignant
C0006352;RAB27A wt Allele
C0006353;Adenoma
C0018330;Reproduction
C1958300;veliparib
C1704265;TACSTD1 protein human
C1704263;Green Tea Extract
C0080188;Antigens CD15
C0744813;Robotic assisted surgery
C0019637;Lymphangiectasis Intestinal
C0020625;Patients
C0019635;Neoplasm Metastasis
C2717969;Pancreatic Ductal Adenocarcinoma
C0018302;Guaiac
C0019633;Teratoma
C0672708;Antineoplastic Agents
C0020629;advanced cancer
C3540546;oxaliplatin
C3827072;Gene Expression Regulation
C0587516;Study
C0020621;Dehydration
C0587519;Hospitals
C0032615;Oxylipins
C0032617;Polyuria
C0019638;Histology
C1332550;Breast
C0019647;Histone H3
C0019646;Wound Healing
C0019643;Histone deacetylase inhibitor
C2717977;Colorectal Carcinoma
C0587503;Hospitals
C0008996;Patients
C0021966;Arteries
C0020632;Malignant Neoplasms
C2584567;Bacteria
C0587500;Hospitals
C1333887;Tumor Angiogenesis
C0021936;Cerebellar tuber
C0021934;Lesion
C1284419;Direct Visualization
C1017328;Body tissue
C1259459;Carcinogens
C1198134;Community
C2716653;Reactive Oxygen Species
C0948680;Adenocarcinoma of liver
C4489237;Pelvis
C0020600;Hypochlorous Acid
C0021933;Mechanical ileus
C0007634;erythromycin propionate-N-acetylcysteinate
C0008964;Clinical Medicine
C0007635;SNHG20 gene
C0007637;Cytomegalovirus
C0587530;Hospitals
C0587532;Hospitals
C0005001;Patients
C1332549;Bilateral Carcinoma
C1704216;Basaloid carcinoma
C1333877;Solid Neoplasm
C0020615;Signal
C1333860;Patients
C0260108;Fungi
C0020614;Cranial nerve deficits
C0019624;Rectum
C0020616;bone morphogenetic protein 4
C0019621;Malignant Childhood Neoplasm
C0008972;Ambulatory Care Facilities
C0008971;Migration Cell
C0007641;anatomical layer
C0587524;Hospitals
C0007642;Pelvis
C0008976;tumor infiltrating lymphocyte therapy
C1704223;Palmitic Acid
C1669512;Cell Count
C0235162;Cancer Patient
C0587520;Hospitals
C0405600;Patients
C1017315;Helice
C0019629;Erythema Multiforme
C0235169;Excitability
C1333866;Patients
C4321464;Patients
C1333972;Partial hepatectomy
C0164371;Patients
C0225730;lobe
C0007613;T-Cell Surface Glycoprotein CD4 human
C0008947;Clostridium perfringens
C1333977;Patients
C0021925;Acute respiratory failure
C0019602;Colorectal Carcinoma
C4512075;Maternal cell free DNA
C0442532;Cells
C0007620;G2 Cell Cycle Arrest
C0007621;Mice Nude
C0937932;Tumor Lysis Syndrome
C0021920;Hematologic Neoplasms
C1969059;Mus
C1512474;Histone Deacetylase
C1537797;Malignant tumor of colon
C0685938;Common Variable Immunodeficiency
C1537799;Sitting position
C0851286;Staff
C4321488;KLF4 gene
C3177188;Laxatives
C2681537;CMTR2 gene
C2681538;Cancer Cell Growth
C3710914;EIF2AK2 protein human
C0393136;Patients
C0007600;PDK1 gene
C0598282;nervous system development
C0007603;Type-II Pneumocytes
C0007605;Cell Membrane Permeability
C0007608;Scaffold protein
C1537770;BCL2L12 gene
C0262718;Muscle
C0877853;Protons
C1825306;Adenocarcinoma
C1825307;Adenocarcinoma
C0153676;Mice Nude
C1101121;Carcinogenesis
C0225779;Malignant Neoplasms
C1969088;Memory T-Lymphocyte
C1704272;Patients
C0683325;Perceived quality of life
C1333931;Cancer Cell Growth
C0406867;Patients
C1826623;Chronic inflammation
C0633055;pentalenolactone F methyl ester
C1318309;higher education institution
C0153662;Malignant neoplasm of abdomen
C2681554;Colorectal Carcinoma
C1704289;Diagnostic radiologic examination
C1333927;HSD17B7 gene
C2118460;Animal Disease Models
C0153661;Non-Small Cell Lung Carcinoma
C0008919;Physical findings
C0683317;Fluorouracil
C1318303;Aneurysm
C0599561;Malignant Epithelial Cell
C0851248;Free flap procedures
C0599566;Tumor cells malignant
C1826618;BAX gene
C0178951;accelerometers
C0200499;Colorectal Carcinoma
C0225754;disease recurrence
C0153690;Analgesics
C4082861;Vascular smooth muscle cell
C0949921;Homo sapiens
C0949920;Homo sapiens
C1536478;Patients
C4489197;Microbiology procedure
C0225759;bony process
C1367202;Malignant neoplasm of descending colon
C0909027;Postoperative ileus
C3650840;Neoplasms
C3891660;Dendritic Cells
C0153687;Palliative Care
C0153685;Secondary malignant neoplasm of kidney
C1333909;HMGB2 gene
C1333908;Patients
C1451099;Receptors Tumor Necrosis Factor Member 10b
C2825796;MIR17 wt Allele
C0332155;First line treatment
C2239486;TACSTD1 protein human
C0153633;Immature cells
C1622858;Tretinoin
C1512409;abnormal fragmented structure
C0695341;Anastomotic Leak
C0056503;Carotenoids
C1537700;herstatin protein human
C2263112;Genes
C0684686;Limb structure
C1321919;JUN kinase activity
C0539906;Genes
C1321914;TNFRSF10B protein human
C0069821;Alkaloids
C0332167;Chemotherapy Adjuvant
C4055223;Urgent desire for stool
C1537719;Transformation function
C0333494;Colectomy
C1827996;Whole-Abdominal Irradiation
C0683357;Cirrhosis
C4079208;BRAF gene
C0153658;Neuroendocrine Tumors
C0178913;Cohort
C0152327;Anus
C3686815;Symptoms
C0126037;Epithelial Cells
C0201709;knocked out
C0165603;Antimalarials
C1825313;Cell Survival
C0442592;Analysis
C1826646;phosphatidylinositol 3-kinase signaling
C1513743;Local excision
C4082832;Patients
C0069841;colon growth
C0682076;Adult
C1414066;Disease
C0127306;TP53 gene
C1414063;RALA gene
C1414062;Liver carcinoma
C0682075;Elderly (population group)
C1138412;colon (non-specific) polyps multiple
C0213709;HCT116 Cells
C0742186;Adenocarcinoma of pancreas
C1451001;Cell Count
C1512441;Biological Markers
C1513778;Assay
C1426048;RAB33A gene
C1427378;DNA Repair
C0742176;cervical mass
C0178906;colonoscopy
C3890397;Tumor cells malignant
C0043299;Primary adenocarcinoma of colon
C0225700;Plasma membrane
C0225706;Coughing
C1513763;knocked out
C1426056;TBC1D4 gene
C1512430;Malignant Female Reproductive System Neoplasm
C1537753;MIR98 gene
C1453650;Weight Loss Adverse Event
C1427383;Secondary Neoplasm
C0430562;Cells
C1838681;Rapidly progressive
C1537750;Malignant neoplasm of kidney
C0129975;Cytopathic effect
C0442540;Cell Proliferation
C1824035;TP63 protein human
C1826697;Phosphorylation
C0082859;Germ-Line Mutation
C1511131;Oxidative Coupling
C1426066;Colorectal Cancer
C1427396;Malignant Neoplasms
C1511130;Epithelium
C0142963;tumor growth
C0067228;Eukaryotic Cells
C2751072;Neoplastic Cell Transformation
C1825352;Adenocarcinoma
C0153601;Excision of inguinal lymph nodes group
C0814244;Dietary intake
C1536403;Aspartate Transaminase
C0069881;Cultured Cell Line
C1334026;High Risk Gastrointestinal Stromal Tumor
C1335354;Adult
C0008024;Deoxycholic Acid
C0010340;Patients
C1563041;Malignant Neoplasms
C0010346;Colon Mucosa-Associated Lymphoid Tissue Lymphoma
C0036974;Shock
C0035649;Infantile Neuroaxonal Dystrophy
C0035648;Clinical Complete Response
C2115941;Jugular thrombophlebitis
C1334015;Cohort
C1334016;reproductive system disorder
C1336677;removal technique
C0008031;Patients
C1334011;High Grade Cervical Intraepithelial Neoplasia
C0010352;Fungi
C0008034;Chest Tubes
C0541828;Patients
C3898998;HCT-116
C0009368;Ectopic pancreatic tissue
C0047611;Cefaclor
C0021009;Lectin
C1311392;HCT116 Cells
C0023660;Relative (related person)
C0010357;Inflammasomes
C0010356;Cross Infection
C0034303;Pharmaceutical Preparations
C0011685;Fluoxetine
C1334017;Patients
C0227691;Abnormality
C0227690;Both ureters
C0265965;Patients
C0023636;License
C0238348;Squamous cell carcinoma of penis
C2950548;mass lesion
C4236779;Neoplastic Cell
C2936239;Cell Survival
C0035622;Flexible fiberoptic sigmoidoscopy
C0012984;Vascular Endothelial Growth Factor A
C1312695;Malignant Neoplasms
C1538072;Marinesco-Sjogren syndrome
C0300824;Hybrids
C0008018;Infiltration
C0300821;Extracellular Signal Regulated Kinases
C0237020;Small bowel obstruction
C2611086;Liver carcinoma
C0237022;Multiple Fibroids
C4550936;Patients
C0035613;Extravasation
C0036945;Sheep
C0010337;Health Care
C1336644;Colorectal Carcinoma
C0442044;Neoplasms
C1336643;Colorectal Carcinoma
C0000975;Acids
C2986517;Merkel cell carcinoma
C0024947;Colonic Neoplasms
C2986518;Rectal Reconstruction
C0009319;Italians
C0000970;Patients
C2986511;Evaluable Patient
C1827293;Radiotherapy Adjuvant
C0012968;polarization
C0770893;Metformin hydrochloride
C1336647;Lymphoid Cells
C0011633;Spontaneous hemorrhage
C1336646;Diffuse Large B-Cell Lymphoma
C1335302;Relative (related person)
C1312689;Malignant Neoplasms
C2698696;PKM2 wt Allele
C0009324;Perivascular Epithelioid Cell Neoplasms
C0060656;Body tissue
C0263358;Erythema annulare centrifugum
C0009326;Collagen Diseases
C0023621;Study
C0009325;Agar
C0000966;Colonic Neoplasms
C0058330;polarization
C0456693;per 30 minutes
C0011649;Colon structure (body structure)
C1563019;Dehiscence
C2986524;Patients
C0348822;Drug-induced interstitial lung disorder
C0237083;Dietitian Registered
C1336636;Carcinogenesis
C0011644;Patients
C1336620;Diffuse Large B-Cell Lymphoma
C0192466;Ulcer
C4284453;NCR1 wt Allele
C0444680;TBATA gene
C0541854;Patients
C2936272;Physiological Processes
C0036916;Acquired Immunodeficiency Syndrome
C4236737;Mus
C4236736;intracellular vesicle
C1157916;Genes
C0011615;Patients
C1336626;Secondary Neoplasm
C1538099;Cell Survival
C1336624;Transcriptional Repression
C2986505;Advanced Malignant Solid Neoplasm
C0000983;Edema
C0024934;Mathematics
C1300683;Medical Devices
C0540511;Malignant neoplasm of pancreas
C2986502;Digestive System Neoplasms
C0238393;Patients
C0336867;Balloon Aircraft
C0276638;Patients
C1311331;Mutant Proteins
C1839238;Colorectal Carcinoma
C0192440;Upper abdominal pain
C0085983;intrinsic apoptosis
C0240604;Portal vein thrombosis
C1527349;Mus
C0240602;Operation on abdominal region
C0085988;Patients
C0000934;Italians
C4331302;CD69 protein human
C0324889;Old World rabbit
C0058361;Tumor-Associated Macrophage
C0012929;Glutathione
C4317009;Colovesical Fistula
C0949861;Glutathione
C2611015;cell cycle quiescence
C0203668;Secondary malignant neoplasm of bone
C0203669;Neoplasm Metastasis
C0181797;Medical Gas Cylinders
C0069014;Alkaloids
C1167331;Proteins
C0012920;Homo sapiens
C0000921;Accidental Falls
C0240611;Mass of ovary
C0024911;Mus
C1566967;Glutathione
C1539337;Renal Cell Carcinoma
C1623258;Mediastinum
C0948540;Magnetic Resonance Imaging
C4307668;redaporfin
C0011603;mTOR Inhibitor
C0012935;Tumor Progression
C1516670;CST9 gene
C0180459;Disks (device)
C1167322;integral to membrane
C3273948;Patients
C1611269;Isoleucine
C3272610;Colorectal Neuroendocrine Neoplasm
C0192420;Body of uterus
C0227613;Thickened
C0227614;Multiple lesions
C0179448;Cytology brush device
C2828372;TS-1
C0071360;DNA Repair
C0277919;Disease
C1300632;In complete remission
C1155379;Replication Origin
C3272608;Patients
C3272607;Patients
C1515370;T-Lymphocyte
C1540309;Genome
C3272603;Secondary Neoplasm
C3273930;Tumor Mass
C0324857;Gorilla gorilla gorilla
C1708747;Appendiceal mucinous neoplasm
C1325924;B Cell Receptor Signaling Pathway
C0949854;phenolic acid
C1516697;Carcinoma
C1180307;F-Actin
C0241910;Patients
C3273927;Multiple malignancy
C1313921;Urinoma
C0312860;Cohort
C0312864;Sensitized cell
C0312861;Neutrophil chemotaxis
C1538039;Patients
C3272629;Epithelial Damage
C1553667;MicroRNAs
C1553666;Calcibiotic Root Canal Sealer
C0227684;Adenocarcinoma Clear Cell
C0538294;Animal protein
C1157968;collagen catabolic process
C0181741;tailor
C0237007;Macrophage Activation Syndrome
C0083355;Water
C0214345;rasagiline
C1553664;Patients
C1144661;Male population group
C0143466;ets-Domain Protein Elk-4
C0057090;water channel
C1157990;Sumoylation
C1156661;Patients
C0565867;Pharmaceutical Preparations
C1157996;Deubiquitination
C1553646;Cisplatin
C1553643;Maxillary left canine abutment
C0227666;Adenoma Villous
C2827093;Accumulation
C1527374;Malignant Neoplasms
C0193704;Pheochromocytoma
C2260797;Tumor Progression
C0563211;First line treatment
C2936206;Minimally Invasive Surgical Procedures
C1553642;Maxillary left lateral incisor abutment
C0454096;Iodine 125 brachytherapy
C2936208;Operative Surgical Procedures
C0334296;Tumor buds
C1011522;Polysaccharides
C0334298;Patients
C0334292;Persons
C0851140;Genetic screening method
C0334294;Duodenum
C1959127;Adenomatous Polyposis Coli
C4330055;Glioblastoma
C0070099;Lesion
C1418194;CLDN11 gene
C0648637;Solid Neoplasm
C3824706;Adult
C1290807;Immunocompromised Host
C4331397;Telomere Length
C1707479;infliximab
C1504769;Neoplasms
C0662925;Intestines
C0432616;Chronic infectious disease
C1456447;Somatostatin-Secreting Cells
C1455147;Did not receive therapy or drug for
C1265823;Colonic mucous membrane
C1265824;Antigens
C1516743;Complement-Dependent Cytotoxicity
C0814177;Patients
C1707484;Adult
C1180255;oxaliplatin
C0203608;(177lutetium-DOTA(O)Tyr3)octreotate
C0649973;goniodiol-7-monoacetate
C1265818;Mucous fistula
C1707496;Consumer
C1721787;Vaccines
C1265815;Duodenoscopy
C0623362;MAP Kinase Cascade
C2985294;Fourth Stage of Labor
C0599220;Colonic Neoplasms
C4317046;Hematological abnormality
C1431123;MAP4K4 gene
C1167250;Sulfoglycosphingolipids
C1420464;AURKB gene
C1167249;Crypt
C0203610;Cohort
C1155266;Bacterial Toxins
C1707438;Cell Differentiation process
C1707439;Patients
C0948501;mass cystic
C1420470;mRNA Expression
C1420476;Mammals
C1707436;Early Diagnosis
C0912567;Hematopoietic stem cells
C1708781;pembrolizumab
C4318390;Rheumatic Fever
C1155299;Telomere Maintenance
C1707440;Patients
C1706111;EGFR wt Allele
C0599209;Fast Protein Liquid Chromatography
C1707443;SMARCB1 protein human
C0841790;Mus
C1514120;Patients
C0034284;Tumor cells malignant
C1708790;Discrepancy
C1527418;bevacizumab
C0034289;Pyrimidines
C0310255;survive
C0203634;Gold
C0396565;Thoracic Surgical Procedures
C1998726;Clinician
C1264521;Mus
C1182883;Neoplasms
C0034272;Dicyclomine
C1420423;Rectal Neoplasms
C1418109;Malignant neoplasm of mouth
C0288589;Malignant Neoplasms
C0022283;Neoplasms
C0457970;Patients
C1290884;Chronic disease
C0456642;Medical Devices
C1290886;Pain
C0814111;Patients
C0444669;Stem cells
C1817832;MUTYH-Associate Polyposis
C1299212;Polyp of large intestine
C1420434;Patients
C0346208;Intraepithelial Neoplasia
C0034266;Blood
C0118522;Glutathione
C2986562;Spiculated Mass
C2986561;Hyperthermic Intraperitoneal Chemotherapy
C2986563;bevacizumab
C0334227;SUMO-1 Protein
C3846112;Fiducial Markers
C0346202;Uterus
C0288590;Tumor cells malignant
C2986560;Rechallenge
C0743178;telotristat etiprate
C0010283;Crataegus pinnatifida
C0684312;Drivers of Vehicles
C0334233;Pleomorphic carcinoma
C0034251;CDK8 gene
C0010280;Protection
C1334088;Insulin-Like Growth Factor I
C0009297;colicin
C0010286;Respiration
C0034255;Pyridines
C0047569;Autophagy
C0022262;Isotopes
C2986530;Intervention Group
C0443315;Cancer Stem Cells
C1420442;SDCBP2 gene
C0010294;Serum
C0034243;CYP1A2 gene
C0334246;Jaundice Obstructive
C1275216;Perianal skin
C0334248;Squamous cell carcinoma large cell nonkeratinizing
C1419465;Growth
C0334240;Combined small cell carcinoma
C0430022;Colonic Diseases
C0334252;Squamous cell carcinoma microinvasive
C0035561;Uptake
C0334254;Ascending colon
C0009274;Phlebosclerosis
C2698720;Receptors Tumor Necrosis Factor Member 10b
C4045974;metastatic colorectal cancer
C0372525;Appendiceal mucinous neoplasm
C0456605;Jejunum
C0022245;SCRT1 gene
C0541912;Papilla
C1698754;Cell Count
C4296384;Diagnostic radiologic examination
C2986594;Anemia Sickle Cell
C2986597;rasagiline
C0047542;3-Mercaptopyruvate sulfurtransferase
C0348898;Irritable bowel syndrome with diarrhea
C2986592;Biliary Tract Cancer
C1275278;Microsatellite Instability
C0035553;Genes
C0036884;ovarian
C0036883;Malignant neoplasm of stomach
C0035552;martynoside
C0432626;Malignant Neoplasms
C3152857;Cohort
C3151529;Myopericarditis
C0671062;Up-Regulation (Physiology)
C0814141;Woman
C0010278;Leucine
C4045991;infection as a complication
C1335377;Medical pathologist
C1334046;Genes Housekeeping
C0334276;Cystic Adenomatoid Malformation of Lung Congenital
C0334277;Male population group
C0009253;Community
C1420406;src-Family Kinases
C0334279;Biopsy
C1334043;Mammals
C1419419;Ubiquitination
C0011570;Symptoms
C1334040;Low grade glioma
C1335371;Patients
C0024885;Mastectomy
C0024880;Mammals
C0024883;Malignant Neoplasms
C1290864;Disorder of abdomen
C0024881;Inflammatory Breast Carcinoma
C0445934;Fusobacterium nucleatum ss animalis
C0731141;Malignant neoplasm of lung
C0035549;Anti-Inflammatory Agents
C0334287;Fibrolamellar Hepatocellular Carcinoma
C1419427;Transcription Factor 7-Like 2
C1420418;Colorectal Carcinoma
C0299212;Presenilin-1
C0011581;general population
C1336692;Microglia
C0132800;venlafaxine
C0815460;Nodule
C1419422;Polyubiquitination
C0290883;Growth
C0024894;Disease
C2986589;Laboratory Procedures
C0036866;Heart failure
C1335475;Patients
C1335470;Premalignant Change
C3873567;Peripheral Neuropathy
C1826031;Study
C0009237;Peptic Ulcer
C0022202;Steroid hormone
C1826035;BCL2L12 gene
C0024868;Intestinal Contents
C2936330;Microalgae
C1540289;Cell Count
C2936333;Wound Closure Techniques
C0058405;Vero Cells
C0023530;Kanglaite Injection
C0035525;Signal Transduction Pathways
C0010222;Couples (persons)
C1299297;Primary malignant neoplasm of pancreas
C0035527;Riboflavin
C1421921;Abdomen
C0012892;Genes
C1334137;Autoimmune Diseases
C4055506;Persons
C0742014;Chemotherapy Adjuvant
C0009240;Reading Frames (Nucleotide Sequence)
C1334131;Neoplasm Metastasis
C0023545;Iodides
C2986605;Disease Progression
C0024875;Edema
C1121849;Tumor tissue sample
C0238493;Operative Surgical Procedures
C4068804;Evaluation
C0048820;Cardiac Arrest
C0024870;Endoscopy (procedure)
C0012899;Immune response
C1539297;Body tissue
C0059747;intrinsic apoptosis
C3151563;Patients
C1334139;midostaurin
C0036847;patchouli alcohol
C0683187;Tetranitromethane
C1334126;Patients
C0012860;Carcinogenesis
C0023518;Pain
C0009210;Carbohydrates
C0263428;Burnett Schwartz Berberian syndrome
C1334122;IL6 gene
C0059752;Rattus norvegicus
C1419618;RPA1 gene
C0009214;Gastrointestinal Motility
C1421939;ARHGEF2 gene
C2947019;Homeostasis
C0948482;Anus
C0024841;Participant
C0023516;Hamartoma Syndrome Multiple
C1826013;E2F3 gene
C0238461;Intestines Small
C3898882;Histone H3 Acetyl Lys27
C0238463;Adult
C0238462;Medullary carcinoma of thyroid
C3898881;Polycomb Repressive Complex 2
C3898884;Locally Advanced Malignant Neoplasm
C0059756;ethyl cellulose
C0010200;Right lung
C1334129;Body tissue
C0010207;Pharmaceutical Preparations
C0012863;HCT116 Cells
C2698508;Transformation function
C1336789;CLOCK gene
C1336776;NOX1 gene
C0012872;metastatic colorectal cancer
C0010210;Patients
C1334111;Granulocyte-Macrophage Colony-Stimulating Factor
C0683174;Dermatitis
C0023524;Malignant Neoplasms
C1826003;N(6)-methyladenosine
C0516983;Electroacupuncture
C0516981;Persons
C4068826;Harsh
C3643437;(R)-(+)-lipoic acid
C0948484;Woman
C0011546;Patients
C1853685;Neoplasms
C0012873;Methyltransferase
C0036825;LAPTM4B gene
C0525032;Radiometry
C0525033;Lactobacillus rhamnosus GG
C2699893;Patients
C1299258;invasive cancer
C1336763;Liposomes
C2986635;Mus
C0525037;Poor outcome
C0525038;K-ras Oncogene
C3898827;IDH1 Gene Mutation
C0541990;Patients
C2936375;Th1-Th2 Balance
C0011519;Liposomes
C1083051;sphingosine 1-phosphate
C1334107;IL17A protein human
C1335437;Antibodies
C0443264;Cells
C0743301;Duodenal Neoplasms
C0023508;Inflammation
C2973330;Colorectal Carcinoma
C0444598;Cells
C4284302;Carcinoma in Situ
C0084728;tebufelone
C4284307;RNA Isolation
C3162255;Colorectal Cancer pT1 TNM Finding v6 and v7
C0733995;Necrotizing fasciitis
C0733996;Abdomen
C1311470;TCF4 gene
C0012854;SP1 gene
C0060780;Lysine
C0525011;Paracrine Communication
C0444567;Ostium
C0000876;research
C0998737;Ascidiacea
C0000872;Biometry
C2936395;Biochemical Reaction
C0012826;Patients
C0071443;Polylactic acid (substance)
C1336748;Old age
C4476563;Enlarged mesenteric lymph node
C0024819;Cancer Control
C0192573;Deep endometriosis
C0060794;Inflammation
C1096380;Malignant neoplasm of mouth
C1540298;CDK19 gene
C1421904;Neoplasms
C1540292;Multiple tumors
C1540293;Immunity
C0024814;Vemurafenib
C0057142;DAPI
C0757929;Signal Transduction
C2986620;TRIM3 gene
C1096384;Neoplasms
C1826052;MDM2 gene
C0012833;Male population group
C0011503;Deoxyguanosine
C2974645;4'-geranyloxyferulic acid
C0011501;Deoxyglucose
C0178282;Hernia
C4318450;Waardenburg Anophthalmia Syndrome
C0577992;Congenital Abnormality
C0069139;Tumor cells malignant
C1527223;Unresectable Pancreatic Carcinoma
C4318455;Splenic mass
C0494809;Patients
C1708838;Shiva-1
C0227759;Hypesthesia
C0732611;Retinoid X Receptors
C1707501;Nodular lesions
C0193884;Malignant neoplasm of penis
C0238418;Symptoms
C1120596;Progressive Neoplastic Disease
C0193883;Malignant Female Reproductive System Neoplasm
C0238419;Male population group
C1864389;Woman
C1963919;Neoplasms
C1527233;Body tissue
C1528563;Carcinoid Tumor
C0012819;general population
C1516559;Community
C1517886;Limited stage (cancer stage)
C0012817;Colon diverticulum anatomic structure
C1155229;Neoplasms
C0012811;Diverticulum
C0070126;Cultured Cell Line
C0012813;Perforation of colon
C0312778;Body tissue
C0012814;Cancer Patient
C4548560;WNK1 protein human
C0069141;Tumor tissue sample
C0240705;Woman
C0525051;Population Based Study
C0000833;Severe pre-eclampsia
C0178238;Mus
C0069151;Neoplasms
C1336708;Testicular Germ Cell Tumor
C2246342;collagen metabolic process
C2246343;Homo sapiens
C0084785;primary tumor
C0526371;PKC412
C0193861;Condoms Male
C0000821;Hemorrhage
C0193867;Excision of axillary lymph nodes
C4331452;Clinical Trials
C0950721;UCN 01
C0540671;Cell Death
C1384494;Jejunum
C0537026;Patients
C4235382;cellular detoxification
C0312740;Immune effector cell
C0949790;atractylodin
C0193854;Patients
C1156523;glycerol metabolic process
C0238449;Jejunum
C0193842;Patients
C0239783;Appendix Mucinous Adenocarcinoma
C0070166;Coronary Arteriosclerosis
C1515263;Patients
C0312737;Immunohistochemistry
C0237125;Patients
C1527249;Persons
C1530899;Neoplastic Cell Transformation
C3272772;napabucasin
C4317106;SERPINA1 wt Allele
C0264714;Myocardial Infarction
C3642155;VEGFA gene
C0949765;Oncogenes
C0949766;Interventional procedure
C4318438;SPINK5 gene
C3714363;Relative (related person)
C3714365;Patients
C0238427;Cohort
C0238421;American College of Cardiology/American Heart Association Lesion Complexity Score C
C1539221;Patients
C0069197;Mucous Membrane
C1539222;DCBLD2 gene
C0181839;Microscopes
C4235354;Cells
C3272767;Child
C4319779;Patients
C1156530;Body tissue
C0154251;Disease
C0565990;Retrospective Cohort Study
C0179533;Flexible endoscope
C1540215;Periodontitis Juvenile
C1096309;Myolipoma
C2936329;Gastrointestinal Stromal Tumors
C1539233;Growth
C0192601;Secondary Lesion
C1456587;Barrett Esophagus
C1290916;Cancer Patient
C1300815;Flat tumor
C1300818;Liver damage
C0647426;Tissue membrane
C1290928;Serious Adverse Event
C2830519;Patients
C1517926;Localized Lesion
C3273990;Rectal Neuroendocrine Neoplasm
C0346164;Neoplasm of small intestine
C0346163;RNA Sequence
C1517925;Colorectal Neoplasms
C0322177;Echinococcus granulosus
C0179630;Cartridge device
C1265957;Intestines
C1744513;Colorectal Carcinoma
C0598034;Germ Line
C3272694;Cohort
C3272697;Patients
C3272693;Mus
C0814058;Patients
C1180138;Adenocarcinoma
C0814053;Patients
C2247725;Immune System Diseases
C1504635;Receptors Death Domain
C1516615;Diagnosis
C0814048;Organoids
C0046188;2-hydroxybutyric acid
C0814042;Universities
C1517940;Fluorouracil
C1443270;Lesion
C3714275;Maternal aunt
C1517942;imatinib
C3714277;Maternal uncle
C1706289;Colonic epithelium
C1527304;Immunity
C0034194;Pyloric Stenosis
C4317169;Pharmacotherapy
C0034193;Ulcer
C4441842;Major minor
C4522088;Persons
C0143630;Anal Gland Neoplasms
C3825962;Middle-aged women
C0574032;Hyalinosis Systemic
C0549099;Intestines Small
C1420599;Neoplasms
C0034186;Patients
C1530963;TRANSCRIPTION FACTOR
C1418277;Carcinoma Endometrioid
C1457887;Functional disorder of intestine
C1516635;Chronic Obstructive Airway Disease
C4522078;Group B
C1265996;Stomach
C1262008;Patients
C1418285;Chronic Obstructive Airway Disease
C1418286;Pharmaceutical Preparations
C0034170;Polyamines
C1516669;EGFR Antibody
C3548680;primary growth
C1515333;tetanus toxoid helper peptide
C1179132;cell motility
C0047487;aldehyde dehydrogenases
C0814098;Relative (related person)
C1073714;Plants
C0854988;Bisphosphonate therapy
C0311461;Nonessential amino acid
C1817908;Cellular Immune Response
C1817907;T cell mediated immunity
C1418297;Adenocarcinoma
C0155626;Arteriosclerosis
C4331496;bevacizumab
C1290905;cancer care
C1998602;Homo sapiens
C1623038;Persons
C1457868;telotristat ethyl
C1179122;Multiple polyps
C0022192;Immunofixation electrophoresis
C0034150;geriatric patients
C0010181;Cost Effectiveness
C0034152;Therapeutic immunosuppression
C4510061;Skin appendage adenoma
C0443213;Extrusion
C4054125;Patients
C3812695;Malignant Neoplasms
C1418222;Inflammatory Bowel Diseases
C4522043;Transient elastography
C0034140;Chronic Lymphocytic Leukemia
C0334102;Lymphangiomatosis
C0455205;Patients
C0022179;Isoflavones
C3176918;hepatoma cell
C4524695;Patients
C2986682;Radiotherapy Intensity-Modulated
C4524696;Patients
C4524697;Epidermal growth factor receptor inhibitor (product)
C0334106;Bowenoid papulosis
C0334108;First Degree Relative
C0034131;Neoplasm Metastasis
C1421896;Malignant Neoplasms
C0334113;Neoplasms
C0671110;DNA Damage
C0023470;Destructive procedure (surgical)
C0023473;omacetaxine mepesuccinate
C2674610;Rectal dilatation
C2674616;mismatch repair protein 1 human
C3885614;Adipogenesis
C1421894;Growth
C1299353;Patients
C1420578;TAGLN gene
C0334121;Inflammatory Myofibroblastic Tumor
C0444534;Present
C0346109;Patients
C1418252;Signal Transduction Pathways
C1334191;Malignant tumor of colon
C2986665;adjuvant therapy
C0286079;High-Grade Squamous Intraepithelial Lesions
C0023485;Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
C3476546;Glomerular Filtration Rate
C0059804;Pharmaceutical Preparations
C4055417;Adenocarcinoma of small intestine
C0334138;Lesion
C0036773;Anastomotic Leak
C1421834;Local excision
C1262091;Cohort
C0336791;Tool device (physical object)
C4525999;Fruquintinib
C0022122;Lesion
C1817997;Disease
C0011479;ORF74 protein Human herpesvirus 8
C0683154;Precision Medicine
C1420512;HIGD1A gene
C0036760;Jejunum and ileum
C4284262;Neoplasms
C0683150;plasma concentration
C1299307;Primary operation
C0023467;Acute leukemia
C0060808;Carotenoids
C2985398;pemetrexed
C1179187;Cryptitis
C0035436;Score 3
C0035435;Patients
C2985394;Male population group
C0683143;IGF2BP3 wt Allele
C0009131;Coal
C0683140;Therapeutic procedure
C0036753;Patients
C0036751;CNS - Brain (MMHCC)
C0012780;Vinegar
C0022104;Functional disorder
C3850987;Gastrointestinal Diseases
C0048733;Antioxidants
C0023434;Colorectal Carcinoma
C4055433;Hypothyroidism
C0598072;bony process
C0022108;Pharmaceutical Preparations
C0334150;metastatic colorectal cancer
C1517914;Tumor Initiation
C0022100;Discontinued
C0299348;Neoplasms
C0010124;Corticosterone
C3849996;Mus
C1420520;cholesteryl sulfate
C1817973;Leukocyte Differentiation
C1817972;immune system development
C4284283;Dendritic Cells
C1420532;Methylation
C0035410;Rhabdomyolysis
C0022115;TP53 gene
C0022116;compromise
C0023449;T-Lymphocyte
C1418212;Hypersensitivity
C0502420;anatomical layer
C0023448;Male population group
C0814002;Neurogenesis
C1024753;Pieris rapae
C0035412;Sarcoma
C0072802;Malignant Neoplasms
C0275551;Complication
C0023414;Growth
C0023413;American College of Cardiology/American Heart Association Lesion Complexity Score A
C0024742;Pentose Phosphate Pathway
C0023418;Child
C0948380;Animal Disease Models
C1564139;Guanosine Diphosphate
C0000772;Blood Vessel
C1156844;alanine metabolic process
C0036734;matriptase
C1552140;26s
C0036733;Breast
C0275553;Primary sclerosing cholangitis
C0012772;CD69 protein human
C0769635;Diastasis
C0036720;Serine
C1144866;Undifferentiated illness
C0744316;Gastritis
C0795907;insulin-like growth factor 2
C0000768;Situs ambiguus
C1540158;ferroptosis
C0024751;High resolution
C0744318;Patients
C3150355;Woman
C0275565;Abdomen
C0719386;Clozapine
C2673579;Prolonged bleeding
C0963992;Malignant Neoplasms
C4055631;Oncologists
C1565489;Renal function
C0263541;Patients
C1539143;removal technique
C0299544;Negative
C0012751;Distance
C0023401;Communicable Diseases
C0000780;Glycoproteins
C2721771;Fluorouracil
C0949696;Surgery Computer-Assisted
C1540138;pharmacophore
C0071511;spermidine
C2708732;Fatty Liver
C0238598;Young Adult
C1852403;Guanosine Diphosphate
C0024708;Tumor cells malignant
C0000737;Abdominal symptom
C0000734;Pelvis
C0000735;Abdominal Neoplasms
C0000731;Generalized abdominal pain
C1565427;HCT116 Cells
C0057239;Calcitriol
C0275518;Acute infectious disease
C0722978;Embryo
C0000727;Intestinal Perforation
C0718005;Bowel preparation
C0000726;Left lateral lumbar region of abdomen
C0530979;Patients
C0000729;Woman
C0758915;Procaspase-3
C1325744;SRRT gene
C0012739;Patients
C2937358;Cohort
C0012737;Donor person
C0454270;Applicator - device
C0071538;Lipopolysaccharides
C0454271;Endometrioid carcinoma of prostate
C0795974;Patients
C2697571;Mus
C2697573;RNF31 gene
C0746921;Patients
C0746922;Left breast
C0528649;Diabetes Mellitus Non-Insulin-Dependent
C3161031;Radiotherapy fractionation
C0057252;HT29 Cells
C3163695;Gastrointestinal Hemorrhage
C0333106;Bleeding varices
C3272805;Energy Metabolism
C3272802;Juvenile polyposis syndrome
C0346429;Italians
C0541605;Malignant Neoplasms
C0084866;Molecular Target
C2721734;Patients
C0360714;Extrahepatic Cholangiocarcinoma
C1540171;UTS2R gene
C1325720;histone methyltransferase complex
C0083536;Malignant neoplasm of breast
C0012715;Iron Metabolism Disorders
C0911014;Muscular Atrophy
C0057277;Colorectal Carcinoma
C1515119;Malignant neoplasm of pancreas
C0589612;Diathermy device
C1096616;contralateral breast cancer
C0949629;Bystander Effect
C1096618;peritoneal lesion
C3272827;Patients
C1962943;Polysaccharides
C1962945;Colorectal Neoplasms
C1397452;Pulmonary Fistula
C0950624;Rectal Juvenile Polyp
C1155589;cAMP-mediated signaling
C1708968;Diffusion weighted imaging
C0948303;Carcinoma of peritoneum
C0541662;Patients
C0589602;Flexible colonoscope
C0180694;Bovie
C1708961;Mediastinal Thymoma
C0949639;STAT3 gene
C0637802;Glycosides
C2247561;Persons
C1962917;High grade (lymphoma grade) (finding)
C1875180;GAUZE PAD
C0541653;Perianal sinus
C1179571;Head
C1301725;Patients
C1516463;Angiogenic Process
C1096638;Woman
C0553695;Macrophage Activation Syndrome
C0553697;Genitalia
C0553692;Patients
C3272841;Intussusception
C0192653;Lymphangiectasis Intestinal
C2926606;Malignant neoplasm of kidney
C0000702;Cell-Free DNA
C2926602;Elderly man
C0949610;Cytochromes
C0082248;GRAP2 gene
C1706322;Lung
C0530993;Patients
C1179517;Autophagy
C0240885;REGIONAL LYMPH NODE ENLARGEMENT
C1527144;oxaliplatin
C0201284;Cell Count
C1096653;Endometrium
C0949665;Antibiotics
C0949664;Disease
C1166209;Viscum album preparation
C1553430;Clinical Trials
C0192636;Malignant neoplasm of ascending colon
C1539136;Thalidomide
C2708700;Malignant neoplasm of brain
C0600472;calcitonin receptor-like receptor
C0948317;Preparation for procedure
C0949647;Vitamin E
C1539100;Body tissue
C0491243;Instrument - device
C4320404;HIF1alpha protein
C3271553;Cells
C0240873;Rectosigmoid Region
C0192616;Patients
C0877441;Chromoendoscopy
C0600465;Family
C0600466;Endogenous Retroviruses
C1539116;ferroptosis
C1142262;regorafenib
C1515162;Neoplastic Cell Transformation
C3546329;Nerve Growth Factor
C1254942;Colorectal Carcinoma
C1420269;LAMB3 gene
C0854893;Ascending colon
C0165101;ABCB1 gene
C1419274;Serum
C0178415;Patients
C1265601;Solitary mass
C1265602;Multiple masses
C1265604;Ulcerated mass
C0155773;Multiple Organ Failure
C0345180;Meckel Diverticulum
C1420267;Trans-Activation Genetic
C0180748;ergometers
C1420266;Colorectal Carcinoma
C3269144;Cell Line Tumor
C3269138;extrinsic apoptosis
C1419285;Inflammatory Bowel Diseases
C0192711;Amputation Stumps
C0192715;Esophagectomy
C0587021;Diagnosis
C0192706;Interventional procedure
C1419292;TP53 gene
C0815275;Malignant neoplasm of breast
C0178421;Malignant Neoplasms
C3534339;Somatostatin-Secreting Cells
C3546313;Necrosis
C1419298;Chronic Obstructive Airway Disease
C1705070;SLC2A1 gene
C0600558;advanced disease
C1420280;Cultured Cell Line
C0166415;PPAR alpha
C0166418;Metabolism
C0034085;DEGS1 wt Allele
C0599013;Nucleic Acids
C1504515;Anal canal
C1995013;Psoas Abscess
C2986382;Germ Line
C1421558;Malignant tumor of colon
C1420225;High Level
C0215848;luciferin monooxygenase activity
C0034079;Patients
C1718327;Patients
C0022086;colon growth
C0226509;E-Cadherin
C0926946;Gastrinoma
C0046056;Left lung
C0227837;Endocervix
C0226504;Structure of venous sinus
C0878826;Distal subtotal pancreatectomy
C1420222;Catabolism
C1708995;mRNA Expression
C1960398;ado-trastuzumab emtansine
C0034065;Sudden death
C3546359;MG 132
C1277615;Male population group
C0034069;Mus
C1420239;fatty acid oxidation
C1419240;Adenosine Phosphosulfate
C1419242;replication fork
C0600521;Volume Modulated Arc Therapy
C0227848;Present
C3812526;fatty acid metabolism
C1705010;Anti-Bacterial Agents
C1421561;YWHAG gene
C1421560;YWHAE gene
C1420234;human cell line
C1421565;CRNDE gene
C1420232;Cell Proliferation
C1421562;Protein Subunits
C0034052;Computed Tomography Angiography
C1420248;trichostatin A
C1420247;Patients
C2816585;Saponin
C1719672;Abdominal Cavity
C0600518;Choroidal Neovascularization
C1419258;RANBP1 gene
C0600513;Extracellular Matrix
C1517874;Heart
C0227813;Endometriosis
C1516545;Histones
C1096715;Physical findings
C1707686;Hereditary Nonpolyposis Colorectal Cancer
C1278926;mass lesion
C0600508;ENPP2 gene
C1419269;Tumor Suppression
C1419272;RARG gene
C1265610;Cronkhite-Canada Syndrome
C1265611;Quantity
C1420251;Cholangiocarcinoma
C0009074;Pharmaceutical Preparations
C1421514;GATA3 gene
C0035363;Self Expandable Metallic Stents
C4511035;Isolated thrombocytopenia
C0686750;Patients
C1335197;tumor growth
C0034035;Public Sector
C0009079;Antipsychotic Agents
C2987648;Small cell carcinoma of lung
C1335196;Chronic Obstructive Airway Disease
C1335191;SOS1 gene
C0036690;Multiple Organ Failure
C3536924;Reactive Oxygen Species
C0023374;Cohort
C3499533;Beta-glucuronidase
C2673622;Radical excision
C0334459;Salivary Glands
C0035369;Patients
C0009085;Hospitals
C1419204;Secondary malignant neoplasm of liver
C0334463;Malignant Fibrous Histiocytoma
C1335186;Oxidoreductase Gene
C1421527;Adoptive Immunotherapy
C1419202;IL27 gene
C0333139;Gas retention
C0035359;Exploratory incision
C0035358;Yolk Sac
C2698934;Adverse reaction to drug
C1421536;Apoptosis
C1419216;Tumor Progression
C0009054;Colonic mucous membrane
C0720298;Dysbiosis
C0009053;COL5A2 gene
C1335177;Intestinal Obstruction
C0035345;Employment status
C0035342;Disease
C2987625;Side-to-end coloanal anastomosis
C2755105;stem cell proliferation
C1419212;N(6)-methyladenosine
C0022023;Superoxides
C2987624;Malignant neoplasm of splenic flexure of colon
C0022022;Antibiotics
C0036679;methylserine phosphate
C1419227;Glycolysis
C1420216;Antineoplastic Agents
C0009063;Neuraminidase
C0037991;Pelvis
C1335168;Ovarian mucinous tumor
C1421544;XPO1 gene
C0037995;Wounds and Injuries
C0035334;Total mesorectal excision
C1335167;Primary malignant neoplasm
C1420219;SLC6A8 gene
C0010054;Inflammation
C0334489;Tissue specimen
C0249197;dioscin
C0037993;RUNX3 gene
C0009068;Anastomotic Leak
C2987636;Secondary Neoplasm
C4054275;Patients
C4524315;Programmed Cell Death Type II
C2987634;colon growth
C0037999;Splenic Neoplasms
C0035335;BRAF gene
C0037998;Multiple Organ Failure
C1120843;TRPV1 gene
C1827449;Adrenal Cortex Hormones
C0035320;Retinal Neovascularization
C0037982;Negative Lymph Node
C0333169;Intestines
C0333167;Intestines
C0333166;Celiac Artery
C0022009;Reconstructive Surgical Procedures
C0333165;Acute obstruction
C0000696;Cell Migration Assays
C0334492;Malignant neoplasm of gastrointestinal tract
C0024660;Fluorides
C0036658;Immunity
C0035328;Microbiome
C2987682;Primary malignant neoplasm of uterine cervix
C0010028;Silk
C0333171;Ileus
C1335147;Osteolytic Neoplasm
C1335144;House mice
C2697642;Glioma
C2697641;Colitis
C2698972;Cancer Diagnostic Procedure
C0010031;Cornea
C0058610;Antineoplastic Agents
C4525628;Ileal Neuroendocrine Tumor
C1826102;Colorectal Carcinoma
C1827434;Patients
C0024671;Woman
C0456853;Carcinoma Small Cell
C1290611;Patients
C0035316;Retinal Ganglion Cells
C0035317;Iron deficiency anemia
C1409894;Normal function
C1422820;Body tissue
C0036631;Secondary Malignant Neoplasm
C0013990;Pathological accumulation of air in tissues
C1335132;Metabolite
C0009013;T-Cell Receptor
C0025978;calponin
C0025979;scinderin
C3536985;Pharmacotherapy
C0024643;Goblet Cells
C0084913;Neoplastic Cell Transformation
C0025974;Digestion
C0746883;Leukopenia
C3837896;Neoplasms
C0058624;American College of Cardiology/American Heart Association Lesion Complexity Score A
C0035302;Retinal Artery Occlusion
C0035309;Retinal Diseases
C2744440;Patients
C1421500;Colorectal Carcinoma
C1422834;KCTD1 gene
C1422839;Cessation of life
C4054230;Peritoneal Cavity
C3849882;Endothelial Cells
C0036623;Semiconductors
C0036628;Malignant neoplasm of prostate
C0059969;extracellular matrix receptor
C3836382;primary Colorectal adenocarcinoma
C0059973;Gene Silencing
C0684296;Isolation procedure
C0024623;First Degree Relative
C1540046;TRAF3IP2 gene
C0024620;Ablation
C0037943;Fatty deposition
C0037949;Spinal Fractures
C0012644;Acute colitis
C0553702;ca increase
C0684287;hepatoma cell
C0013982;AKT Signaling Pathway
C1335221;PLA2G2A gene
C2674784;Colorectal Carcinoma
C0037930;Patients
C0069304;Mast/Stem Cell Growth Factor Receptor Signaling Pathway
C0059985;Antimetabolites
C3898639;LOX IMVI
C0745761;Indocyanine Green
C0025965;Micrococcal Nuclease
C1826268;Multiple malignancy
C0001973;Neoplasms
C0733796;Gastrografin
C0948268;Patients
C0236075;Woman
C0036609;Disease
C0037939;Neoplasms
C0025962;Anesthesia management
C3899964;BRCA2 Mutation Carrier
C0286330;Polyubiquitination
C0950580;Malignant tumor of colon
C0037937;Spinal Injuries
C0013987;Fatty Acids Volatile
C0012655;Imbalance
C0299636;Octreotide
C1336558;Adenocarcinoma
C1335212;monodehydroascorbate reductase (NADH) activity
C0025938;Anti-Antibodies
C1335210;Fluorouracil
C0684275;Cancer Detection
C3899977;Patients
C1826251;Chromosomes Human Pair 2
C0025936;Mice Transgenic
C0025932;Xenograft procedure
C0025933;Inflammation
C0037929;Persons
C0236048;Persons
C1276393;Control Groups
C0037922;Neoplasms
C0037926;Compression of spinal cord
C0012621;Gallbladder
C0072978;Colorectal Carcinoma
C0071649;Colonic Diseases
C0037925;Radiation-induced myelopathy
C0071629;Gastrointestinal Diseases
C1515091;Surgically-Created Resection Cavity
C0937596;Melanosis coli
C0745744;Non-alcoholic Fatty Liver Disease
C3899988;Autosomal Recessive Disorder
C1325881;biofilm formation
C0001998;Attention
C3899989;Autosomal Dominant Disorder
C1826242;MIR663AHG gene
C1325887;focal adhesion assembly
C0001992;Colorectal Carcinoma
C1335209;Glycolysis
C0011306;C-C Chemokine Receptor Type 4 human
C1515089;Pancreaticoduodenectomy
C0013969;Emergency operation
C0037910;Tumeric
C0011307;Prophylactic treatment
C1553323;Cambodians
C0012634;Lethal
C2004041;silence
C0068008;Disease
C0025919;Mice Inbred BALB C
C0001948;Communicable Diseases
C0000618;Acids
C1539093;Colorectal Neoplasms
C0025914;ING1 gene
C1540089;TSPAN9 gene
C1540085;Cessation of life
C0999806;Persons
C0999807;Human papillomavirus 18
C0037907;Rectal Carcinoma
C1567966;Aryl Hydrocarbon Receptor
C0037906;Lipids
C0516792;Operative Surgical Procedures
C1539087;Pharmaceutical Preparations
C0037900;sphingosine kinase-1
C0013936;Gene Family
C0013935;QPCT wt Allele
C1336528;Vagina
C0013930;Embolism Tumor
C0013931;Splenomegaly
C3272903;Tucatinib
C0527443;Autophagy
C0334302;Stomach
C2987738;Vegan
C1540079;Metabolism
C0025921;Mice Inbred C57BL
C0072980;Malignant neoplasm of hepatic flexure of colon
C0070320;Stat3 Signaling Pathway
C0454156;Patients
C0334306;Cohort
C0334307;Woman
C1336515;Infiltration
C3887946;Cultured Cell Line
C0012611;Gastrointestinal Diseases
C1540061;Multiple tumors
C0001963;Propolis
C2004062;Control Groups
C1540063;STAT3 gene
C0001962;Colonic Neoplasms
C0262374;Male population group
C0071687;Malignant Neoplasms
C1553373;Ecuadorian
C0070358;Neurons
C3887958;Dioxygenases
C3536909;Apolipoprotein E
C0442158;Erythema
C1540054;Phosphorylation
C2987716;Intestinal Microbiome
C1540056;Ubiquitination
C3899947;Did not receive therapy or drug for
C0262361;Growth abnormality
C4235517;autophagosome organization
C1553362;Catalonian
C0013922;Left lung
C1539079;Carcinogenesis
C0264939;Disease
C0852077;early detection of colorectal cancer
C0310367;Plant Roots
C0001904;Malignant neoplasm of duodenum
C0564439;Ergocalciferol
C0227998;Malaise
C0225334;Implantation procedure
C0225337;Columnar epithelium
C0225336;Blood supply aspects
C0240962;Male population group
C0564436;Colorectal Carcinoma
C0877373;Malnutrition
C1179435;Caveolae
C0202691;Lesion
C1325834;Variation (Genetics)
C0541791;Intestines
C0225339;Anus
C0225338;Columnar epithelial cell
C0238644;Transverse colon
C0225340;Anus
C0225342;Vagina
C1517648;K-ras Oncogene
C1516317;Cauliflower-Like Mass
C0239981;Anastomotic Leak
C1517649;Asians
C0069389;Toxin
C0013900;cyclin A2
C0237326;Male population group
C1142163;Small bowel obstruction
C3897380;biological radiation resistance
C3897381;Serum
C0577749;Cancer Cell Growth
C0239984;Patients
C0056080;Malignant tumor of colon
C0001924;Prealbumin
C1155494;Estrogen Receptors
C0227970;Structure of lobe of prostate
C0225317;Reconstructive Surgical Procedures
C1142173;Tumor swelling
C2248778;Equilibrium
C0238637;Operative Surgical Procedures
C4331219;Sarcopenia
C2248760;Tumor cells malignant
C0225326;Intestinal Microbiome
C1698484;Vaccination
C0001911;PRKAA1 wt Allele
C0225325;Detection
C1516334;Cell Proliferation
C0564461;Sunlight
C0565793;Colorectal Carcinoma
C0178487;Antioxidants
C1516337;Cell Cycle
C0180799;Colorectal Carcinoma
C1142182;Finding of body mass index
C3886682;Endoplasmic Reticulum Stress
C0852035;CTCAE Grade 3 Hypertension
C1456380;mitogen-activated protein kinase p38
C4319504;Superior margin
C1456389;PLA2G12B gene
C2926735;Anxiety symptoms
C0949541;Adrenal Glands
C0179784;Patients
C1516369;Malignant tumor of colon
C0238686;Patients
C1167402;Non-squamous epithelial cell
C0192751;Anastomotic Leak
C1961537;Absorbable suture
C0179799;Condoms Male
C0192755;Patients
C0192754;Slow transit constipation
C0248007;B-Cell Lymphoma 6 Protein
C1528365;FITC-annexin A5
C0877341;Cancer Patient
C3670817;Cecal mass
C3897342;postoperative analgesia
C1516353;Cell Mobility
C0238697;Coffin-Siris syndrome
C0853389;Transversus Abdominis Plane Block
C0564418;Colorectal Carcinoma
C0192742;Duodenojejunostomy
C0225358;Necrosis
C0225355;Anus
C1155452;NOTCH1 gene
C1179412;plakoglobin
C0600597;Oligonucleotide Arrays
C0225360;Glycolysis
C0936223;Rectal examination
C0564428;Folate intake
C1456377;Growth
C1706406;Intussusception
C3670832;Cancer Patient
C3670831;Mass of mesentery
C0577725;Male population group
C0948209;Neoplasms
C1516373;Cellular Stress
C0854776;Pharmacotherapy
C0142580;Patients
C0854778;CD69 protein human
C0815172;patient characteristics
C0178539;Cellular
C1431046;Colorectal Carcinoma
C1456349;Phosphorylation
C3813707;Neoplasms
C0599155;Cystic Fibrosis
C0877425;Head
C0878751;late pregnancy
C0600688;Stomach Carcinoma
C1420393;Mesentery
C1420392;Patients
C0600680;Transcription Genetic
C1705192;Peritoneum
C0192817;Delirium Dementia Amnestic Cognitive Disorders
C0383327;Biological Processes
C0035298;Homo sapiens
C0178523;Kidney
C2248809;Patients
C0406457;Autoimmune Diseases
C1276413;Locally Advanced Malignant Neoplasm
C0238605;South African
C0238607;AIDS patient
C4331229;Adenocarcinoma of large intestine
C0239937;Male population group
C0227952;Mesenteric Arteries
C0842749;HTATIP wt Allele
C1420343;Mus
C0240919;Persons
C1420357;SPHK1 gene
C0035273;Operative Surgical Procedures
C0239946;Cholangiocarcinoma
C0215955;Oxygen
C0611285;Carcinoma
C1155389;fibroblast growth factor receptor signaling pathway
C0647210;Pneumoperitoneum
C0252902;Accumulation
C1517722;Situs ambiguus
C3849701;Diarrhea
C0166524;sinapinic acid
C1420369;Cytoplasm
C1420368;Germ-Line Mutation
C0854750;Metastatic Malignant Testicular Germ Cell Tumor
C1419373;Immune System Diseases
C4331246;Pathologic Complete Response
C0179800;Urethral Catheters
C1419379;Animal Model
C0815189;Cohort
C1420362;PRSS8 protein human
C1720782;Liposomes
C1420365;Cancer-Associated Fibroblasts
C0036581;Injury of liver
C0600627;Catenins
C1419388;Patients
C1085943;Polysaccharides
C1180347;Argonaute Proteins
C0035258;Colectomy
C0036572;Italians
C1421638;caspase-7
C0035243;Fatigue
C2718059;Solid carcinoma
C0333002;Body Parts - Canal
C0600615;Pharmaceutical Preparations
C0333000;Enterogenous cyst
C3812452;Neoplasms
C2936179;CD69 protein human
C0024586;Neuroendocrine Tumors
C0347646;Colitis
C1275122;Secondary malignant neoplasm of lung
C3620627;Bacteroidetes
C1420315;SOS2 gene
C1420314;PAWR gene
C0444793;Hemicolectomy
C0334342;Mucinous metaplasia
C0036563;Euphorbia lathyris
C1420317;GATA3 gene
C0334346;Anal Sacs
C3811114;High Level
C0023269;Sarcoma
C4078326;Dextran Sulfate Sodium
C1265799;Massive embolus
C0023263;Mucuna
C0454111;Malignant neoplasm of vulva
C0600600;BET1L gene
C0359627;Colorectal Carcinoma
C0443469;Small intestine contents
C0334357;Spleen
C0012582;Combined Modality Therapy
C0333027;Microlithiasis
C2986418;Fatty Acids Volatile
C1419330;Gene Silencing
C0358321;Anti-Antibodies
C2718080;Survivors
C0104203;neutrophil
C2706046;Palpable mass
C1420322;Colorectal Cancer
C0037871;Natural Killer Cells
C1419349;RFC2 gene
C0334368;Gallbladder
C0443442;Colorectal Carcinoma
C0131875;CXCL1 protein human
C1335280;Dephosphorylation
C2986423;Mus
C0442115;Neoplastic Cell
C1420331;Stem cells
C1335278;Patients
C2718019;Drug Packaging
C0744369;Anus
C0419786;Surgical Wound Infection
C0023216;Varicosity
C0025879;Mevalonic Acid
C1335273;Oxidative Phosphorylation
C1335271;PTGS1 gene
C0334371;Salivary Glands
C0334372;Pancreas
C0025872;Ulcer
C0601900;Periampullary Adenocarcinoma
C0035203;Crypt
C0035204;Respiration Disorders
C0334385;Inflammatory carcinoma
C1335267;Male population group
C1335262;PRKDC gene
C3536832;SUPPLY NOT OTHERWISE SPECIFIED
C0001899;Alanine Transaminase
C0333056;colonoscopy
C0001898;Cyanobacteria
C0396621;Deep Sedation
C4525742;cancer therapy
C0384648;Patients
C0444757;Water soluble contrast medium
C0347697;Control Groups
C0684249;Bypass Surgery
C0333062;Hernia sac
C0299583;Malignant neoplasm of gallbladder
C0024525;Present
C0025859;Adrenergic beta-Antagonists
C0599161;Monensin
C2985123;TFF3 gene
C0733688;Etoposide
C0013879;Carcinogenesis
C2744325;Persons
C0815107;Depressive disorder
C4513755;Thickened
C0744333;Papilloma
C1419308;RBMX gene
C1826201;Colorectal Carcinoma
C0023206;Immune response
C1675748;1-(4-((4-(dimethylamino)piperidin-1-yl)carbonyl)phenyl)-3-(4-(46-dimorpholin-4-yl-135-triazin-2-yl)phenyl)urea
C0731033;Patients
C0024530;Malignant Neoplasms
C0672250;Small intestine carcinoma
C0036503;Malignant Neoplasms
C1335249;MicroRNA 19B
C0444263;Healthy Volunteers
C0193373;Biliary Tract Cancer
C0034790;Clone Cells
C0227230;Macrophage Activation Syndrome
C0229890;Anabolism
C0019158;glyphosate
C1419959;Cysteine
C0007177;tomography
C0019156;Hepatic Veno-Occlusive Disease
C0019155;Structure of hepatic vein
C0019151;Patients
C3849574;USP10 gene
C0949466;RNA
C1831742;Patients
C0032134;Patients
C1831741;Pharmacotherapy
C0032136;Sf9 Cells
C1420952;Signal Transduction Pathways
C1831738;Persons
C2745948;capecitabine
C1334497;Non-Small Cell Lung Carcinoma
C0746730;Cancer Patient
C0034782;Receptor-Mediated Signal Transduction
C1831735;high-risk group
C0032120;Patients
C0019169;Microorganism
C0034783;Signal Transduction Pathways
C0019168;Transplanted tissue
C1334492;Ectopic Gene Expression
C1334490;Protein Subunits
C0019163;CATHEPSIN D
C1418630;ASCL2 gene
C0699893;Inflammatory Bowel Diseases
C1095592;caffeic acid
C2984300;Insulin/Insulin Receptor Signaling Pathway
C0021485;Tube feeding of patient
C1369136;First line treatment
C0034786;Colorectal Carcinoma
C1155748;Cell Death
C0278838;Irreversible Electroporation
C0019139;Anticoagulants
C3887874;Anterior chamber angle tumor
C3887875;Visual field defects
C0019134;Blood Vessel
C0008487;MTOR gene
C0008489;valbenazine
C0699889;Brachytherapy
C0266811;Patients
C1418641;Tumor Microenvironment
C0699885;Complete cystectomy
C0242853;Family
C0950430;Metalloproteases
C0032112;B-Lymphocytes
C0444255;Venous blood specimen
C1334477;histone deacetylase 6
C0230871;Wound Healing
C0278851;BRAF gene
C0936147;Nutritional status
C0034760;Assay
C0266808;Chronic gastrointestinal hemorrhage
C1334474;AKR1A1 wt Allele
C0008497;Metaplasia
C0032100;Cathepsins B
C1334470;Accumulation
C0019144;Stage IV Colon Carcinoma
C0289507;Antioxidant Effect
C0019143;Bone Marrow-Derived Cell
C0229889;Lymphangioma
C0227226;Gastrointestinal Stromal Tumors
C0227224;Thickened
C1418652;Warburg Effect
C1418653;Genomic Instability
C0022790;ovarian neoplasm
C0242842;Cell Count
C0242844;Abdomen
C0733413;Meprin
C3178960;LRP6 gene
C0242849;Ultracentrifugation
C0032105;Endotoxins
C0458892;Squamous cell carcinoma
C0277524;TNF receptor-associated factor 6
C0227276;Stem cells
C0021439;irinotecan liposomal
C0007130;Perianal fistula
C0019116;G-Protein-Coupled Receptors
C0007131;Malignant neoplasm of thorax
C0019113;Stroma
C0007133;Carcinoma Papillary
C0007134;Urologic Neoplasms
C0019112;Ligation
C0008466;Tissue specific
C0007135;Ascending colon
C0007137;general population
C0007138;Genitourinary Neoplasms
C0021436;Infusion Pump
C1155711;Stem Cell Self-Renewal
C0180022;Detection
C1831786;Solid Neoplasm
C1831784;Malignant tumor of colon
C1334468;activin A
C0227286;Lipids
C0020119;Human Development
C0007140;Pelvis
C1419924;SEC22B gene
C4304118;Advanced Adult Hepatocellular Carcinoma
C1660642;Neoplastic Cell Transformation
C0007144;Multiple polyps
C0008479;Pharmaceutical Preparations
C0021440;Patients
C3887824;Lesion
C0033413;DCBLD1 gene
C1334459;Lymphatic Spread
C0010798;Cytochrome P450
C1333112;SATB2 gene
C1418600;Malignant Neoplasms
C1333114;Transanal Excision
C0010760;Mitochondria
C1418605;PKHD1 gene
C1333110;Colorectal High Grade Intraepithelial Neoplasia
C1309483;Ribonuclease III
C0007112;Epithelium
C0007113;Graft acceptance
C0007114;Persons
C0007115;Large Cell Lung Neuroendocrine Carcinoma
C0240225;Liver carcinoma
C0007117;Basal Cell Nevus Syndrome
C0227258;Pancreatic lipase
C0061516;Glutathione Disulfide
C3178914;Curcumin
C0074830;Somatostatin analog
C0278803;Italians
C0010763;Neoplastic Cell Transformation
C0278802;Patients
C0010762;Pharmaceutical Preparations
C0278804;Small intestine carcinoma
C2610186;SRSF2 gene
C1333115;Endoscopic biopsy
C1418610;Replication Origin
C0009780;Connective Tissue
C1335760;Resected Mass
C1419946;Hypersensitivity
C0007121;Survivors
C0007124;Mammary Neoplasms
C0227268;Matrix
C1321139;Study
C0007129;Liver
C0086808;Growth Factor
C2732618;Medical pathologist
C1321132;Steroids
C2984323;Signal Transduction
C4296896;Patients
C0074825;Insulin-Like Growth Factor Binding Protein 3
C1334435;Luc Gene
C0169661;PPDPF gene
C0022727;Pneumonia
C0529793;HMOX1 gene
C0009753;Study
C0156347;Endoscopic Ultrasound-Guided Fine Needle Aspiration
C1321107;Patients
C0878585;1 - 3
C0170657;Serotonin
C0022722;Immunotherapy
C0009758;Squamous cell carcinoma
C0034716;Rats Wistar
C0010749;TIPARP gene
C1513178;Metastasis Suppression
C3897254;Diagnostic tests
C0229815;External iliac lymph node group
C0205847;Childhood Hepatocellular Carcinoma
C1853135;Cessation of life
C0600290;Dehydration
C0034715;Rats Sprague-Dawley
C1334424;Patients
C1334425;Poorly differentiated carcinoma
C1334411;Locally Metastatic Malignant Neoplasm
C1310468;Patients
C0205832;Metastatic Carcinoma
C0061542;Obesity
C0007102;Relative (related person)
C0007103;Persons
C0007104;Unmarried person
C0022735;follow-up
C0007107;Patients
C0171998;noggin
C0021403;Endoscopy (procedure)
C0398686;Chronic granulomatous disease
C1828173;Symptoms
C2936623;Immunoprecipitation
C0182638;Radiopharmaceuticals
C0770460;Cessation of life
C2936622;Tumor Burden
C0183964;Gastrointestinal Neoplasms
C2936626;Cancer Cell Growth
C0034703;Rats Inbred F344
C1550101;cytokine
C0203201;Third lumbar vertebra
C4330475;LAG3 gene
C0022702;Kinetics
C0008405;Carcinogens
C0398650;Inflammatory Bowel Diseases
C0216510;Phosphotransferases
C1817498;Family
C1335737;cancer therapy
C1334407;Prostate
C0010723;Mouse Model
C1550100;Cohort
C1539782;HIGD1A gene
C1538453;CHKB gene
C0183956;Patients
C2936637;Patients
C0877248;Persons
C0060231;RNA Messenger
C0229800;Metastatic Lesion
C0399997;Appendicitis
C0565434;Laparoscopic total cystectomy
C0183941;Patients
C0229807;Secondary Neoplasm
C0600269;Oncologists
C1513183;penis
C0059249;annexin A5
C1539791;IMPACT gene
C1419906;TNFRSF11A protein human
C1335729;Monoclonal Gammapathies
C0169658;Neuroblastoma
C1831796;Lymphangiectasis Intestinal
C2936643;Did not receive therapy or drug for
C3274817;Patients
C0230840;Inner mitochondrial membrane
C0768176;Abnormality of mitochondrial metabolism
C0085542;Hydroxymethylglutaryl-CoA Reductase Inhibitors
C0060240;Immunostimulating conjugate (antigen)
C1867743;Metabolic Diseases
C3489483;Gadoxetic acid
C0010709;Polycystic Kidney Autosomal Dominant
C0010707;Bladder Neoplasm
C4018878;Gastrointestinal Microbiome
C0010702;Bladder Neoplasm
C0086860;CYP1A1 protein human
C0085532;Stenosis
C0085533;High risk of
C0085536;Protein Tyrosine Phosphatase
C0085537;Caregiver
C2986924;schisantherin A
C1155780;Mitosis
C2609147;Pharmacotherapy
C0242821;Cells
C1155789;nuclear division
C0254803;Malignant tumor of colon
C0060264;fludarabine
C1142499;erlotinib
C0230825;Multivesicular body
C1538499;Genes
C3898565;Tumor Lysis Syndrome
C1167791;Doxycycline
C4018859;Massive hemorrhage
C0086890;Non-Small Cell Lung Carcinoma
C2609129;Acute inflammation
C1310406;Acclimatization
C0085559;intensive care
C0205890;Rupture
C0230839;Translocase
C0073571;Obstruction
C0456276;Transverse incision
C0600228;Male population group
C1879736;Hemorrhagic proctitis
C4329454;Persons
C0085584;Beriberi
C0118111;Family
C2188405;removal technique
C0878627;Mucosal neuromas
C0854652;Proton Therapy
C0360105;Family history
C0815047;Pathologic Neovascularization
C0600334;Tumor cells uncertain whether benign or malignant
C1710648;TLR4 gene
C0815043;Organism
C0815045;Storage proteins
C0347129;Persons
C2827459;Neoplasms
C0085580;Hypertensive disease
C0060282;Patients
C1275631;Macrophage Activation Syndrome
C0119452;Body tissue
C0073590;Pentalogy of Cantrell
C0073591;Glutathione
C3814904;Tumor Progression
C1514534;Mass Spectrometry
C0060291;Endothelial Cells
C0914700;Malignant neoplasm of lung
C0118134;Membrane Potential Mitochondrial
C2754092;Oxidative Demethylation
C1552809;Study
C3813609;Anastomotic Leak
C2827433;Protein complex
C1708335;Blood specimen
C0422813;Clinical function
C1514560;Chemicals
C1708350;Chemotherapy Adjuvant
C3489579;Tissue Microarray Analysis
C1514559;DPYSL3 gene
C1515884;Chronic disease
C3489575;Tube feeding of patient
C1539835;Adenosine Phosphosulfate
C0085590;Patients
C0084261;Malignant neoplasm of stomach
C0120465;KRAS gene
C0085593;Woman
C1961006;Recent weight loss
C0554794;Participant
C3274777;Liver
C1865043;TFF3 gene
C3274775;Mildly Abnormal Ejection Fraction
C0288148;solute carrier family 11- (proton-coupled divalent metal ion transporters) member 2
C1539887;Infiltration
C1538557;OXCT1 gene
C1710602;Patients
C0815089;Adenocarcinoma of large intestine
C1948023;Stimulation (motivation)
C2126192;Woman
C1709603;post surgery radiation therapy
C3491856;Diffuse Large B-Cell Lymphoma
C3272108;PERIANAL condyloma acuminata
C1274347;Bacterial cellulitis
C1880662;Patients
C1880660;cetuximab
C1538561;Patients
C2936719;Mechanical Allodynia
C0312443;Patients
C1865068;Genes
C1709627;Prognosis bad
C0398730;Phagocytic cell defect
C1538532;mRNA Expression
C1710625;Blood Vessel
C1513276;Neoplasm Micrometastasis
C0205824;liposarcoma
C1539862;ST3GAL4 gene
C3825618;Challenge
C2827483;Cohort
C1513266;Microbial Physiology
C2827486;Patients
C1539878;Tumor Immunity
C3715044;envelope
C1513269;Microcyst
C0288171;Immune response
C0032098;FAT1 gene
C1417250;Mutation
C1418581;T-Lymphocyte
C0239181;Disease
C0349707;Aspiration-action
C3838965;Patients
C3826972;Patients
C0032082;Plant Growth Regulators
C1418591;Memory impairment
C0699819;Gut
C1261074;Macrophage Activation Syndrome
C1418596;Lipopolysaccharides
C0032081;Agent
C1261076;Adenocarcinoma
C0699810;age differences
C0264122;Endoscopic Submucosal Dissection
C1261077;Macrophage Activation Syndrome
C0239182;Patients
C0276138;Viral myocarditis
C3838947;Patients
C0806957;Urinary tract infection
C0227188;Neoplasms
C1443559;PTPRF gene
C4510392;Tamoxifen therapy
C2755352;DNA Demethylation
C0746674;Male population group
C3826981;Main Duct Pancreatic Intraductal Papillary-Mucinous Neoplasm
C0948089;Cancer Patient
C0007093;Carcinoid Tumor
C1418544;Adenocarcinoma of large intestine
C1420865;RNF168 gene
C1419876;Mucous Membrane
C0007095;general population
C3812373;Somatostatin-Secreting Cells
C0033382;Proline
C1417216;multiple pathologies
C0007097;Mice Nude
C0252194;Colorectal Carcinoma
C0007099;Esophagus
C0019079;Symptoms
C0815004;Ganglioneuroma
C0021390;Italians
C0019080;Injury of intestine
C0374711;Patients
C1539803;neuronal
C1456828;HSF4 gene
C0422837;Neurological observations
C0278751;localized malignant mesothelioma
C0032042;High-Risk Cancer
C1710670;Ovarian cancer disseminated
C1418552;Long Term Survivorship
C0265493;Malignant Neoplasms
C2827421;Construct
C1431519;ZNF750 gene
C0033377;removal technique
C1420871;Lysine
C3812393;ERBB3 Receptor Protein-Tyrosine Kinase
C1719039;Manometry
C1333196;Severe Acute Respiratory Syndrome
C1417239;MPG gene
C0034693;Fc Receptor
C0193398;Liver Mucosa-Associated Lymphoid Tissue Lymphoma
C1333198;FOXO3 gene
C0007078;carbuncle
C0021376;Mucinous metaplasia
C1419892;Tumor Cell Invasion
C4054465;Solid Neoplasm
C1333190;Pancreas
C1419895;Malignant Neoplasms
C1998319;Hepatic
C1514521;DNA
C1431543;Neoplasms
C4042483;Bcl-2-Like Protein 11 human
C0179084;Anoscope
C1417246;Patients
C0007082;Stage IV Colorectal Cancer
C0337795;Austrians
C0806987;Spleen
C0686521;Benign neoplasm of paraganglion
C1417249;hepcidin
C0337799;Czech
C4054479;Liquid Biopsy
C0193388;Liver diseases
C0019069;Blood Coagulation Disorders
C0046666;23-seleno-25-homotaurocholic acid
C1418571;Conventional (Clear Cell) Renal Cell Carcinoma
C0019065;Pancreatic Fistula
C1417244;Anastomotic Leak
C1418576;Body tissue
C1515844;rhein
C4521000;Patients
C0007090;Functional disorder of intestine
C1333299;Patients
C0227353;Aspartate
C3657629;Neoplasms
C0022688;TNFRSF9 gene
C0022686;Apoptosis
C0020025;Diagnosis
C0020028;Teaching Hospitals
C0020027;Hospitals University
C0021358;Oncogenes
C0240320;medication use
C0021359;Interventional procedure
C0020029;colonoscopy
C1155631;Chromosome Condensation
C0242994;Paraffin Embedded Tissue
C1155632;Diastasis
C0020022;colonoscopy
C0034678;Cultured Cell Line
C0034677;Carcinogenesis
C0238003;Epithelioma
C0032019;Colorectal Carcinoma
C0746852;neuroendocrine cell cancer
C0746857;Patients
C0032000;Benign Neoplasm
C0032001;Acromegaly
C0240339;Plants
C0019046;Patients
C0021367;Therapeutic immunosuppression
C0007068;Curcumin
C0021368;multiple pathologies
C1333282;Hydrolysis
C3824143;proteasome complex disassembly
C0179199;Neoplasms
C4284739;Cessation of life
C1622204;AKR1A1 wt Allele
C1817569;Stem cells
C1549092;Ceramide Glucosyltransferase human
C0020030;Study
C0241657;Hemorrhage
C0457468;Lumbar spinal ganglion
C0032002;Pituitary Diseases
C0034665;HSP90AA1 gene
C0033333;Cancer Vaccines
C3812195;Colorectal Carcinoma
C0229992;Patients
C1880814;AES gene
C0019018;NF2 gene
C0936012;TCEA1 gene
C0684030;Immune System Processes
C0010682;Cystine
C0007033;Homo sapiens
C4054667;Colonic Neoplasms
C4282114;Small bowel bacterial overgrowth syndrome
C0022665;Liver
C4054664;Patients
C0019010;Hemodynamics
C0020006;Analysis
C1418761;Colon structure (body structure)
C4546318;Patients
C0227335;Gland
C0020008;Biometry
C0242972;MTUS1 gene
C0457431;Cohort
C0022661;Stereotactic Body Radiotherapy
C0179167;ASPIRATOR ULTRASONIC
C0022660;Renal function
C2697654;IL17RE gene
C0033325;Magnetic Resonance Imaging
C0034656;Pharmacotherapy
C0008370;Hypercholesterolemia
C1418776;TCFL5 gene
C0008372;Neoplasm Metastasis
C1167622;Stabilization
C0019029;Kidney Failure Acute
C1418779;Mitochondria
C0266929;Patients
C0240318;Patients
C1120972;GW 6471
C0227349;WNK1 gene
C0020013;Hospitals
C0008377;Colonic Neoplasms
C0022677;Kidney Tubules Proximal
C0020012;Retrospective Studies
C0021344;Anal warts
C0227348;Liver
C0242961;epidermal growth factor receptor signaling pathway
C0457447;Anastomosis of intestine large-to-anus
C3898410;PPP2R5E gene
C0242966;Malignant tumor of colon
C0022671;Kidney Failure
C4317559;World
C2697666;Early Diagnosis
C0035976;CATALASE
C0035973;Particle
C0948008;Dyspnea
C0202098;Acromegaly
C0011991;Gastrointestinal Diseases
C0227395;Metastatic melanoma
C0062941;Myeloid Leukemia Chronic
C0009671;Malignant Neoplasms
C0008340;Complication
C0771627;Malignant tumor of colon
C0227391;Large Mass
C0008342;Malignant Biliary Obstruction
C0936077;Patients
C1285092;TFF1 protein human
C0009676;Medical pathologist
C0023977;Negative
C0227398;Dissecting hemorrhage
C0046616;Protein Kinase C
C0022646;Cystadenocarcinoma Mucinous
C0033308;Colon Carcinoma
C0086908;Repetitive Region
C1394254;Anus
C0278907;Intractable diarrhea
C0035962;Rural Population
C0073603;Colorectal Carcinoma
C0034633;Adoptive Immunotherapy
C0011993;Tumor Burden
C0010668;Atypical hyperplasia
C0202087;Immunoblotting
C0008350;Cholangiocarcinoma
C0719214;Disease
C0035950;Ruminants
C1418715;Colonic Neoplasms
C1333242;Enzymes
C0007022;Cirrhosis
C0023985;Endoscopic dilatation
C0061622;Glycocalyx
C0008357;Vaccines
C0948075;Male population group
C0007028;Scientific Study
C0022658;Patients
C0023981;Hospitals Cancer
C0181464;Needle knife
C0035953;Patients
C0010674;Persons
C2983134;Federation of Gynecology and Obstetrics
C0181467;Staple Surgical
C0338908;Mus
C0050975;Neoplastic Cell Transformation
C0034624;recurrent cervical cancer
C0227375;Varicosity
C1308278;Quantitative Reverse Transcriptase PCR
C1418724;Adverse reactions
C1335892;mRNA Expression
C0086930;mercaptopurine/methotrexate/vincristine
C0795617;Cell Proliferation
C0008320;Colorectal Neoplasms
C1418727;Patients
C0086934;DHX58 gene
C0009653;Acute colitis
C0008325;Finding of body mass index
C0085605;Multiple Organ Failure
C0684072;albino rat
C0022625;Pharmaceutical Preparations
C0008328;Peptides
C0949366;Colorectal Carcinoma
C1418729;Colorectal Neoplasms
C0251006;protein expression
C1333237;DNA Repair-Deficiency
C0936060;JUN kinase activity
C0062970;Mus
C0227385;Adenocarcinoma
C0227386;Varicosity
C0011980;Hernia
C0021308;Infarction
C1418735;Woman
C0684063;Eukaryota
C0009663;Front of neck
C0007004;Moringa oleifera leaf extract
C0022631;Persons
C0457406;Hinge (physical object)
C0193425;Reconstructive Surgical Procedures
C0227389;Large Mass
C0007007;Growth
C0227387;Colon Carcinoma
C0007009;Liquid Chromatography
C0227388;Phlebitis
C0034606;Relative (related person)
C0238033;Patients
C0180112;Pharmaceutical Preparations
C0010654;Taurine
C0010651;Early complication
C0010658;Patients
C0034603;Evaluation
C0010656;TNF-related apoptosis-inducing ligand
C0940933;Surgeon
C1335875;YTHDF2 gene
C1335872;Myeloid-Derived Suppressor Cells
C0385242;JUN kinase activity
C0940937;Diagnosis Noninvasive
C0060323;Thromboembolism
C0314961;Malignant neoplasm of urinary bladder
C1551338;Entity
C0179108;Brachytherapy
C0008307;Evaluation
C0769345;caspase-5
C1537028;Relative (related person)
C0010626;Presacral space
C0203306;Intraoperative echography
C0204636;Patients
C1333218;Stage III Colon Cancer
C0205969;Adenocarcinoma
C1333214;Neoplastic Cell Transformation
C1335876;Neuroblastoma
C1334532;MSH6 gene
C0085610;Sinus bradycardia
C0008310;Biliary stricture
C0008312;Autoimmune Diseases
C0008311;Sarcoidosis
C0022614;Pain Intractable
C0008318;Immune response
C3489393;Malignant neoplasm of stomach
C3874484;Anti-Inflammatory Agents
C3898473;Interventional procedure
C0242903;Pharmaceutical Preparations
C1333203;Mutation
C1333206;Brain Neoplasms
C1513041;Patients
C1335850;FOXP3 gene
C1540661;cell fate
C0023911;Transplantation
C0074992;Superficial ulcer
C0010606;Organoids
C1710701;YES1 wt Allele
C1709707;Proportion
C1710706;Cancer-Associated Fibroblasts
C0539219;PPP6C protein human
C1622271;neutrophil degranulation
C1335858;DNA
C0011933;Subgroup A Nepoviruses
C1310550;CST9 gene
C0023928;Birth
C1334510;melanoma
C1335841;SMARCA4 gene
C3274902;Neoplasms
C0553576;Systemic mycosis
C1335840;other medicated shampoos in ATC
C0194710;Disease
C0086965;Long Term Survivorship
C0086969;cancer therapy
C0085639;Metastasectomy
C0600388;Phosphatidylethanolamine Binding Protein
C0301630;Reduction (chemical)
C0625700;Autophagy
C0194708;Excision of inguinal lymph nodes group
C0167117;Mus
C2935436;HER2-positive carcinoma of breast
C0530870;Pharmaceutical Preparations
C1096745;Ergocalciferol
C1335843;SMARCA2 gene
C1334512;Patients
C0202010;Laboratory Procedures
C1879848;Biomedicine
C0940978;Syndrome
C0085668;Mus
C0085669;Leukemia Myelocytic Acute
C0227317;Intraepithelial Neoplasia
C0060369;Growth
C2609259;Detection
C0912024;Anisomycin
C1096776;Ambulatory Care Facilities
C1155676;Cell Cycle Progression
C0242957;Extracellular Signal Regulated Kinases
C1513095;Genes Regulator
C1334508;Epithelial proliferation
C0145779;Malignant neoplasm of breast
C0554836;Malignant neoplasm of lung
C0011911;Syndrome
C1335837;Glycolysis
C0554837;Patients
C0949307;sample fixation
C0795674;Liver carcinoma
C0314924;Bacteroides thetaiotaomicron
C2935448;colon growth
C0085652;Dermatologic disorders
C0023903;Mice Nude
C0086982;Eukaryotic Cells
C0085653;Cohort
C0060375;fibromodulin
C0023907;Liver Regeneration
C0227327;Thickened
C1308226;SDHB protein human
C0058056;Gastrointestinal Motility
C0229985;Vitality
C0023901;angiogram
C1155661;durvalumab
C0227322;Patients
C0539266;Malignant neoplasm of gastrointestinal tract
C0011929;Physical and emotional exhaustion state
C0168424;Tumor Suppressor Genes
C0011923;Metastatic Lesion
C0302912;Bile duct carcinoma
C0071042;Patients
C0795692;Lactates
C0242937;Surgeon
C1335812;Neoplasm Metastasis
C0242939;Colorectal Cancer pT1 TNM Finding v6 and v7
C1537044;protein activity
C1853237;Patients
C0084340;Carcinogenesis
C0085672;Negative
C3274946;Decedent
C0060397;Chloroquine
C0854467;Fluorouracil
C0085678;Obstruction
C0227306;Duodenum
C4284724;Secondary malignant neoplasm of lymph node
C0227300;Macrophage Activation Syndrome
C0011906;Indicators
C3260303;colonoscopy
C0011905;Colonic Polyps
C0227308;CCL2 protein human
C3260300;Adenoma dysplasia
C0011900;Abnormality
C1335804;Pharmaceutical Preparations
C0638953;oxaliplatin
C0878500;Vaginal intraepithelial neoplasia
C0854532;Lethal
C1709771;Primary Carcinoma
C1514428;Cytoreductive Surgery
C0058087;Neoplastic Cell Transformation
C1708438;Woman
C0600457;Decidua
C0347001;Rectal mucous membrane
C1527755;Carcinogenesis
C0085694;Cholelithiasis
C0085695;Chronic gastritis
C1527752;Receptors Tumor Necrosis Factor Member 10b
C1709780;Gallbladder
C0878517;T-Lymphocyte
C0399935;Patients
C0600449;Biosynthetic Pathways
C0347011;Patients
C4476917;Chemotherapy Adjuvant
C3538813;Klinefelter Syndrome
C0347016;Patients
C0083032;Interleukin 7 Receptor
C0349672;Low dose rate brachytherapy
C0083031;cytokine
C1708460;Iatrogenic Lesion
C0805586;Community
C1275743;Alopecia
C0600438;Weakness
C0132555;Nitric Oxide Synthase
C1263762;Neoplasms
C0205903;Program
C0205908;Patients
C1707128;CHEK1 wt Allele
C0347023;Operative Surgical Procedures
C1009574;MBD4 gene
C1539711;Homo sapiens
C0600420;Proxy
C1708464;Magnetic Resonance Imaging
C0553580;Sarcoma
C1311906;Angiogenesis Inhibitors
C3538862;Pharmaceutical Preparations
C0699900;bergenin
C2827382;Protein Biosynthesis
C1453024;Chronic Obstructive Airway Disease
C0373345;Prostate
C1539765;Neoplastic Cell Transformation
C3538869;Multiple tumors
C0577559;Abdomen
C0348374;vinyltriethoxysilane
C1262481;Eosinophilic gastroenteritis
C0071095;pinocembrin
C0071097;Mus
C4018909;Patients
C0385333;Tumor tissue sample
C0205944;Sarcoma
C0663937;TSC1 protein human
C1428093;DOCK10 gene
C0132513;Pharmaceutical Preparations
C0132515;Esophagus
C1262471;Substance administration
C1539745;Body tissue
C1262477;Basis
C0205945;Canis familiaris
C0854519;Malnutrition
C0325628;Meleagris gallopavo
C0744176;Patients
C2827365;Toxic effect
C1514474;Rectal Neuroendocrine Neoplasm
C1275771;Salmonella enterica subsp. salamae
C1539750;Hepatocarcinogenesis
C3812213;Secondary Neoplasm
C0805525;Membrane
C1697746;Rectal Obstruction
C1428025;Colonic epithelium
C1428023;Colorectal Cancer
C3826857;CISH protein human
C3825521;primary tumor
C4282042;Stage III Colon Cancer
C1119921;Protein Component
C1658122;Mitosis
C3814864;colon growth
C2744579;Protoplasm
C0276264;Sexually Transmitted Diseases
C0227296;Adenosquamous carcinoma
C0227292;Infiltration
C1417395;TP53 gene
C0745472;jaundice painless
C1453005;Chitosan
C0686619;Stage III Colon Cancer
C0277599;Multiple Organ Failure
C1119918;Mental disorders
C0699919;Plants Medicinal
C3813556;Hypomethylation
C0699918;Elastases
C3272283;Advanced adenomas
C4078586;SR9243
C3272281;disorder control (procedure)
C0732165;Carcinoid syndrome diarrhea
C2984480;POU5F1 protein human
C3887804;Persons
C1417334;Radiation
C1416001;Intestines Small
C0033262;Lyase
C0034595;Radioisotopes
C2697752;Accumulation
C0045246;22'-azino-di-(3-ethylbenzothiazoline)-6-sulfonic acid
C1419991;METTL3 gene
C1419992;Discrepancy
C3838887;Retrospective Studies
C1419994;SRSF3 gene
C0021270;Infant
C0684017;Colorectal Carcinoma
C0684004;Secondary Neoplasm
C0033251;Proctoscopy
C1383501;Phosphoproteins
C0021289;Infection
C0745442;Pharmacotherapy
C1418674;Inflammatory Bowel Diseases
C2744535;Malignant neoplasm of kidney
C0277545;Patients
C0278883;bevacizumab
C0277552;Patients
C1443643;Multiple Myeloma
C0277554;primary disorders
C0277553;Idiopathic disease
C0337664;Microsatellite Instability
C0034573;AIR FLUID LEVEL (finding)
C0699967;Taxotere
C1831808;rivaroxaban
C4054580;Patients
C1285158;Unresectable Malignant Neoplasm
C1514402;Operative Surgical Procedures
C0033246;regorafenib
C2829932;Malignant neoplasm of gastrointestinal tract
C3849511;ANGPT2 protein human
C0277556;Chemotherapy Adjuvant
C0277555;Secondary disease NOS
C3825589;Diagnosis clinical
C0277565;Patients
C0277564;Acquired disease
C0034561;Recombinant Human Epidermal Growth Factor
C0045214;Angiogenic Process
C1285162;Degenerative disorder
C0337672;Malignant Neoplasms
C0010583;bevacizumab
C1420702;WFDC2 protein human
C1420701;Body tissue
C1420708;Cultured Cell Line
C0022567;matriptase
C0021236;tryptophan analog
C0023896;Italians
C1420706;Colonic mucous membrane
C0021234;Nodule of liver
C0023895;Digestive System Disorders
C0008269;Antimalarials
C0045206;Adenosine
C0023890;Colonic varices
C2936452;Patients
C0023891;Performance
C0238124;Abdomen
C0033228;HT29 Cells
C1879915;Patients
C0010590;Interleukin-12
C0227481;Secondary malignant neoplasm of liver
C0034541;Patients
C1419727;Methyl-CpG-Binding Protein 2
C4054774;High-performance Liquid Chromatography-UV
C0021246;Pancreatic stent
C0914594;Cytoplasm
C4319834;Leukemia Myelocytic Acute
C0687670;29+
C1420716;Eosinum eosin Homeopathic preparation
C1384515;Multiple polyps
C4524855;Patients
C0952877;SODIUM THIOGLYCOLATE
C0061704;Bile Acids
C0021242;Tumor cells uncertain whether benign or malignant
C0033213;World
C4042794;recurrent prostate cancer
C3887624;Multiple tumors
C0253754;Alamar Blue
C1418401;Advanced Malignant Solid Neoplasm
C0193594;Communicable Diseases
C0008240;rosoxacin
C1418403;Malignant Neoplasms
C1418404;PDCD4 gene
C0034530;Lung
C0023875;Th17 Cells
C1420728;Embryonic Development
C0021212;Laxatives
C0022548;Patients
C1829645;Hydrolysis
C0240421;Woman
C2936470;Interventional procedure
C0673013;Proto-Oncogene Proteins c-akt
C0673011;Homo sapiens
C0021210;Malignant tumor of colon
C0034533;Whole-Abdominal Irradiation
C0238106;Molecular Imaging
C3887634;Anastomotic Leak
C0033204;Probability
C2936478;Cold Plasma
C0035869;Child
C0034538;Migration Cell
C1419743;Phosphorylation
C1419746;Colorectal Carcinoma
C0939895;CXCR4 Receptors
C0009586;Intervention regimes
C3887642;Extracellular Vesicles
C0444498;Cytotoxic T-Lymphocytes
C0023885;Liver Abscess Pyogenic
C4524837;Malignant Neoplasms
C0023884;Laceration
C3899629;Dyes
C1419741;HT29 Cells
C0673026;Prominin-1 human
C0455142;Patients
C0949216;Small bowel obstruction
C0180279;Cell Count
C0949219;Patients
C1817666;Relative (related person)
C0034525;Curcumin
C0238115;Boerhaave syndrome
C0337920;Neoplasms
C0060400;Antibiotics
C4524824;Dysplasia
C0009555;Disease Progression
C0085704;Hernia
C0009556;Screening procedure
C4524827;Cohort
C2936494;MicroRNAs
C0265783;Syndrome
C2985420;TNFRSF9 gene
C0949266;Patients
C2936499;Gastrectomy
C1166607;Inflammasomes
C0034510;Racial group
C1334229;Intestinal Intraepithelial Neoplasia
C0011882;Diabetic Neuropathies
C1143976;macrophage
C0443147;Family
C0009566;Postoperative Hemorrhage
C2985436;Apoptosis
C2985438;Transformation function
C2985439;Cell Count
C3825392;Duplex ultrasonography
C0877071;Control Groups
C0073716;rutecarpine
C0011884;Diabetic Retinopathy
C0010558;Pharmaceutical Preparations
C0686377;Neoplasms
C1142652;Cytomegalovirus
C1335532;multiple pathologies
C1336860;Undifferentiated Malignant Neoplasm
C0008203;Pharmaceutical Preparations
C0058108;mitochondrial toxicity
C2371925;Patients
C0699680;MicroRNA Gene
C0180249;Injury of intestine
C0059438;Fluorouracil
C1311561;Cell Survival
C1336869;Gastrointestinal tract reconstruction
C0011860;Gastrointestinal sequelae of disorders
C0769218;Caco-2 Cells
C1384573;Rectal Carcinoma
C4078701;Feeling suicidal (finding)
C0061764;Intestines
C1419703;Tumor cells malignant
C1419705;Cell Proliferation
C0337954;Biopsy of prostate
C0444454;Cytotoxic T-Lymphocytes
C0455107;Injection of heart
C0432487;early identification
C1155964;protrusion
C0674396;rosoxacin
C0432485;Patients
C1155966;Cell Shape
C0072402;Hypoxia
C1831994;Liver and Intrahepatic Biliary Tract Carcinoma
C1831992;PMAIP1 gene
C0085741;BECN1 wt Allele
C0215407;Catenins
C0060444;Flavonols
C0023810;interleukin-6 production
C0058126;Colorectal Neoplasms
C1565860;Dinoprostone
C1335519;Adenocarcinoma
C1336848;Cancer Cell Growth
C0035804;topiramate
C0023828;Biologic Development
C0023827;Liposarcoma Dedifferentiated
C0940824;Endoscopy (procedure)
C0085732;Augmentation procedure
C0085733;Pain Intractable
C0023821;macrophage
C0023820;Lipoproteins
C0009521;Neutrophil Extracellular Traps
C0023824;Patients
C0009528;Patients
C0023822;NF2 gene
C0600047;Patient counseling
C0865016;Carcinomatosis secondary
C0865015;Peritoneum
C0011847;Liver Cirrhosis Alcoholic
C0011849;Negative
C1384593;Screening procedure
C0203418;Thickened
C1095785;Polysaccharides
C1563226;Patients
C0072453;Proto-Oncogene Protein c-met
C0011816;toll-like receptor 4 signaling pathway
C0083104;Diarrhea
C0202118;Care setting
C1336827;Tropical Disease
C0085756;reception
C0193504;Patients
C1865377;Small lymph nodes
C0023801;Intestines
C0071112;Adenocarcinoma
C2936405;Neoplasms
C0059497;polyphenols
C3887654;Negative
C0085786;CDKN2B-AS1 gene
C0084455;Glycolysis
C4331504;Dysbiosis
C1176007;DNA Damage
C0227435;Malignant Neoplasms
C4283742;Ceramide Glucosyltransferase human
C0072470;Anal Gland Neoplasms
C2262744;lipid homeostasis
C0542565;Patients
C0600015;Health Care
C2936411;Lithocholic Acid
C0914559;Plasma
C1880945;statistical cluster
C0240417;Patients
C0194810;recurrent prostate cancer
C0542559;Community
C1565830;Cancer-Associated Fibroblasts
C0072461;Malignant Neoplasms
C0072460;Cancer Cell Growth
C0940836;functional measurement
C0879615;Jejunum
C0143251;Tumor Progression
C0227414;Human papilloma virus infection
C3272410;Adenocarcinoma
C0227411;Multiple lesions
C0058187;Aberrant Crypt Foci
C0301944;Rectal Carcinoma
C0194804;Tertiary care hospital
C1176020;Edema
C1622116;Proteolysis
C2321625;Patients
C0481430;Woman
C2924460;Patients
C3887684;LATS2 gene
C3887681;Tissue specimen from colon
C3887682;Fatty deposition
C2611689;IGF2BP2 gene
C0879626;Metastatic melanoma
C0227423;Distal margin
C1539599;PINK1 gene
C0072486;Alkaloids
C0144576;Ascites
C0940841;polyps
C0940842;Complete excision
C1565900;Growth
C1709883;Malignant neoplasm of transverse colon
C0084484;Microfilaments
C0854404;Ureter
C2826380;Chemoembolization
C0565255;Locally Advanced Malignant Neoplasm
C0795585;Bee pollen
C1708566;Male population group
C0386983;glypican 3
C0577256;Patients
C0311395;Patients
C1707252;Genetic Translation Process
C2826346;Stent device
C2826345;Interventional procedure
C0311392;Blood Vessel
C1515657;Xenograft procedure
C1515655;Cells
C0853109;colonoscopy
C0071196;tissue-factor-pathway inhibitor 2
C0347390;Standard of Care
C0145988;Colorectal Carcinoma
C2598145;Colorectal Carcinoma
C1707257;Microsatellite instability-high colorectal cancer
C0311375;Toxic effect
C1417051;Malignant tumor of colon
C1417052;Uveal melanoma
C0334092;Persons
C4076075;Perforation of small intestine
C0334094;Assay
C0334097;Prebiotics
C1709846;BECN1 wt Allele
C1853292;Conventional (Clear Cell) Renal Cell Carcinoma
C1418392;Ruminococcus
C1515670;Metabolism
C1010861;Alkaloids
C3501843;Non-medullary thyroid carcinoma
C3501844;Malignant neoplasm of endocrine gland
C1516998;Screening procedure
C1095830;Colorectal Carcinoma
C2140250;Patients
C1709854;Recipient
C1444662;Disease
C0204732;Patients
C0915830;midostaurin
C1709868;Rectal mass
C4329281;bevacizumab
C1513038;Prospective Studies
C0203408;Cyst
C1539620;Biologic Development
C3258060;Primary sign and symptom
C1538309;Protein Isoforms
C1538301;ATXN3 gene
C1622067;Adenocarcinoma
C1417092;ME1 gene
C0145947;Intercellular adhesion molecule 1
C0204727;Dysentery
C0145946;Adenocarcinoma
C0664965;Tight Junction Proteins
C1421999;Elevation procedure
C3272399;Gastric Neuroendocrine Tumor
C1419676;PRDX2 gene
C2986793;Parametric Image
C0033173;colonoscopy
C0033176;Private Sector
C1419683;FOXO3 gene
C1429002;SGO2 gene
C0238093;Primary operation
C1456639;Cancer--Living with Cancer
C1444656;Physicians
C0664945;Mucins
C1417039;Malignant Neoplasms
C4511497;AKR1A1 wt Allele
C1417032;Low grade glioma
C1143949;PMAIP1 gene
C1429015;Patients
C0431123;Solitary neurofibroma
C0238062;inhibitors
C1420699;Phosphogluconate Dehydrogenase
C1417049;MBD1 gene
C0334003;Glandular and muscular hyperplasia
C0133938;Oncogene Proteins
C1418377;PCNAP1 gene
C1167909;T-Cell Surface Glycoprotein CD4 human
C1417050;Multiple tumors
C1420690;Malignant tumor of colon
C1420622;Patients
C0034471;CD274 protein human
C1419637;TFEB gene
C2826325;Implantation procedure
C1418308;MYL2 gene
C0033144;Vaccination
C3826770;Older people
C1516924;Carcinogenesis
C1286104;Dietary Assessment
C0033147;Primates
C1831940;TMEM173 gene
C0278987;inhibitors
C0747742;Appendix
C0746412;Eye lid
C0033131;Primary Care Physicians
C1421968;Pancreatic carcinoma
C1420636;Neoplasms
C1334294;Cohort
C0021167;6/5
C1420639;Ubiquitination
C1419640;Colorectal Carcinoma
C1997217;MARCO gene
C0962190;fluorescein isothiocyanate dextran
C0033137;Interventional procedure
C0278996;Squamous cell carcinoma of the head and neck
C1420645;Colonization
C0009492;Pain
C0010481;ACTH Syndrome Ectopic
C1421974;Pharmaceutical Preparations
C0334037;Endometriosis of appendix
C1420648;PPARA gene
C0009498;Complement System Proteins
C0334038;Patients
C0334039;SATB2 gene
C0746405;Ultrasound examination
C0023798;Benign Neoplasm
C0023796;Lipolysis
C0723760;Pharmaceutical Preparations
C0433745;Injury of rectum
C0577294;Woman
C1419653;Ubiquitination
C0023791;Wound Healing
C0746408;Wall of rectum
C1831920;sorafenib
C0334044;HPV-High Risk
C1831914;Extramural vein invasion
C1417005;Cultured Cell Line
C1334278;Patients
C0334048;removal technique
C1334274;Malignant Neoplasms
C1419663;RPL34 gene
C0334040;Malignant tumor of colon
C1457907;Rectum
C2985490;Pain
C0033117;Edema
C3840882;colonoscopy
C0008145;Mammals
C1420828;N-Cadherins
C0023776;Fluorides
C0023775;phenolic acid
C1420827;Tumor tissue sample
C0021113;Artificial Implants
C2985505;Health Care Systems
C2985506;Magnetic Resonance Imaging
C0227598;Adenocarcinoma Clear Cell
C0023779;Lipid Metabolism
C1155873;Mus
C1155872;Growth
C4318618;Stomach Carcinoma
C1155874;RNA methylation
C0010467;Effects of radiation
C0034435;thymoquinone
C0251223;Melatonin
C0033109;Survivors
C1167841;obesity surgery
C3840892;Day 4
C3658706;Catastrophic antiphospholipid syndrome
C0301818;Isomerase
C1419846;Immune Cell
C0192398;gastric adenoma
C0022457;Malignant neoplasm of pancreas
C0009488;Drug problem
C4319954;Prostaglandin I2 Metabolite
C0023786;cell growth
C4522312;Tissue Adhesions
C0759922;Cell Death
C0023783;Neoplasms
C0241898;Woman
C0759923;Cell Death
C3887509;Rabbits
C0238258;Intestines
C0034428;Colorectal Carcinoma
C1384665;Carcinogenesis
C3164626;CDKN2A gene
C1384666;hearing impairment
C1333034;Chronic Cancer Pain
C0009450;Zoonoses
C1334363;melanoma
C1333030;DNA Repair
C3852849;Receptor Protein-Tyrosine Kinases
C1335690;CD69 protein human
C2960226;Malignant neoplasm of descending colon
C0022423;Patients
C0227579;Macrophage Activation Syndrome
C1418520;PGP gene
C0241880;Gynecologic Surgical Procedures
C0431085;Membrane bound regulatory protein
C4296962;Stomach
C0241889;First Degree Relative
C0431080;colonoscopy
C0011777;CYP1A2 gene
C3887515;iatrogenic injury
C2936599;Observation parameter
C0034414;AKR1B10 gene
C3840862;Patients
C1335688;removal technique
C1417203;Tumor Cell Invasion
C1335685;Male population group
C1335686;Child
C1419866;Cytoplasm
C0227582;Macrophage Activation Syndrome
C1335683;Patients
C0009462;Melinda
C1417208;MMP20 gene
C0685110;Colon Carcinoma
C1335680;Leukocyte L1 Antigen Complex
C0023764;Lipase
C0021102;Erectile dysfunction
C0021107;Mice Nude
C1418531;Malignant tumor of colon
C1624602;invasive growth
C0252527;Colorectal Carcinoma
C1816452;mitochondrial depolarization
C1335676;Mus
C0445673;Granulicatella adiacens
C2985546;bevacizumab
C0879593;ERBB3 Receptor Protein-Tyrosine Kinase
C0023730;Retrospective Studies
C0085826;SERPINE1 gene
C0009437;Common bile duct structure
C0506994;Mucous body substance
C0085828;Transcription Factor AP-1
C0060527;Mus
C3825288;Mammalian Cell
C4041537;Pain
C4042860;Reporting
C0277814;MIR145 gene
C1335678;Local excision
C0747919;Colorectal Carcinoma
C0192352;Patients
C0023749;Linoleic Acid
C0059541;Adult Fanconi syndrome
C0337810;Colitis
C1384672;HPT gene
C0531946;Crohn Disease
C1334331;FBXW10 gene
C0337812;Norwegians
C1419805;Ovum
C0192353;Control Groups
C0009442;Common Bile Duct Neoplasms
C0008114;Skin Ulcer
C0023743;Autopsy
C0009447;Malignant neoplasm of gastrointestinal tract
C2960235;Inflammation
C0022417;Cyst
C3825277;Overweight persons
C4042879;Purines
C4042877;patient care
C0058218;high-risk group
C4319914;N(6)-methyladenosine
C2984223;Weakness
C4042875;Neoplasms
C4247991;Neoplasms
C0035711;Sessile Lesion
C0518989;Thickened
C1335651;Ulcer
C1744278;fluorocholine
C0009410;Obstruction
C1419815;Neuroendocrine Tumors
C0085845;Intestinal Mucosa
C0061878;Granzyme K
C1298180;tomography
C1420806;Helper-Inducer T-Lymphocyte
C2986858;Primary peritoneal carcinoma
C0085846;Pelvic swelling
C4524926;Metastatic Gastrointestinal Carcinoma
C0009417;Colposcopy
C0010408;Therapeutic immunosuppression
C1309370;Rattus norvegicus
C1419818;Laboratory Procedures
C0166059;Functional disorder of intestine
C0035701;EIF2AK4 gene
C0010405;Cryopreservation
C0010404;Cryoglobulins
C0010403;Cryoglobulinemia
C0194992;Malignant neoplasm of ascending colon
C1335643;KRAS NP_004976.2:p.G12C
C1311699;Pharmaceutical Preparations
C0059563;cytochrome P450 3A
C1419822;Non-Small Cell Lung Carcinoma
C1420813;Chimeric Antigen Receptor T-cells
C0059565;Cells
C1420811;Liver carcinoma
C2985535;Secondary Neoplasm
C2960259;Patients
C1420817;Gastrointestinal tract reconstruction
C1420816;Patients
C2986868;soluble
C0023726;Lincomycin
C0058231;STIL wt Allele
C0009429;Did not receive therapy or drug for
C0263214;FDG-Positron Emission Tomography and Computed Tomography Scan
C0010418;Cancer Patient
C4319935;Malignant neoplasm of pancreas
C0699790;Incarcerated Inguinal Hernia
C0072523;Paraffin Embedded Tissue
C0181687;loops
C0699791;Severe (severity modifier)
C1335648;Hereditary Leiomyomatosis and Renal Cell Cancer
C1334314;KRT19 gene
C1336963;Villous Neoplasm
C3887572;Malignant neoplasm of gastrointestinal tract
C1336960;Very Low Risk Gastrointestinal Stromal Tumor
C0541315;Clinical Trials
C0879554;Patients
C0059570;Visceral Pain
C1538115;Cohort
C1853490;Child
C3898222;ano-rectal
C3898221;advanced disease
C4042823;Animals Exotic
C1334307;Real-Time Polymerase Chain Reaction
C1538110;Mice Nude
C0384156;Tumor cells malignant
C1165265;Pharmaceutical Preparations
C3887582;TCFL5 gene
C0204864;colorectal resection
C0227525;peptide hormone
C1082338;Fabaceae
C0009402;Cancer Cell Growth
C0009404;Tissue Donors
C0084529;Mus
C0009407;Cell Count
C0301896;Doxorubicin
C0071216;Matrix Metalloproteinase 2
C3850290;Control Groups
C1335625;Mus
C2936506;Livestock
C1335623;Mus
C1335624;Ubiquitination
C0085880;Persons
C3887595;Protoplasm
C0385463;Mammary Gland Parenchyma
C0770114;Methylation
C0555980;Foot problem
C0301869;ferric oxide
C0373483;Drug screen (procedure)
C0154061;Patients
C0300533;CD97 Antigen
C1539429;Cancer-Associated Fibroblasts
C0179323;Insertion of pack into vagina
C1539428;Tumor Progression
C4042840;RAW 264.7 Cells
C1335616;Malignant tumor of colon
C0083220;deslorelin
C0193621;Adenoma of ampulla of Vater
C0580939;Practitioner
C0301872;Hyperglycemia
C0565313;Stomach Neoplasms
C1096984;Patients
C2346836;Patients
C1335607;oxaliplatin
C0011702;Desmosine
C0011703;keratinocyte
C2936529;NLRP6 gene
C3272517;SLC28A1 wt Allele
C0194941;En Bloc Resection
C0072591;Cell Proliferation
C0241863;Screening procedure
C0600139;Prostate feature
C0179302;Study
C3887537;Partner
C0241868;acute aortic dissection
C1538153;Proteins
C1336921;inhibitors
C2309860;Crataegus
C3899527;Has difficulty doing (qualifier value)
C0058298;Colitis
C2974829;Growth retardation
C0071253;Metastatic Renal Cell Cancer
C0181620;Hoist device
C0182953;Aggr
C1541792;Leukopenia
C0301821;colon growth
C0915798;Matrix Metalloproteinase 2
C3887559;Liver Cirrhosis
C1336905;Tumor tissue sample
C1538131;Neoplasms
C1538132;Immunity
C0455052;Polyethylene glycol electrolyte solution
C1538134;Binding Sites
C0555952;Cell Line Tumor
C0530678;general population
C3272528;Syndrome
C0203597;Neoplasms
C0301838;Ovum
C1179889;tacrolimus binding protein 4
C0566602;Cholestatic liver disease
C4042807;Retrospective Studies
C1179885;Cancer invasiveness
C1539479;treatment failure
C1154599;Intestinal Microbiome
C0169975;Malignant neoplasm of stomach
C1539477;FAS gene
C1538145;Mesothelioma
C0336598;Vascular device
C2826244;Life Threatening
C2611772;autophagosome assembly
C0600209;Polyacrylamide Gel Electrophoresis
C0806692;Pelvis
C0311273;Patients
C0311277;Persons
C1999727;1-methyltryptophan
C0817321;Macrophage Activation Syndrome
C0347266;Polyp of duodenum
C1948124;Patients
C0312594;Antigens Neoplasm
C2608114;Cerebral Infarction
C0590323;Gauzes
C0868945;Liver Failure
C1455498;TYRP1 protein human
C1516857;Serous Endometrial Intraepithelial Carcinoma
C0347272;Patients
C0347271;Patients
C0589347;Age
C0045093;docetaxel
C1417178;RNA Untranslated
C1528871;Galactosylceramides
C2826293;Colonic Neoplasms
C1539524;Malignant Neoplasms
C1539525;Malignant Neoplasms
C0577304;Syndrome
C1417189;TP53 gene
C1516879;Cohort
C1514216;bergenin
C3489630;Patients
C3489631;Cervical carcinoma stage IIB
C0577305;African race
C1707312;Bromelains
C1539531;Colorectal Carcinoma
C1444783;Cytidine Deaminase
C1707313;Caspase-Independent Apoptosis
C1539503;LATS2 gene
C1514248;Post-Transcriptional Regulation
C1720301;Streptococcus gallolyticus subspecies gallolyticus
C0758584;stanniocalcin 2
C0312555;Neoplasms
C2826279;Patients
C0868908;Patients
C1541822;Vaginal delivery procedure
C1514235;Interventional procedure
C1539512;Malignant tumor of colon
C1539518;FLCN gene
C0384228;Rattus norvegicus
C2936606;Drug Packaging
C1706005;CD40LG wt Allele
C1419799;SAA1 gene
C0034392;Cancer Cell Growth
C1419790;S100 Calcium Binding Protein beta Subunit
C0021079;Mammary Ductal Carcinoma
C1418465;PER2 gene
C0949073;Woman
C1418466;Genes
C0021073;Pulmonary Fibrosis
C0264490;Intubation
C4522286;Colorectal Carcinoma
C0120715;tumor growth
C1718097;Lung Neoplasms
C3840922;40-49
C0420338;Follow-up 1 year
C1299575;Patients
C2697961;Anchoring procedure
C0746574;Patients
C0949083;Septic Shock
C0021084;Epidermal Growth Factor Receptor
C0288472;Colon Carcinoma
C0021083;Outpatients
C3826603;Cell metabolism
C0021081;Azathioprine
C1299586;colonoscopy
C1418489;Monocytes
C0033046;Genetic Variation Analysis
C0021059;Immunity
C1418482;CFP gene
C1418483;FILIP1L gene
C3489624;Malignant Neoplasms
C1417154;Anna
C1418488;Patients
C0021051;Virus
C2985560;Yttrium-90 microspheres
C2985562;Radiotherapy Adjuvant
C0021055;Mouse Model
C0458922;Neoplasm Metastasis
C0021053;toll-like receptor 4 signaling pathway
C2985566;Unresectable Malignant Neoplasm
C0021054;cytokine
C0687707;Colorectostomy
C0035693;Sf9 Cells
C0035691;Gastroenteritis
C0445623;Disease
C0035696;ING1 gene
C0419358;Colonic Polyps
C1417163;Arteriosclerosis
C0021069;chromatin immunoprecipitation
C0746552;Mesenteric lymphadenopathy
C4522252;Turcot syndrome (disorder)
C0238196;Targeted Therapy
C0238198;Genitourinary Neoplasms
C0949059;Middle Aged
C0033036;CD69 protein human
C3491920;Pharmacologic Substance
C1420744;vitexin
C1298200;Patients
C4510264;Adenocarcinoma of lung stage IV
C1419759;Woman
C1333097;Neuroendocrine Tumors
C1333096;Crohn Disease
C0034354;Colorectal Carcinoma
C1444716;Injury wounds
C1333093;Colon Leiomyosarcoma
C0022369;JC Virus
C0699749;Tetranitromethane
C0023692;Ligation
C1516801;Electrospray Ionization
C0023690;Carcinoid tumor of rectum
C1817756;Radical excision
C0021031;Malignant Neoplasms
C0021032;Immunoglobulin Fc Fragments
C4040167;Growing Teratoma Syndrome
C0035687;RNA Splicing
C1298201;Massive gastrointestinal bleed
C0008073;Developmental Disabilities
C0277785;Postoperative ileus
C0033011;Pregnant Women
C0010395;Subphylum Crustacea
C0034343;Oxidative Stress
C1333087;Neoplasms
C1333082;Colon Adenosquamous Carcinoma
C0022378;Varicosity
C0673129;Body tissue
C1417102;Transcription Genetic
C0021044;Cancer Cell Growth
C0022374;ileum
C0035678;DNA Damage
C0034348;Muscle Proteins
C0277786;Intestines
C0687759;traveler
C1420765;Adenomatous Polyposis Coli
C1420764;TM4SF4 gene
C0009373;polyphenols
C0009375;Acetaldehyde
C1418449;Secondary malignant neoplasm of liver
C0036992;Patients
C0009376;Endoscopic mucosal resection
C0022346;Physicians
C0009378;Varicosity
C1419771;moesin
C0023676;Lifestyle changes
C1418440;Cultured Cell Line
C1419772;Stage III Colon Cancer
C1516828;Nitric Oxide
C1706077;user - individual
C0035668;WTAP gene
C0011696;Neoplasms Fibrous Tissue
C3840940;Elderly (population group)
C1419788;Infiltration
C0036983;Pelvic abscess
C0034320;Diphosphates
C0036982;Cessation of life
C0008059;Disease
C0023689;Insulin Resistance
C0021027;Chemoradiotherapy
C0023688;Urease
C1419786;Pharmaceutical Preparations
C0022359;Infantile Neuroaxonal Dystrophy
C1384617;LEF1 gene
C0588055;Neoplasm Metastasis
C0674432;Carcinoma Lobular
C0023685;Complete excision
C0022354;Secondary Neoplasm
C0010377;Pre-operative chemotherapy
C0034325;Heterocyclic Compounds
C0588054;Accumulation
